sampleID	_EVENT	_INTEGRATION	_OS	_OS_IND	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_treatment_completion_success_outcome	adjuvant_rad_therapy_prior_admin	age_at_initial_pathologic_diagnosis	age_began_smoking_in_years	agent_total_dose_count	bcr_followup_barcode	birth_control_pill_history_usage_category	brachytherapy_administered_status	brachytherapy_first_reference_point_administered_total_dose	brachytherapy_method_other_specify_text	brachytherapy_method_type	cervical_carcinoma_corpus_uteri_involvement_indicator	cervical_carcinoma_pelvic_extension_text	cervical_neoplasm_pathologic_margin_involved_text	cervical_neoplasm_pathologic_margin_involved_type	chemotherapy_negation_radiation_therapy_concurrent_adminstrd_txt	chemotherapy_negation_radiation_therapy_concurrnt_nt_dmnstrd_rsn	chemotherapy_regimen_type	clinical_stage	concurrent_chemotherapy_dose	days_to_birth	days_to_brachytherapy_begin_occurrence	days_to_brachytherapy_end_occurrence	days_to_chemotherapy_end	days_to_chemotherapy_start	days_to_collection	days_to_death	days_to_diagnostic_computed_tomography_performed	days_to_diagnostic_mri_performed	days_to_fdg_or_ct_pet_performed	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	days_to_performance_status_assessment	days_to_performance_status_follow_up_score	days_to_radiation_therapy_end	days_to_radiation_therapy_start	death_cause_text	diagnostic_ct_result_outcome	diagnostic_mri_result_outcome	dose_frequency_text	eastern_cancer_oncology_group	ectopic_pregnancy_count	external_beam_radiation_therapy_administered_status	external_beam_radiation_therapy_administrd_prrtc_rgn_lymph_nd_ds	fdg_or_ct_pet_performed_outcome	female_breast_feeding_or_pregnancy_status_indicator	followup_case_report_form_submission_reason	form_completion_date	gender	height	histological_type	history_of_neoadjuvant_treatment	human_papillomavirus_laboratory_procedure_performed_name	human_papillomavirus_laboratory_procedure_performed_text	human_papillomavirus_other_type_text	human_papillomavirus_type	hysterectomy_performed_text	hysterectomy_performed_type	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	keratinizing_squamous_cell_carcinoma_present_indicator	lost_follow_up	lymph_node_examined_count	lymph_node_location_positive_pathology_name	lymph_node_location_positive_pathology_text	lymphovascular_invasion_indicator	menopause_status	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_post_initial_therapy_diagnosis_method_text	new_neoplasm_event_post_initial_therapy_diagnosis_method_type	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	number_of_successful_pregnancies_which_resultd_n_t_lst_1_lv_brth	number_pack_years_smoked	oct_embedded	oligonucleotide_primer_pair_laboratory_procedure_performed_name	other_chemotherapy_agent_administration_specify	pathologic_M	pathologic_N	pathologic_T	pathology_report_file_name	patient_death_reason	patient_history_immune_system_and_related_disorders_name	patient_history_immune_system_and_related_disorders_text	patient_pregnancy_spontaneous_abortion_count	patient_pregnancy_therapeutic_abortion_count	percent_lymphocyte_infiltration_BOTTOM	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_BOTTOM	percent_monocyte_infiltration_TOP	percent_necrosis_BOTTOM	percent_necrosis_TOP	percent_neutrophil_infiltration_BOTTOM	percent_neutrophil_infiltration_TOP	percent_normal_cells_BOTTOM	percent_normal_cells_TOP	percent_stromal_cells_BOTTOM	percent_stromal_cells_TOP	percent_tumor_cells_BOTTOM	percent_tumor_cells_TOP	percent_tumor_nuclei_BOTTOM	percent_tumor_nuclei_TOP	performance_status_assessment_timepoint_category_other_text	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	pregnancy_stillbirth_count	primary_lymph_node_presentation_assessment	primary_therapy_outcome_success	prior_dx	radiation_therapy	radiation_therapy_not_administered_reason	radiation_therapy_not_administered_specify	radiation_type_notes	residual_disease_post_new_tumor_event_margin_status	rt_administered_type	rt_pelvis_administered_total_dose	sample_type	sample_type_id	standardized_uptake_value_cervix_uteri_assessment_measurement	stopped_smoking_year	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tobacco_smoking_history	total_number_of_pregnancies	tumor_response_cdus_type	tumor_tissue_site	vial_number	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_CESC_mutation_broad_gene	_GENOMIC_ID_TCGA_CESC_RPPA	_GENOMIC_ID_TCGA_CESC_mutation_bcgsc_gene	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2	_GENOMIC_ID_TCGA_CESC_gistic2	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_CESC_hMethyl450	_GENOMIC_ID_TCGA_CESC_miRNA_HiSeq	_GENOMIC_ID_TCGA_CESC_mutation_ucsc_maf_gene	_GENOMIC_ID_TCGA_CESC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_CESC_GSNP6noCNV	_GENOMIC_ID_TCGA_CESC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_CESC_GSNP6raw	_GENOMIC_ID_TCGA_CESC_mutation_ucsc_vcf_gene	_GENOMIC_ID_TCGA_CESC_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_CESC_PDMRNAseq	_GENOMIC_ID_TCGA_CESC_gistic2thd	_GENOMIC_ID_TCGA_CESC_mutation
TCGA-2W-A8YY-01		TCGA-2W-A8YY-01			TCGA-2W-A8YY				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer																												93																																									120	NO																				true						TCGA-2W-A8YY.C24A4F00-23CD-44A4-B8B3-580A9CEAB16A.pdf							30		20		10		30		0		20		70		70																Primary Tumor	01												A					C29F674F-5572-4F11-9AA4-8D7F7464BE44		3be9f1e8-94ae-476e-b146-38385d130f38	TCGA-2W-A8YY-01A-11D-A37M-01	3be9f1e8-94ae-476e-b146-38385d130f38	TCGA-2W-A8YY-01A-11D-A37Q-05	TCGA-2W-A8YY-01A-11R-A37P-13		TCGA-2W-A8YY-01	3be9f1e8-94ae-476e-b146-38385d130f38	b4312865-b1fd-430e-a78c-b99184cb67bc	3be9f1e8-94ae-476e-b146-38385d130f38	b4312865-b1fd-430e-a78c-b99184cb67bc			TCGA-2W-A8YY-01	TCGA-2W-A8YY-01A-11D-A37M-01	
TCGA-4J-AA1J-01	0	TCGA-4J-AA1J-01	377	0	TCGA-4J-AA1J	377	0	377	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		31			TCGA-4J-AA1J-F67415	Never Used		40		HDR	ABSENT	no extention						Stage IB2		-11640					51					0	377			377								0	0						2014-11-13	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Non-keratinizing squamous cell carcinoma	NO	15			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		4		false			M0	N0	T1b2	TCGA-4J-AA1J.A052742F-3CD5-4881-B004-A7E13ECDC9C2.pdf				0	0		5		0		5		0		5		20		70		70		Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	NO	YES	NO	4J	Lifelong Non-smoker	4		cervical	A	LIVING	48	2013		4EE077A4-25B8-4C6B-B0D3-06301827E402		9d09804a-304a-4f05-af84-af513c97f3ed	TCGA-4J-AA1J-01A-21D-A386-01	9d09804a-304a-4f05-af84-af513c97f3ed	TCGA-4J-AA1J-01A-21D-A388-05	TCGA-4J-AA1J-01A-21R-A38M-13		TCGA-4J-AA1J-01	9d09804a-304a-4f05-af84-af513c97f3ed	21cb455d-7f93-43fc-b985-a449d7688eae	9d09804a-304a-4f05-af84-af513c97f3ed	21cb455d-7f93-43fc-b985-a449d7688eae			TCGA-4J-AA1J-01	TCGA-4J-AA1J-01A-21D-A386-01	
TCGA-BI-A0VR-01	0	TCGA-BI-A0VR-01	1505	0	TCGA-BI-A0VR			1505	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					53	22								PRESENT							Stage IIIB		-19473					1554		15			0	1505								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent				1				NO		2011-4-1	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	100	NO	Non-keratinizing squamous cell carcinoma		43	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3								1		0	20	true			M0	N1	T2b	TCGA-BI-A0VR.BA4A1AA9-C1C7-4F84-A375-02B51FB95494.pdf				2		40	60	5	10	5	10	50	20	0	0	25	20	70	70	70	70			TUMOR FREE		3			No								Primary Tumor	01		1995			NO	YES	BI	Current reformed smoker for < or = 15 years	6		cervical	A	LIVING		2006	TCGA-BI-A0VR-01A-11D-A10S-08		TCGA-BI-A0VR-01A-11D-A10S-08	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01A-11D-A10T-01	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	TCGA-BI-A0VR-01A-11D-A10W-05	TCGA-BI-A0VR-01A-11R-A10V-13	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	6a0edb0b-76ed-4652-b265-1c7593a82a6b	73bf920b-b9dc-4f81-b57a-63ebebccf9cd	6a0edb0b-76ed-4652-b265-1c7593a82a6b	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01A-11D-A10S-08	TCGA-BI-A0VR-01	TCGA-BI-A0VR-01A-11D-A10T-01	TCGA-BI-A0VR-01A-11D-A10S-08
TCGA-BI-A0VS-01	0	TCGA-BI-A0VS-01	1735	0	TCGA-BI-A0VS	1735	0	1735	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		48			TCGA-BI-A0VS-F34079													Stage IB		-17839							12		12	0	1735								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO		2012-7-29	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)			Non-keratinizing squamous cell carcinoma	NO	8	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0						M0	N0	T1b1					0	0																			TUMOR FREE	NO	0		Complete Remission/Response	No	NO							Primary Tumor	01				NO	NO	YES	BI	Current smoker			cervical		LIVING		2007	TCGA-BI-A0VS-01A-11D-A10S-08		TCGA-BI-A0VS-01A-11D-A10S-08	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01A-11D-A10T-01	a57566b4-dd26-46bd-a00f-82136bc2a9be	TCGA-BI-A0VS-01A-11D-A10W-05	TCGA-BI-A0VS-01A-11R-A10V-13	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01	a57566b4-dd26-46bd-a00f-82136bc2a9be	b71a6f02-3d0e-4dd4-8f33-0f5bb051ebee	a57566b4-dd26-46bd-a00f-82136bc2a9be	b71a6f02-3d0e-4dd4-8f33-0f5bb051ebee	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01A-11D-A10S-08	TCGA-BI-A0VS-01	TCGA-BI-A0VS-01A-11D-A10T-01	TCGA-BI-A0VS-01A-11D-A10S-08
TCGA-BI-A20A-01	0	TCGA-BI-A20A-01	462	0	TCGA-BI-A20A	462	0	462	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		49			TCGA-BI-A20A-F39615						PRESENT			Microscopic parametrial involvement				Stage IB1		-18215					218					0	462																		2013-1-28	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	60	NO	Non-keratinizing squamous cell carcinoma	NO	6			PRESENT		G3							NO	0		2		true			M0	N0	T1b1	TCGA-BI-A20A.FA32D74F-9855-489A-8217-F588682F96CE.pdf							40		10		10		30		0		20		70		70			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			7th		NO	YES	BI		2		cervical	A	LIVING	59	2010	TCGA-BI-A20A-01A-11D-A14W-08		TCGA-BI-A20A-01A-11D-A14W-08	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01A-11D-A14V-01	5015be4c-acad-4536-bb65-59696b168717	TCGA-BI-A20A-01A-11D-A14Z-05	TCGA-BI-A20A-01A-11R-A14X-13	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01	5015be4c-acad-4536-bb65-59696b168717	e7e675d2-8e97-4d25-854e-53fd491cf569	5015be4c-acad-4536-bb65-59696b168717	e7e675d2-8e97-4d25-854e-53fd491cf569	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01A-11D-A14W-08	TCGA-BI-A20A-01	TCGA-BI-A20A-01A-11D-A14V-01	TCGA-BI-A20A-01A-11D-A14W-08
TCGA-C5-A0TN-01	1	TCGA-C5-A0TN-01	348	1	TCGA-C5-A0TN	62	1	348	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	YES	Progressive Disease	YES	21			TCGA-C5-A0TN-F30748						ABSENT			Microscopic parametrial involvement				Stage IB2		-7760					4740	348		-2		0			62			57	47			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent				Treatment not completed				Scheduled Follow-up Submission	2012-4-16	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	surgery	Other method, specify:	170	NO	Keratinizing squamous cell carcinoma		10	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis/Liver		YES	2		1		true			MX	N1	T1b	TCGA-C5-A0TN.33FE7DA3-EDB0-4301-BA6A-C51B75312FCA.pdf	Cervical Cancer				3	30	30	0	10	0	5	20	20	0	0	5	5	95	90	95	90			WITH TUMOR			YES	Progressive Disease	No	YES					External beam radiation	1440	Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	4	Progression	cervical	A	DECEASED	55	1997	TCGA-C5-A0TN-01A-21D-A14W-08	40F6A1D0-844F-412D-94CF-5F5BA0FD62E5	TCGA-C5-A0TN-01A-21D-A14W-08	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01A-21D-A14V-01	edd006f4-1914-48b6-84d9-420a09dd82d1	TCGA-C5-A0TN-01A-21D-A14Z-05	TCGA-C5-A0TN-01A-21R-A14X-13	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01	edd006f4-1914-48b6-84d9-420a09dd82d1	e7a33b84-8a6a-4aba-befa-59ffde38bdb4	edd006f4-1914-48b6-84d9-420a09dd82d1	e7a33b84-8a6a-4aba-befa-59ffde38bdb4	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01A-21D-A14W-08	TCGA-C5-A0TN-01	TCGA-C5-A0TN-01A-21D-A14V-01	TCGA-C5-A0TN-01A-21D-A14W-08
TCGA-C5-A1BE-01	1	TCGA-C5-A1BE-01	2094	1	TCGA-C5-A1BE	1674	1	2094	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease	YES	64			TCGA-C5-A1BE-F30504		Completed as planned			HDR	PRESENT		Anterior lower uterine segment	Other Location, specify			Cisplatin	Stage IB2		-23727	65	90		84	3839	2094				0			1674			90	65						0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-11	FEMALE	149	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	40	NO	Non-keratinizing squamous cell carcinoma		38	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							YES	2		4		true			MX	N1	T1b		Cervical Cancer			1	1		15		0		0		1		0		40		60		60			WITH TUMOR		0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	C5	Current reformed smoker for > 15 years	6		cervical	B	DECEASED	76	2000	TCGA-C5-A1BE-01B-11D-A13W-08		TCGA-C5-A1BE-01B-11D-A13W-08	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01B-11D-A13V-01	8b82c786-64be-410a-89bf-d28dc8d7c4e9	TCGA-C5-A1BE-01B-11D-A13Z-05	TCGA-C5-A1BE-01B-11R-A13X-13	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01	8b82c786-64be-410a-89bf-d28dc8d7c4e9	2674376a-68fa-4ef4-9733-900db9a5cb78	8b82c786-64be-410a-89bf-d28dc8d7c4e9	2674376a-68fa-4ef4-9733-900db9a5cb78	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01B-11D-A13W-08	TCGA-C5-A1BE-01	TCGA-C5-A1BE-01B-11D-A13V-01	TCGA-C5-A1BE-01B-11D-A13W-08
TCGA-C5-A1BF-01	1	TCGA-C5-A1BF-01	570	1	TCGA-C5-A1BF	93	1	570	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	YES	Progressive Disease	YES	46			TCGA-C5-A1BF-F30729					HDR						Not done per treating physicians discretion		Stage IB		-16975					4992	570	13			0			93			69	26		Bladder Present|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent					Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-16	FEMALE		Cervical Squamous Cell Carcinoma	No				HPV 18			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Keratinizing squamous cell carcinoma		33					G1	Other, specify	CT/Core Biopsy	Other, specify	Distant Metastasis	Lung, Sternum		YES	0	0	4	30	true			MX	N0	TX	TCGA-C5-A1BF.45EC2A51-EDE1-44E9-8756-A094B998A68B.pdf	Cervical Cancer			1			15		1		5		3		0		30		65		70			WITH TUMOR			YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	NO	NO	YES	C5	Current smoker	5		cervical	B	DECEASED	76	1997	TCGA-C5-A1BF-01B-11D-A13W-08		TCGA-C5-A1BF-01B-11D-A13W-08	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01B-11D-A13V-01	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	TCGA-C5-A1BF-01B-11D-A13Z-05	TCGA-C5-A1BF-01B-11R-A13X-13	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	fd7d0f9b-6ecf-46f1-9aa0-c4d7c69fc3d8	5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc	fd7d0f9b-6ecf-46f1-9aa0-c4d7c69fc3d8	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01B-11D-A13W-08	TCGA-C5-A1BF-01	TCGA-C5-A1BF-01B-11D-A13V-01	TCGA-C5-A1BF-01B-11D-A13W-08
TCGA-C5-A1BI-01	0	TCGA-C5-A1BI-01	1112	0	TCGA-C5-A1BI	1112	0	1112	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	31	16	6	TCGA-C5-A1BI-F57886	Former User	Completed as planned			HDR							Cisplatin	Stage IIIB		-11564	62	74	74	27	3550		1		16	0	1112					74	27		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly		0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES	ECC	Other method, specify:	30	NO		YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			2	15	true										0	1		45		0		0		5		0		10		90		90			TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	4320	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	3		cervical	B	LIVING	59	2001	TCGA-C5-A1BI-01B-11D-A13W-08		TCGA-C5-A1BI-01B-11D-A13W-08	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01B-11D-A13V-01	cde3fda7-c23f-480b-bc20-ac27bcfe4536	TCGA-C5-A1BI-01B-11D-A13Z-05	TCGA-C5-A1BI-01B-11R-A13X-13	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01	cde3fda7-c23f-480b-bc20-ac27bcfe4536	53811af6-1334-4137-9142-6f43dc6e2ea0	cde3fda7-c23f-480b-bc20-ac27bcfe4536	53811af6-1334-4137-9142-6f43dc6e2ea0	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01B-11D-A13W-08	TCGA-C5-A1BI-01	TCGA-C5-A1BI-01B-11D-A13V-01	TCGA-C5-A1BI-01B-11D-A13W-08
TCGA-C5-A1BJ-01	0	TCGA-C5-A1BJ-01	4385	0	TCGA-C5-A1BJ	4385	0	4385	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	34	24		TCGA-C5-A1BJ-F57082		Completed as planned			HDR						Not done per treating physicians discretion		Stage IIB		-12611	21	35			4972					0	4385					57	2						0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	169	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO		YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			0	10	true						TCGA-C5-A1BJ.9F012D5B-DF59-43C3-96FC-4E6EE55BDAD6.pdf				0	0		40		20		0		20		0		20		80		80			TUMOR FREE		0		Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1997	1995	NO	NO	YES	C5	Current reformed smoker for < or = 15 years	0		cervical	A	LIVING	49	1997	TCGA-C5-A1BJ-01A-11D-A13W-08	AD09DC41-D11F-40EC-BEDA-17B761E52DC8	TCGA-C5-A1BJ-01A-11D-A13W-08	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01A-11D-A13V-01	a1d00776-9535-4361-af77-8896e51465fe	TCGA-C5-A1BJ-01A-11D-A13Z-05	TCGA-C5-A1BJ-01A-11R-A13X-13	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01	a1d00776-9535-4361-af77-8896e51465fe	83136251-d7be-4805-9eab-ef1c7ebfafaa	a1d00776-9535-4361-af77-8896e51465fe	83136251-d7be-4805-9eab-ef1c7ebfafaa	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01A-11D-A13W-08	TCGA-C5-A1BJ-01	TCGA-C5-A1BJ-01A-11D-A13V-01	TCGA-C5-A1BJ-01A-11D-A13W-08
TCGA-C5-A1BK-01	0	TCGA-C5-A1BK-01	5385	0	TCGA-C5-A1BK	5385	0	5385	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	36			TCGA-C5-A1BK-F62484						ABSENT		margins free of tumor	Other Location, specify		Participant refusal		Stage IB		-13297					5966					0	5385												0				NO	Scheduled Follow-up Submission	2014-7-17	FEMALE	151	Cervical Squamous Cell Carcinoma	No			52	HPV 16|Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	ECC	Other method, specify:	80	NO	Keratinizing squamous cell carcinoma	YES	20			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4		true			MX	N0	T1b					0	0		50		0		0		5		0		30		70		70			TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			1988	NO	NO	YES	C5	Lifelong Non-smoker	4		cervical	B	LIVING	82	1994	TCGA-C5-A1BK-01B-11D-A13W-08		TCGA-C5-A1BK-01B-11D-A13W-08	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01B-11D-A13V-01	feb35af1-052d-41a6-9e76-f47b610ab956	TCGA-C5-A1BK-01B-11D-A13Z-05	TCGA-C5-A1BK-01B-11R-A13X-13	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01	feb35af1-052d-41a6-9e76-f47b610ab956	5c39ff92-65c2-47e7-8780-ce7158aa3548	feb35af1-052d-41a6-9e76-f47b610ab956	5c39ff92-65c2-47e7-8780-ce7158aa3548	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01B-11D-A13W-08	TCGA-C5-A1BK-01	TCGA-C5-A1BK-01B-11D-A13V-01	TCGA-C5-A1BK-01B-11D-A13W-08
TCGA-C5-A1BL-01	0	TCGA-C5-A1BL-01	5271	0	TCGA-C5-A1BL	5271	0	5271	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	32	16		TCGA-C5-A1BL-F57887	Never Used	Completed as planned	8867		HDR	ABSENT				On randomized study and received arm without chemotherapy	Other		Stage IB		-11723	33	54			5950		1			0	5271			-5	1479	64	19		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	168	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Non-keratinizing squamous cell carcinoma	YES	25	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1	0	1	12	true	GP5+/GP6+					TCGA-C5-A1BL.C3312E18-832F-4126-8E9E-F829128F7530.pdf				0	0		60		20		10		20		0		20		70		70		Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1988	1988	NO	NO	YES	C5	Current reformed smoker for < or = 15 years	1	Complete response	cervical	A	LIVING	78	1994	TCGA-C5-A1BL-01A-11D-A13W-08	BB6DD49D-01BA-4049-828A-8CA7BE399418	TCGA-C5-A1BL-01A-11D-A13W-08	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01A-11D-A13V-01	5a7840e4-48ef-4d10-8709-c963b6b4c25a	TCGA-C5-A1BL-01A-11D-A13Z-05	TCGA-C5-A1BL-01A-11R-A13X-13	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01	5a7840e4-48ef-4d10-8709-c963b6b4c25a	1aa6d77d-3ed2-43bb-9ced-563183de0cca	5a7840e4-48ef-4d10-8709-c963b6b4c25a	1aa6d77d-3ed2-43bb-9ced-563183de0cca	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01A-11D-A13W-08	TCGA-C5-A1BL-01	TCGA-C5-A1BL-01A-11D-A13V-01	TCGA-C5-A1BL-01A-11D-A13W-08
TCGA-C5-A1BM-01	1	TCGA-C5-A1BM-01	2520	1	TCGA-C5-A1BM	2520	0	2520	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	78			TCGA-C5-A1BM-F30745		Completed as planned			HDR	PRESENT			Positive vaginal margin				Stage IB		-28815	171	186			4853	2520	22		102	0							154						0	Completed as Planned		Extra-Pelvic Metastatic Disease Present	NO	Scheduled Follow-up Submission	2012-4-16	FEMALE	171	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Non-keratinizing squamous cell carcinoma		23	Pelvic (external iliac, internal iliac, obturator)|Other Location, specify	perigastric	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	8	0	2		true			MX	N1	T2	TCGA-C5-A1BM.D23DE232-F930-40C8-A560-4B75C41C6115.pdf	Other, specify			1	0		50		20		10		20		0		10		80		80			TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	Current reformed smoker for < or = 15 years	3		cervical	A	DECEASED	56	1997	TCGA-C5-A1BM-01A-11D-A13W-08		TCGA-C5-A1BM-01A-11D-A13W-08	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01A-11D-A13V-01	0bb1946f-bc01-47d8-887f-e63f3a16e32d	TCGA-C5-A1BM-01A-11D-A13Z-05	TCGA-C5-A1BM-01A-11R-A13X-13	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01	0bb1946f-bc01-47d8-887f-e63f3a16e32d	078bd470-f68e-42ea-93f7-7a187982d9be	0bb1946f-bc01-47d8-887f-e63f3a16e32d	078bd470-f68e-42ea-93f7-7a187982d9be	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01A-11D-A13W-08	TCGA-C5-A1BM-01	TCGA-C5-A1BM-01A-11D-A13V-01	TCGA-C5-A1BM-01A-11D-A13W-08
TCGA-C5-A1BN-01	1	TCGA-C5-A1BN-01	166	1	TCGA-C5-A1BN	166	0	166	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease	YES	26	15		TCGA-C5-A1BN-F30414	Never Used	Completed as planned			HDR							Cisplatin	Stage IB2		-9783	36	85	67	32	1253	166			1	0						85	36						0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-4-9	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO						PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	11	true							Cervical Cancer			0	0		25		0		0		8		0		20		80		80			WITH TUMOR		0		Progressive Disease	No	YES					External beam radiation		Primary Tumor	01	17.36		1995	YES	NO	YES	C5	Current smoker	2		cervical	B	DECEASED	68	2007	TCGA-C5-A1BN-01B-11D-A14W-08		TCGA-C5-A1BN-01B-11D-A14W-08	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01B-11D-A14V-01	3f679347-cd3b-4711-aa6c-e5d87fa93052	TCGA-C5-A1BN-01B-11D-A14Z-05	TCGA-C5-A1BN-01B-11R-A14X-13	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01	3f679347-cd3b-4711-aa6c-e5d87fa93052	de8882de-b123-4909-9a17-51eb774d7ca2	3f679347-cd3b-4711-aa6c-e5d87fa93052	de8882de-b123-4909-9a17-51eb774d7ca2	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01B-11D-A14W-08	TCGA-C5-A1BN-01	TCGA-C5-A1BN-01B-11D-A14V-01	TCGA-C5-A1BN-01B-11D-A14W-08
TCGA-C5-A1BQ-01	1	TCGA-C5-A1BQ-01	604	1	TCGA-C5-A1BQ	604	0	604	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		65	12	6	TCGA-C5-A1BQ-F34245					HDR							Cisplatin	Stage IIIB		-24018						604				0											Once weekly		0						2012-8-7	FEMALE	147	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			6	25								Cervical Cancer			3	0																			TUMOR FREE	YES	1		Partial Remission/Response	No	YES					External beam radiation		Primary Tumor	01		1999	1995	YES	NO	YES	C5	Current reformed smoker for < or = 15 years	10		cervical		DECEASED	69	2002			TCGA-C5-A1BQ-01C-11D-A20U-09	ab31f363-93f1-4ef9-a47a-731657fdf534	TCGA-C5-A1BQ-01C-11D-A20T-01	ab31f363-93f1-4ef9-a47a-731657fdf534	TCGA-C5-A1BQ-01C-11D-A212-05	TCGA-C5-A1BQ-01C-11R-A214-13	TCGA-C5-A1BQ-01C-11D-A20U-09	TCGA-C5-A1BQ-01	ab31f363-93f1-4ef9-a47a-731657fdf534	b9fd15fe-a475-40f9-81cc-af173274d48a	ab31f363-93f1-4ef9-a47a-731657fdf534	b9fd15fe-a475-40f9-81cc-af173274d48a	TCGA-C5-A1BQ-01C-11D-A20U-09	TCGA-C5-A1BQ-01C-11D-A20U-09	TCGA-C5-A1BQ-01	TCGA-C5-A1BQ-01C-11D-A20T-01	
TCGA-C5-A1M5-01	1	TCGA-C5-A1M5-01	2052	1	TCGA-C5-A1M5	693	1	2052	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	YES	Progressive Disease	NO	53			TCGA-C5-A1M5-F29079						ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-19672					5395	2052				0			693		14							1	0				NO	Scheduled Follow-up Submission	2012-3-7	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma		59			PRESENT	Indeterminate (neither Pre or Postmenopausal)	G2	Other, specify		Tumor Resection	Distant Metastasis	Regional recurrence NOS		YES	0	0	4		true			M0	N0	T1b	TCGA-C5-A1M5.B7A07894-8654-49F3-9583-7AD930443F08.pdf	Cervical Cancer			0	0		60		2		0		3		0		10		90		90		Preoperative	WITH TUMOR		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	4		cervical	A	DECEASED	70	1996	TCGA-C5-A1M5-01A-11D-A13W-08	36EF8DA6-EB98-460D-B983-553061F6C566	TCGA-C5-A1M5-01A-11D-A13W-08	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01A-11D-A13V-01	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	TCGA-C5-A1M5-01A-11D-A13Z-05	TCGA-C5-A1M5-01A-11R-A13X-13	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	62b86d57-e565-4621-b026-d1bd564aa38e	f301f3e6-eaec-4d35-b8c0-b0eb6acd2847	62b86d57-e565-4621-b026-d1bd564aa38e	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01A-11D-A13W-08	TCGA-C5-A1M5-01	TCGA-C5-A1M5-01A-11D-A13V-01	TCGA-C5-A1M5-01A-11D-A13W-08
TCGA-C5-A1M6-01	1	TCGA-C5-A1M6-01	955	1	TCGA-C5-A1M6	316	1	955	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease	YES	55			TCGA-C5-A1M6-F29215	Former User	Completed as planned									Not done per treating physicians discretion		Stage IIB		-20090	20	75			4668	955	316			0			316		204	75	20		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2012-3-12	FEMALE	165	Cervical Squamous Cell Carcinoma	No				HPV 18			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	CT	Other, specify	Distant Metastasis			YES			1		true						TCGA-C5-A1M6.849F2BBF-C820-4C31-B213-648545060C3E.pdf	Cervical Cancer			0	0		3		5		10		2		0		5		85		95		Post-Adjuvant Therapy	WITH TUMOR		0		Complete Remission/Response	No	YES					External beam radiation	5840	Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	1		cervical	A	DECEASED	77	1998	TCGA-C5-A1M6-01A-11D-A13W-08	1F43A50D-9930-4F21-8EF8-1A09A5DABDF4	TCGA-C5-A1M6-01A-11D-A13W-08	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01A-11D-A13V-01	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	TCGA-C5-A1M6-01A-11D-A13Z-05	TCGA-C5-A1M6-01A-11R-A13X-13	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	0b30dfe8-e928-42d7-9fe7-982d328efdc2	c4c15b15-8010-47d8-8c6b-3c6b9dae9716	0b30dfe8-e928-42d7-9fe7-982d328efdc2	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01A-11D-A13W-08	TCGA-C5-A1M6-01	TCGA-C5-A1M6-01A-11D-A13V-01	TCGA-C5-A1M6-01A-11D-A13W-08
TCGA-C5-A1M7-01	0	TCGA-C5-A1M7-01	1409	0	TCGA-C5-A1M7	1409	0	1409	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	37	16		TCGA-C5-A1M7-F57890	Never Used					ABSENT		margins free of tumor	Other Location, specify				Stage IB		-13808					4265					0	1409			-33	228							1	0				NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 18		Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	90	NO	Non-keratinizing squamous cell carcinoma	YES	30			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4	26	true	GP5+/GP6+		MX	N0	T1b	TCGA-C5-A1M7.ABC2B2A7-E5EE-4198-80E0-E64A6305B47A.pdf				0	0		75		5		2		5		0		40		58		60		Post-Adjuvant Therapy	TUMOR FREE		1	YES	Complete Remission/Response	No	NO	Other						Primary Tumor	01			1995		NO	YES	C5	Current smoker	5	Complete response	cervical	A	LIVING	69	1999	TCGA-C5-A1M7-01A-11D-A13W-08	FC4D06F1-DFC3-4660-A049-EDED1CF39AE4	TCGA-C5-A1M7-01A-11D-A13W-08	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01A-11D-A13V-01	a8717ede-a85b-4133-bafc-48abd7892f71	TCGA-C5-A1M7-01A-11D-A13Z-05	TCGA-C5-A1M7-01A-11R-A13X-13	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01	a8717ede-a85b-4133-bafc-48abd7892f71	f4b82010-c076-46ae-8649-e688aa0e9ecb	a8717ede-a85b-4133-bafc-48abd7892f71	f4b82010-c076-46ae-8649-e688aa0e9ecb	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01A-11D-A13W-08	TCGA-C5-A1M7-01	TCGA-C5-A1M7-01A-11D-A13V-01	TCGA-C5-A1M7-01A-11D-A13W-08
TCGA-C5-A1M8-01	0	TCGA-C5-A1M8-01	919	0	TCGA-C5-A1M8	919	0	919	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	43			TCGA-C5-A1M8-F57891	Never Used					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-15848					3397			4		0	919				-273	130	64			Pelvic Nodes Present		0	0	Completed as Planned			NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	100	NO		YES	13			ABSENT	Indeterminate (neither Pre or Postmenopausal)	G2							NO	0	0	0		true			MX	N0	T1b	TCGA-C5-A1M8.7EC6DEFF-B0FC-45FF-9B45-92714D5EDBEB.pdf				0	1		5		2		2		3		0		15		83		85		Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	1		cervical	A	LIVING	75	2001	TCGA-C5-A1M8-01A-21D-A13W-08	11C08BC4-2E3E-47BB-80F7-4758587F2EF6	TCGA-C5-A1M8-01A-21D-A13W-08	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01A-21D-A13V-01	a4de3863-03d5-44b0-b711-87aadcb29008	TCGA-C5-A1M8-01A-21D-A13Z-05	TCGA-C5-A1M8-01A-21R-A13X-13	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01	a4de3863-03d5-44b0-b711-87aadcb29008	d536312b-7a52-452a-aa30-e2407396f51a	a4de3863-03d5-44b0-b711-87aadcb29008	d536312b-7a52-452a-aa30-e2407396f51a	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01A-21D-A13W-08	TCGA-C5-A1M8-01	TCGA-C5-A1M8-01A-21D-A13V-01	TCGA-C5-A1M8-01A-21D-A13W-08
TCGA-C5-A1M9-01	1	TCGA-C5-A1M9-01	1065	1	TCGA-C5-A1M9	555	1	1065	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease	YES	46		6	TCGA-C5-A1M9-F29254	Former User					ABSENT		margins free of tumor	Other Location, specify			Cisplatin	Stage IB1		-17020			116	81	3120	1065	5		5	0			555		215	116	76		Extra-Pelvic Metastatic Disease Present|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0	Completed as Planned	540	Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	155	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO			19	Pelvic (external iliac, internal iliac, obturator)|Para-aortic|Supraclavicular		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	CT	Other, specify	Distant Metastasis			YES	14		0		true			M0	N1	T3b	TCGA-C5-A1M9.6D91450A-9499-4B66-90DF-E68B4880E64C.pdf	Cervical Cancer			0	1		8		10		10		5		0		15		75		85		Post-Adjuvant Therapy	WITH TUMOR		0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	1		cervical	A	DECEASED	49	2002		9169E928-8406-4FF7-824A-AA5FA7B3BF5A	TCGA-C5-A1M9-01A-11D-A13W-08	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01A-11D-A13V-01	721c59a5-22b6-4388-a47d-d0108ea2c1aa	TCGA-C5-A1M9-01A-11D-A13Z-05	TCGA-C5-A1M9-01A-11R-A13X-13	TCGA-C5-A1M9-01A-11D-A13W-08	TCGA-C5-A1M9-01	721c59a5-22b6-4388-a47d-d0108ea2c1aa	9af1d32f-2f3c-4943-85dd-7fc5ddd0ec9a	721c59a5-22b6-4388-a47d-d0108ea2c1aa	9af1d32f-2f3c-4943-85dd-7fc5ddd0ec9a	TCGA-C5-A1M9-01A-11D-A13W-08	TCGA-C5-A1M9-01A-11D-A13W-08	TCGA-C5-A1M9-01	TCGA-C5-A1M9-01A-11D-A13V-01	TCGA-C5-A1M9-01A-11D-A13W-08
TCGA-C5-A1ME-01	0	TCGA-C5-A1ME-01	1756	0	TCGA-C5-A1ME	1756	0	1756	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	40	18		TCGA-C5-A1ME-F29281	Former User					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-14970					2632		13			0	1756				69							0	0				NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	165	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO			27			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0	0	1	22	true			M0	N0	T1b1	TCGA-C5-A1ME.00322045-7A7F-44D1-8381-94F027200227.pdf				0	0		15		0		0		5		0		40		60		60		Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01		2003	1995	NO	NO	YES	C5	Current reformed smoker for < or = 15 years	1		cervical	A	LIVING	69	2003	TCGA-C5-A1ME-01A-11D-A13W-08	B27BC67D-DE4A-4713-A07F-65322FB64A5B	TCGA-C5-A1ME-01A-11D-A13W-08	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01A-11D-A13V-01	318e2cdd-08c5-4611-913f-7f4a6f49677d	TCGA-C5-A1ME-01A-11D-A13Z-05	TCGA-C5-A1ME-01A-11R-A13X-13	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01	318e2cdd-08c5-4611-913f-7f4a6f49677d	24044c33-3461-4c15-8444-e15025ec9de6	318e2cdd-08c5-4611-913f-7f4a6f49677d	24044c33-3461-4c15-8444-e15025ec9de6	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01A-11D-A13W-08	TCGA-C5-A1ME-01	TCGA-C5-A1ME-01A-11D-A13V-01	TCGA-C5-A1ME-01A-11D-A13W-08
TCGA-C5-A1MF-01	0	TCGA-C5-A1MF-01	1617	0	TCGA-C5-A1MF	1617	0	1617	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	49	20		TCGA-C5-A1MF-F55178	Former User	Completed as planned			HDR	ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB2		-17911	72	119			2591		31			0	1617			34	168	119	72		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned	0		NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR		45	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Keratinizing squamous cell carcinoma	YES	40			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2	10	true	GP5+/GP6+		MX	N0	T1b2	TCGA-C5-A1MF.1FEEF445-9E69-4AAB-A336-C688BA807CDA.pdf				0	0		30		10		2		3		0		20		78		80		Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1995	1995	NO	NO	YES	C5	Current reformed smoker for < or = 15 years	2	Complete response	cervical	A	LIVING	70	2004	TCGA-C5-A1MF-01A-11D-A13W-08	AE69D647-895F-4476-873B-18BA147D1489	TCGA-C5-A1MF-01A-11D-A13W-08	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01A-11D-A13V-01	70b5a53a-d822-4634-b181-79fef68346c0	TCGA-C5-A1MF-01A-11D-A13Z-05	TCGA-C5-A1MF-01A-11R-A13X-13	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01	70b5a53a-d822-4634-b181-79fef68346c0	e6df4d2d-19cb-4418-a53c-116358016d88	70b5a53a-d822-4634-b181-79fef68346c0	e6df4d2d-19cb-4418-a53c-116358016d88	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01A-11D-A13W-08	TCGA-C5-A1MF-01	TCGA-C5-A1MF-01A-11D-A13V-01	TCGA-C5-A1MF-01A-11D-A13W-08
TCGA-C5-A1MH-01	1	TCGA-C5-A1MH-01	1186	1	TCGA-C5-A1MH	178	1	1186	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease	YES	71			TCGA-C5-A1MH-F29283		Completed as planned			HDR							Cisplatin	Stage IIIB		-26234	38	71	65	8	2417	1186	-2		1	0			178		155	71	38		Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0	Completed as Planned		Extra-Pelvic Metastatic Disease Absent	NO	Scheduled Follow-up Submission	2012-3-13	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Lung	PET, needle biopsy	Other, specify	Distant Metastasis			YES			2	15	true						TCGA-C5-A1MH.4FDCED4B-0729-4B37-8EA7-F66293680952.pdf	Cervical Cancer			0	0		40		20		10		20		0		30		60		60		Post-Adjuvant Therapy	WITH TUMOR		0		Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01	9.95	2003	1995	YES	NO	YES	C5	Current reformed smoker for > 15 years	2	Progression	cervical	A	DECEASED		2004	TCGA-C5-A1MH-01A-11D-A14W-08	4790E476-B3DE-4E7A-AFB1-03842F146150	TCGA-C5-A1MH-01A-11D-A14W-08	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01A-11D-A14V-01	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	TCGA-C5-A1MH-01A-11D-A14Z-05	TCGA-C5-A1MH-01A-11R-A14X-13	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	9de5cd33-8353-4912-82c3-48a26bc621b5	7a1f4f51-4bea-4e5f-b59a-02fb223d2965	9de5cd33-8353-4912-82c3-48a26bc621b5	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01A-11D-A14W-08	TCGA-C5-A1MH-01	TCGA-C5-A1MH-01A-11D-A14V-01	TCGA-C5-A1MH-01A-11D-A14W-08
TCGA-C5-A1MI-01	1	TCGA-C5-A1MI-01	1083	1	TCGA-C5-A1MI	805	1	1083	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease	YES	50	15	6	TCGA-C5-A1MI-F29733		Completed as planned	1200		HDR	ABSENT						Cisplatin	Stage IB1	40mg/m2/wk	-18336	83	118	118	76	2346	1083	16		23	0			805		41	125	76		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	1	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2012-3-28	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO			17	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G2	Other, specify			Distant Metastasis	distant recurrence multiple sites		YES	1		2	35	true			M0	N1	T1b1	TCGA-C5-A1MI.FD31F805-C852-467E-9708-7D00339944B5.pdf	Cervical Cancer	Other, specify	Herpes	2	2		40		20		10		20		0		10		80		80		Pre-Adjuvant Therapy	WITH TUMOR		0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	7		cervical	A	DECEASED	77	2004	TCGA-C5-A1MI-01A-11D-A14W-08	6424B36F-37F0-4816-8964-D1DB61A06F63	TCGA-C5-A1MI-01A-11D-A14W-08	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01A-11D-A14V-01	e5452386-f28c-450f-b13b-4b1ef4713fa1	TCGA-C5-A1MI-01A-11D-A14Z-05	TCGA-C5-A1MI-01A-11R-A14X-13	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01	e5452386-f28c-450f-b13b-4b1ef4713fa1	a2cb9e28-e008-47ae-add3-00ac0be66e93	e5452386-f28c-450f-b13b-4b1ef4713fa1	a2cb9e28-e008-47ae-add3-00ac0be66e93	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01A-11D-A14W-08	TCGA-C5-A1MI-01	TCGA-C5-A1MI-01A-11D-A14V-01	TCGA-C5-A1MI-01A-11D-A14W-08
TCGA-C5-A1MJ-01	1	TCGA-C5-A1MJ-01	14	1	TCGA-C5-A1MJ			14	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					61			TCGA-C5-A1MJ-F29745						ABSENT		margins free of tumor	Other Location, specify				Stage IB1		-22308					2234	14				0					-69							1	1				NO	Scheduled Follow-up Submission	2012-3-28	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO			18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								0	0	3		true			MX	N0	T1b1	TCGA-C5-A1MJ.A0D7B6A3-BE64-4736-894D-AF69320180AC.pdf	Other, specify			0	2		40		20		10		20		0		20		70		70		Preoperative	TUMOR FREE		0	YES		No								Primary Tumor	01			1995		NO	YES	C5	Lifelong Non-smoker	6		cervical	A	DECEASED	75	2005	TCGA-C5-A1MJ-01A-11D-A14W-08	A0036B29-51AD-4A3B-A405-7929D1A483E1	TCGA-C5-A1MJ-01A-11D-A14W-08	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01A-11D-A14V-01	45ce60c9-d18f-43a2-b240-8dc7d854cd27	TCGA-C5-A1MJ-01A-11D-A14Z-05	TCGA-C5-A1MJ-01A-11R-A14X-13	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01	45ce60c9-d18f-43a2-b240-8dc7d854cd27	b41b6389-009d-490f-892b-9c798c39c5a4	45ce60c9-d18f-43a2-b240-8dc7d854cd27	b41b6389-009d-490f-892b-9c798c39c5a4	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01A-11D-A14W-08	TCGA-C5-A1MJ-01	TCGA-C5-A1MJ-01A-11D-A14V-01	TCGA-C5-A1MJ-01A-11D-A14W-08
TCGA-C5-A1MK-01	1	TCGA-C5-A1MK-01	74	1	TCGA-C5-A1MK	74	0	74	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease	YES	79		5	TCGA-C5-A1MK-F30183		Treatment not completed			HDR							Carboplatin	Stage IIIB		-28939	41	74	74	41	2052	74				0						74	41				Once weekly		0	Treatment not completed	2200	Paraaortic Nodes Present|Pelvic Nodes Present	NO	Scheduled Follow-up Submission	2012-4-4	FEMALE	155	Cervical Squamous Cell Carcinoma	No			58	Other HPV type(s)			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO	Keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2		true						TCGA-C5-A1MK.75B6D26C-3C3C-4D2E-BFDD-C9CB81AE3793.pdf	Cervical Cancer			0	2		40		20		10		20		0		10		80		80			WITH TUMOR		1		Progressive Disease	No	YES					External beam radiation	1980	Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	5		cervical	A	DECEASED	63	2005	TCGA-C5-A1MK-01A-11D-A14W-08		TCGA-C5-A1MK-01A-11D-A14W-08	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01A-11D-A14V-01	174159b7-d7a4-43d5-8c04-7f62f8d0db14	TCGA-C5-A1MK-01A-11D-A14Z-05	TCGA-C5-A1MK-01A-11R-A14X-13	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01	174159b7-d7a4-43d5-8c04-7f62f8d0db14	1044e811-afb9-4f8b-a30d-8272e77806ad	174159b7-d7a4-43d5-8c04-7f62f8d0db14	1044e811-afb9-4f8b-a30d-8272e77806ad	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01A-11D-A14W-08	TCGA-C5-A1MK-01	TCGA-C5-A1MK-01A-11D-A14V-01	TCGA-C5-A1MK-01A-11D-A14W-08
TCGA-C5-A1ML-01	1	TCGA-C5-A1ML-01	636	1	TCGA-C5-A1ML	636	0	636	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease	YES	49			TCGA-C5-A1ML-F30188		Completed as planned			HDR						Other		Stage IB2		-18067	68	111			2037	636	37		37	0						111	68		Extra-Pelvic Metastatic Disease Present	Extra-Pelvic Metastatic Disease Present			0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-4	FEMALE		Cervical Squamous Cell Carcinoma	No				HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2	37	true						TCGA-C5-A1ML.D27AF07C-E69A-46DE-B1E6-4F494E3602B5.pdf	Cervical Cancer			0	0		40		20		0		20		0		10		90		90			WITH TUMOR		0		Progressive Disease	No	YES					External beam radiation	5040	Primary Tumor	01	14.46		1995	NO	NO	YES	C5	Current smoker	2		cervical	A	DECEASED	120	2005	TCGA-C5-A1ML-01A-11D-A14W-08		TCGA-C5-A1ML-01A-11D-A14W-08	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01A-11D-A14V-01	1f870a12-9d70-4fe4-a176-4cbee06c44e6	TCGA-C5-A1ML-01A-11D-A14Z-05	TCGA-C5-A1ML-01A-11R-A14X-13	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01	1f870a12-9d70-4fe4-a176-4cbee06c44e6	8fa96c04-188c-45f6-8f9a-2ad2100307ba	1f870a12-9d70-4fe4-a176-4cbee06c44e6	8fa96c04-188c-45f6-8f9a-2ad2100307ba	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01A-11D-A14W-08	TCGA-C5-A1ML-01	TCGA-C5-A1ML-01A-11D-A14V-01	TCGA-C5-A1ML-01A-11D-A14W-08
TCGA-C5-A1MN-01	1	TCGA-C5-A1MN-01	1245	1	TCGA-C5-A1MN	1245	0	1245	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				YES	42			TCGA-C5-A1MN-F30192	Former User	Completed as planned			HDR							Cisplatin	Stage IIIB		-15499	25			25	1441	1245			1	0				875	875		25					1	0	Completed as Planned		Parametrium Present|Pelvic Nodes Present	NO	Scheduled Follow-up Submission	2012-4-4	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			0	25	true						TCGA-C5-A1MN.8C677406-F68A-429E-BC9A-9AE26928D226.pdf	Other, specify			0	0		40		20		5		20		0		10		85		85		Post-Adjuvant Therapy	TUMOR FREE		0		Complete Remission/Response	No	YES					IMRT		Primary Tumor	01	16.92		1995	YES	NO	YES	C5	Current smoker	0	Complete response	cervical	A	DECEASED	64	2007	TCGA-C5-A1MN-01A-11D-A14W-08	FCCC4EAA-62B7-4005-887C-716C7FB52D63	TCGA-C5-A1MN-01A-11D-A14W-08	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01A-11D-A14V-01	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	TCGA-C5-A1MN-01A-11D-A14Z-05	TCGA-C5-A1MN-01A-11R-A14X-13	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	aeedc122-9f0f-4955-bfc0-86cfb1eb01ae	029c4ec1-b4a1-4aea-a126-aceadb8ab52a	aeedc122-9f0f-4955-bfc0-86cfb1eb01ae	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01A-11D-A14W-08	TCGA-C5-A1MN-01	TCGA-C5-A1MN-01A-11D-A14V-01	TCGA-C5-A1MN-01A-11D-A14W-08
TCGA-C5-A1MP-01	0	TCGA-C5-A1MP-01	109	0	TCGA-C5-A1MP	109	0	109	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	34			TCGA-C5-A1MP-F57086								margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB2		-12692					747		7		7	0	109												0				NO	Scheduled Follow-up Submission	2014-3-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		YES	54	Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	6		3		true			MX	N1	T1b2	TCGA-C5-A1MP.AA5A1858-A926-4CCE-BC1C-1F1E964EAA96.pdf				0	0		40		20		0		20		0		15		85		85			TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01	8.7		1995	NO	NO	YES	C5	Lifelong Non-smoker	3		cervical	A	LIVING		2009	TCGA-C5-A1MP-01A-11D-A14W-08	42E384BE-242F-4BBB-87B1-FAF9D49D8C3D	TCGA-C5-A1MP-01A-11D-A14W-08	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01A-11D-A14V-01	a1ff456d-7a22-4200-a429-c2a41e5c3e04	TCGA-C5-A1MP-01A-11D-A14Z-05	TCGA-C5-A1MP-01A-11R-A14X-13	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01	a1ff456d-7a22-4200-a429-c2a41e5c3e04	dfd02a8a-7111-4b99-ac08-161e89d06d1a	a1ff456d-7a22-4200-a429-c2a41e5c3e04	dfd02a8a-7111-4b99-ac08-161e89d06d1a	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01A-11D-A14W-08	TCGA-C5-A1MP-01	TCGA-C5-A1MP-01A-11D-A14V-01	TCGA-C5-A1MP-01A-11D-A14W-08
TCGA-C5-A1MQ-01	0	TCGA-C5-A1MQ-01	1031	0	TCGA-C5-A1MQ	1031	0	1031	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	35		6	TCGA-C5-A1MQ-F31340		Completed as planned	2400		HDR	ABSENT			Microscopic parametrial involvement			Cisplatin	Stage IIA	70mg	-12836	99	151	151	99	667				23	0	1031				1031	151	99				Once weekly	0	0	Completed as Planned			NO	Scheduled Follow-up Submission	2012-4-30	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO			33			PRESENT		G2							NO	0	0	2		true			M0	N0	T2b	TCGA-C5-A1MQ.C77E58E6-6536-4DBE-9703-8EA34A3C908B.pdf				2	0		40		20		5		20		0		5		90		90		Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	5120	Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	4		cervical	A	LIVING	116	2009	TCGA-C5-A1MQ-01A-11D-A14W-08	135CDBF1-DF8E-4F67-A2BF-821C1E48EF15	TCGA-C5-A1MQ-01A-11D-A14W-08	1e7b2ed2-be35-4cce-a613-9c8203c49ebb		1e7b2ed2-be35-4cce-a613-9c8203c49ebb	TCGA-C5-A1MQ-01A-11D-A14Z-05	TCGA-C5-A1MQ-01A-11R-A14X-13	TCGA-C5-A1MQ-01A-11D-A14W-08		1e7b2ed2-be35-4cce-a613-9c8203c49ebb		1e7b2ed2-be35-4cce-a613-9c8203c49ebb		TCGA-C5-A1MQ-01A-11D-A14W-08	TCGA-C5-A1MQ-01A-11D-A14W-08			TCGA-C5-A1MQ-01A-11D-A14W-08
TCGA-C5-A2LS-01	0	TCGA-C5-A2LS-01	1345	0	TCGA-C5-A2LS	1345	0	1345	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					37	17		TCGA-C5-A2LS-F55254								margins free of tumor	Other Location, specify				Stage IB2		-13857					2199					0	1345												0						2014-1-3	FEMALE	173	Endocervical Adenocarcinoma of the Usual Type	No						Radical Hysterectomy	C53.9	8380/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO		YES	41					G1							NO	0		2	11	false			M0	N0	T1b2	TCGA-C5-A2LS.0D3F75AE-DFF5-47DB-A875-78D35DE393E0.pdf				1	0		0		0		0		0		0		0		100		65			TUMOR FREE	NO	0	YES	Complete Remission/Response	No	NO							Primary Tumor	01			1995	NO	NO	YES	C5	Current smoker	3		cervical	A	LIVING	92	2005			TCGA-C5-A2LS-01A-22D-A22X-09	06121f93-9719-4d96-94e1-5b8afcc347a7	TCGA-C5-A2LS-01A-22D-A22W-01	06121f93-9719-4d96-94e1-5b8afcc347a7	TCGA-C5-A2LS-01A-22D-A230-05	TCGA-C5-A2LS-01A-22R-A22V-13	TCGA-C5-A2LS-01A-22D-A22X-09	TCGA-C5-A2LS-01	06121f93-9719-4d96-94e1-5b8afcc347a7	18849922-723e-412f-95d0-b6e6675c6b46	06121f93-9719-4d96-94e1-5b8afcc347a7	18849922-723e-412f-95d0-b6e6675c6b46	TCGA-C5-A2LS-01A-22D-A22X-09	TCGA-C5-A2LS-01A-22D-A22X-09	TCGA-C5-A2LS-01	TCGA-C5-A2LS-01A-22D-A22W-01	
TCGA-C5-A2LT-01	0	TCGA-C5-A2LT-01	2226	0	TCGA-C5-A2LT	2226	0	2226	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	38	20	6	TCGA-C5-A2LT-F20928	Current User					ABSENT		margins free of tumor	Other Location, specify			Cisplatin	Stage IB	50mg/m2	-13966			152	115	3715					0	2226			14	110	152	115				Once weekly	1	0	Completed as Planned	0		NO	Scheduled Follow-up Submission	2012-1-25	FEMALE	163	Cervical Squamous Cell Carcinoma	No	PCR		70	Other HPV type(s)		Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Keratinizing squamous cell carcinoma		31			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	2	19	false	GP5+/GP6+		M0	N0	T1b	TCGA-C5-A2LT.C9125C3D-81F0-4E3A-93BB-E2DD191B0B78.pdf				0	0		0		0		0		0		0		25		75		65		Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	2	Complete response	cervical	A	LIVING	59	2001		A1308ED2-5DA8-4E39-A1D4-6290246973ED	TCGA-C5-A2LT-01A-11D-A18J-09	26616de7-08df-4359-9c00-c649409b1480	TCGA-C5-A2LT-01A-11D-A18H-01	26616de7-08df-4359-9c00-c649409b1480	TCGA-C5-A2LT-01A-11D-A18K-05	TCGA-C5-A2LT-01A-11R-A18L-13	TCGA-C5-A2LT-01A-11D-A18J-09	TCGA-C5-A2LT-01	26616de7-08df-4359-9c00-c649409b1480	133d7e1c-0da4-4587-893f-f94b3bf3e3a6	26616de7-08df-4359-9c00-c649409b1480	133d7e1c-0da4-4587-893f-f94b3bf3e3a6	TCGA-C5-A2LT-01A-11D-A18J-09	TCGA-C5-A2LT-01A-11D-A18J-09	TCGA-C5-A2LT-01	TCGA-C5-A2LT-01A-11D-A18H-01	
TCGA-C5-A2LV-01	0	TCGA-C5-A2LV-01	2234	0	TCGA-C5-A2LV	2234	0	2234	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	36	20		TCGA-C5-A2LV-F57088	Never Used					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-13447					3016		8			0	2234			-1	69				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0				NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	YES	49	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	1	0	3	16	false	GP5+/GP6+		MX	N1	T1b	TCGA-C5-A2LV.7D80B4D1-8480-4C06-9067-CF78DA3EBA69.pdf				1	2		0		0		0		0		0		0		100		85	post-operative	Other	TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	C5	Current smoker	6	Complete response	cervical	A	LIVING	84	2003		7BB3C290-D76B-4013-B020-527ADA351E3F	TCGA-C5-A2LV-01A-11D-A18J-09	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	TCGA-C5-A2LV-01A-11D-A18H-01	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	TCGA-C5-A2LV-01A-11D-A18K-05	TCGA-C5-A2LV-01A-11R-A18L-13	TCGA-C5-A2LV-01A-11D-A18J-09	TCGA-C5-A2LV-01	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	5d3cdafc-82ee-4eaf-bbae-ef7b08679eb4	a6a4630e-3d28-4a38-8c9f-29fc0c7b380a	5d3cdafc-82ee-4eaf-bbae-ef7b08679eb4	TCGA-C5-A2LV-01A-11D-A18J-09	TCGA-C5-A2LV-01A-11D-A18J-09	TCGA-C5-A2LV-01	TCGA-C5-A2LV-01A-11D-A18H-01	
TCGA-C5-A2LX-01	0	TCGA-C5-A2LX-01	2526	0	TCGA-C5-A2LX	2526	0	2526	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	54	18	6	TCGA-C5-A2LX-F57087	Former User	Completed as planned			HDR	ABSENT	severe squamous dysplasia (CIN3) extending to the vaginal margin of excision		Positive vaginal margin			Cisplatin	Stage IB1		-20070	77	134	134	77	1583				31	0	2526			52	73	134	93				Once weekly	1	0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	NO	39	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	3	0	4	35	false	GP5+/GP6+		MX	N1	T2	TCGA-C5-A2LX.CF12FC3E-41CA-48EE-AF88-15ACA2C0067D.pdf				0	0		0		0		0		0		0		0		100		90		Pre-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					IMRT	5120	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	4	Complete response	cervical	A	LIVING	65	2007		48EC2082-9A47-44FB-9E0E-19120B7365A7	TCGA-C5-A2LX-01A-11D-A18J-09	c188647f-7c72-4228-acd8-de6e5892f7fe	TCGA-C5-A2LX-01A-11D-A18H-01	c188647f-7c72-4228-acd8-de6e5892f7fe	TCGA-C5-A2LX-01A-11D-A18K-05	TCGA-C5-A2LX-01A-11R-A18L-13	TCGA-C5-A2LX-01A-11D-A18J-09	TCGA-C5-A2LX-01	c188647f-7c72-4228-acd8-de6e5892f7fe	90bcc542-fc4d-4728-a79e-92d2d14ffbee	c188647f-7c72-4228-acd8-de6e5892f7fe	90bcc542-fc4d-4728-a79e-92d2d14ffbee	TCGA-C5-A2LX-01A-11D-A18J-09	TCGA-C5-A2LX-01A-11D-A18J-09	TCGA-C5-A2LX-01	TCGA-C5-A2LX-01A-11D-A18H-01	
TCGA-C5-A2LY-01	0	TCGA-C5-A2LY-01	2383	0	TCGA-C5-A2LY	2383	0	2383	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	30		6	TCGA-C5-A2LY-F55200	Former User	Completed as planned			HDR	ABSENT						Cisplatin	Stage IB1	40mg/m2	-11018	78	106	106	45	3169		12		12	0	2383			15	110	106	45		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0	Completed as Planned	0	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-28	FEMALE	160	Cervical Squamous Cell Carcinoma	No	PCR			HPV 16			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Non-keratinizing squamous cell carcinoma	YES	8			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1		false	GP5+/GP6+		M0	N0	T1b1	TCGA-C5-A2LY.BA97051E-10A1-46D8-B5EF-D8163C5430D9.pdf				0	0		40		20		5		20		0		15		80		80		Post-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	1	Complete response	cervical	A	LIVING	88	2002		C159F07D-C0B9-450E-BC7D-777552F38ADD	TCGA-C5-A2LY-01A-31D-A18J-09	0046fef7-052b-4d4e-b264-b3bf2e2699b1	TCGA-C5-A2LY-01A-31D-A18H-01	0046fef7-052b-4d4e-b264-b3bf2e2699b1	TCGA-C5-A2LY-01A-31D-A18K-05	TCGA-C5-A2LY-01A-31R-A18L-13	TCGA-C5-A2LY-01A-31D-A18J-09	TCGA-C5-A2LY-01	0046fef7-052b-4d4e-b264-b3bf2e2699b1	c715d2b5-085e-4175-b9ea-b9649b3535e7	0046fef7-052b-4d4e-b264-b3bf2e2699b1	c715d2b5-085e-4175-b9ea-b9649b3535e7	TCGA-C5-A2LY-01A-31D-A18J-09	TCGA-C5-A2LY-01A-31D-A18J-09	TCGA-C5-A2LY-01	TCGA-C5-A2LY-01A-31D-A18H-01	
TCGA-C5-A2LZ-01	1	TCGA-C5-A2LZ-01	3046	1	TCGA-C5-A2LZ	2893	1	3046	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		65	15		TCGA-C5-A2LZ-F33609					LDR						Not done per treating physicians discretion		Stage IIIB		-24059					4886	3046				0			2893										0						2012-7-10	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2				Distant Metastasis			YES			4	50	false						TCGA-C5-A2LZ.EF2D354D-F959-45B3-AA5C-170E00AF3F45.pdf	Cervical Cancer			1	0		0		0		0		0		0		30		70		65			WITH TUMOR	NO	0		Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	NO	NO	YES	C5	Current smoker	5		cervical	A	DECEASED	85	1998		11B6B548-475A-4F7F-A3F1-DBFC8B2BDE6F	TCGA-C5-A2LZ-01A-11D-A20U-09	93810b75-cbbb-4dbb-bbe1-efb66d19516d	TCGA-C5-A2LZ-01A-11D-A20T-01	93810b75-cbbb-4dbb-bbe1-efb66d19516d	TCGA-C5-A2LZ-01A-11D-A212-05	TCGA-C5-A2LZ-01A-11R-A214-13	TCGA-C5-A2LZ-01A-11D-A20U-09	TCGA-C5-A2LZ-01	93810b75-cbbb-4dbb-bbe1-efb66d19516d	009dda02-ce4c-4de1-82e2-b6f43827af53	93810b75-cbbb-4dbb-bbe1-efb66d19516d	009dda02-ce4c-4de1-82e2-b6f43827af53	TCGA-C5-A2LZ-01A-11D-A20U-09	TCGA-C5-A2LZ-01A-11D-A20U-09	TCGA-C5-A2LZ-01	TCGA-C5-A2LZ-01A-11D-A20T-01	
TCGA-C5-A2M1-01	0	TCGA-C5-A2M1-01	1169	0	TCGA-C5-A2M1	1169	0	1169	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	37			TCGA-C5-A2M1-F63928	Former User					ABSENT		margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB1		-13835					2275					0	1169			13	86							1	0				NO	Scheduled Follow-up Submission	2014-8-21	FEMALE	168	Endocervical Type of Adenocarcinoma	No	PCR			HPV 16		Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		YES	31			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2		false	GP5+/GP6+		MX	N0	T1b1	TCGA-C5-A2M1.13B5E17B-0613-4A86-8DB5-1DD3B5AF7A23.pdf				0	0		0		0		0		0		0		0		100		70		Pre-Adjuvant Therapy	TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	2	Complete response	cervical	A	LIVING	76	2005			TCGA-C5-A2M1-01A-11D-A18J-09	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	TCGA-C5-A2M1-01A-11D-A18H-01	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	TCGA-C5-A2M1-01A-11D-A18K-05	TCGA-C5-A2M1-01A-11R-A18L-13	TCGA-C5-A2M1-01A-11D-A18J-09	TCGA-C5-A2M1-01	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	9537e111-3721-4b10-af03-2b6235155955	5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8	9537e111-3721-4b10-af03-2b6235155955	TCGA-C5-A2M1-01A-11D-A18J-09	TCGA-C5-A2M1-01A-11D-A18J-09	TCGA-C5-A2M1-01	TCGA-C5-A2M1-01A-11D-A18H-01	
TCGA-C5-A2M2-01	1	TCGA-C5-A2M2-01	1011	1	TCGA-C5-A2M2	1011	0	1011	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					56	24		TCGA-C5-A2M2-F55539	Former User												Stage IB2		-20480					774	1011			18	0	25												0			Bladder Absent|Parametrium Absent|Paraaortic Nodes Present|Pelvic Nodes Present|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE		Endocervical Type of Adenocarcinoma	No							C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			1	8	false						TCGA-C5-A2M2.716583F1-32F6-4CAC-853F-7A0773BB31F9.pdf				0	0		0		0		0		0		0		0		100		75					0			No								Primary Tumor	01		2003	2009		NO	YES	C5	Current reformed smoker for < or = 15 years	1		cervical	A	DECEASED		2009		E8A1C40D-96A1-4505-9E4B-42CC804182E2	TCGA-C5-A2M2-01A-21D-A18J-09	00471faf-5a40-430a-8555-564fa885f618	TCGA-C5-A2M2-01A-21D-A18H-01	00471faf-5a40-430a-8555-564fa885f618	TCGA-C5-A2M2-01A-21D-A18K-05	TCGA-C5-A2M2-01A-21R-A18L-13	TCGA-C5-A2M2-01A-21D-A18J-09	TCGA-C5-A2M2-01	00471faf-5a40-430a-8555-564fa885f618	cc7bb20a-8a69-48dc-965f-c2f93361c7f4	00471faf-5a40-430a-8555-564fa885f618	cc7bb20a-8a69-48dc-965f-c2f93361c7f4	TCGA-C5-A2M2-01A-21D-A18J-09	TCGA-C5-A2M2-01A-21D-A18J-09	TCGA-C5-A2M2-01	TCGA-C5-A2M2-01A-21D-A18H-01	
TCGA-C5-A3HD-01	0	TCGA-C5-A3HD-01	1582	0	TCGA-C5-A3HD	1582	0	1582	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	51	16		TCGA-C5-A3HD-F55537	Former User	Completed as planned			HDR							Cisplatin	Stage IIB		-18690	13			17	2848				3	0	1582			0			13					1	0	Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2014-3-3	FEMALE	170	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		YES						G2							NO			2	27	true										0	0		30		0		10		10		0		10		80		80		Preoperative	TUMOR FREE		0		Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1995	1995	YES	NO	YES	C5	Current reformed smoker for < or = 15 years	2	Complete response	cervical	B	LIVING	83	2004			TCGA-C5-A3HD-01B-11D-A20U-09	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	TCGA-C5-A3HD-01B-11D-A20T-01	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	TCGA-C5-A3HD-01B-11D-A212-05	TCGA-C5-A3HD-01B-11R-A214-13	TCGA-C5-A3HD-01B-11D-A20U-09	TCGA-C5-A3HD-01	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	286ec507-644f-47f2-bfa2-144b2715ff54	cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d	286ec507-644f-47f2-bfa2-144b2715ff54	TCGA-C5-A3HD-01B-11D-A20U-09	TCGA-C5-A3HD-01B-11D-A20U-09	TCGA-C5-A3HD-01	TCGA-C5-A3HD-01B-11D-A20T-01	
TCGA-C5-A3HE-01	0	TCGA-C5-A3HE-01	548	0	TCGA-C5-A3HE			548	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44			TCGA-C5-A3HE-F55255								margins free of tumor	Other Location, specify				Stage IB2		-16139					1801					0	548												0						2014-1-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Non-keratinizing squamous cell carcinoma	YES						G3							YES			0		true			M0	N0	T1b2	TCGA-C5-A3HE.8D7665DB-F820-4545-81C8-233A3AE3F9C9.pdf				0	1		0		0		0		0		0		0		100		80				NO	0	NO		No	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	1		cervical	A	LIVING		2006		8AD07B41-00BD-4A85-84CA-F529626BF6C3	TCGA-C5-A3HE-01A-21D-A22X-09	e26f5a99-6a8d-429e-8849-8a9b5680d466	TCGA-C5-A3HE-01A-21D-A22W-01	e26f5a99-6a8d-429e-8849-8a9b5680d466	TCGA-C5-A3HE-01A-21D-A230-05	TCGA-C5-A3HE-01A-21R-A22V-13	TCGA-C5-A3HE-01A-21D-A22X-09	TCGA-C5-A3HE-01	e26f5a99-6a8d-429e-8849-8a9b5680d466	cc8b992c-f694-494e-a7cf-10dbcc02d9e9	e26f5a99-6a8d-429e-8849-8a9b5680d466	cc8b992c-f694-494e-a7cf-10dbcc02d9e9	TCGA-C5-A3HE-01A-21D-A22X-09	TCGA-C5-A3HE-01A-21D-A22X-09	TCGA-C5-A3HE-01	TCGA-C5-A3HE-01A-21D-A22W-01	
TCGA-C5-A3HF-01	1	TCGA-C5-A3HF-01	543	1	TCGA-C5-A3HF	450	1	543	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	NO	Progressive Disease	YES	24	16		TCGA-C5-A3HF-F30756		Completed as planned			HDR						Not done per treating physicians discretion		Stage IB2		-9115	71	88			5464	543				0			450			101	57						0	Completed as Planned	5040		NO	Scheduled Follow-up Submission	2012-4-16	FEMALE		Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO			32	Pelvic (external iliac, internal iliac, obturator)|Para-aortic			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify	CT	Other, specify	Distant Metastasis	Pelvis		YES	11		1	9	true						TCGA-C5-A3HF.BDC1F089-937D-4812-9EF6-259A00FEAB80.pdf	Cervical Cancer			0	0		15		2		5		0		15		0		80		65			WITH TUMOR		0	YES		No	YES					External beam radiation	5040	Primary Tumor	01			1995	NO	NO	YES	C5	Current smoker	1		cervical	A	DECEASED		1996		98528687-3F27-43C9-9472-C399EA10D856	TCGA-C5-A3HF-01A-11D-A20U-09	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	TCGA-C5-A3HF-01A-11D-A20T-01	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	TCGA-C5-A3HF-01A-11D-A212-05	TCGA-C5-A3HF-01A-11R-A214-13	TCGA-C5-A3HF-01A-11D-A20U-09	TCGA-C5-A3HF-01	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	776c2b60-6522-49bb-8575-e17df1c3fdc9	f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa	776c2b60-6522-49bb-8575-e17df1c3fdc9	TCGA-C5-A3HF-01A-11D-A20U-09	TCGA-C5-A3HF-01A-11D-A20U-09	TCGA-C5-A3HF-01	TCGA-C5-A3HF-01A-11D-A20T-01	
TCGA-C5-A3HL-01	0	TCGA-C5-A3HL-01	621	0	TCGA-C5-A3HL	621	0	621	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	76			TCGA-C5-A3HL-F47688	Never Used					ABSENT		margins free of tumor	Other Location, specify				Stage IB2		-27963					1519					0	621					174	130						0	Completed as Planned			NO	Scheduled Follow-up Submission	2014-6-16	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	YES	21			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	4		true			MX	N0	T1b2	TCGA-C5-A3HL.0A258AD5-AE6C-4866-AE39-78C29DB89CAF.pdf				0	1		0		0		0		0		0		15		85		75			TUMOR FREE		0	YES	Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	5	Complete response	cervical	A	LIVING		2007		7DA4AAC5-2CE9-49F6-A3AA-DBD843C5CF20	TCGA-C5-A3HL-01A-11D-A20U-09	3337929b-5381-41ae-88f2-b6dbeb17f088	TCGA-C5-A3HL-01A-11D-A20T-01	3337929b-5381-41ae-88f2-b6dbeb17f088	TCGA-C5-A3HL-01A-11D-A212-05	TCGA-C5-A3HL-01A-11R-A214-13	TCGA-C5-A3HL-01A-11D-A20U-09	TCGA-C5-A3HL-01	3337929b-5381-41ae-88f2-b6dbeb17f088	482f975e-45f6-4105-8e33-89d1ca2e2117	3337929b-5381-41ae-88f2-b6dbeb17f088	482f975e-45f6-4105-8e33-89d1ca2e2117	TCGA-C5-A3HL-01A-11D-A20U-09	TCGA-C5-A3HL-01A-11D-A20U-09	TCGA-C5-A3HL-01	TCGA-C5-A3HL-01A-11D-A20T-01	
TCGA-C5-A7CG-01	0	TCGA-C5-A7CG-01	6408	0	TCGA-C5-A7CG	6408	0	6408	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		55			TCGA-C5-A7CG-F63991	Never Used							margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-20242					6043		20			0	6408												0						2014-8-22	FEMALE	169	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Keratinizing squamous cell carcinoma	NO	47					G2							NO	0		5		true			MX	N0	T1b	TCGA-C5-A7CG.E511E773-AAEF-4685-AC83-3EF5F31C489F.pdf				0	0		4		0		3		0		0		0		97		75			TUMOR FREE	NO	1	YES		No	NO							Primary Tumor	01			1995	NO	NO	YES	C5	Lifelong Non-smoker	6		cervical	A	LIVING	94	1997		9864C71F-FFC6-4BAD-99FA-EA39BEBD99DC	TCGA-C5-A7CG-01A-11D-A32I-09	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	TCGA-C5-A7CG-01A-11D-A32H-01	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	TCGA-C5-A7CG-01A-11D-A32T-05	TCGA-C5-A7CG-01A-11R-A32K-13	TCGA-C5-A7CG-01A-11D-A32I-09	TCGA-C5-A7CG-01	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	2c1bbd15-6bfb-417e-8b52-06ed48fd53b0	5abdff9b-a6a9-4564-9ac3-98a563f65fe6	2c1bbd15-6bfb-417e-8b52-06ed48fd53b0	TCGA-C5-A7CG-01A-11D-A32I-09	TCGA-C5-A7CG-01A-11D-A32I-09	TCGA-C5-A7CG-01	TCGA-C5-A7CG-01A-11D-A32H-01	
TCGA-C5-A7CH-01	0	TCGA-C5-A7CH-01	4694	0	TCGA-C5-A7CH	4694	0	4694	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		43			TCGA-C5-A7CH-F63994													Stage IIB		-15777					4329					0	4694												0						2014-8-22	FEMALE	161	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Keratinizing squamous cell carcinoma	NO						G2							NO			8		true						TCGA-C5-A7CH.68C37151-5277-4370-BEA9-5DBD6429E06F.pdf				0	1		2		0		0		0		0		0		100		80			TUMOR FREE	YES	0			No	YES							Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	9		cervical	A	LIVING	104	2001			TCGA-C5-A7CH-01A-11D-A33O-09	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	TCGA-C5-A7CH-01A-11D-A33N-01	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	TCGA-C5-A7CH-01A-11D-A340-05	TCGA-C5-A7CH-01A-11R-A342-13	TCGA-C5-A7CH-01A-11D-A33O-09	TCGA-C5-A7CH-01	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	5ecac012-db86-4783-9279-770e325d40b1	09f55b71-b6ee-42a5-96eb-6a2929e35bbf	5ecac012-db86-4783-9279-770e325d40b1	TCGA-C5-A7CH-01A-11D-A33O-09	TCGA-C5-A7CH-01A-11D-A33O-09	TCGA-C5-A7CH-01	TCGA-C5-A7CH-01A-11D-A33N-01	
TCGA-C5-A7CJ-01	1	TCGA-C5-A7CJ-01	3097	1	TCGA-C5-A7CJ	3097	0	3097	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					42	22										margins free of tumor	Other Location, specify			Cisplatin	Stage IIA		-15652					3977	3097				0													0						2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Keratinizing squamous cell carcinoma		30	Pelvic (external iliac, internal iliac, obturator)				G2							NO	2		2	30	true			MX	N1	T2a	TCGA-C5-A7CJ.3EA65A3A-81EC-4121-AFA9-620B37BB23A8.pdf				0	0		5		0		0		0		0		0		100		65			TUMOR FREE	YES	0	YES		No	YES					External beam radiation		Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	2		cervical	A	DECEASED	60	2002			TCGA-C5-A7CJ-01A-11D-A32I-09	723cafa2-ce72-4c19-954b-9be09a1b08e9	TCGA-C5-A7CJ-01A-11D-A32H-01	723cafa2-ce72-4c19-954b-9be09a1b08e9	TCGA-C5-A7CJ-01A-11D-A32T-05	TCGA-C5-A7CJ-01A-11R-A32K-13	TCGA-C5-A7CJ-01A-11D-A32I-09	TCGA-C5-A7CJ-01	723cafa2-ce72-4c19-954b-9be09a1b08e9	027ee271-4f35-4e48-ae98-6056da71830b	723cafa2-ce72-4c19-954b-9be09a1b08e9	027ee271-4f35-4e48-ae98-6056da71830b	TCGA-C5-A7CJ-01A-11D-A32I-09	TCGA-C5-A7CJ-01A-11D-A32I-09	TCGA-C5-A7CJ-01	TCGA-C5-A7CJ-01A-11D-A32H-01	
TCGA-C5-A7CK-01	1	TCGA-C5-A7CK-01	4086	1	TCGA-C5-A7CK	4086	0	4086	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					58															Cisplatin	Stage IVA		-21520					4483	4086				0													0						2014-1-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Keratinizing squamous cell carcinoma							G2							NO			3	40	true						TCGA-C5-A7CK.6E6806E3-7BAD-48EB-AAE9-9C15DAC56B2E.pdf				0	0		5		0		0		0		0		0		100		60			TUMOR FREE	YES	0			No	YES							Primary Tumor	01			1995	YES	NO	YES	C5	Current Reformed Smoker, Duration Not Specified	3		cervical	A	DECEASED	55	2001		6BA5E751-37D0-493C-B9C6-69062263C497	TCGA-C5-A7CK-01A-11D-A32I-09	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	TCGA-C5-A7CK-01A-11D-A32H-01	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	TCGA-C5-A7CK-01A-11D-A32T-05	TCGA-C5-A7CK-01A-11R-A32K-13	TCGA-C5-A7CK-01A-11D-A32I-09	TCGA-C5-A7CK-01	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	2a1580c0-7332-4912-9e76-e0025ead03e8	5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb	2a1580c0-7332-4912-9e76-e0025ead03e8	TCGA-C5-A7CK-01A-11D-A32I-09	TCGA-C5-A7CK-01A-11D-A32I-09	TCGA-C5-A7CK-01	TCGA-C5-A7CK-01A-11D-A32H-01	
TCGA-C5-A7CL-01	1	TCGA-C5-A7CL-01	471	1	TCGA-C5-A7CL	471	0	471	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					48	29														Cisplatin	Stage IIIB		-17869					4090	471				0													0						2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Keratinizing squamous cell carcinoma							G2							NO			3	20	true						TCGA-C5-A7CL.8AC84EA1-1A57-4263-9AA1-832DFAABBA08.pdf	Cervical Cancer			0	0		5		0		15		0		0		0		85		75			WITH TUMOR	YES	0			No	YES							Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	3		cervical	A	DECEASED	103	2002			TCGA-C5-A7CL-01A-11D-A32I-09	131525c8-7f24-48c3-bef9-cc9414e793b8	TCGA-C5-A7CL-01A-11D-A32H-01	131525c8-7f24-48c3-bef9-cc9414e793b8	TCGA-C5-A7CL-01A-11D-A32T-05	TCGA-C5-A7CL-01A-11R-A32K-13	TCGA-C5-A7CL-01A-11D-A32I-09	TCGA-C5-A7CL-01	131525c8-7f24-48c3-bef9-cc9414e793b8	19433c81-83a7-4d2e-881c-b8d41f81325d	131525c8-7f24-48c3-bef9-cc9414e793b8	19433c81-83a7-4d2e-881c-b8d41f81325d	TCGA-C5-A7CL-01A-11D-A32I-09	TCGA-C5-A7CL-01A-11D-A32I-09	TCGA-C5-A7CL-01	TCGA-C5-A7CL-01A-11D-A32H-01	
TCGA-C5-A7CM-01	0	TCGA-C5-A7CM-01	619	0	TCGA-C5-A7CM	619	0	619	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		35			TCGA-C5-A7CM-F63996					HDR							Cisplatin	Stage IB2		-12853					254					0	619			294								0							2014-8-22	FEMALE	168	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO						G2							NO					true						TCGA-C5-A7CM.E9F95E79-28C9-4AA3-B0D7-02B00447B321.pdf							2		0		4		0		0		0		96		75		Post-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1997	2009	YES	NO	YES	C5	Current reformed smoker for < or = 15 years			cervical	A	LIVING	75	2012			TCGA-C5-A7CM-01A-11D-A33O-09	f227e397-0bc7-4e98-a7ea-befd78191cc3	TCGA-C5-A7CM-01A-11D-A33N-01	f227e397-0bc7-4e98-a7ea-befd78191cc3	TCGA-C5-A7CM-01A-11D-A340-05	TCGA-C5-A7CM-01A-11R-A342-13	TCGA-C5-A7CM-01A-11D-A33O-09	TCGA-C5-A7CM-01	f227e397-0bc7-4e98-a7ea-befd78191cc3	8716ea6f-0177-4cd7-94e7-3761bb9f5bf0	f227e397-0bc7-4e98-a7ea-befd78191cc3	8716ea6f-0177-4cd7-94e7-3761bb9f5bf0	TCGA-C5-A7CM-01A-11D-A33O-09	TCGA-C5-A7CM-01A-11D-A33O-09	TCGA-C5-A7CM-01	TCGA-C5-A7CM-01A-11D-A33N-01	
TCGA-C5-A7CO-01	0	TCGA-C5-A7CO-01	4482	0	TCGA-C5-A7CO	4482	0	4482	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		68	20		TCGA-C5-A7CO-F63995												Cisplatin	Stage IB2		-25045					4117					0	4482												0						2014-8-22	FEMALE	158	Cervical Squamous Cell Carcinoma	No								8070/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			5	38	true						TCGA-C5-A7CO.D677E858-2615-413D-859E-5889286B4398.pdf				0	0		4		0		0		0		0		0		100		75			TUMOR FREE	YES	0		Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1972	1995	YES	NO	YES	C5	Current reformed smoker for > 15 years	5		cervical	A	LIVING	98	2002			TCGA-C5-A7CO-01A-11D-A351-09	3292c30c-9fa5-4c11-a6ff-57282c7961fa	TCGA-C5-A7CO-01A-11D-A350-01	3292c30c-9fa5-4c11-a6ff-57282c7961fa	TCGA-C5-A7CO-01A-11D-A357-05	TCGA-C5-A7CO-01A-11R-A358-13	TCGA-C5-A7CO-01A-11D-A351-09	TCGA-C5-A7CO-01	3292c30c-9fa5-4c11-a6ff-57282c7961fa	b5caa3e5-7d64-4e68-9f86-b22c8749cb34	3292c30c-9fa5-4c11-a6ff-57282c7961fa	b5caa3e5-7d64-4e68-9f86-b22c8749cb34	TCGA-C5-A7CO-01A-11D-A351-09	TCGA-C5-A7CO-01A-11D-A351-09	TCGA-C5-A7CO-01	TCGA-C5-A7CO-01A-11D-A350-01	
TCGA-C5-A7UC-01	1	TCGA-C5-A7UC-01	523	1	TCGA-C5-A7UC			523	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					48											margins free of tumor	Other Location, specify		Not done per treating physicians discretion		Stage IB		-17765					3993	523				0																			2014-1-3	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES			20	NO	Non-keratinizing squamous cell carcinoma		27					G3								0				true			M0	N0	T1b	TCGA-C5-A7UC.C9E3A2CF-96E4-4DB5-A47B-9CADB3555A61.pdf							0		0		0		0		0		20		80		95			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			1995	NO	NO	YES	C5				cervical	A	DECEASED		2002			TCGA-C5-A7UC-01A-11D-A351-09	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	TCGA-C5-A7UC-01A-11D-A350-01	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	TCGA-C5-A7UC-01A-11D-A357-05	TCGA-C5-A7UC-01A-11R-A358-13	TCGA-C5-A7UC-01A-11D-A351-09	TCGA-C5-A7UC-01	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	631c966e-5e26-4e3b-9a7f-61aa86c6fd9e	4dfd8634-77b6-40c5-9b01-e9e4e354be1e	631c966e-5e26-4e3b-9a7f-61aa86c6fd9e	TCGA-C5-A7UC-01A-11D-A351-09	TCGA-C5-A7UC-01A-11D-A351-09	TCGA-C5-A7UC-01	TCGA-C5-A7UC-01A-11D-A350-01	
TCGA-C5-A7UE-01	0	TCGA-C5-A7UE-01	4738	0	TCGA-C5-A7UE			4738	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		45	17	6	TCGA-C5-A7UE-F66716					HDR							Cisplatin	Stage IB1	1000 ml	-16473					4375					0	4738												0						2014-10-22	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		NO	23	Pelvic (external iliac, internal iliac, obturator)				G2	Lung			New Primary Tumor			YES	1		3	35	true						TCGA-C5-A7UE.445F27B0-FFBC-474E-A750-04052A852FB2.pdf				0	1		0		0		0		0		0		10		90		95			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES						3060	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	4		cervical	A	LIVING	63	2001			TCGA-C5-A7UE-01A-11D-A33O-09	41a6b734-2741-4d93-8813-ed27b21c81c0	TCGA-C5-A7UE-01A-11D-A33N-01	41a6b734-2741-4d93-8813-ed27b21c81c0	TCGA-C5-A7UE-01A-11D-A340-05	TCGA-C5-A7UE-01A-11R-A342-13	TCGA-C5-A7UE-01A-11D-A33O-09	TCGA-C5-A7UE-01	41a6b734-2741-4d93-8813-ed27b21c81c0	69eec0f0-fd09-45fe-b552-f41b92242a8e	41a6b734-2741-4d93-8813-ed27b21c81c0	69eec0f0-fd09-45fe-b552-f41b92242a8e	TCGA-C5-A7UE-01A-11D-A33O-09	TCGA-C5-A7UE-01A-11D-A33O-09	TCGA-C5-A7UE-01	TCGA-C5-A7UE-01A-11D-A33N-01	
TCGA-C5-A7UH-01	0	TCGA-C5-A7UH-01	3988	0	TCGA-C5-A7UH	3988	0	3988	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		55			TCGA-C5-A7UH-F66737	Former User				HDR							Cisplatin	Stage IIIB		-20189					3604					0	3988												0						2014-10-22	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	10	NO		NO						G3							NO			2		true						TCGA-C5-A7UH.5D5876DB-6A68-4862-8982-8E15F26C9BF9.pdf				0	0		0		0		0		0		0		20		80		95			TUMOR FREE	YES	0			No	YES					External beam radiation		Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	2		cervical	A	LIVING	56	2003			TCGA-C5-A7UH-01A-11D-A351-09	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	TCGA-C5-A7UH-01A-11D-A350-01	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	TCGA-C5-A7UH-01A-11D-A357-05	TCGA-C5-A7UH-01A-11R-A358-13	TCGA-C5-A7UH-01A-11D-A351-09	TCGA-C5-A7UH-01	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	70cb3af5-ae67-4196-88b3-1b9112601052	1bf205a9-a7fb-4a53-8b3d-9943b91481c2	70cb3af5-ae67-4196-88b3-1b9112601052	TCGA-C5-A7UH-01A-11D-A351-09	TCGA-C5-A7UH-01A-11D-A351-09	TCGA-C5-A7UH-01	TCGA-C5-A7UH-01A-11D-A350-01	
TCGA-C5-A7UI-01	1	TCGA-C5-A7UI-01	2888	1	TCGA-C5-A7UI	2888	0	2888	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					42											margins free of tumor	Other Location, specify				Stage IB1		-15349					3221	2888				0																			2014-4-1	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		24					G3							NO	0		3	12	true			MX	N0	T1b1	TCGA-C5-A7UI.A07E7AF1-55EA-4EA1-A5DA-A54E17771CA9.pdf				1			0		0		5		0		0		15		80		95			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			1995		NO	YES	C5	Current smoker	4		cervical	A	DECEASED	86	2004				01d666b4-9605-422a-bfba-231b0d6ef20f	TCGA-C5-A7UI-01A-11D-A36I-01	01d666b4-9605-422a-bfba-231b0d6ef20f	TCGA-C5-A7UI-01A-11D-A36K-05	TCGA-C5-A7UI-01A-11R-A36A-13		TCGA-C5-A7UI-01	01d666b4-9605-422a-bfba-231b0d6ef20f	d7123d15-8f6b-4437-9bec-660a1a638bed	01d666b4-9605-422a-bfba-231b0d6ef20f	d7123d15-8f6b-4437-9bec-660a1a638bed			TCGA-C5-A7UI-01	TCGA-C5-A7UI-01A-11D-A36I-01	
TCGA-C5-A7X3-01	1	TCGA-C5-A7X3-01	284	1	TCGA-C5-A7X3	284	0	284	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					70				Never Used				HDR							Cisplatin|Other	Stage IIIB		-25665					5915	284				0													0						2014-1-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma							G2							NO			7		true		|5 fu RTOG protocol				TCGA-C5-A7X3.34E0772A-D90C-48BE-86CF-E7968CADDFD7.pdf				0	0		10		5		1		5		0		39		60		60			TUMOR FREE	YES	0			No	YES					External beam radiation	3060	Primary Tumor	01			1995	YES	NO	YES	C5	Lifelong Non-smoker	7		cervical	A	DECEASED	79	1997		BB6C8BE2-DCC9-43E3-A15F-19252A08BBA9	TCGA-C5-A7X3-01A-11D-A351-09	fb4a5161-67f4-4679-8d85-bb1843f3b897	TCGA-C5-A7X3-01A-11D-A350-01	fb4a5161-67f4-4679-8d85-bb1843f3b897	TCGA-C5-A7X3-01A-11D-A357-05	TCGA-C5-A7X3-01A-11R-A358-13	TCGA-C5-A7X3-01A-11D-A351-09	TCGA-C5-A7X3-01	fb4a5161-67f4-4679-8d85-bb1843f3b897	2b813912-62bf-4a67-b00f-ad73be7d5559	fb4a5161-67f4-4679-8d85-bb1843f3b897	2b813912-62bf-4a67-b00f-ad73be7d5559	TCGA-C5-A7X3-01A-11D-A351-09	TCGA-C5-A7X3-01A-11D-A351-09	TCGA-C5-A7X3-01	TCGA-C5-A7X3-01A-11D-A350-01	
TCGA-C5-A7X5-01	1	TCGA-C5-A7X5-01	414	1	TCGA-C5-A7X5	414	0	414	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					72								HDR							Carboplatin|Other	Stage IVB		-26542					3836	414				0																			2014-1-3	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Keratinizing squamous cell carcinoma							G3							NO					true		|Taxol				TCGA-C5-A7X5.0807894B-043D-4074-85C4-6C7BFB2C8C54.pdf	Cervical Cancer						5		3		0		2		0		20		80		80			WITH TUMOR	YES				No	YES							Primary Tumor	01			1995	YES	NO	YES	C5				cervical	A	DECEASED	59	2003				39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	TCGA-C5-A7X5-01A-11D-A36I-01	39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	TCGA-C5-A7X5-01A-11D-A36K-05	TCGA-C5-A7X5-01A-11R-A36A-13		TCGA-C5-A7X5-01	39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	f50365c4-feff-46fd-8c93-c4359c580c91	39d645d6-f7ca-4a01-a3b0-5ae3754c8a68	f50365c4-feff-46fd-8c93-c4359c580c91			TCGA-C5-A7X5-01	TCGA-C5-A7X5-01A-11D-A36I-01	
TCGA-C5-A7X8-01	0	TCGA-C5-A7X8-01	83	0	TCGA-C5-A7X8	83	0	83	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					35	25							HDR			margins free of tumor	Other Location, specify			Cisplatin	Stage IB1		-12977					3868					0	83												0						2014-1-3	FEMALE	170	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO			27	Pelvic (external iliac, internal iliac, obturator)		PRESENT		G2							NO	1		2	5	true			M0	N1	T2a	TCGA-C5-A7X8.06979EDA-C06B-46E7-A4B0-C20D1E340F4B.pdf				1	0		2		0		0		0		15		5		80		80			TUMOR FREE	YES	0	YES		No	YES					External beam radiation	720	Primary Tumor	01			1995	YES	NO	YES	C5	Current smoker	3		cervical	A	LIVING	74	2003				7a835fc9-6dfb-464a-bbe0-d42782abab4c	TCGA-C5-A7X8-01A-11D-A36I-01	7a835fc9-6dfb-464a-bbe0-d42782abab4c	TCGA-C5-A7X8-01A-11D-A36K-05	TCGA-C5-A7X8-01A-11R-A36A-13		TCGA-C5-A7X8-01	7a835fc9-6dfb-464a-bbe0-d42782abab4c	a24f0462-fe29-4283-bf7f-4a33f1bad9ea	7a835fc9-6dfb-464a-bbe0-d42782abab4c	a24f0462-fe29-4283-bf7f-4a33f1bad9ea			TCGA-C5-A7X8-01	TCGA-C5-A7X8-01A-11D-A36I-01	
TCGA-C5-A7XC-01	0	TCGA-C5-A7XC-01	1551	0	TCGA-C5-A7XC	1551	0	1551	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					26			TCGA-C5-A7XC-F66722								margins free of tumor	Other Location, specify				Stage IB1		-9776					3358					0	1551																		2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	30	NO		YES	42					G2							NO	0		1	5	true			M0	N0	T1b	TCGA-C5-A7XC.5BE71CCD-AA13-4B9E-BD99-2122F9A00B3A.pdf							0		0		0		0		0		40		60		60			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			1995		NO	YES	C5	Current smoker	1		cervical	A	LIVING	53	2004				8130cfd8-49c8-429d-b559-7ff8f1d359fa	TCGA-C5-A7XC-01A-11D-A386-01	8130cfd8-49c8-429d-b559-7ff8f1d359fa	TCGA-C5-A7XC-01A-11D-A388-05	TCGA-C5-A7XC-01A-11R-A38M-13		TCGA-C5-A7XC-01	8130cfd8-49c8-429d-b559-7ff8f1d359fa	04472113-b3fd-42c0-bfe4-dd50133d9ad4	8130cfd8-49c8-429d-b559-7ff8f1d359fa	04472113-b3fd-42c0-bfe4-dd50133d9ad4			TCGA-C5-A7XC-01	TCGA-C5-A7XC-01A-11D-A386-01	
TCGA-C5-A8XH-01	1	TCGA-C5-A8XH-01	1394	1	TCGA-C5-A8XH	1394	0	1394	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					39											margins free of tumor	Other Location, specify				Stage IB1		-14444						1394				0																			2014-4-17	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Keratinizing squamous cell carcinoma		33												NO	0		2	20				MX	N0	T1b1																									TUMOR FREE	NO		YES		No	NO							Primary Tumor	01		2007	2009		NO	YES	C5	Current reformed smoker for < or = 15 years	2		cervical		DECEASED	60	2007				ea9fda3a-9efa-4847-aea0-d85f22ab14ca	TCGA-C5-A8XH-01A-11D-A37M-01	ea9fda3a-9efa-4847-aea0-d85f22ab14ca	TCGA-C5-A8XH-01A-11D-A37Q-05	TCGA-C5-A8XH-01A-11R-A37P-13		TCGA-C5-A8XH-01	ea9fda3a-9efa-4847-aea0-d85f22ab14ca	fa777d75-36ec-4503-aa97-b9ea658a7f36	ea9fda3a-9efa-4847-aea0-d85f22ab14ca	fa777d75-36ec-4503-aa97-b9ea658a7f36			TCGA-C5-A8XH-01	TCGA-C5-A8XH-01A-11D-A37M-01	
TCGA-C5-A8XI-01	0	TCGA-C5-A8XI-01	254	0	TCGA-C5-A8XI	254	0	254	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					69	29		TCGA-C5-A8XI-F66724								margins free of tumor	Other Location, specify				Stage IB2		-25220					2069					0	254																		2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	YES	10				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		4	57	true			MX	N0	T1b2	TCGA-C5-A8XI.57D0E001-5535-4687-B04D-5CBEF5D6EF6F.pdf				1			10		0		0		0		0		15		85		85			TUMOR FREE	YES		YES		No	YES							Primary Tumor	01			1995		NO	YES	C5	Current smoker	5		cervical	A	LIVING		2008		49680150-87AC-4D5E-A4CE-CE96E2997D53		d1d352f8-4919-4288-8e6a-bbf550a7236b	TCGA-C5-A8XI-01A-11D-A37M-01	d1d352f8-4919-4288-8e6a-bbf550a7236b	TCGA-C5-A8XI-01A-11D-A37Q-05	TCGA-C5-A8XI-01A-11R-A37P-13		TCGA-C5-A8XI-01	d1d352f8-4919-4288-8e6a-bbf550a7236b	e54ccb6e-1a9d-46fe-95fa-fb9a0ecf527b	d1d352f8-4919-4288-8e6a-bbf550a7236b	e54ccb6e-1a9d-46fe-95fa-fb9a0ecf527b			TCGA-C5-A8XI-01	TCGA-C5-A8XI-01A-11D-A37M-01	
TCGA-C5-A8XJ-01	0	TCGA-C5-A8XJ-01	4467	0	TCGA-C5-A8XJ	4467	0	4467	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		74			TCGA-C5-A8XJ-F66731													Stage IB		-27087					4175					0	4467																		2014-10-22	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		NO													NO			4		true						TCGA-C5-A8XJ.0758C57C-F182-48E1-BEA7-27C5B9206FB9.pdf							5		0		0		0		15		15		70		70			TUMOR FREE	YES		NO		Yes	YES							Primary Tumor	01			1995		NO	YES	C5	Lifelong Non-smoker	4		cervical	A	LIVING	114	2002		E396C1F2-2B80-413F-822F-056FA27A5C88		971dec7f-6cb5-4575-85f7-be59097ae606	TCGA-C5-A8XJ-01A-11D-A37M-01	971dec7f-6cb5-4575-85f7-be59097ae606	TCGA-C5-A8XJ-01A-11D-A37Q-05	TCGA-C5-A8XJ-01A-11R-A37P-13		TCGA-C5-A8XJ-01	971dec7f-6cb5-4575-85f7-be59097ae606	1c3311b2-3832-4a0f-9e5c-be71dc163493	971dec7f-6cb5-4575-85f7-be59097ae606	1c3311b2-3832-4a0f-9e5c-be71dc163493			TCGA-C5-A8XJ-01	TCGA-C5-A8XJ-01A-11D-A37M-01	
TCGA-C5-A8XK-01	0	TCGA-C5-A8XK-01	3039	0	TCGA-C5-A8XK	3039	0	3039	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					30			TCGA-C5-A8XK-F66732															-11268					4840					0	3039																		2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO		YES						G3							NO					true						TCGA-C5-A8XK.1F6ED6D4-2EF5-4F87-8F4E-08CD7834A2E5.pdf							3		3		0		3		0		15		85		85			TUMOR FREE	YES		NO		No	YES							Primary Tumor	01				YES	NO	YES	C5				cervical	A	LIVING		2000				94f22e5d-e471-4add-9291-27bc5c96a519	TCGA-C5-A8XK-01A-11D-A37M-01	94f22e5d-e471-4add-9291-27bc5c96a519	TCGA-C5-A8XK-01A-11D-A37Q-05	TCGA-C5-A8XK-01A-11R-A37P-13		TCGA-C5-A8XK-01	94f22e5d-e471-4add-9291-27bc5c96a519	a98c4cec-7643-4512-ba5e-fd0a44e913ef	94f22e5d-e471-4add-9291-27bc5c96a519	a98c4cec-7643-4512-ba5e-fd0a44e913ef			TCGA-C5-A8XK-01	TCGA-C5-A8XK-01A-11D-A37M-01	
TCGA-C5-A8YQ-01	1	TCGA-C5-A8YQ-01	715	1	TCGA-C5-A8YQ	715	0	715	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					79	23															Stage IB1		-28873						715				0																			2014-4-17	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)					23				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	3		1	56								Cervical Cancer																							WITH TUMOR	YES		YES		No	YES							Primary Tumor	01			1995		NO	YES	C5	Current smoker	2		cervical		DECEASED	70	2006				f11b075c-7ada-4945-b3a2-2eee097c077d	TCGA-C5-A8YQ-01A-11D-A37M-01	f11b075c-7ada-4945-b3a2-2eee097c077d	TCGA-C5-A8YQ-01A-11D-A37Q-05	TCGA-C5-A8YQ-01A-11R-A37P-13		TCGA-C5-A8YQ-01	f11b075c-7ada-4945-b3a2-2eee097c077d	c085861c-602a-4bf0-8b99-56df4e7b260f	f11b075c-7ada-4945-b3a2-2eee097c077d	c085861c-602a-4bf0-8b99-56df4e7b260f			TCGA-C5-A8YQ-01	TCGA-C5-A8YQ-01A-11D-A37M-01	
TCGA-C5-A8YR-01	1	TCGA-C5-A8YR-01	837	1	TCGA-C5-A8YR			837	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					56																Stage IB		-20672					7049	837				0																			2014-4-1	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO	Non-keratinizing squamous cell carcinoma		29					G3							YES	0		4		true			M0	N0	T1b	TCGA-C5-A8YR.C808B5E4-A426-4E68-9BFE-A98533562FD4.pdf				2			10		0		0		2		15		25		60		60				NO		YES		No	NO							Primary Tumor	01			1988		NO	YES	C5	Lifelong Non-smoker	6		cervical	A	DECEASED	80	1994				073d66b5-917e-45e3-8104-b8d4dfa28e6b	TCGA-C5-A8YR-01A-12D-A37M-01	073d66b5-917e-45e3-8104-b8d4dfa28e6b	TCGA-C5-A8YR-01A-12D-A37Q-05	TCGA-C5-A8YR-01A-12R-A37P-13		TCGA-C5-A8YR-01	073d66b5-917e-45e3-8104-b8d4dfa28e6b	625f78c1-6dd9-4975-8d17-d30b6c55b9eb	073d66b5-917e-45e3-8104-b8d4dfa28e6b	625f78c1-6dd9-4975-8d17-d30b6c55b9eb			TCGA-C5-A8YR-01	TCGA-C5-A8YR-01A-12D-A37M-01	
TCGA-C5-A8YT-01	1	TCGA-C5-A8YT-01	633	1	TCGA-C5-A8YT	633	0	633	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					36	16		TCGA-C5-A8YT-F66723	Never Used												Stage IB1		-13253					1939	633				0	186																		2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO						G3							NO			3	20	true						TCGA-C5-A8YT.78E3AF70-E5A9-4A7F-ABD1-4E08238EAB9D.pdf							5		1		0		1		10		15		75		75			WITH TUMOR	YES		NO		No	YES							Primary Tumor	01			1995		NO	YES	C5	Current smoker	3		cervical	A	DECEASED		2008				6cec0faf-100b-48b0-9221-fb1be7ff8597	TCGA-C5-A8YT-01A-11D-A37M-01	6cec0faf-100b-48b0-9221-fb1be7ff8597	TCGA-C5-A8YT-01A-11D-A37Q-05	TCGA-C5-A8YT-01A-11R-A37P-13		TCGA-C5-A8YT-01	6cec0faf-100b-48b0-9221-fb1be7ff8597	b83a5438-fd3d-428c-b865-2a1c151aadaf	6cec0faf-100b-48b0-9221-fb1be7ff8597	b83a5438-fd3d-428c-b865-2a1c151aadaf			TCGA-C5-A8YT-01	TCGA-C5-A8YT-01A-11D-A37M-01	
TCGA-C5-A8ZZ-01	0	TCGA-C5-A8ZZ-01	636	0	TCGA-C5-A8ZZ	636	0	636	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					41	21		TCGA-C5-A8ZZ-F66736													Stage IIB		-15262					3023					0	636												0						2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Cone Biopsy / LEEP	70	NO	Keratinizing squamous cell carcinoma	YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			4	20	false						TCGA-C5-A8ZZ.38E42051-6D04-4C54-BA9A-8206CC0AFBCB.pdf				0	0		60		20		10		40		0		20		70		70			TUMOR FREE	YES	0			No	YES							Primary Tumor	01			1995		NO	YES	C5	Current smoker	4		cervical	A	LIVING		2005				5f23cd19-f7f0-43e3-961d-0236da5f49ae	TCGA-C5-A8ZZ-01A-11D-A37M-01	5f23cd19-f7f0-43e3-961d-0236da5f49ae	TCGA-C5-A8ZZ-01A-11D-A37Q-05	TCGA-C5-A8ZZ-01A-11R-A37P-13		TCGA-C5-A8ZZ-01	5f23cd19-f7f0-43e3-961d-0236da5f49ae	dffe3861-733c-45ed-9a54-56695803762d	5f23cd19-f7f0-43e3-961d-0236da5f49ae	dffe3861-733c-45ed-9a54-56695803762d			TCGA-C5-A8ZZ-01	TCGA-C5-A8ZZ-01A-11D-A37M-01	
TCGA-C5-A901-01	0	TCGA-C5-A901-01	518	0	TCGA-C5-A901	518	0	518	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44			TCGA-C5-A901-F66739									Positive vaginal margin						-16186					4811					0	518																		2014-10-22	FEMALE	166	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	20	NO	Keratinizing squamous cell carcinoma	YES	19	Pelvic (external iliac, internal iliac, obturator)				G2							NO	2			2	false			MX	N1	TX	TCGA-C5-A901.5190FB9E-E28B-4CAB-9FB1-9DF839F2D977.pdf							40		20		10		20		0		20		70		70			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			5th		NO	YES	C5	Current Reformed Smoker, Duration Not Specified	0		cervical	A	LIVING	54	2000				8f532265-5436-4bd8-9766-4b768c84514a		8f532265-5436-4bd8-9766-4b768c84514a	TCGA-C5-A901-01A-11D-A37Q-05	TCGA-C5-A901-01A-11R-A37P-13			8f532265-5436-4bd8-9766-4b768c84514a		8f532265-5436-4bd8-9766-4b768c84514a				TCGA-C5-A901-01		
TCGA-C5-A902-01	0	TCGA-C5-A902-01	149	0	TCGA-C5-A902	149	0	149	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					35	14		TCGA-C5-A902-F66734													Stage IB2		-12959					1829					0	149																		2014-10-22	FEMALE	177	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		YES						G3							NO			1	21	false						TCGA-C5-A902.72D0C467-BF42-45A3-B472-00652B7B1705.pdf							40		20		10		20		0		10		80		80			TUMOR FREE	YES		NO		No	YES							Primary Tumor	01			2009		NO	YES	C5	Current smoker	1		cervical	A	LIVING	83	2008				7a1a71ad-c117-4091-bc20-88617bcb99d9		7a1a71ad-c117-4091-bc20-88617bcb99d9	TCGA-C5-A902-01A-11D-A37Q-05	TCGA-C5-A902-01A-11R-A37P-13			7a1a71ad-c117-4091-bc20-88617bcb99d9		7a1a71ad-c117-4091-bc20-88617bcb99d9				TCGA-C5-A902-01		
TCGA-C5-A905-01	0	TCGA-C5-A905-01	4879	0	TCGA-C5-A905	4879	0	4879	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					37			TCGA-C5-A905-F66740													Stage IB		-13584					7129					0	4879																		2014-10-22	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma	YES	33					G2							NO	0		9		false			MX	N0	T1b	TCGA-C5-A905.A2899C0E-696C-4613-8443-35FDC795CD01.pdf							4		0		5		1		5		15		75		75			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			1988		NO	YES	C5		9		cervical	A	LIVING	73	1994				729d243c-73f2-42d2-8737-55275a062a8f		729d243c-73f2-42d2-8737-55275a062a8f	TCGA-C5-A905-01A-11D-A37Q-05	TCGA-C5-A905-01A-11R-A37P-13			729d243c-73f2-42d2-8737-55275a062a8f		729d243c-73f2-42d2-8737-55275a062a8f				TCGA-C5-A905-01		
TCGA-C5-A907-01	0	TCGA-C5-A907-01	361	0	TCGA-C5-A907	361	0	361	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		47	17	6	TCGA-C5-A907-F66735												Cisplatin	Stage IB2		-17304					48					0	361										Once weekly								2014-10-22	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO		NO						G2							NO			3		false						TCGA-C5-A907.6AC8C0C6-A43A-427E-90D3-6584FC2F723E.pdf				1			8		1		5		1		10		15		70		70			TUMOR FREE	YES		NO		No	YES						4860	Primary Tumor	01		2006	2009	YES	NO	YES	C5	Current reformed smoker for < or = 15 years	4		cervical	A	LIVING	95	2013		2396FB56-1204-4736-8BD4-7C40A569A39E		13b52657-459f-45f6-a4ce-a2da459104ac	TCGA-C5-A907-01A-11D-A37M-01	13b52657-459f-45f6-a4ce-a2da459104ac	TCGA-C5-A907-01A-11D-A37Q-05	TCGA-C5-A907-01A-11R-A37P-13		TCGA-C5-A907-01	13b52657-459f-45f6-a4ce-a2da459104ac	4bf3bf35-46c9-4f3b-beab-282f949e19bc	13b52657-459f-45f6-a4ce-a2da459104ac	4bf3bf35-46c9-4f3b-beab-282f949e19bc			TCGA-C5-A907-01	TCGA-C5-A907-01A-11D-A37M-01	
TCGA-DG-A2KH-01	0	TCGA-DG-A2KH-01	34	0	TCGA-DG-A2KH			34	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					25			TCGA-DG-A2KH-F49830						ABSENT	The pelvic nodules show circumscribed area of adipose tissue with local fat necrosis. No evidence of malignancy within this pelvic nodule.						Stage IB1		-9209										0	34											0							2013-10-11	FEMALE		Adenosquamous	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO		YES	12			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX								0	0	1		false			M0	N0	T1b1	TCGA-DG-A2KH.E92814BB-F3A7-45E6-9F18-B775CD53693F.pdf							40		10		10		30		0		10		80		80		Pre-Adjuvant Therapy				YES		No								Primary Tumor	01			1995		NO	YES	DG	Current reformed smoker for < or = 15 years			cervical	A	LIVING				857EBB46-CE0C-4F46-80F5-DFDD54ECC704	TCGA-DG-A2KH-01A-21D-A22X-09	a5793d2b-3dec-477f-b29b-163d235431ac	TCGA-DG-A2KH-01A-21D-A22W-01	a5793d2b-3dec-477f-b29b-163d235431ac	TCGA-DG-A2KH-01A-21D-A230-05	TCGA-DG-A2KH-01A-21R-A22V-13	TCGA-DG-A2KH-01A-21D-A22X-09	TCGA-DG-A2KH-01	a5793d2b-3dec-477f-b29b-163d235431ac	429961e2-a202-4f7f-99f4-4a159b480c28	a5793d2b-3dec-477f-b29b-163d235431ac	429961e2-a202-4f7f-99f4-4a159b480c28	TCGA-DG-A2KH-01A-21D-A22X-09	TCGA-DG-A2KH-01A-21D-A22X-09	TCGA-DG-A2KH-01	TCGA-DG-A2KH-01A-21D-A22W-01	
TCGA-DG-A2KJ-01	0	TCGA-DG-A2KJ-01	1791	0	TCGA-DG-A2KJ	1791	0	1791	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		50		5	TCGA-DG-A2KJ-F49764						ABSENT						Cisplatin	Stage IIIB												0	1791								Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0							2013-10-10	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	endometrial biopsy	Other method, specify:	40	NO	Non-keratinizing squamous cell carcinoma	NO	23	Pelvic (external iliac, internal iliac, obturator)				G3							NO	1				false			M0	N1	T1b	TCGA-DG-A2KJ.F5EBC22F-D2D9-4944-9A24-390811798F5B.pdf							60		10		5		10		0		15		80		80		Pre-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	DG				cervical	A	LIVING		2006			TCGA-DG-A2KJ-01A-11D-A18J-09	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	TCGA-DG-A2KJ-01A-11D-A18H-01	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	TCGA-DG-A2KJ-01A-11D-A18K-05	TCGA-DG-A2KJ-01A-11R-A18L-13	TCGA-DG-A2KJ-01A-11D-A18J-09	TCGA-DG-A2KJ-01	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	78d79502-304f-49e4-9845-32675036e06b	c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc	78d79502-304f-49e4-9845-32675036e06b	TCGA-DG-A2KJ-01A-11D-A18J-09	TCGA-DG-A2KJ-01A-11D-A18J-09	TCGA-DG-A2KJ-01	TCGA-DG-A2KJ-01A-11D-A18H-01	
TCGA-DG-A2KK-01	0	TCGA-DG-A2KK-01	1544	0	TCGA-DG-A2KK	1544	0	1544	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		51	27	5	TCGA-DG-A2KK-F49821						ABSENT						Cisplatin	Stage IIIB												0	1544								Bladder AbsentParametrium AbsentPelvic Nodes Present	Bladder AbsentParametrium AbsentPelvic Nodes Present|		0							2013-10-11	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	280	NO		NO	28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	2	0		25	false			M0	N1	T1b1	TCGA-DG-A2KK.D01A3CDE-6669-434E-800D-3344E2A5FA48.pdf							60		10		5		10		0		25		70		70		Pre-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01		2007	1995	YES	NO	YES	DG	Current reformed smoker for < or = 15 years	0		cervical	A	LIVING	64	2007		E86D642C-A5D4-4D95-9BD0-16FEB48F2960	TCGA-DG-A2KK-01A-11D-A17W-09	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	TCGA-DG-A2KK-01A-11D-A17U-01	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	TCGA-DG-A2KK-01A-11D-A17Z-05	TCGA-DG-A2KK-01A-11R-A17X-13	TCGA-DG-A2KK-01A-11D-A17W-09	TCGA-DG-A2KK-01	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	267f3c42-0e84-4a22-9e23-64aae5439831	b58a46e6-797d-4f88-88ef-932d0d2a6f6e	267f3c42-0e84-4a22-9e23-64aae5439831	TCGA-DG-A2KK-01A-11D-A17W-09	TCGA-DG-A2KK-01A-11D-A17W-09	TCGA-DG-A2KK-01	TCGA-DG-A2KK-01A-11D-A17U-01	
TCGA-DG-A2KL-01	0	TCGA-DG-A2KL-01	1367	0	TCGA-DG-A2KL	1367	0	1367	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		53		5	TCGA-DG-A2KL-F61032			2100			ABSENT			Positive vaginal margin			Cisplatin	Stage IIA		-19539										0	1367								Bladder AbsentParametrium AbsentPelvic Nodes Absent|			0	0						2014-6-20	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Dilation and curettage	Other method, specify:	380	NO	Keratinizing squamous cell carcinoma	YES	8			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	0	5	25	false			M0	N0	T2a	TCGA-DG-A2KL.A0EED671-A0A6-4F3E-86B2-AB8277B134ED.pdf				0	0		60		10		5		20		0		25		70		70		Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	DG	Current smoker	5		cervical	A	LIVING	75			5BF84867-52E7-4E3A-9B13-944FA8E8EAC4	TCGA-DG-A2KL-01A-11D-A17W-09	b107d3e2-8d45-425c-9aa7-0293463b6d66	TCGA-DG-A2KL-01A-11D-A17U-01	b107d3e2-8d45-425c-9aa7-0293463b6d66	TCGA-DG-A2KL-01A-11D-A17Z-05	TCGA-DG-A2KL-01A-11R-A17X-13	TCGA-DG-A2KL-01A-11D-A17W-09	TCGA-DG-A2KL-01	b107d3e2-8d45-425c-9aa7-0293463b6d66	030e5697-5832-48a2-8d60-3ee898cb5253	b107d3e2-8d45-425c-9aa7-0293463b6d66	030e5697-5832-48a2-8d60-3ee898cb5253	TCGA-DG-A2KL-01A-11D-A17W-09	TCGA-DG-A2KL-01A-11D-A17W-09	TCGA-DG-A2KL-01	TCGA-DG-A2KL-01A-11D-A17U-01	
TCGA-DG-A2KM-01	0	TCGA-DG-A2KM-01	1218	0	TCGA-DG-A2KM	1218	0	1218	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		46		2	TCGA-DG-A2KM-F49776	Former User					ABSENT						Cisplatin	Stage IB1		-16808											1218								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0			4500				2013-10-10	FEMALE	169	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO		NO	9	Pelvic (external iliac, internal iliac, obturator)		ABSENT		G2							NO	4	0	2		false			M0	N1	T1b1	TCGA-DG-A2KM.CDF128FF-AEED-450F-B882-09A020F3DB36.pdf							60		10		0		10		0		10		90		90		Pre-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	5500	Primary Tumor	01			1995	YES	NO	YES	DG	Lifelong Non-smoker	2		cervical	A	LIVING		2008		655D5978-8AF4-42DB-9ADB-801D8ACEDFB8	TCGA-DG-A2KM-01A-11D-A17W-09	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	TCGA-DG-A2KM-01A-11D-A17U-01	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	TCGA-DG-A2KM-01A-11D-A17Z-05	TCGA-DG-A2KM-01A-11R-A17X-13	TCGA-DG-A2KM-01A-11D-A17W-09	TCGA-DG-A2KM-01	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	94c3c91f-112e-442c-93a3-20a0804d201d	04bf866a-cb97-4e47-a3dd-2fe2e0c5d123	94c3c91f-112e-442c-93a3-20a0804d201d	TCGA-DG-A2KM-01A-11D-A17W-09	TCGA-DG-A2KM-01A-11D-A17W-09	TCGA-DG-A2KM-01	TCGA-DG-A2KM-01A-11D-A17U-01	
TCGA-DR-A0ZL-01	0	TCGA-DR-A0ZL-01	2669	0	TCGA-DR-A0ZL	2669	0	2669	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	53			TCGA-DR-A0ZL-F17115	Never Used					ABSENT							Stage IB		-19384					2384		9			0	2669				4				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0	0				NO	Scheduled Follow-up Submission	2011-3-28	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma		24			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	1		false			M0	N0	T1b1	TCGA-DR-A0ZL.6CE9D5FB-FE9B-4727-974E-43691EF974F6.pdf				0	0	35	40	1	1	3	0	40	2	60	0	12	20	25	80	6	80		Preoperative	TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Other						Primary Tumor	01			2009		NO	YES	DR	Lifelong Non-smoker	1	Complete response	cervical	A	LIVING	57	2004	TCGA-DR-A0ZL-01A-11D-A10S-08		TCGA-DR-A0ZL-01A-11D-A10S-08	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01A-11D-A10T-01	6252138d-526e-4ed4-8369-7d6e4bde3fbe	TCGA-DR-A0ZL-01A-11D-A10W-05	TCGA-DR-A0ZL-01A-11R-A10V-13	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01	6252138d-526e-4ed4-8369-7d6e4bde3fbe	a2376928-2447-4b6b-a544-9fc2e23c3d94	6252138d-526e-4ed4-8369-7d6e4bde3fbe	a2376928-2447-4b6b-a544-9fc2e23c3d94	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01A-11D-A10S-08	TCGA-DR-A0ZL-01	TCGA-DR-A0ZL-01A-11D-A10T-01	TCGA-DR-A0ZL-01A-11D-A10S-08
TCGA-DR-A0ZM-01	0	TCGA-DR-A0ZM-01	1791	0	TCGA-DR-A0ZM	1791	0	1791	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	61	30	6	TCGA-DR-A0ZM-F17116	Former User					PRESENT		Patient had clear margins	Other Location, specify			Cisplatin	Stage IIIB		-22464					1506		8	519	521	0	1791			8	1289	92	55		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		0		Completed as Planned		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO	Scheduled Follow-up Submission	2011-3-28	FEMALE	158	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	90	NO	Non-keratinizing squamous cell carcinoma		58	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3	15	false			M0	N0	T2b	TCGA-DR-A0ZM.14F05EE0-B739-42F8-99B0-0628ABB1B634.pdf				1		25	20	0	0	0	0	2	3	0	0	40	50	60	50	60	50		Post-Adjuvant Therapy	TUMOR FREE			YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	DR	Current smoker	4	Complete response	cervical	A	LIVING	64	2006	TCGA-DR-A0ZM-01A-12D-A10S-08		TCGA-DR-A0ZM-01A-12D-A10S-08	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01A-12D-A10T-01	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	TCGA-DR-A0ZM-01A-12D-A10W-05	TCGA-DR-A0ZM-01A-12R-A10V-13	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	6380fdfc-a71e-486a-9024-f06e81240f17	dfb5da30-7995-4132-8bc9-439b0f4f7c4c	6380fdfc-a71e-486a-9024-f06e81240f17	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01A-12D-A10S-08	TCGA-DR-A0ZM-01	TCGA-DR-A0ZM-01A-12D-A10T-01	TCGA-DR-A0ZM-01A-12D-A10S-08
TCGA-DS-A0VK-01	1	TCGA-DS-A0VK-01	1118	1	TCGA-DS-A0VK			1118	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45				Never Used					ABSENT			Positive vaginal margin				Stage IB		-16792					5025	1118	-1			0				-71					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2011-2-3	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	210	NO	Keratinizing squamous cell carcinoma		16	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3								1	0	1		true			M0	N1	T1b1	TCGA-DS-A0VK.0E3B9035-0498-4DDB-B2CD-12C823C5521B.pdf				0	3	0	12	0	0	0	5	0	1	0	35	20	10	80	50	70	60		Preoperative	WITH TUMOR		0			No								Primary Tumor	01					NO	YES	DS	Current reformed smoker for < or = 15 years	4	Progression	cervical	A	DECEASED	52	1996	TCGA-DS-A0VK-01A-21D-A10S-08	4FB37041-5A5A-492B-B730-CE4D9D0839F7	TCGA-DS-A0VK-01A-21D-A10S-08	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01A-21D-A10T-01	7e67a342-4e90-47f9-9c95-03d32009e858	TCGA-DS-A0VK-01A-21D-A10W-05	TCGA-DS-A0VK-01A-21R-A10V-13	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01	7e67a342-4e90-47f9-9c95-03d32009e858	a434839c-d61f-4864-ad76-ae82588e21e1	7e67a342-4e90-47f9-9c95-03d32009e858	a434839c-d61f-4864-ad76-ae82588e21e1	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01A-21D-A10S-08	TCGA-DS-A0VK-01	TCGA-DS-A0VK-01A-21D-A10T-01	TCGA-DS-A0VK-01A-21D-A10S-08
TCGA-DS-A0VL-01	0	TCGA-DS-A0VL-01	81	0	TCGA-DS-A0VL			81	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					25				Never Used					ABSENT		Posterior radical soft tissue	Other Location, specify				Stage IB		-9186					3243					0	81			0								0	0				NO		2011-1-7	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma		8			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								0	0	4		true			M0	N0	T1b1	TCGA-DS-A0VL.89391955-6647-4F46-969D-9AC4205B2D9C.pdf				1	0	0	0	0	0	0	0	0	0	0	0	0	0	100	100	75	75		Preoperative	TUMOR FREE		0			No								Primary Tumor	01					NO	YES	DS	Lifelong Non-smoker	5	Complete response	cervical	A	LIVING	86	2001	TCGA-DS-A0VL-01A-21D-A10S-08	8B8C4526-49B9-4DF0-9298-772F08C6CC21	TCGA-DS-A0VL-01A-21D-A10S-08	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01A-21D-A10T-01	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	TCGA-DS-A0VL-01A-21D-A10W-05	TCGA-DS-A0VL-01A-21R-A10V-13	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	5a7202f1-1877-44e5-aef6-7a870a73d7bf	b9e35423-81e4-4ffe-b08a-4bb93b3cf976	5a7202f1-1877-44e5-aef6-7a870a73d7bf	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01A-21D-A10S-08	TCGA-DS-A0VL-01	TCGA-DS-A0VL-01A-21D-A10T-01	TCGA-DS-A0VL-01A-21D-A10S-08
TCGA-DS-A0VM-01	0	TCGA-DS-A0VM-01	3589	0	TCGA-DS-A0VM	3589	0	3589	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		51			TCGA-DS-A0VM-F53351	Former User					ABSENT		No involved margins. Margins clear as per pathology report.	Other Location, specify				Stage IB		-18839					2813		1			0	3589			0					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2013-12-11	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma	NO	21	Other Location, specify	Parametrial	PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1	0	2		true			M0	N1	T1b1	TCGA-DS-A0VM.7C9830C1-15CB-4D38-8995-3A061E80741F.pdf				0	0	0	0	0	0	0	0	0	0	0	0	20	0	80	100	75	75		Preoperative	TUMOR FREE	YES	0		Complete Remission/Response	No	NO							Primary Tumor	01					NO	YES	DS	Lifelong Non-smoker	2	Complete response	cervical	A	LIVING	69	2003	TCGA-DS-A0VM-01A-11D-A10S-08	B2E5BD97-D176-4560-8FC7-B082EF9A66E9	TCGA-DS-A0VM-01A-11D-A10S-08	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01A-11D-A10T-01	16ced370-3e97-40a5-9743-6bdd7bbc37d3	TCGA-DS-A0VM-01A-11D-A10W-05	TCGA-DS-A0VM-01A-11R-A10V-13	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01	16ced370-3e97-40a5-9743-6bdd7bbc37d3	bdad6a1c-e145-4f34-86ce-a64b32964492	16ced370-3e97-40a5-9743-6bdd7bbc37d3	bdad6a1c-e145-4f34-86ce-a64b32964492	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01A-11D-A10S-08	TCGA-DS-A0VM-01	TCGA-DS-A0VM-01A-11D-A10T-01	TCGA-DS-A0VM-01A-11D-A10S-08
TCGA-DS-A0VN-01	0	TCGA-DS-A0VN-01	3609	0	TCGA-DS-A0VN	3609	0	3609	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		47			TCGA-DS-A0VN-F53350	Former User					ABSENT		deep cervical	Other Location, specify				Stage IB		-17433					2831		8			0	3609			18					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO		2013-12-11	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma	NO	19			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2		true			M0	N0	T1b2	TCGA-DS-A0VN.F98AC018-6C95-44F5-BEF4-4A5C422970C4.pdf				0	2	0	0	0	0	0	0	0	0	0	0	0	20	100	80	65	45		Preoperative	TUMOR FREE	YES	0		Complete Remission/Response	No	YES							Primary Tumor	01					NO	YES	DS	Lifelong Non-smoker	4	Complete response	cervical	A	LIVING	81	2002	TCGA-DS-A0VN-01A-21D-A10S-08	A833FC95-34C0-4E8B-82C6-BE2E99E23411	TCGA-DS-A0VN-01A-21D-A10S-08	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01A-21D-A10T-01	1fc14ee0-e307-4349-a2ac-9e28c31163f2	TCGA-DS-A0VN-01A-21D-A10W-05	TCGA-DS-A0VN-01A-21R-A10V-13	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01	1fc14ee0-e307-4349-a2ac-9e28c31163f2	8de3225c-9ab8-4161-890b-e1ca3dd4c020	1fc14ee0-e307-4349-a2ac-9e28c31163f2	8de3225c-9ab8-4161-890b-e1ca3dd4c020	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01A-21D-A10S-08	TCGA-DS-A0VN-01	TCGA-DS-A0VN-01A-21D-A10T-01	TCGA-DS-A0VN-01A-21D-A10S-08
TCGA-DS-A1O9-01	1	TCGA-DS-A1O9-01	266	1	TCGA-DS-A1O9	266	0	266	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				NO	75			TCGA-DS-A1O9-F15174	Never Used					PRESENT			Positive vaginal margin		Not done per treating physicians discretion		Stage IVA		-27433					4152	266	-18			0	266			10					Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0				NO	Scheduled Follow-up Submission	2011-8-12	FEMALE	132	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO	Keratinizing squamous cell carcinoma		19			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	2		true			M0	N0	T4	TCGA-DS-A1O9.DDC9EA73-6412-4D20-A422-0F57A8925536.pdf	Cervical Cancer			0	0		40		10		5		30		0		25		70		70		Preoperative	WITH TUMOR		0	YES		No	NO	Participant refusal						Primary Tumor	01			2009		NO	YES	DS	Current smoker	2	Complete response	cervical	A	DECEASED	32	1999		3B37639D-EC0D-426D-ABC5-9243B346F13D		4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0		4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0	TCGA-DS-A1O9-01A-11D-A14Z-05	TCGA-DS-A1O9-01A-11R-A14X-13			4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0		4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0						
TCGA-DS-A1OA-01	1	TCGA-DS-A1OA-01	879	1	TCGA-DS-A1OA	379	1	879	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO		YES	77		5	TCGA-DS-A1OA-F15176	Never Used	Completed as planned	1000		LDR	ABSENT		None	Other Location, specify			Carboplatin	Stage IB	150 mg	-28160	113	120	91	63	3621	879	24			0	879		379	29					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0				NO	Scheduled Follow-up Submission	2003-8-12	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Non-keratinizing squamous cell carcinoma		8	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3				Locoregional Recurrence			YES	8	0	7		true			M0	N1	T1b1	TCGA-DS-A1OA.A2FAE559-D2B2-4132-9B16-37E677C1B09A.pdf	Cervical Cancer			0	0		40		10		10		40		0		20		70		70		Preoperative	WITH TUMOR		0	YES		No	YES							Primary Tumor	01			1995	YES	NO	YES	DS	Lifelong Non-smoker	7	Partial response	cervical	A	DECEASED	51	2001	TCGA-DS-A1OA-01A-11D-A16Y-08	C1F108EE-1D61-4EC1-9F0E-A85272154696	TCGA-DS-A1OA-01A-11D-A16Y-08	656bb2ee-b7f9-4cee-a694-1217fecf25a7		656bb2ee-b7f9-4cee-a694-1217fecf25a7	TCGA-DS-A1OA-01A-11D-A14Z-05	TCGA-DS-A1OA-01A-11R-A14X-13	TCGA-DS-A1OA-01A-11D-A16Y-08		656bb2ee-b7f9-4cee-a694-1217fecf25a7		656bb2ee-b7f9-4cee-a694-1217fecf25a7		TCGA-DS-A1OA-01A-11D-A16Y-08	TCGA-DS-A1OA-01A-11D-A16Y-08			
TCGA-DS-A1OB-01	1	TCGA-DS-A1OB-01	861	1	TCGA-DS-A1OB	652	1	861	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Complete Response	YES	45		3	TCGA-DS-A1OB-F19926	Never Used					ABSENT		None	Other Location, specify			Carboplatin|Other	Stage IB		-16685					1199	861				0			652	29		121	70					1		Completed as Planned			NO	Scheduled Follow-up Submission	2012-1-4	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO	Keratinizing squamous cell carcinoma		31	Pelvic (external iliac, internal iliac, obturator)|Common iliac|Para-aortic		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Head and Neck		Other, specify	Distant Metastasis			YES	16	0	1		true		Taxol	M0	N1	T1b2	TCGA-DS-A1OB.65C2A525-AEE4-48E9-83F3-CFBADAF161C1.pdf	Cervical Cancer						50		5		10		30		0		10		80		80		Preoperative	WITH TUMOR			YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			1995	YES	NO	YES	DS		4	Progression	cervical	A	DECEASED	72	2007	TCGA-DS-A1OB-01A-11D-A16Y-08	6F74B999-D13D-458C-90F2-30D59F8D9B54	TCGA-DS-A1OB-01A-11D-A16Y-08	aabf5831-8886-4570-9266-00cd858ba17b		aabf5831-8886-4570-9266-00cd858ba17b	TCGA-DS-A1OB-01A-11D-A14Z-05	TCGA-DS-A1OB-01A-11R-A14X-13	TCGA-DS-A1OB-01A-11D-A16Y-08		aabf5831-8886-4570-9266-00cd858ba17b		aabf5831-8886-4570-9266-00cd858ba17b		TCGA-DS-A1OB-01A-11D-A16Y-08		TCGA-DS-A1OB-01		
TCGA-DS-A1OC-01	0	TCGA-DS-A1OC-01	376	0	TCGA-DS-A1OC	376	0	376	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	47		4	TCGA-DS-A1OC-F53356						ABSENT		None	Other Location, specify			Cisplatin|Other	Stage IB	Cisplatin: 90 mg; Gemzar: 1770 mg	-17357			332	252	378		34			0	376			0		155	117		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			1	0	Completed as Planned			NO	Scheduled Follow-up Submission	2013-12-11	FEMALE	140	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	190	NO	Keratinizing squamous cell carcinoma	YES	19	Other Location, specify	Left External Iliac/Obturator		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	2	0	3		true		Gemzar	M0	N1	T1b1	TCGA-DS-A1OC.8E48E714-87FA-4B0A-86DB-75E58784AA2C.pdf				0	0		40		5		5		30		0		15		80		80		Preoperative	TUMOR FREE	YES	0	YES		Yes	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	NO	YES	DS	Current reformed smoker for < or = 15 years	3	Complete response	cervical	A	LIVING	78	2010	TCGA-DS-A1OC-01A-11D-A14W-08	53BE8C06-2C3C-42EF-A4B8-202A39B34E36	TCGA-DS-A1OC-01A-11D-A14W-08	694a3bf4-f789-4aef-9dc8-13f4f8ae0283		694a3bf4-f789-4aef-9dc8-13f4f8ae0283	TCGA-DS-A1OC-01A-11D-A14Z-05	TCGA-DS-A1OC-01A-11R-A14X-13	TCGA-DS-A1OC-01A-11D-A14W-08		694a3bf4-f789-4aef-9dc8-13f4f8ae0283		694a3bf4-f789-4aef-9dc8-13f4f8ae0283		TCGA-DS-A1OC-01A-11D-A14W-08		TCGA-DS-A1OC-01		TCGA-DS-A1OC-01A-11D-A14W-08
TCGA-DS-A1OD-01	0	TCGA-DS-A1OD-01	3874	0	TCGA-DS-A1OD	3874	0	3874	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	49		4	TCGA-DS-A1OD-F51565	Never Used					ABSENT		None	Other Location, specify			Cisplatin	Stage IB1	70 mg	-17954			96	75	2968		2			0	3874			5		96	71		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0	Completed as Planned	4500		NO	Scheduled Follow-up Submission	2013-11-26	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Keratinizing squamous cell carcinoma	NO	16			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	1		true			M0	N0	T1b1	TCGA-DS-A1OD.81536C16-0708-483D-AAE9-DD3477D85177.pdf				0	0		40		5		5		30		0		15		80		80		Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	DS	Current reformed smoker for < or = 15 years	1	Complete response	cervical	A	LIVING	89	2003	TCGA-DS-A1OD-01A-11D-A14W-08	04640F98-D09E-4760-9F47-5E68498D3176	TCGA-DS-A1OD-01A-11D-A14W-08	3ed6846b-8a17-4eed-bc64-c28fb9aed192		3ed6846b-8a17-4eed-bc64-c28fb9aed192	TCGA-DS-A1OD-01A-11D-A14Z-05	TCGA-DS-A1OD-01A-11R-A14X-13	TCGA-DS-A1OD-01A-11D-A14W-08		3ed6846b-8a17-4eed-bc64-c28fb9aed192		3ed6846b-8a17-4eed-bc64-c28fb9aed192		TCGA-DS-A1OD-01A-11D-A14W-08		TCGA-DS-A1OD-01		TCGA-DS-A1OD-01A-11D-A14W-08
TCGA-DS-A3LQ-01	0	TCGA-DS-A3LQ-01	699	0	TCGA-DS-A3LQ	699	0	699	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	46		6	TCGA-DS-A3LQ-F51567	Former User							None	Other Location, specify			Cisplatin	Stage IIIB	40 mg/m2	-16861			89	54	175					0	699			2		90	55				Once weekly	1		Completed as Planned			NO	Scheduled Follow-up Submission	2013-11-26	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	180	NO	Non-keratinizing squamous cell carcinoma	NO	8	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	1	0	2		true			M0	N1	T3b	TCGA-DS-A3LQ.179CB483-18CC-4770-9C5E-22B5CC1E80C4.pdf							0		0		5		0		0		20		75		75		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES						4500	Primary Tumor	01		1978	2009	YES	YES	NO	DS	Current reformed smoker for > 15 years	7	Complete response	cervical	A	LIVING	72	2011		8048B959-1198-4626-B674-E34FB36F51CD	TCGA-DS-A3LQ-01A-21D-A21Q-09	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	TCGA-DS-A3LQ-01A-21D-A21P-01	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	TCGA-DS-A3LQ-01A-21D-A21R-05	TCGA-DS-A3LQ-01A-21R-A21U-13	TCGA-DS-A3LQ-01A-21D-A21Q-09	TCGA-DS-A3LQ-01	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	3eb07a33-4d0b-42fe-a681-459d5ae09a37	6f54279a-f0b1-4e9d-9e71-7f91cef40ba2	3eb07a33-4d0b-42fe-a681-459d5ae09a37	TCGA-DS-A3LQ-01A-21D-A21Q-09	TCGA-DS-A3LQ-01A-21D-A21Q-09	TCGA-DS-A3LQ-01	TCGA-DS-A3LQ-01A-21D-A21P-01	
TCGA-DS-A5RQ-01	0	TCGA-DS-A5RQ-01	208	0	TCGA-DS-A5RQ	208	0	208	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		80	27	6	TCGA-DS-A5RQ-F43182						ABSENT						Cisplatin	Stage IB1	60 mg	-29526					203		32			0	208			208					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	0						2013-5-15	FEMALE	148	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	220	NO	Keratinizing squamous cell carcinoma	NO	42			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3	35	true			MX	N0	T1b1	TCGA-DS-A5RQ.DE25B703-53D6-488B-AFAF-BFA8DA52FF62.pdf				0	0		3		0		0		0		0		0		100		75		Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	DS	Current smoker	3		cervical	A	LIVING	61	2012		D4ECE36C-3B7F-467F-AB01-BFA1F7DE7684	TCGA-DS-A5RQ-01A-11D-A28B-09	80241bee-c4e9-4ce7-a920-022f8b00e21d	TCGA-DS-A5RQ-01A-11D-A28A-01	80241bee-c4e9-4ce7-a920-022f8b00e21d	TCGA-DS-A5RQ-01A-11D-A28C-05	TCGA-DS-A5RQ-01A-11R-A28L-13	TCGA-DS-A5RQ-01A-11D-A28B-09	TCGA-DS-A5RQ-01	80241bee-c4e9-4ce7-a920-022f8b00e21d	6e3638e2-4538-46f5-b1f0-3446725cf715	80241bee-c4e9-4ce7-a920-022f8b00e21d	6e3638e2-4538-46f5-b1f0-3446725cf715	TCGA-DS-A5RQ-01A-11D-A28B-09	TCGA-DS-A5RQ-01A-11D-A28B-09	TCGA-DS-A5RQ-01	TCGA-DS-A5RQ-01A-11D-A28A-01	
TCGA-DS-A7WF-01	1	TCGA-DS-A7WF-01	492	1	TCGA-DS-A7WF	321	1	492	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	YES	Partial Response		41			TCGA-DS-A7WF-F54754	Never Used				Other							Cisplatin	Stage IB2		-15319					2483	492				0			321									1	0						2013-12-23	FEMALE	160	Adenosquamous	No						Radical Hysterectomy		8560/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma	NO	23			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	CT scan		Distant Metastasis		NO	YES	0	0	1	7	true			MX	N0	T1b2	TCGA-DS-A7WF.0C2D7B64-5F80-4F95-BCFC-D550A9674A2E.pdf	Cervical Cancer			1	1		40		20		0		20		0		10		90		90		Preoperative	WITH TUMOR	YES	0	YES	Partial Remission/Response	No	YES							Primary Tumor	01			1995	YES	NO	YES	DS	Current smoker	3		cervical	A	DECEASED	63	2006			TCGA-DS-A7WF-01A-11D-A351-09	5f6b58e1-df96-4c94-aa88-e4f23339794c	TCGA-DS-A7WF-01A-11D-A350-01	5f6b58e1-df96-4c94-aa88-e4f23339794c	TCGA-DS-A7WF-01A-11D-A357-05	TCGA-DS-A7WF-01A-11R-A358-13	TCGA-DS-A7WF-01A-11D-A351-09	TCGA-DS-A7WF-01	5f6b58e1-df96-4c94-aa88-e4f23339794c	9a144042-c8fc-4c4e-a56f-c02a0c267fb5	5f6b58e1-df96-4c94-aa88-e4f23339794c	9a144042-c8fc-4c4e-a56f-c02a0c267fb5	TCGA-DS-A7WF-01A-11D-A351-09	TCGA-DS-A7WF-01A-11D-A351-09	TCGA-DS-A7WF-01	TCGA-DS-A7WF-01A-11D-A350-01	
TCGA-DS-A7WH-01	0	TCGA-DS-A7WH-01	533	0	TCGA-DS-A7WH	533	0	533	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		34		7	TCGA-DS-A7WH-F63889	Former User											Cisplatin	Stage IB1	40 mg/m2 (62.4 mg)	-12644					230				5	0	533			502							Once weekly	0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-8-20	FEMALE	168	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy		8480/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Non-keratinizing squamous cell carcinoma	NO	22				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	0		true			MX	N0	T1b1	TCGA-DS-A7WH.069FDE0B-57A4-4398-856D-F3FE511F89B4.pdf				1	1		20		20		10		40		0		30		60		60		Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					3D conformal	5040	Primary Tumor	01			2009	YES	YES	NO	DS	Lifelong Non-smoker	2		cervical	A	LIVING	50	2013		BB0D8B6B-4065-4562-A677-A92977A81BC9	TCGA-DS-A7WH-01A-22D-A351-09	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	TCGA-DS-A7WH-01A-22D-A350-01	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	TCGA-DS-A7WH-01A-22D-A357-05	TCGA-DS-A7WH-01A-22R-A358-13	TCGA-DS-A7WH-01A-22D-A351-09	TCGA-DS-A7WH-01	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	f4684177-6697-46cb-85a0-1b3a4a6e87f6	3380e6d8-52a0-4b19-acb1-2fb686cbd5df	f4684177-6697-46cb-85a0-1b3a4a6e87f6	TCGA-DS-A7WH-01A-22D-A351-09	TCGA-DS-A7WH-01A-22D-A351-09	TCGA-DS-A7WH-01	TCGA-DS-A7WH-01A-22D-A350-01	
TCGA-DS-A7WI-01	1	TCGA-DS-A7WI-01	252	1	TCGA-DS-A7WI	206	1	252	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	NO	Complete Response		43		5	TCGA-DS-A7WI-F54771	Never Used											Cisplatin	Stage IIA2	40 mg/m2	-15970					222	252	4			0			206						Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0						2013-12-23	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	NO	15	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Locoregional Recurrence	Retroperitoneum	NO	YES	1	0	7		true			MX	N1	T2a2	TCGA-DS-A7WI.4538B5EA-E6C8-4EEA-8387-A1E3C5A754F9.pdf	Cervical Cancer			1	0		40		20		10		20		0		10		80		80		Preoperative	WITH TUMOR	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	YES	NO	DS	Lifelong Non-smoker	8		cervical	A	DECEASED	57	2013		817F7D56-55EA-4F67-999F-5E94870D3AAB	TCGA-DS-A7WI-01A-12D-A351-09	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	TCGA-DS-A7WI-01A-12D-A350-01	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	TCGA-DS-A7WI-01A-12D-A357-05	TCGA-DS-A7WI-01A-12R-A358-13	TCGA-DS-A7WI-01A-12D-A351-09	TCGA-DS-A7WI-01	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	e63bffae-0b91-4358-8a6e-460d5299db2f	fcbdaa46-c576-42e9-ac1f-0ba553247f4f	e63bffae-0b91-4358-8a6e-460d5299db2f	TCGA-DS-A7WI-01A-12D-A351-09	TCGA-DS-A7WI-01A-12D-A351-09	TCGA-DS-A7WI-01	TCGA-DS-A7WI-01A-12D-A350-01	
TCGA-EA-A1QS-01	0	TCGA-EA-A1QS-01	23	0	TCGA-EA-A1QS	23	0	23	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					46				Never Used					ABSENT							Stage IB1		-16940					80					0	23												0						2012-7-6	FEMALE	164	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1240	NO	Non-keratinizing squamous cell carcinoma		18			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			M0	N0	T1b1	TCGA-EA-A1QS.827FEDD4-5D89-4706-A81D-DAFA017EC7FF.pdf				0	4		60		10		10		20		10		20		60		60			TUMOR FREE		0	YES	Complete Remission/Response	No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	6		cervical	A	LIVING		2011		A770A8A6-09BA-46E2-B221-3B81ECA16660	TCGA-EA-A1QS-01A-61D-A22X-09	88ee3a4f-7688-4247-b03c-73f6e3af7493	TCGA-EA-A1QS-01A-61D-A22W-01	88ee3a4f-7688-4247-b03c-73f6e3af7493	TCGA-EA-A1QS-01A-61D-A230-05	TCGA-EA-A1QS-01A-61R-A22V-13	TCGA-EA-A1QS-01A-61D-A22X-09	TCGA-EA-A1QS-01	88ee3a4f-7688-4247-b03c-73f6e3af7493	db3e999d-136b-43d0-9836-595b14e77fe4	88ee3a4f-7688-4247-b03c-73f6e3af7493	db3e999d-136b-43d0-9836-595b14e77fe4	TCGA-EA-A1QS-01A-61D-A22X-09	TCGA-EA-A1QS-01A-61D-A22X-09	TCGA-EA-A1QS-01	TCGA-EA-A1QS-01A-61D-A22W-01	
TCGA-EA-A1QT-01	0	TCGA-EA-A1QT-01	376	0	TCGA-EA-A1QT	376	0	376	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				NO	47			TCGA-EA-A1QT-F29729	Never Used					ABSENT							Stage IB		-17475					64					0	376				376							0	0				NO	Scheduled Follow-up Submission	2012-3-28	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	680	NO	Non-keratinizing squamous cell carcinoma		18			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			M0	N0	T1b	TCGA-EA-A1QT.87B05129-51AC-401B-AAEC-CAF13E97061E.pdf				0	3		60		10		5		20		0		25		70		70		Preoperative	TUMOR FREE		0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	5		cervical	A	LIVING	68	2011	TCGA-EA-A1QT-01A-11D-A14W-08	C7D3A64F-5697-4AE3-A459-947CDE9BBFAF	TCGA-EA-A1QT-01A-11D-A14W-08	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01A-11D-A14V-01	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	TCGA-EA-A1QT-01A-11D-A14Z-05	TCGA-EA-A1QT-01A-11R-A14X-13	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	67bf0d1f-5e2f-4340-bf1e-2ebdd583913a	3aab069c-f3e6-4a95-89eb-bf896b36c4b3	67bf0d1f-5e2f-4340-bf1e-2ebdd583913a	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01A-11D-A14W-08	TCGA-EA-A1QT-01	TCGA-EA-A1QT-01A-11D-A14V-01	TCGA-EA-A1QT-01A-11D-A14W-08
TCGA-EA-A3HQ-01	0	TCGA-EA-A3HQ-01	53	0	TCGA-EA-A3HQ			53	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					60				Never Used					ABSENT							Stage II		-21978					244					0	53												0				NO		2012-2-17	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1360	NO	Non-keratinizing squamous cell carcinoma		13			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								0	0	2		true			M0	N0	T2a	TCGA-EA-A3HQ.868FEAAA-6A22-47A9-A309-49119D36E75E.pdf				0	2		4		0		0		0		25		0		75		80			TUMOR FREE		0	YES		No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	4	Complete response	cervical	A	LIVING	88	2011		C8052E35-8571-457C-8A92-A7806AB50F69	TCGA-EA-A3HQ-01A-11D-A20U-09	886e8f4f-107d-4ebd-a312-7cdbacabd35e	TCGA-EA-A3HQ-01A-11D-A20T-01	886e8f4f-107d-4ebd-a312-7cdbacabd35e	TCGA-EA-A3HQ-01A-11D-A212-05	TCGA-EA-A3HQ-01A-11R-A214-13	TCGA-EA-A3HQ-01A-11D-A20U-09	TCGA-EA-A3HQ-01	886e8f4f-107d-4ebd-a312-7cdbacabd35e	dd45bd05-f8dc-4fad-ad01-ea3fc0f820db	886e8f4f-107d-4ebd-a312-7cdbacabd35e	dd45bd05-f8dc-4fad-ad01-ea3fc0f820db	TCGA-EA-A3HQ-01A-11D-A20U-09	TCGA-EA-A3HQ-01A-11D-A20U-09	TCGA-EA-A3HQ-01	TCGA-EA-A3HQ-01A-11D-A20T-01	
TCGA-EA-A3HR-01	0	TCGA-EA-A3HR-01	940	0	TCGA-EA-A3HR	940	0	940	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		57			TCGA-EA-A3HR-F66108	Never Used					ABSENT							Stage II		-20980					219					0	940			940								0					NO		2014-10-2	FEMALE	146	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1820	NO	Non-keratinizing squamous cell carcinoma	NO	11			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			M0	N0	T2a	TCGA-EA-A3HR.BE99BE0C-3FB8-4AE6-B66D-977B858D880E.pdf				0	13		1		1		10		0		20		5		65		75	At last contact	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	15	Complete response	cervical	A	LIVING	86	2011		1AC7B9FF-7D24-4540-98B2-CAC49BFC4E5C	TCGA-EA-A3HR-01A-11D-A20U-09	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	TCGA-EA-A3HR-01A-11D-A20T-01	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	TCGA-EA-A3HR-01A-11D-A212-05	TCGA-EA-A3HR-01A-11R-A214-13	TCGA-EA-A3HR-01A-11D-A20U-09	TCGA-EA-A3HR-01	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	107a24e7-043e-4dcb-a0e5-8a05b9977535	7feffd22-85c5-4bf9-9a41-28a1f4e0586d	107a24e7-043e-4dcb-a0e5-8a05b9977535	TCGA-EA-A3HR-01A-11D-A20U-09	TCGA-EA-A3HR-01A-11D-A20U-09	TCGA-EA-A3HR-01	TCGA-EA-A3HR-01A-11D-A20T-01	
TCGA-EA-A3HS-01	0	TCGA-EA-A3HS-01	25	0	TCGA-EA-A3HS			25	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					35				Never Used					ABSENT							Stage IB		-13132					219					0	25												0				NO		2011-12-20	FEMALE	169	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1586	NO	Keratinizing squamous cell carcinoma		10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1								0	0	1		true			M0	N0	T1b	TCGA-EA-A3HS.103C790B-65FE-4E6A-9CD8-C8B35BB09ABB.pdf				0	1		2		2		10		1		0		0		90		90			TUMOR FREE		0	YES		No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	2	Complete response	cervical	A	LIVING	54	2011		B8DA1194-2F9C-4792-8B40-B582F8D8B501	TCGA-EA-A3HS-01A-11D-A20U-09	833baf21-bec9-4fde-aa6b-fb1b1256ae26	TCGA-EA-A3HS-01A-11D-A20T-01	833baf21-bec9-4fde-aa6b-fb1b1256ae26	TCGA-EA-A3HS-01A-11D-A212-05	TCGA-EA-A3HS-01A-11R-A214-13	TCGA-EA-A3HS-01A-11D-A20U-09	TCGA-EA-A3HS-01	833baf21-bec9-4fde-aa6b-fb1b1256ae26	42793737-10f8-455d-9513-d21b261dd164	833baf21-bec9-4fde-aa6b-fb1b1256ae26	42793737-10f8-455d-9513-d21b261dd164	TCGA-EA-A3HS-01A-11D-A20U-09		TCGA-EA-A3HS-01	TCGA-EA-A3HS-01A-11D-A20T-01	
TCGA-EA-A3HT-01	0	TCGA-EA-A3HT-01	19	0	TCGA-EA-A3HT			19	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					68				Never Used					ABSENT							Stage IB		-25138					198					0	19												0				NO		2011-12-20	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1	NO	Keratinizing squamous cell carcinoma		9			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1								0	0	1		true			M0	N0	T1b	TCGA-EA-A3HT.ADE9CA35-C9F2-417E-8B27-59ACC7E1AE32.pdf				0	2		7		0		0		0		5		0		95		85					0	YES		No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	83	2011		F2BA7AA4-9BFA-463E-A2A8-EC141BC66ACA	TCGA-EA-A3HT-01A-61D-A21Q-09	6cf5747f-22b4-498f-b8ce-13e4a2741883	TCGA-EA-A3HT-01A-61D-A21P-01	6cf5747f-22b4-498f-b8ce-13e4a2741883	TCGA-EA-A3HT-01A-61D-A21R-05	TCGA-EA-A3HT-01A-61R-A21U-13	TCGA-EA-A3HT-01A-61D-A21Q-09	TCGA-EA-A3HT-01	6cf5747f-22b4-498f-b8ce-13e4a2741883	6a51eb81-8bb0-4b05-879d-9a5e48363357	6cf5747f-22b4-498f-b8ce-13e4a2741883	6a51eb81-8bb0-4b05-879d-9a5e48363357	TCGA-EA-A3HT-01A-61D-A21Q-09	TCGA-EA-A3HT-01A-61D-A21Q-09	TCGA-EA-A3HT-01	TCGA-EA-A3HT-01A-61D-A21P-01	
TCGA-EA-A3HU-01	0	TCGA-EA-A3HU-01	1013	0	TCGA-EA-A3HU	1013	0	1013	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		43			TCGA-EA-A3HU-F66112	Never Used					ABSENT							Stage II		-15909					182					0	1013			1013								0	0				NO		2014-10-2	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	1440	NO	Non-keratinizing squamous cell carcinoma	NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	2		true			M0	N0	T2a2	TCGA-EA-A3HU.3A6FE044-430D-4D43-9365-9FA788758BE5.pdf				0	10		1		0		0		0		0		0		100		95	At last contact	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	12	Complete response	cervical	A	LIVING	68	2011		852A3427-BBBC-436E-884F-B58AF5A7ACF3	TCGA-EA-A3HU-01A-11D-A20U-09	b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91		b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91	TCGA-EA-A3HU-01A-11D-A212-05	TCGA-EA-A3HU-01A-11R-A214-13	TCGA-EA-A3HU-01A-11D-A20U-09		b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91		b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91		TCGA-EA-A3HU-01A-11D-A20U-09	TCGA-EA-A3HU-01A-11D-A20U-09	TCGA-EA-A3HU-01		
TCGA-EA-A3QD-01	0	TCGA-EA-A3QD-01	397	0	TCGA-EA-A3QD	397	0	397	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		59			TCGA-EA-A3QD-F58163	Former User											Cisplatin	Stage IIIB		-21655					146					0	397			395								0	0				NO		2014-4-1	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	250	NO	Non-keratinizing squamous cell carcinoma	YES	6			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1	0	5		true			M0	N1	T1b1	TCGA-EA-A3QD.C5F8BF41-F7A7-4870-890E-861D2DE51DBE.pdf				1	0		13		0		0		0		0		0		100		80		Post-Adjuvant Therapy	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	EA	Lifelong Non-smoker	6	Complete response	cervical	A	LIVING	105	2011		C86A293C-53BA-4937-AC97-FF272952998A	TCGA-EA-A3QD-01A-32D-A22X-09	e35790f7-26df-4d0a-9474-88f13372d606	TCGA-EA-A3QD-01A-32D-A22W-01	e35790f7-26df-4d0a-9474-88f13372d606	TCGA-EA-A3QD-01A-32D-A230-05	TCGA-EA-A3QD-01A-32R-A22V-13	TCGA-EA-A3QD-01A-32D-A22X-09	TCGA-EA-A3QD-01	e35790f7-26df-4d0a-9474-88f13372d606	62a4ad97-9432-45d6-a81b-78d84d58fac6	e35790f7-26df-4d0a-9474-88f13372d606	62a4ad97-9432-45d6-a81b-78d84d58fac6	TCGA-EA-A3QD-01A-32D-A22X-09	TCGA-EA-A3QD-01A-32D-A22X-09	TCGA-EA-A3QD-01	TCGA-EA-A3QD-01A-32D-A22W-01	
TCGA-EA-A3QE-01	0	TCGA-EA-A3QE-01	36	0	TCGA-EA-A3QE			36	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45				Never Used					ABSENT							Stage IB		-16471					126					0	36												0				NO		2012-5-9	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	380	NO	Non-keratinizing squamous cell carcinoma		14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2										1		true			M0	N0	T1b	TCGA-EA-A3QE.E3358197-B104-4672-863F-8BE50488B2D0.pdf				0	4		15		0		0		0		0		0		100		80			TUMOR FREE		0	YES		No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	5	Complete response	cervical	A	LIVING		2011		0C3AE6A1-F10D-4EE1-A357-D2F3E0F217D1	TCGA-EA-A3QE-01A-21D-A21Q-09	6edc7d3a-9f83-449f-a371-c040d8b5164d	TCGA-EA-A3QE-01A-21D-A21P-01	6edc7d3a-9f83-449f-a371-c040d8b5164d	TCGA-EA-A3QE-01A-21D-A21R-05	TCGA-EA-A3QE-01A-21R-A21U-13	TCGA-EA-A3QE-01A-21D-A21Q-09	TCGA-EA-A3QE-01	6edc7d3a-9f83-449f-a371-c040d8b5164d	98ed58e2-b012-49f2-b964-c94e912d913e	6edc7d3a-9f83-449f-a371-c040d8b5164d	98ed58e2-b012-49f2-b964-c94e912d913e	TCGA-EA-A3QE-01A-21D-A21Q-09	TCGA-EA-A3QE-01A-21D-A21Q-09	TCGA-EA-A3QE-01	TCGA-EA-A3QE-01A-21D-A21P-01	
TCGA-EA-A3Y4-01	0	TCGA-EA-A3Y4-01	441	0	TCGA-EA-A3Y4	441	0	441	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		40			TCGA-EA-A3Y4-F46396						ABSENT							Stage IB		-14706					146					0	441			441								0	0						2013-8-7	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1310	NO	Non-keratinizing squamous cell carcinoma	NO	12			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1		true			M0	N0	T1b	TCGA-EA-A3Y4.D0A5BC9D-D39C-4A0D-9832-E062AA024D17.pdf				0	2		0		0		0		0		0		15		85		60		Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	YES					External beam radiation	3740	Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	99	2012		5D8CB763-CC51-417E-B960-560E5C59938A	TCGA-EA-A3Y4-01A-51D-A243-09	6171e1c5-1243-4fde-8964-7d1a4d387a86	TCGA-EA-A3Y4-01A-51D-A242-01	6171e1c5-1243-4fde-8964-7d1a4d387a86	TCGA-EA-A3Y4-01A-51D-A244-05	TCGA-EA-A3Y4-01A-51R-A24J-13	TCGA-EA-A3Y4-01A-51D-A243-09	TCGA-EA-A3Y4-01	6171e1c5-1243-4fde-8964-7d1a4d387a86	e4e986e8-08be-4101-a09b-141f26b84d27	6171e1c5-1243-4fde-8964-7d1a4d387a86	e4e986e8-08be-4101-a09b-141f26b84d27	TCGA-EA-A3Y4-01A-51D-A243-09	TCGA-EA-A3Y4-01A-51D-A243-09	TCGA-EA-A3Y4-01	TCGA-EA-A3Y4-01A-51D-A242-01	
TCGA-EA-A410-01	0	TCGA-EA-A410-01	41	0	TCGA-EA-A410	41	0	41	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51				Never Used					ABSENT							Stage IIA2		-18735					172					0	41												0						2012-9-24	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	700	NO	Non-keratinizing squamous cell carcinoma		14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			M0	N0	T2a2	TCGA-EA-A410.EA3DC9B0-2680-4F3C-B14A-05CB047305BD.pdf				0	4		2		0		5		0		10		0		85		75			TUMOR FREE		0	YES	Complete Remission/Response	No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	6		cervical	A	LIVING	80	2012		5852B79F-E34E-4B67-ADDA-CD19B9FDF975	TCGA-EA-A410-01A-11D-A243-09	e9e998be-4353-441e-83ec-d8c010b0dc79	TCGA-EA-A410-01A-11D-A242-01	e9e998be-4353-441e-83ec-d8c010b0dc79	TCGA-EA-A410-01A-11D-A244-05	TCGA-EA-A410-01A-11R-A24J-13	TCGA-EA-A410-01A-11D-A243-09	TCGA-EA-A410-01	e9e998be-4353-441e-83ec-d8c010b0dc79	8178da6d-6510-496d-be38-befdfbeaafd7	e9e998be-4353-441e-83ec-d8c010b0dc79	8178da6d-6510-496d-be38-befdfbeaafd7	TCGA-EA-A410-01A-11D-A243-09	TCGA-EA-A410-01A-11D-A243-09	TCGA-EA-A410-01	TCGA-EA-A410-01A-11D-A242-01	
TCGA-EA-A411-01	0	TCGA-EA-A411-01	747	0	TCGA-EA-A411	747	0	747	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		50			TCGA-EA-A411-F66116	Former User					ABSENT							Stage IB1		-18561					100					0	747			747								0	0						2014-10-2	FEMALE	176	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	740	NO	Non-keratinizing squamous cell carcinoma	NO	13			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0		2		true			M0	N0	T1b1	TCGA-EA-A411.A7CCC7A3-CF3C-4722-B1F5-890B3A4D9A6D.pdf				0	3		2		0		0		0		0		0		100		65	At last contact	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	5		cervical	A	LIVING	74	2012		A92FDF5F-D4BE-4084-B677-6AAB64AD1342	TCGA-EA-A411-01A-11D-A243-09	27e35f6c-7d6c-46e8-844d-e08a5920af3e	TCGA-EA-A411-01A-11D-A242-01	27e35f6c-7d6c-46e8-844d-e08a5920af3e	TCGA-EA-A411-01A-11D-A244-05	TCGA-EA-A411-01A-11R-A24J-13	TCGA-EA-A411-01A-11D-A243-09	TCGA-EA-A411-01	27e35f6c-7d6c-46e8-844d-e08a5920af3e	1c8be459-21da-4748-ae03-4d53b308991c	27e35f6c-7d6c-46e8-844d-e08a5920af3e	1c8be459-21da-4748-ae03-4d53b308991c	TCGA-EA-A411-01A-11D-A243-09	TCGA-EA-A411-01A-11D-A243-09	TCGA-EA-A411-01	TCGA-EA-A411-01A-11D-A242-01	
TCGA-EA-A439-01	0	TCGA-EA-A439-01	441	0	TCGA-EA-A439	316	1	441	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	NO	Complete Response		50			TCGA-EA-A439-F45847			4000		LDR	PRESENT	No pelvic spread						Stage IIA1		-18529					98		12			0	441	321	316	441					Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent			0							2013-7-23	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	500	NO	Non-keratinizing squamous cell carcinoma	NO				PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Cervix			Locoregional Recurrence		YES	YES			2		true			M0	N0	T2a1	TCGA-EA-A439.15BB85F2-5EF6-4569-B354-D543A0466983.pdf							5		0		5		0		0		0		95		65		Post-Adjuvant Therapy	TUMOR FREE	NO		NO	Complete Remission/Response	No	YES				R0			Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker	2		cervical	A	LIVING	47	2012		6614076A-C936-48EA-97E2-3A12301EDC8A	TCGA-EA-A439-01A-11D-A243-09	f930146b-0cec-4630-8f79-0e233c238b15	TCGA-EA-A439-01A-11D-A242-01	f930146b-0cec-4630-8f79-0e233c238b15	TCGA-EA-A439-01A-11D-A244-05	TCGA-EA-A439-01A-11R-A24J-13	TCGA-EA-A439-01A-11D-A243-09	TCGA-EA-A439-01	f930146b-0cec-4630-8f79-0e233c238b15	46a465fd-6caf-4591-a288-7fdc2101c9e6	f930146b-0cec-4630-8f79-0e233c238b15	46a465fd-6caf-4591-a288-7fdc2101c9e6	TCGA-EA-A439-01A-11D-A243-09	TCGA-EA-A439-01A-11D-A243-09	TCGA-EA-A439-01	TCGA-EA-A439-01A-11D-A242-01	
TCGA-EA-A43B-01	0	TCGA-EA-A43B-01	791	0	TCGA-EA-A43B	791	0	791	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		43			TCGA-EA-A43B-F58719	Never Used		3500		LDR							Cisplatin|Other	Stage IB1		-15871					196		36			0	791			53					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0							2014-4-22	FEMALE	164	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	540	NO	Keratinizing squamous cell carcinoma	NO	24				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true		|5-Fluorouracil	M0	N0	T1b1	TCGA-EA-A43B.D2D8553E-1C68-4ADC-9D3E-024D04E948C1.pdf							10		3		5		0		0		30		65		70		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	8200	Primary Tumor	01			2009	YES	YES	NO	EA	Lifelong Non-smoker	2		cervical	A	LIVING	72	2012		485976D3-82C9-44C3-99E9-DC8A454E7225	TCGA-EA-A43B-01A-81D-A243-09	05dbcfac-b558-4621-bc29-30d46658a121	TCGA-EA-A43B-01A-81D-A242-01	05dbcfac-b558-4621-bc29-30d46658a121	TCGA-EA-A43B-01A-81D-A244-05	TCGA-EA-A43B-01A-81R-A24J-13	TCGA-EA-A43B-01A-81D-A243-09	TCGA-EA-A43B-01	05dbcfac-b558-4621-bc29-30d46658a121	5ce65ecb-cf89-4039-97be-3b5c879871aa	05dbcfac-b558-4621-bc29-30d46658a121	5ce65ecb-cf89-4039-97be-3b5c879871aa	TCGA-EA-A43B-01A-81D-A243-09	TCGA-EA-A43B-01A-81D-A243-09	TCGA-EA-A43B-01	TCGA-EA-A43B-01A-81D-A242-01	
TCGA-EA-A44S-01	0	TCGA-EA-A44S-01	385	0	TCGA-EA-A44S	385	0	385	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Stable Disease		31			TCGA-EA-A44S-F49899	Never Used					ABSENT						Carboplatin|Other|Other|Other	Stage IIIB		-11621					120					0	385			9								1	0						2013-10-14	FEMALE	182	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1200	NO	Non-keratinizing squamous cell carcinoma	NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	4		1		true		|Bleomycin|Gemcitabine|Doxorubicin	M0	N1	T2a2	TCGA-EA-A44S.25D56763-173A-4F45-AA4E-118382CD2296.pdf				0	0		5		5		0		1		10		0		90		70		Preoperative	TUMOR FREE	YES	0	YES	Stable Disease	No	YES					External beam radiation	3470	Primary Tumor	01			2009	YES	YES	NO	EA	Lifelong Non-smoker	1		cervical	A	LIVING	83	2012		DA2D285B-32D4-475C-8195-DCEF5563578C	TCGA-EA-A44S-01A-12D-A26G-09	41c1975d-219d-4131-a77e-e70224ed6c41	TCGA-EA-A44S-01A-12D-A26F-01	41c1975d-219d-4131-a77e-e70224ed6c41	TCGA-EA-A44S-01A-12D-A26S-05	TCGA-EA-A44S-01A-12R-A26X-13	TCGA-EA-A44S-01A-12D-A26G-09	TCGA-EA-A44S-01	41c1975d-219d-4131-a77e-e70224ed6c41	e1ccaa92-37a9-488f-96e6-1d6f334a81b9	41c1975d-219d-4131-a77e-e70224ed6c41	e1ccaa92-37a9-488f-96e6-1d6f334a81b9	TCGA-EA-A44S-01A-12D-A26G-09	TCGA-EA-A44S-01A-12D-A26G-09	TCGA-EA-A44S-01	TCGA-EA-A44S-01A-12D-A26F-01	
TCGA-EA-A4BA-01	0	TCGA-EA-A4BA-01	390	0	TCGA-EA-A4BA	390	0	390	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		49			TCGA-EA-A4BA-F49908	Never Used					ABSENT						Carboplatin|Other|Other	Stage IB2		-17995					122					0	390			7								1							2013-10-14	FEMALE	162	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	400	NO		NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true		|Cyclophosphamide|Doxorubicin	M0	N0	T1b2	TCGA-EA-A4BA.E9335EB7-5DF6-4C05-AC5C-FEEC629ED84E.pdf					2		5		3		5		3		0		40		55		60		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	3770	Primary Tumor	01			2009	YES	YES	NO	EA	Lifelong Non-smoker	4		cervical	A	LIVING	96	2012		7F604A99-19D9-42F8-BA04-4E42C885D118	TCGA-EA-A4BA-01A-21D-A26G-09	c3db032d-a822-4eca-8891-2c4d13a5866a	TCGA-EA-A4BA-01A-21D-A26F-01	c3db032d-a822-4eca-8891-2c4d13a5866a	TCGA-EA-A4BA-01A-21D-A26S-05	TCGA-EA-A4BA-01A-21R-A26X-13	TCGA-EA-A4BA-01A-21D-A26G-09	TCGA-EA-A4BA-01	c3db032d-a822-4eca-8891-2c4d13a5866a	3e2de9d5-126f-4a63-9ede-162dcc1c5d85	c3db032d-a822-4eca-8891-2c4d13a5866a	3e2de9d5-126f-4a63-9ede-162dcc1c5d85	TCGA-EA-A4BA-01A-21D-A26G-09	TCGA-EA-A4BA-01A-21D-A26G-09	TCGA-EA-A4BA-01	TCGA-EA-A4BA-01A-21D-A26F-01	
TCGA-EA-A50E-01	1	TCGA-EA-A50E-01	227	1	TCGA-EA-A50E	208	1	227	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		45			TCGA-EA-A50E-F45973	Former User					PRESENT	Pelvic spread		Positive bladder margin				Stage IVA		-16609					142	227	-1			0	8		208																2013-7-26	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1520	NO	Non-keratinizing squamous cell carcinoma	NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Vulva			Locoregional Recurrence		NO	YES	6		2		true			M0	N1	T4	TCGA-EA-A50E.9AF109CD-57A9-4560-8B36-9977F208AEE1.pdf	Cervical Cancer						40		20		10		20		0		30		60		60			WITH TUMOR	NO		YES	Progressive Disease	No	NO							Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker	2		cervical	A	DECEASED	45	2012		F6177AB7-60E5-414C-87A0-80D3AA346E5D	TCGA-EA-A50E-01A-21D-A26G-09	6b9951d1-1bae-4c66-acad-c6c618d5387d	TCGA-EA-A50E-01A-21D-A26F-01	6b9951d1-1bae-4c66-acad-c6c618d5387d	TCGA-EA-A50E-01A-21D-A26S-05	TCGA-EA-A50E-01A-21R-A26X-13	TCGA-EA-A50E-01A-21D-A26G-09	TCGA-EA-A50E-01	6b9951d1-1bae-4c66-acad-c6c618d5387d	f61e5a2f-668e-42b0-a6ad-209c7cb0e956	6b9951d1-1bae-4c66-acad-c6c618d5387d	f61e5a2f-668e-42b0-a6ad-209c7cb0e956	TCGA-EA-A50E-01A-21D-A26G-09	TCGA-EA-A50E-01A-21D-A26G-09	TCGA-EA-A50E-01	TCGA-EA-A50E-01A-21D-A26F-01	
TCGA-EA-A556-01	0	TCGA-EA-A556-01	453	0	TCGA-EA-A556	453	0	453	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		38	18		TCGA-EA-A556-F53440	Never Used					ABSENT							Stage IB1		-13988					119					0	453			453								0	0						2013-12-11	FEMALE	160	Endometrioid Adenocarcinoma of Endocervix	No						Radical Hysterectomy	C53.9	8380/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	360	NO		NO	7				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1	20	true			M0	N0	T1b1	TCGA-EA-A556.EDEF2B45-54BF-4329-B7ED-FBF59E13B438.pdf				0	0		2		0		3		0		0		0		97		75	At time of last contact	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	EA	Current smoker	1		cervical	A	LIVING	62	2012		DE361C5C-452A-4E8B-AC77-E037AC111087	TCGA-EA-A556-01A-11D-A26G-09	0dadcb32-0c50-4d9b-8112-d4e533e789d6	TCGA-EA-A556-01A-11D-A26F-01	0dadcb32-0c50-4d9b-8112-d4e533e789d6	TCGA-EA-A556-01A-11D-A26S-05	TCGA-EA-A556-01A-11R-A26X-13	TCGA-EA-A556-01A-11D-A26G-09	TCGA-EA-A556-01	0dadcb32-0c50-4d9b-8112-d4e533e789d6	0e4b81af-7030-46a8-8b18-8a432f331280	0dadcb32-0c50-4d9b-8112-d4e533e789d6	0e4b81af-7030-46a8-8b18-8a432f331280	TCGA-EA-A556-01A-11D-A26G-09	TCGA-EA-A556-01A-11D-A26G-09	TCGA-EA-A556-01	TCGA-EA-A556-01A-11D-A26F-01	
TCGA-EA-A5FO-01	0	TCGA-EA-A5FO-01	427	0	TCGA-EA-A5FO	427	0	427	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		59			TCGA-EA-A5FO-F58802			3500		LDR	ABSENT							Stage IB1		-21561					132					0	427			45								1							2014-4-23	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	570	NO	Non-keratinizing squamous cell carcinoma	NO	21			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0		2		true			M0	N0	T1b1	TCGA-EA-A5FO.4022C7F9-CECA-4C6B-92D5-729518405F30.pdf							5		0		0		0		30		10		60		60		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES					External beam radiation	4200	Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker			cervical	A	LIVING	58	2012		D91C5622-88A7-4D01-ACA5-14A0123D0ADF	TCGA-EA-A5FO-01A-21D-A28B-09	1ff2db10-00fe-4ddc-98d1-e15ffea42333	TCGA-EA-A5FO-01A-21D-A28A-01	1ff2db10-00fe-4ddc-98d1-e15ffea42333	TCGA-EA-A5FO-01A-21D-A28C-05	TCGA-EA-A5FO-01A-21R-A28L-13	TCGA-EA-A5FO-01A-21D-A28B-09	TCGA-EA-A5FO-01	1ff2db10-00fe-4ddc-98d1-e15ffea42333	d1791884-dfc7-4758-b7d4-373527233060	1ff2db10-00fe-4ddc-98d1-e15ffea42333	d1791884-dfc7-4758-b7d4-373527233060	TCGA-EA-A5FO-01A-21D-A28B-09	TCGA-EA-A5FO-01A-21D-A28B-09	TCGA-EA-A5FO-01	TCGA-EA-A5FO-01A-21D-A28A-01	
TCGA-EA-A5O9-01	0	TCGA-EA-A5O9-01	423	0	TCGA-EA-A5O9	423	0	423	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		39			TCGA-EA-A5O9-F56059	Never Used					ABSENT							Stage IB2		-14472					112					0	423			423								0	0						2014-1-24	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.1	8070/3	C53.1	YES		Biopsy (cervical / CT-guided / Other)	330	NO	Non-keratinizing squamous cell carcinoma	NO	10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		4		true			M0	N0	T1b2	TCGA-EA-A5O9.289C553F-685F-4308-B429-C741585BD25F.pdf				0	7		0		0		0		0		0		15		85		90		Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker	11		cervical	A	LIVING	99	2012		F287E787-B947-4C1D-9B34-66D426732136	TCGA-EA-A5O9-01A-11D-A28B-09	9ecc833d-b92d-474a-a981-d6e0c12292e0	TCGA-EA-A5O9-01A-11D-A28A-01	9ecc833d-b92d-474a-a981-d6e0c12292e0	TCGA-EA-A5O9-01A-11D-A28C-05	TCGA-EA-A5O9-01A-11R-A28L-13	TCGA-EA-A5O9-01A-11D-A28B-09	TCGA-EA-A5O9-01	9ecc833d-b92d-474a-a981-d6e0c12292e0	511a7211-0cdd-4d64-8093-57413ad6c015	9ecc833d-b92d-474a-a981-d6e0c12292e0	511a7211-0cdd-4d64-8093-57413ad6c015	TCGA-EA-A5O9-01A-11D-A28B-09	TCGA-EA-A5O9-01A-11D-A28B-09	TCGA-EA-A5O9-01	TCGA-EA-A5O9-01A-11D-A28A-01	
TCGA-EA-A5ZD-01	0	TCGA-EA-A5ZD-01	457	0	TCGA-EA-A5ZD	457	0	457	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		40			TCGA-EA-A5ZD-F57091						ABSENT							Stage IB1		-14629					102					0	457																		2014-3-3	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	2290	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			2		true			M0	N0	T1b1	TCGA-EA-A5ZD.4BB00D13-61EA-409C-AB1D-07DE3B949C85.pdf				1			5		0		0		0		20		20		60		60			TUMOR FREE	NO		NO	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	47	2012		C681D567-D4DB-460D-BABE-AD14C6FB9D92	TCGA-EA-A5ZD-01A-11D-A28B-09	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	TCGA-EA-A5ZD-01A-11D-A28A-01	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	TCGA-EA-A5ZD-01A-11D-A28C-05	TCGA-EA-A5ZD-01A-11R-A28L-13	TCGA-EA-A5ZD-01A-11D-A28B-09	TCGA-EA-A5ZD-01	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	8212de58-5c63-4d0f-94e3-2ee3853b754a	8bb52467-45b2-40d5-abd2-69ff0ad83bc5	8212de58-5c63-4d0f-94e3-2ee3853b754a	TCGA-EA-A5ZD-01A-11D-A28B-09	TCGA-EA-A5ZD-01A-11D-A28B-09	TCGA-EA-A5ZD-01	TCGA-EA-A5ZD-01A-11D-A28A-01	
TCGA-EA-A5ZE-01	0	TCGA-EA-A5ZE-01	456	0	TCGA-EA-A5ZE	425	1	456	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer		NO	Complete Response		54			TCGA-EA-A5ZE-F57092	Former User					ABSENT							Stage IB1		-19868					101					0	456	425	425																2014-3-3	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	2320	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Peri (6-12 months since last menstrual period)	G3	Other, specify			Distant Metastasis	Lymph node, inguinal	YES	YES			3		true			M0	N0	T1b1	TCGA-EA-A5ZE.316CE4CE-B951-4DFA-B2CC-B0512AA86871.pdf							0		0		0		0		30		10		60		70			TUMOR FREE	NO		NO	Complete Remission/Response	No	NO				R0			Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	55	2012		07182B36-7B4A-4EE6-9A92-E922AC718242	TCGA-EA-A5ZE-01A-11D-A28B-09	0ec8f213-1b87-4c8e-86b8-90362601df4a	TCGA-EA-A5ZE-01A-11D-A28A-01	0ec8f213-1b87-4c8e-86b8-90362601df4a	TCGA-EA-A5ZE-01A-11D-A28C-05	TCGA-EA-A5ZE-01A-11R-A28L-13	TCGA-EA-A5ZE-01A-11D-A28B-09	TCGA-EA-A5ZE-01	0ec8f213-1b87-4c8e-86b8-90362601df4a	a80b85eb-c7dc-4089-bb6d-cd17c8394aae	0ec8f213-1b87-4c8e-86b8-90362601df4a	a80b85eb-c7dc-4089-bb6d-cd17c8394aae	TCGA-EA-A5ZE-01A-11D-A28B-09	TCGA-EA-A5ZE-01A-11D-A28B-09	TCGA-EA-A5ZE-01	TCGA-EA-A5ZE-01A-11D-A28A-01	
TCGA-EA-A5ZF-01	0	TCGA-EA-A5ZF-01	455	0	TCGA-EA-A5ZF	440	1	455	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		56			TCGA-EA-A5ZF-F57094	Former User					ABSENT							Stage IB1		-20506					100					0	455	440	440																2014-3-3	FEMALE	151	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1060	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Peri (6-12 months since last menstrual period)	G2	Cervix			Locoregional Recurrence		YES	YES			3		true			M0	NX	T1b1	TCGA-EA-A5ZF.B4189C9E-2244-4C36-AABB-00B57F9540FF.pdf							0		0		0		0		10		10		80		90			WITH TUMOR	NO		NO	Complete Remission/Response	No	NO				R0			Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	51	2012		A2E4E986-D906-4AF4-B9E8-A14D9B8F9F07	TCGA-EA-A5ZF-01A-11D-A28B-09	687d43fb-fb87-464d-a661-697889b99aed	TCGA-EA-A5ZF-01A-11D-A28A-01	687d43fb-fb87-464d-a661-697889b99aed	TCGA-EA-A5ZF-01A-11D-A28C-05	TCGA-EA-A5ZF-01A-11R-A28L-13	TCGA-EA-A5ZF-01A-11D-A28B-09	TCGA-EA-A5ZF-01	687d43fb-fb87-464d-a661-697889b99aed	8e1bbdc9-cd19-4dcc-ab9b-3fd4a7ad7272	687d43fb-fb87-464d-a661-697889b99aed	8e1bbdc9-cd19-4dcc-ab9b-3fd4a7ad7272	TCGA-EA-A5ZF-01A-11D-A28B-09	TCGA-EA-A5ZF-01A-11D-A28B-09	TCGA-EA-A5ZF-01	TCGA-EA-A5ZF-01A-11D-A28A-01	
TCGA-EA-A6QX-01	0	TCGA-EA-A6QX-01	413	0	TCGA-EA-A6QX	413	0	413	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		49			TCGA-EA-A6QX-F59802						ABSENT							Stage IIIB		-18035					99					0	413																		2014-5-27	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1260	NO	Non-keratinizing squamous cell carcinoma	NO	3	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G3							NO	2		2		true			M0	N1	T1b1	TCGA-EA-A6QX.84774C0F-D4E4-4BE3-9159-4E932890F7EC.pdf					2		1		1		0		0		10		10		80		80			TUMOR FREE	NO		YES	Complete Remission/Response	No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	4		cervical	A	LIVING	49	2013		A8AC0A62-1CC2-43E6-AFC2-6B455B8F5759	TCGA-EA-A6QX-01A-12D-A33O-09	9ce21675-b3ac-45b0-85c6-f3b2e4188944	TCGA-EA-A6QX-01A-12D-A33N-01	9ce21675-b3ac-45b0-85c6-f3b2e4188944	TCGA-EA-A6QX-01A-12D-A340-05	TCGA-EA-A6QX-01A-12R-A342-13	TCGA-EA-A6QX-01A-12D-A33O-09	TCGA-EA-A6QX-01	9ce21675-b3ac-45b0-85c6-f3b2e4188944	56854deb-6618-46e9-876c-37dca7bb80f5	9ce21675-b3ac-45b0-85c6-f3b2e4188944	56854deb-6618-46e9-876c-37dca7bb80f5	TCGA-EA-A6QX-01A-12D-A33O-09	TCGA-EA-A6QX-01A-12D-A33O-09	TCGA-EA-A6QX-01	TCGA-EA-A6QX-01A-12D-A33N-01	
TCGA-EA-A78R-01	0	TCGA-EA-A78R-01	410	0	TCGA-EA-A78R	410	0	410	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		54			TCGA-EA-A78R-F59968						ABSENT							Stage IB1		-19942					126					0	410																		2014-5-27	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	890	NO	Non-keratinizing squamous cell carcinoma	NO				PRESENT	Peri (6-12 months since last menstrual period)	G2							NO			3		true			M0	NX	T1b1	TCGA-EA-A78R.36A90083-5078-435F-B9C2-337B75807716.pdf							5		0		5		0		10		25		60		60			TUMOR FREE			NO	Complete Remission/Response	No								Primary Tumor	01			2009		YES	NO	EA	Lifelong Non-smoker	3		cervical	A	LIVING	63	2013		6E230015-A5EA-43CD-9BCE-4FB37061E492	TCGA-EA-A78R-01A-11D-A32I-09	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	TCGA-EA-A78R-01A-11D-A32H-01	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	TCGA-EA-A78R-01A-11D-A32T-05	TCGA-EA-A78R-01A-11R-A32K-13	TCGA-EA-A78R-01A-11D-A32I-09	TCGA-EA-A78R-01	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	4d8c6dde-b51e-490b-8a1b-28320de2e771	f96c0c4c-5d06-4606-9c58-aebdc3e2cef4	4d8c6dde-b51e-490b-8a1b-28320de2e771	TCGA-EA-A78R-01A-11D-A32I-09	TCGA-EA-A78R-01A-11D-A32I-09	TCGA-EA-A78R-01	TCGA-EA-A78R-01A-11D-A32H-01	
TCGA-EA-A97N-01	0	TCGA-EA-A97N-01	11	0	TCGA-EA-A97N	11	0	11	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					38				Never Used					ABSENT							Stage IB2		-13984					83					0	11			11								1							2014-4-18	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	630	NO	Non-keratinizing squamous cell carcinoma		10			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		true			M0	N0	T1b2	TCGA-EA-A97N.23982BB4-8B3A-4F8B-98EE-11E63B92FA17.pdf					3		40		20		10		20		0		30		60		60		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009	NO	YES	NO	EA	Lifelong Non-smoker	5		cervical	A	LIVING	60	2013		DA5131EF-4E20-4519-BE27-4C016B087F14		05293acf-1896-4a84-af90-0fe7483bdb66	TCGA-EA-A97N-01A-11D-A386-01	05293acf-1896-4a84-af90-0fe7483bdb66	TCGA-EA-A97N-01A-11D-A388-05	TCGA-EA-A97N-01A-11R-A38M-13		TCGA-EA-A97N-01	05293acf-1896-4a84-af90-0fe7483bdb66	660000b5-6b18-4986-baee-44abbf179427	05293acf-1896-4a84-af90-0fe7483bdb66	660000b5-6b18-4986-baee-44abbf179427			TCGA-EA-A97N-01	TCGA-EA-A97N-01A-11D-A386-01	
TCGA-EK-A2GZ-01	0	TCGA-EK-A2GZ-01	383	0	TCGA-EK-A2GZ	383	0	383	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				NO	64			TCGA-EK-A2GZ-F31876											Other		Stage IIIB		-23599					1099				-3	0	383			-1	26							0						Scheduled Follow-up Submission	2012-5-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma		14				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO		0	5		false						TCGA-EK-A2GZ.793DCC7F-E9F9-4A23-A5C3-2738AD4E0091.pdf							1		0		5		0		0		65		30		98		Preoperative	WITH TUMOR			YES		Yes	NO							Primary Tumor	01			1995		NO	YES	EK		5		cervical	A	LIVING	64	2008			TCGA-EK-A2GZ-01A-11D-A17W-09	76e090d4-d2c2-4918-97d8-4dd1dbea5452	TCGA-EK-A2GZ-01A-11D-A17U-01	76e090d4-d2c2-4918-97d8-4dd1dbea5452	TCGA-EK-A2GZ-01A-11D-A17Z-05	TCGA-EK-A2GZ-01A-11R-A17X-13	TCGA-EK-A2GZ-01A-11D-A17W-09	TCGA-EK-A2GZ-01	76e090d4-d2c2-4918-97d8-4dd1dbea5452	684386f0-695f-4dae-b8a0-490bbdab5293	76e090d4-d2c2-4918-97d8-4dd1dbea5452	684386f0-695f-4dae-b8a0-490bbdab5293	TCGA-EK-A2GZ-01A-11D-A17W-09	TCGA-EK-A2GZ-01A-11D-A17W-09	TCGA-EK-A2GZ-01	TCGA-EK-A2GZ-01A-11D-A17U-01	
TCGA-EK-A2H0-01	0	TCGA-EK-A2H0-01	1398	0	TCGA-EK-A2H0	1398	0	1398	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	24		6	TCGA-EK-A2H0-F31965		Completed as planned	60		HDR							Cisplatin	Stage IIB	385 mg/m2	-8918	79	100	90	54	1268				21	0	1398			28	28	112	54				Once weekly	0		Treatment not completed	0			Scheduled Follow-up Submission	2012-5-14	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			0		false						TCGA-EK-A2H0.AEDD5CA3-2E0A-414F-AA38-CCF5229EC7F2.pdf							2		0		5		0		0		10		85		94		Preoperative	TUMOR FREE				Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			1995	YES	NO	YES	EK		0		cervical	A	LIVING	88	2007		A420B883-B083-453C-BF60-128E2737BBE3	TCGA-EK-A2H0-01A-11D-A17W-09	c59486e3-0de6-4fd2-adef-b3b369d41e7c	TCGA-EK-A2H0-01A-11D-A17U-01	c59486e3-0de6-4fd2-adef-b3b369d41e7c	TCGA-EK-A2H0-01A-11D-A17Z-05	TCGA-EK-A2H0-01A-11R-A17X-13	TCGA-EK-A2H0-01A-11D-A17W-09	TCGA-EK-A2H0-01	c59486e3-0de6-4fd2-adef-b3b369d41e7c	c736f214-bcfe-48ba-84da-abb53322f868	c59486e3-0de6-4fd2-adef-b3b369d41e7c	c736f214-bcfe-48ba-84da-abb53322f868	TCGA-EK-A2H0-01A-11D-A17W-09	TCGA-EK-A2H0-01A-11D-A17W-09	TCGA-EK-A2H0-01	TCGA-EK-A2H0-01A-11D-A17U-01	
TCGA-EK-A2H1-01	0	TCGA-EK-A2H1-01	799	0	TCGA-EK-A2H1	799	0	799	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				YES	20			TCGA-EK-A2H1-F21350												Other	Stage IB2		-7649				70	1319					0	799			44	44		70					0						Scheduled Follow-up Submission	2012-2-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES	Endocervical curettage, cervical cone biopsy	Other method, specify:	140	NO	Non-keratinizing squamous cell carcinoma					ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO					false		Cetuximab				TCGA-EK-A2H1.90313D4A-1DB7-42E5-8778-2CB92794B05D.pdf							20		0		3		0		2		15		80		70		Pre-Adjuvant Therapy	TUMOR FREE					No	YES							Primary Tumor	01			1995	YES	NO	YES	EK				cervical	A	LIVING	62	2007		FDBD4A06-DE72-4AB2-9949-A4929D93B712	TCGA-EK-A2H1-01A-11D-A17W-09	4b80a4f6-c58b-4955-b390-53c9d722ebfa	TCGA-EK-A2H1-01A-11D-A17U-01	4b80a4f6-c58b-4955-b390-53c9d722ebfa	TCGA-EK-A2H1-01A-11D-A17Z-05	TCGA-EK-A2H1-01A-11R-A17X-13	TCGA-EK-A2H1-01A-11D-A17W-09	TCGA-EK-A2H1-01	4b80a4f6-c58b-4955-b390-53c9d722ebfa	d4d905eb-bce8-4ab4-8845-522d3b8d28d5	4b80a4f6-c58b-4955-b390-53c9d722ebfa	d4d905eb-bce8-4ab4-8845-522d3b8d28d5	TCGA-EK-A2H1-01A-11D-A17W-09	TCGA-EK-A2H1-01A-11D-A17W-09	TCGA-EK-A2H1-01	TCGA-EK-A2H1-01A-11D-A17U-01	
TCGA-EK-A2IP-01	0	TCGA-EK-A2IP-01	202	0	TCGA-EK-A2IP	202	0	202	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer				NO	28			TCGA-EK-A2IP-F21349													Stage IB1		-10347					1675		-2			0	202			8	8							0						Scheduled Follow-up Submission	2012-2-10	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma		18					G3							NO			1		false			MX	N0	T1b1	TCGA-EK-A2IP.973889C0-DC63-43F2-9DF4-CA67AFADFA87.pdf				1			2		0		1		0		0		15		84		85		Preoperative				YES		No	NO							Primary Tumor	01			1995		NO	YES	EK		2		cervical	A	LIVING	69	2006		939F11BA-747F-4A0A-A885-FCF46C2500F7	TCGA-EK-A2IP-01A-11D-A17W-09	099a51db-4d31-4d90-b9cb-fd482309479a	TCGA-EK-A2IP-01A-11D-A17U-01	099a51db-4d31-4d90-b9cb-fd482309479a	TCGA-EK-A2IP-01A-11D-A17Z-05	TCGA-EK-A2IP-01A-11R-A17X-13	TCGA-EK-A2IP-01A-11D-A17W-09	TCGA-EK-A2IP-01	099a51db-4d31-4d90-b9cb-fd482309479a	1bf1298b-4919-40d4-bfe5-d8aaa083a096	099a51db-4d31-4d90-b9cb-fd482309479a	1bf1298b-4919-40d4-bfe5-d8aaa083a096	TCGA-EK-A2IP-01A-11D-A17W-09	TCGA-EK-A2IP-01A-11D-A17W-09	TCGA-EK-A2IP-01	TCGA-EK-A2IP-01A-11D-A17U-01	
TCGA-EK-A2IR-01	0	TCGA-EK-A2IR-01	3442	0	TCGA-EK-A2IR	3442	0	3442	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	NO	48			TCGA-EK-A2IR-F21345						ABSENT							Stage IB2		-17581					4950				4	0	3442			-7	-7							0						Scheduled Follow-up Submission	2012-2-10	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Retroperitoneal pelvic and para-aortic lymph node dissection, radical hysterectomy and BSO.	Other method, specify:	130	NO	Keratinizing squamous cell carcinoma		24			PRESENT		G3							NO			1	18	false			MX	N0	T1b	TCGA-EK-A2IR.2A0B2B7B-4EBC-49BC-929C-2E5AED2CCBC5.pdf							2		0		1		0		0		20		79		90		Preoperative	TUMOR FREE			YES	Complete Remission/Response	No	NO							Primary Tumor	01			1995		NO	YES	EK		1		cervical	A	LIVING	61	1997		4E99977A-5CA0-49FC-A1AC-69B4138A18BF		3c109286-fa30-4f6b-98d1-70cd89f87f31		3c109286-fa30-4f6b-98d1-70cd89f87f31	TCGA-EK-A2IR-01A-11D-A17Z-05	TCGA-EK-A2IR-01A-11R-A17X-13			3c109286-fa30-4f6b-98d1-70cd89f87f31		3c109286-fa30-4f6b-98d1-70cd89f87f31				TCGA-EK-A2IR-01		
TCGA-EK-A2PG-01	0	TCGA-EK-A2PG-01	46	0	TCGA-EK-A2PG			46	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					88			TCGA-EK-A2PG-F58223															-32500					2165					0	46			0								4							2014-4-2	FEMALE	155	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO		YES					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3												false						TCGA-EK-A2PG.373213AD-4641-426B-AD9F-6C868CAE2868.pdf							15		0		1		0		29		20		50		60		Preoperative						No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	55	2005			TCGA-EK-A2PG-01A-11D-A18J-09	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	TCGA-EK-A2PG-01A-11D-A18H-01	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	TCGA-EK-A2PG-01A-11D-A18K-05	TCGA-EK-A2PG-01A-11R-A18L-13	TCGA-EK-A2PG-01A-11D-A18J-09	TCGA-EK-A2PG-01	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	6347a231-5d7d-4499-8366-d5e172026154	9f86c904-9c2f-4413-a5ad-95a6fd65cb71	6347a231-5d7d-4499-8366-d5e172026154	TCGA-EK-A2PG-01A-11D-A18J-09	TCGA-EK-A2PG-01A-11D-A18J-09	TCGA-EK-A2PG-01	TCGA-EK-A2PG-01A-11D-A18H-01	
TCGA-EK-A2PI-01	0	TCGA-EK-A2PI-01	42	0	TCGA-EK-A2PI			42	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44			TCGA-EK-A2PI-F58244													Stage IIIB		-16324					881					0	42			0								0							2014-4-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		YES						G2												false						TCGA-EK-A2PI.1DA80321-4DC2-4BEF-B932-1B38B6BEDB24.pdf							10		0		2		0		30		18		50		68		Preoperative	WITH TUMOR					No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	53	2009			TCGA-EK-A2PI-01A-11D-A18J-09	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	TCGA-EK-A2PI-01A-11D-A18H-01	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	TCGA-EK-A2PI-01A-11D-A18K-05	TCGA-EK-A2PI-01A-11R-A18L-13	TCGA-EK-A2PI-01A-11D-A18J-09	TCGA-EK-A2PI-01	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	92383368-b5fa-4014-aa42-f6c0af2c697a	689fb0d6-789a-45c2-8f2f-12cc3a2ea553	92383368-b5fa-4014-aa42-f6c0af2c697a	TCGA-EK-A2PI-01A-11D-A18J-09	TCGA-EK-A2PI-01A-11D-A18J-09	TCGA-EK-A2PI-01	TCGA-EK-A2PI-01A-11D-A18H-01	
TCGA-EK-A2PK-01		TCGA-EK-A2PK-01			TCGA-EK-A2PK				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					43																Stage IB1		-15939					2043					0	0			0								1							2011-12-8	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Hysterectomy	Other method, specify:	110	NO	Non-keratinizing squamous cell carcinoma		35					G3												false						TCGA-EK-A2PK.F447FFBB-73CD-404F-A078-A894079F30C2.pdf							4		0		1		0		0		6		93		90		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	94	2006		580103D7-9873-4F83-857F-4D46A9DD24A2	TCGA-EK-A2PK-01A-11D-A18J-09	1e176d9d-dba9-4d41-946e-05b7f35eba64	TCGA-EK-A2PK-01A-11D-A18H-01	1e176d9d-dba9-4d41-946e-05b7f35eba64	TCGA-EK-A2PK-01A-11D-A18K-05	TCGA-EK-A2PK-01A-11R-A18L-13	TCGA-EK-A2PK-01A-11D-A18J-09	TCGA-EK-A2PK-01	1e176d9d-dba9-4d41-946e-05b7f35eba64	0a49955a-2771-4047-8e91-55e4dde56ca7	1e176d9d-dba9-4d41-946e-05b7f35eba64	0a49955a-2771-4047-8e91-55e4dde56ca7	TCGA-EK-A2PK-01A-11D-A18J-09	TCGA-EK-A2PK-01A-11D-A18J-09	TCGA-EK-A2PK-01	TCGA-EK-A2PK-01A-11D-A18H-01	
TCGA-EK-A2PL-01	0	TCGA-EK-A2PL-01	13	0	TCGA-EK-A2PL			13	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					36			TCGA-EK-A2PL-F58252													Stage IIIB		-13384					1181					0	13			13								0							2014-4-3	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	YES																3		false						TCGA-EK-A2PL.B51554EF-AA39-4A99-BC15-A80EC759316E.pdf							10		0		1		0		7		12		80		80		Preoperative	WITH TUMOR					No								Primary Tumor	01			1988		NO	YES	EK		6		cervical	A	LIVING	113	2008		338F2045-F35A-402B-A07C-83AFC37DB6E4	TCGA-EK-A2PL-01A-11D-A18J-09	550b677c-c33a-499c-95dc-68250384b6a8	TCGA-EK-A2PL-01A-11D-A18H-01	550b677c-c33a-499c-95dc-68250384b6a8	TCGA-EK-A2PL-01A-11D-A18K-05	TCGA-EK-A2PL-01A-11R-A18L-13	TCGA-EK-A2PL-01A-11D-A18J-09	TCGA-EK-A2PL-01	550b677c-c33a-499c-95dc-68250384b6a8	d3599ced-8d7d-46c0-90ac-c6703801d18b	550b677c-c33a-499c-95dc-68250384b6a8	d3599ced-8d7d-46c0-90ac-c6703801d18b	TCGA-EK-A2PL-01A-11D-A18J-09	TCGA-EK-A2PL-01A-11D-A18J-09	TCGA-EK-A2PL-01	TCGA-EK-A2PL-01A-11D-A18H-01	
TCGA-EK-A2PM-01	0	TCGA-EK-A2PM-01	18	0	TCGA-EK-A2PM			18	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					81			TCGA-EK-A2PM-F58253													Stage IIB		-29747					1199					0	18			18								0							2014-4-3	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO	Keratinizing squamous cell carcinoma	YES					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3										3		false						TCGA-EK-A2PM.B1AB121F-E75E-4AE1-9C9A-16076A3B7879.pdf							1		0		15		0		0		5		80		96		Preoperative	WITH TUMOR					No								Primary Tumor	01			1988		NO	YES	EK		3		cervical	A	LIVING	51	2008		62C8376A-9A66-4499-A4E3-E7C0102B5EB4	TCGA-EK-A2PM-01A-11D-A18J-09	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	TCGA-EK-A2PM-01A-11D-A18H-01	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	TCGA-EK-A2PM-01A-11D-A18K-05	TCGA-EK-A2PM-01A-11R-A18L-13	TCGA-EK-A2PM-01A-11D-A18J-09	TCGA-EK-A2PM-01	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	ddd0d360-7ea7-4085-a392-60242b314eb0	44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476	ddd0d360-7ea7-4085-a392-60242b314eb0	TCGA-EK-A2PM-01A-11D-A18J-09	TCGA-EK-A2PM-01A-11D-A18J-09	TCGA-EK-A2PM-01	TCGA-EK-A2PM-01A-11D-A18H-01	
TCGA-EK-A2R7-01	0	TCGA-EK-A2R7-01	18	0	TCGA-EK-A2R7			18	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45				Current User												Stage IB		-16487					546					0	18			16								0							2011-12-2	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO			21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										2		false			M0	N1	T1b1	TCGA-EK-A2R7.5EE5A64B-9025-4C3E-8CD8-8293515BC1F8.pdf							6		0		1		0		19		5		75		88		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		2		cervical	A	LIVING	75	2010		5084B39A-9371-4D27-9812-371724EED76C	TCGA-EK-A2R7-01A-11D-A18J-09	ebe70126-032b-4f1e-9d89-1e0bd2f05907	TCGA-EK-A2R7-01A-11D-A18H-01	ebe70126-032b-4f1e-9d89-1e0bd2f05907	TCGA-EK-A2R7-01A-11D-A18K-05	TCGA-EK-A2R7-01A-11R-A18L-13	TCGA-EK-A2R7-01A-11D-A18J-09	TCGA-EK-A2R7-01	ebe70126-032b-4f1e-9d89-1e0bd2f05907	8e132c07-321d-4e79-bfc6-165c9e3a0062	ebe70126-032b-4f1e-9d89-1e0bd2f05907	8e132c07-321d-4e79-bfc6-165c9e3a0062	TCGA-EK-A2R7-01A-11D-A18J-09	TCGA-EK-A2R7-01A-11D-A18J-09	TCGA-EK-A2R7-01	TCGA-EK-A2R7-01A-11D-A18H-01	
TCGA-EK-A2R8-01	0	TCGA-EK-A2R8-01	44	0	TCGA-EK-A2R8			44	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					48			TCGA-EK-A2R8-F58216						ABSENT							Stage IB2		-17692					554					0	44			44								0							2014-4-2	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	100	NO	Keratinizing squamous cell carcinoma	YES	17			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										5		false			MX	N1	T1b2	TCGA-EK-A2R8.7E69142C-4F3A-4F81-9DC8-72C86F689083.pdf							5		0		15		25		2		5		78		65		Preoperative	WITH TUMOR			YES		No								Primary Tumor	01			1988		NO	YES	EK		5		cervical	A	LIVING	75	2010		AC94BFF4-8049-498D-987E-297D102E8F1D	TCGA-EK-A2R8-01A-21D-A18J-09	5ff64ded-bdb0-4125-b1b9-8a3945e82810	TCGA-EK-A2R8-01A-21D-A18H-01	5ff64ded-bdb0-4125-b1b9-8a3945e82810	TCGA-EK-A2R8-01A-21D-A18K-05	TCGA-EK-A2R8-01A-21R-A18L-13	TCGA-EK-A2R8-01A-21D-A18J-09	TCGA-EK-A2R8-01	5ff64ded-bdb0-4125-b1b9-8a3945e82810	b3b13916-6161-4bff-8047-319a2bad7808	5ff64ded-bdb0-4125-b1b9-8a3945e82810	b3b13916-6161-4bff-8047-319a2bad7808	TCGA-EK-A2R8-01A-21D-A18J-09	TCGA-EK-A2R8-01A-21D-A18J-09	TCGA-EK-A2R8-01	TCGA-EK-A2R8-01A-21D-A18H-01	
TCGA-EK-A2R9-01	0	TCGA-EK-A2R9-01	4	0	TCGA-EK-A2R9			4	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					58			TCGA-EK-A2R9-F58255						ABSENT							Stage IB1		-21242					230					0	4			4								0							2014-4-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical Total Abdominal Hysterectomy and BSO	Other method, specify:	100	NO		YES	14			PRESENT		G3												false				N0	T1b1	TCGA-EK-A2R9.05E84255-196B-424A-B317-9A4D2072BD5D.pdf							10		0		3		0		50		7		40		65		Preoperative	WITH TUMOR			YES		No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	185	2011		58CD44F1-118D-4675-A3F8-0F28F8F98EF9	TCGA-EK-A2R9-01A-11D-A18J-09	359ed529-c947-47f9-8119-78f2fd038ee5	TCGA-EK-A2R9-01A-11D-A18H-01	359ed529-c947-47f9-8119-78f2fd038ee5	TCGA-EK-A2R9-01A-11D-A18K-05	TCGA-EK-A2R9-01A-11R-A18L-13	TCGA-EK-A2R9-01A-11D-A18J-09	TCGA-EK-A2R9-01	359ed529-c947-47f9-8119-78f2fd038ee5	9f8ea9a4-48ef-4f29-bd45-fc1525dda0cd	359ed529-c947-47f9-8119-78f2fd038ee5	9f8ea9a4-48ef-4f29-bd45-fc1525dda0cd	TCGA-EK-A2R9-01A-11D-A18J-09	TCGA-EK-A2R9-01A-11D-A18J-09	TCGA-EK-A2R9-01	TCGA-EK-A2R9-01A-11D-A18H-01	
TCGA-EK-A2RA-01	0	TCGA-EK-A2RA-01	489	0	TCGA-EK-A2RA	489	0	489	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Stable Disease		74	41		TCGA-EK-A2RA-F58256						PRESENT							Stage IIA2		-27209					232		30			0	489			5								0							2014-4-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No					Total Abdominal Hysterectomy	Other	C53.9	8072/3	C53.9	YES	aortic and pelvic lymphadenectomy, total abdominal hysterectomy and BSO.	Other method, specify:	130	NO	Non-keratinizing squamous cell carcinoma	YES	32			ABSENT		G3							NO	0	0			false			MX	N0	T2a2	TCGA-EK-A2RA.4BF58062-E21B-4C5E-91D3-8AB242D8D62E.pdf							25		0		3		0		15		22		60		65		Preoperative	WITH TUMOR	NO		YES		No	NO							Primary Tumor	01		2010	2009		NO	YES	EK	Current reformed smoker for < or = 15 years			cervical	A	LIVING	72	2011		A6DF7C14-361B-4DFF-B886-9EE48F169CD4	TCGA-EK-A2RA-01A-11D-A18J-09	95a815e7-101e-416c-90b0-5c6c568ab897	TCGA-EK-A2RA-01A-11D-A18H-01	95a815e7-101e-416c-90b0-5c6c568ab897	TCGA-EK-A2RA-01A-11D-A18K-05	TCGA-EK-A2RA-01A-11R-A18L-13	TCGA-EK-A2RA-01A-11D-A18J-09	TCGA-EK-A2RA-01	95a815e7-101e-416c-90b0-5c6c568ab897	62e462c2-6394-4a59-8814-236d0b0b6413	95a815e7-101e-416c-90b0-5c6c568ab897	62e462c2-6394-4a59-8814-236d0b0b6413	TCGA-EK-A2RA-01A-11D-A18J-09	TCGA-EK-A2RA-01A-11D-A18J-09	TCGA-EK-A2RA-01	TCGA-EK-A2RA-01A-11D-A18H-01	
TCGA-EK-A2RB-01	0	TCGA-EK-A2RB-01	2	0	TCGA-EK-A2RB			2	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					48																Stage IVB		-17752					169					0	2			0								0							2011-12-7	FEMALE	175	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES	Cervical biopsies and cystoscopy	Other method, specify:	70	NO								G3												false						TCGA-EK-A2RB.F973731C-16D2-4391-ACCF-381C362B8438.pdf							5		0		1		0		0		15		84		92		Preoperative				NO		No								Primary Tumor	01			1988		NO	YES	EK	Current smoker			cervical	A	LIVING	105	2011			TCGA-EK-A2RB-01A-11D-A18J-09	59d21a33-8d29-4c23-95a8-7986d2a3db36	TCGA-EK-A2RB-01A-11D-A18H-01	59d21a33-8d29-4c23-95a8-7986d2a3db36	TCGA-EK-A2RB-01A-11D-A18K-05	TCGA-EK-A2RB-01A-11R-A18L-13	TCGA-EK-A2RB-01A-11D-A18J-09	TCGA-EK-A2RB-01	59d21a33-8d29-4c23-95a8-7986d2a3db36	8310aad7-e4ee-47bd-9861-d03ee458b1f1	59d21a33-8d29-4c23-95a8-7986d2a3db36	8310aad7-e4ee-47bd-9861-d03ee458b1f1	TCGA-EK-A2RB-01A-11D-A18J-09	TCGA-EK-A2RB-01A-11D-A18J-09	TCGA-EK-A2RB-01	TCGA-EK-A2RB-01A-11D-A18H-01	
TCGA-EK-A2RC-01	0	TCGA-EK-A2RC-01	123	0	TCGA-EK-A2RC			123	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					33																Stage IB1		-12353					786					0	123			120								0					NO		2011-12-7	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Biopsy and endocervical curettage	Other method, specify:	100	NO			16			PRESENT		G3										3		false						TCGA-EK-A2RC.1FBD6F5F-52DB-4DA3-AB1D-BB81200A032B.pdf							2		0		1		0		5		10		84		92		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		4		cervical	A	LIVING	72	2009		272D7304-B95D-43A9-B70C-20E37C81082C	TCGA-EK-A2RC-01A-11D-A18J-09	fa8d81bb-a026-426c-8e24-2c8ca93007c4	TCGA-EK-A2RC-01A-11D-A18H-01	fa8d81bb-a026-426c-8e24-2c8ca93007c4	TCGA-EK-A2RC-01A-11D-A18K-05	TCGA-EK-A2RC-01A-11R-A18L-13	TCGA-EK-A2RC-01A-11D-A18J-09	TCGA-EK-A2RC-01	fa8d81bb-a026-426c-8e24-2c8ca93007c4	2f32b0a1-6e45-4b61-80e7-bf49abf99654	fa8d81bb-a026-426c-8e24-2c8ca93007c4	2f32b0a1-6e45-4b61-80e7-bf49abf99654	TCGA-EK-A2RC-01A-11D-A18J-09	TCGA-EK-A2RC-01A-11D-A18J-09	TCGA-EK-A2RC-01	TCGA-EK-A2RC-01A-11D-A18H-01	
TCGA-EK-A2RD-01	0	TCGA-EK-A2RD-01	1	0	TCGA-EK-A2RD			1	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					47																Stage IB1		-17191					658					0	1			0								0							2011-12-5	FEMALE	161	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Biopsy, Robotic Hysterectomy, BSO, Pelvic and periaortic LN dissection.	Other method, specify:	120	NO	Non-keratinizing squamous cell carcinoma		10			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										2		false			MX	N0	T1b1	TCGA-EK-A2RD.CD011A7E-A4C0-4BCE-8D21-C2CC6B97E85E.pdf							10		0		2		0		0		13		85		85		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		2		cervical	A	LIVING	114	2009		84C57E10-A656-4563-8F7A-71CD0ECD84B0	TCGA-EK-A2RD-01A-12D-A20U-09		TCGA-EK-A2RD-01A-12D-A20T-01		TCGA-EK-A2RD-01A-12D-A212-05	TCGA-EK-A2RD-01A-12R-A214-13	TCGA-EK-A2RD-01A-12D-A20U-09			f0e8b2c6-4741-4d48-824b-311c9714ab65		f0e8b2c6-4741-4d48-824b-311c9714ab65	TCGA-EK-A2RD-01A-12D-A20U-09	TCGA-EK-A2RD-01A-12D-A20U-09		TCGA-EK-A2RD-01A-12D-A20T-01	
TCGA-EK-A2RE-01	0	TCGA-EK-A2RE-01	11	0	TCGA-EK-A2RE			11	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					26									ABSENT							Stage IIA		-9743					364					0	11			0								0							2011-12-5	FEMALE	161	Cervical Squamous Cell Carcinoma	No			atypia positive hpv	Other HPV type(s)			C53.9	8071/3	C53.9	YES	laparoscopic-assisted radical vaginal trachelectomy with pelvic periaortic lymph node dissection and cerclage	Other method, specify:	120	NO	Keratinizing squamous cell carcinoma		21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2												false			MX	N0	T2a2	TCGA-EK-A2RE.86AFFE75-2DB8-40E3-9BCA-A2F695173DCC.pdf							20		0		1		4		10		19		70		70		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	54	2010		CC285FB3-7E31-4A64-BEFF-36F0909E6C8D	TCGA-EK-A2RE-01A-11D-A18J-09	51257d94-f973-4dfd-93d7-72ec4013def7	TCGA-EK-A2RE-01A-11D-A18H-01	51257d94-f973-4dfd-93d7-72ec4013def7	TCGA-EK-A2RE-01A-11D-A18K-05	TCGA-EK-A2RE-01A-11R-A18L-13	TCGA-EK-A2RE-01A-11D-A18J-09	TCGA-EK-A2RE-01	51257d94-f973-4dfd-93d7-72ec4013def7	78c941e9-c082-49b4-8059-29938afdcb29	51257d94-f973-4dfd-93d7-72ec4013def7	78c941e9-c082-49b4-8059-29938afdcb29	TCGA-EK-A2RE-01A-11D-A18J-09	TCGA-EK-A2RE-01A-11D-A18J-09	TCGA-EK-A2RE-01	TCGA-EK-A2RE-01A-11D-A18H-01	
TCGA-EK-A2RJ-01	0	TCGA-EK-A2RJ-01	36	0	TCGA-EK-A2RJ			36	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51																Stage IB2		-18664					714					0	36			33								0							2011-12-2	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma		22			PRESENT		G3										1		false			MX	N0	T1b2	TCGA-EK-A2RJ.6761746F-0149-4AE4-840F-D99B8FCEF6F5.pdf							20		0		12		5		0		2		86		70		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		1		cervical	A	LIVING	85	2009		23F28333-7FA9-41C6-8039-57739EC99A30	TCGA-EK-A2RJ-01A-11D-A18J-09	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	TCGA-EK-A2RJ-01A-11D-A18H-01	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	TCGA-EK-A2RJ-01A-11D-A18K-05	TCGA-EK-A2RJ-01A-11R-A18L-13	TCGA-EK-A2RJ-01A-11D-A18J-09	TCGA-EK-A2RJ-01	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	218ca6bd-a262-4e8b-a209-5cc9e5e15d88	48ee0be7-9c0f-4e6d-81cf-638c52beef8b	218ca6bd-a262-4e8b-a209-5cc9e5e15d88	TCGA-EK-A2RJ-01A-11D-A18J-09	TCGA-EK-A2RJ-01A-11D-A18J-09	TCGA-EK-A2RJ-01	TCGA-EK-A2RJ-01A-11D-A18H-01	
TCGA-EK-A2RK-01		TCGA-EK-A2RK-01			TCGA-EK-A2RK				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					67																Stage IA2		-24541					709					0	0			13								0							2011-12-2	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	Radical hysterectomy, BSO, bilateral pelvic lymphadenectomy	Other method, specify:	120	NO	Non-keratinizing squamous cell carcinoma		27			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3										1		false			MX	N0	T1b1	TCGA-EK-A2RK.53039912-13F8-4EB8-B8DD-39B39F2AE486.pdf				1			10		0		3		0		37		10		50		70		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		2		cervical	A	LIVING	101	2009		8946907D-9AB9-4A3F-80CD-5689DAAB4556	TCGA-EK-A2RK-01A-11D-A18J-09	2713b35a-f04a-4078-85c6-34140350398f	TCGA-EK-A2RK-01A-11D-A18H-01	2713b35a-f04a-4078-85c6-34140350398f	TCGA-EK-A2RK-01A-11D-A18K-05	TCGA-EK-A2RK-01A-11R-A18L-13	TCGA-EK-A2RK-01A-11D-A18J-09	TCGA-EK-A2RK-01	2713b35a-f04a-4078-85c6-34140350398f	bbcba02a-f37e-4f6a-a973-b19e6c11ff31	2713b35a-f04a-4078-85c6-34140350398f	bbcba02a-f37e-4f6a-a973-b19e6c11ff31	TCGA-EK-A2RK-01A-11D-A18J-09	TCGA-EK-A2RK-01A-11D-A18J-09	TCGA-EK-A2RK-01	TCGA-EK-A2RK-01A-11D-A18H-01	
TCGA-EK-A2RL-01	1	TCGA-EK-A2RL-01	1453	1	TCGA-EK-A2RL	1143	1	1453	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		32			TCGA-EK-A2RL-F58210						PRESENT							Stage IB		-12047					723	1453	20			0	721		1143	29								0							2014-4-2	FEMALE	154	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	biopsy and endocervical curettage	Other method, specify:	140	NO		NO	33	Pelvic (external iliac, internal iliac, obturator)		ABSENT		G2	Cervix	Radiographic		Locoregional Recurrence			YES					false			MX	N1	T1b1	TCGA-EK-A2RL.7AE4CF2E-602B-4860-8919-095EA5378504.pdf	Cervical Cancer						3		1		2		20		0		25		73		70		Preoperative	WITH TUMOR	YES		YES	Progressive Disease	No	NO							Primary Tumor	01			1988	NO	NO	YES	EK				cervical	A	DECEASED	89	2009		7E06C3E0-3B9D-4AEF-B73B-2793790747FA	TCGA-EK-A2RL-01A-11D-A18J-09	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	TCGA-EK-A2RL-01A-11D-A18H-01	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	TCGA-EK-A2RL-01A-11D-A18K-05	TCGA-EK-A2RL-01A-11R-A18L-13	TCGA-EK-A2RL-01A-11D-A18J-09	TCGA-EK-A2RL-01	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	29023e49-3565-4545-8b81-06fdc0d4f842	0e842eda-bb7f-4f4a-b1bc-9d6dcf563125	29023e49-3565-4545-8b81-06fdc0d4f842	TCGA-EK-A2RL-01A-11D-A18J-09	TCGA-EK-A2RL-01A-11D-A18J-09	TCGA-EK-A2RL-01	TCGA-EK-A2RL-01A-11D-A18H-01	
TCGA-EK-A2RM-01	0	TCGA-EK-A2RM-01	68	0	TCGA-EK-A2RM			68	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					40																Stage IB		-14781					839					0	68			82								1							2011-12-1	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Radical Hysterectomy, BSO	Other method, specify:	100	NO			36			PRESENT		G3										4		false						TCGA-EK-A2RM.3810E8FD-27A9-4E65-9BD2-BFA5594813B8.pdf							1		0		5		0		0		20		75		95		Preoperative	WITH TUMOR			YES		No								Primary Tumor	01			1988		NO	YES	EK		4		cervical	A	LIVING	105	2009		8E91B507-4AF4-432F-9A6A-1B07118A6AE2	TCGA-EK-A2RM-01A-21D-A18J-09	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	TCGA-EK-A2RM-01A-21D-A18H-01	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	TCGA-EK-A2RM-01A-21D-A18K-05	TCGA-EK-A2RM-01A-21R-A18L-13	TCGA-EK-A2RM-01A-21D-A18J-09	TCGA-EK-A2RM-01	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	02215c58-6fca-44ab-b81b-c5c11bd3fb49	1a6ee24e-975c-4ba8-8cc3-666555fb89d6	02215c58-6fca-44ab-b81b-c5c11bd3fb49	TCGA-EK-A2RM-01A-21D-A18J-09	TCGA-EK-A2RM-01A-21D-A18J-09	TCGA-EK-A2RM-01	TCGA-EK-A2RM-01A-21D-A18H-01	
TCGA-EK-A2RN-01	0	TCGA-EK-A2RN-01	3	0	TCGA-EK-A2RN			3	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45											parametrial involvement on the right side only	Other Location, specify				Stage IB1		-16485					758					0	3			16								0							2011-12-5	FEMALE	176	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Cone Biopsy / LEEP	60	NO	Keratinizing squamous cell carcinoma		15	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										0		false			MX	N1	T2b	TCGA-EK-A2RN.5B78C1A5-1A21-4970-8CB9-54B6D7C5F672.pdf					1		0		0		5		0		0		0		95		98		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		1		cervical	A	LIVING	68	2009			TCGA-EK-A2RN-01A-12D-A20U-09	f1f0a4e6-8757-43f2-96c5-5b6bae173590	TCGA-EK-A2RN-01A-12D-A20T-01	f1f0a4e6-8757-43f2-96c5-5b6bae173590	TCGA-EK-A2RN-01A-12D-A212-05	TCGA-EK-A2RN-01A-12R-A214-13	TCGA-EK-A2RN-01A-12D-A20U-09	TCGA-EK-A2RN-01	f1f0a4e6-8757-43f2-96c5-5b6bae173590	0dc7de6d-9e12-46fe-b248-f981bc031fb5	f1f0a4e6-8757-43f2-96c5-5b6bae173590	0dc7de6d-9e12-46fe-b248-f981bc031fb5	TCGA-EK-A2RN-01A-12D-A20U-09	TCGA-EK-A2RN-01A-12D-A20U-09	TCGA-EK-A2RN-01	TCGA-EK-A2RN-01A-12D-A20T-01	
TCGA-EK-A2RO-01	0	TCGA-EK-A2RO-01	2	0	TCGA-EK-A2RO			2	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					59												Macroscopic parametrial involvement				Stage IIB		-21844					409				-11	0	2			1								0							2011-12-5	FEMALE	168	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES	Robotic bilateral pelvic and paraaortic lymph node dissection, attempted radical hysterectomy unsuccessful due to disease invading the right parametria, surrounding the right ureter and right vesicouterine ligament.	Other method, specify:	90	NO	Keratinizing squamous cell carcinoma		32				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1								0	0			false						TCGA-EK-A2RO.49E0E89E-7DB0-4FFD-8246-1EF8E4308829.pdf							5		1		2		0		0		48		50		65		Preoperative				YES		No								Primary Tumor	01	12		1988		NO	YES	EK				cervical	A	LIVING	77	2010		33DF4CED-0F6D-4E70-BD3F-D21D94310B95	TCGA-EK-A2RO-01A-11D-A18J-09	6c6c44ac-3626-482e-8d33-adbd122f8352	TCGA-EK-A2RO-01A-11D-A18H-01	6c6c44ac-3626-482e-8d33-adbd122f8352	TCGA-EK-A2RO-01A-11D-A18K-05	TCGA-EK-A2RO-01A-11R-A18L-13	TCGA-EK-A2RO-01A-11D-A18J-09	TCGA-EK-A2RO-01	6c6c44ac-3626-482e-8d33-adbd122f8352	9aa3c042-d4d8-49d1-b72b-6b0a8ef6f432	6c6c44ac-3626-482e-8d33-adbd122f8352	9aa3c042-d4d8-49d1-b72b-6b0a8ef6f432	TCGA-EK-A2RO-01A-11D-A18J-09	TCGA-EK-A2RO-01A-11D-A18J-09	TCGA-EK-A2RO-01	TCGA-EK-A2RO-01A-11D-A18H-01	
TCGA-EK-A3GJ-01	0	TCGA-EK-A3GJ-01	3	0	TCGA-EK-A3GJ			3	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51									ABSENT							Stage IB1		-18630					407					0	3			0								1							2012-2-3	FEMALE	171	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	Radical hysterectomy with bso and pnd	Other method, specify:	90	NO	Keratinizing squamous cell carcinoma		24			ABSENT		G3										6		false				N0	T1b1	TCGA-EK-A3GJ.45318527-2DCC-472C-8712-8639CCF4931D.pdf							8		1		5		1		0		10		75		85		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		10		cervical	A	LIVING	96	2010			TCGA-EK-A3GJ-01A-21D-A20U-09	1dbe0951-14cc-4489-aaf2-f3592be05f07	TCGA-EK-A3GJ-01A-21D-A20T-01	1dbe0951-14cc-4489-aaf2-f3592be05f07	TCGA-EK-A3GJ-01A-21D-A212-05	TCGA-EK-A3GJ-01A-21R-A214-13	TCGA-EK-A3GJ-01A-21D-A20U-09	TCGA-EK-A3GJ-01	1dbe0951-14cc-4489-aaf2-f3592be05f07	8b35ba44-f6ca-47bd-aa8f-8c94219bcc88	1dbe0951-14cc-4489-aaf2-f3592be05f07	8b35ba44-f6ca-47bd-aa8f-8c94219bcc88	TCGA-EK-A3GJ-01A-21D-A20U-09	TCGA-EK-A3GJ-01A-21D-A20U-09	TCGA-EK-A3GJ-01	TCGA-EK-A3GJ-01A-21D-A20T-01	
TCGA-EK-A3GK-01	0	TCGA-EK-A3GK-01	3	0	TCGA-EK-A3GK			3	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					33				Current User					ABSENT							Stage IB1		-12207					744					0	3			15								0							2012-2-2	FEMALE	165	Endocervical Type of Adenocarcinoma	No				HPV 16		Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Radical hysterectomy, BSO, Bilateral pelvic LND, upper vaginectomy, omental and cecal biopsy.	Other method, specify:	90	NO			22			PRESENT		G3								0	0	0		false			MX	N0	T1b1	TCGA-EK-A3GK.FA43F625-0F3A-4CAD-B55D-A00113DEA927.pdf							1		0		2		0		0		2		96		96		Preoperative				YES		No								Primary Tumor	01			1988		NO	YES	EK		0		cervical	A	LIVING	73	2009		84DFB78B-2D19-4F71-BCB0-F7A141BC6690	TCGA-EK-A3GK-01A-11D-A20U-09	6878010a-30d5-44ef-bd70-99f532a584d5	TCGA-EK-A3GK-01A-11D-A20T-01	6878010a-30d5-44ef-bd70-99f532a584d5	TCGA-EK-A3GK-01A-11D-A212-05	TCGA-EK-A3GK-01A-11R-A214-13	TCGA-EK-A3GK-01A-11D-A20U-09	TCGA-EK-A3GK-01	6878010a-30d5-44ef-bd70-99f532a584d5	e2cf8929-bc9f-48e9-8d4b-2571a68fe644	6878010a-30d5-44ef-bd70-99f532a584d5	e2cf8929-bc9f-48e9-8d4b-2571a68fe644	TCGA-EK-A3GK-01A-11D-A20U-09	TCGA-EK-A3GK-01A-11D-A20U-09	TCGA-EK-A3GK-01	TCGA-EK-A3GK-01A-11D-A20T-01	
TCGA-EK-A3GM-01		TCGA-EK-A3GM-01			TCGA-EK-A3GM				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					65									ABSENT							Stage IIA		-23879					2122					0	0			23								0							2012-2-2	FEMALE	150	Endocervical Type of Adenocarcinoma	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO						ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										10		false						TCGA-EK-A3GM.15E809A3-4A09-426E-B816-C31246ECCCA4.pdf							1		0		5		0		0		10		85		97		Preoperative						No								Primary Tumor	01			1988		NO	YES	EK	Lifelong Non-smoker	10		cervical	A	LIVING	83	2006		E932E7D1-9C9C-446B-B772-CAA451D3A27E	TCGA-EK-A3GM-01A-11D-A20U-09	8bae571a-8285-48dd-aea3-9eb002c0610b	TCGA-EK-A3GM-01A-11D-A20T-01	8bae571a-8285-48dd-aea3-9eb002c0610b	TCGA-EK-A3GM-01A-11D-A212-05	TCGA-EK-A3GM-01A-11R-A214-13	TCGA-EK-A3GM-01A-11D-A20U-09	TCGA-EK-A3GM-01	8bae571a-8285-48dd-aea3-9eb002c0610b	b479859c-e125-475c-b410-7127f9ffddb1	8bae571a-8285-48dd-aea3-9eb002c0610b	b479859c-e125-475c-b410-7127f9ffddb1	TCGA-EK-A3GM-01A-11D-A20U-09	TCGA-EK-A3GM-01A-11D-A20U-09	TCGA-EK-A3GM-01	TCGA-EK-A3GM-01A-11D-A20T-01	
TCGA-EK-A3GN-01	0	TCGA-EK-A3GN-01	1	0	TCGA-EK-A3GN			1	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					47									ABSENT							Stage IIIB		-17425					2374					0	1			27								1							2012-2-2	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO						ABSENT		G3												false				NX	TX	TCGA-EK-A3GN.357A8CB5-F1BF-4BFC-97DF-07CEF0D55026.pdf							10		1		5		0		30		25		40		60		Preoperative	WITH TUMOR					No								Primary Tumor	01			1988		NO	YES	EK				cervical	A	LIVING	83	2005		C68D40B8-F4FA-49CF-A16D-CBA515D9EEC9	TCGA-EK-A3GN-01A-11D-A20U-09	b74c4373-3809-4536-85ef-4c9e651a913e	TCGA-EK-A3GN-01A-11D-A20T-01	b74c4373-3809-4536-85ef-4c9e651a913e	TCGA-EK-A3GN-01A-11D-A212-05	TCGA-EK-A3GN-01A-11R-A214-13	TCGA-EK-A3GN-01A-11D-A20U-09	TCGA-EK-A3GN-01	b74c4373-3809-4536-85ef-4c9e651a913e	c2ce8955-a17a-44aa-851a-b17941b9987c	b74c4373-3809-4536-85ef-4c9e651a913e	c2ce8955-a17a-44aa-851a-b17941b9987c	TCGA-EK-A3GN-01A-11D-A20U-09	TCGA-EK-A3GN-01A-11D-A20U-09	TCGA-EK-A3GN-01	TCGA-EK-A3GN-01A-11D-A20T-01	
TCGA-EX-A1H5-01	0	TCGA-EX-A1H5-01	619	0	TCGA-EX-A1H5	619	0	619	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response	YES	58	33		TCGA-EX-A1H5-F50657	Never Used					ABSENT			Microscopic parametrial involvement	not part of recommended treatment plan	Other		Stage IIB		-21338					163					0	619													Completed as Planned				Scheduled Follow-up Submission	2013-10-28	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	220	NO	Non-keratinizing squamous cell carcinoma	NO	21	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	4		4	12	false			MX	N1	T2b	TCGA-EX-A1H5.C596A314-A98F-4E6C-92FA-017BDF820E88.pdf							40		10		5		30		0		35		60		60			TUMOR FREE	NO		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	NO	YES	NO	EX	Current smoker	4	Complete response	cervical	A	LIVING	67	2010	TCGA-EX-A1H5-01A-31D-A13W-08	05E67180-E51A-488E-BD2D-BD24DA4F2D38	TCGA-EX-A1H5-01A-31D-A13W-08	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01A-31D-A13V-01	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	TCGA-EX-A1H5-01A-31D-A13Z-05	TCGA-EX-A1H5-01A-31R-A13X-13	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	0d079b1d-272a-4d4b-90d1-9c535f173782	6a65b2f5-ebe5-4974-9ca6-7e824e7ca087	0d079b1d-272a-4d4b-90d1-9c535f173782	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01A-31D-A13W-08	TCGA-EX-A1H5-01	TCGA-EX-A1H5-01A-31D-A13V-01	TCGA-EX-A1H5-01A-31D-A13W-08
TCGA-EX-A1H6-01	0	TCGA-EX-A1H6-01	241	0	TCGA-EX-A1H6	241	0	241	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					38			TCGA-EX-A1H6-F38911	Current User					ABSENT							Stage IB1		-14214					576		24			0	241								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent										2013-1-8	FEMALE	158	Endocervical Type of Adenocarcinoma	No							C53.9	8140/3	C53.9	YES		Cone Biopsy / LEEP	50	NO		YES	20			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0		2		false			MX	N0	T1b1						1		60		10		10		20		0		10		80		80			TUMOR FREE	NO		YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			2009		NO	YES	EX	Lifelong Non-smoker	3		cervical	B	LIVING	74	2009			TCGA-EX-A1H6-01B-11D-A22X-09	7fb5882c-6f15-462f-83e6-8bff997bf16d	TCGA-EX-A1H6-01B-11D-A22W-01	7fb5882c-6f15-462f-83e6-8bff997bf16d	TCGA-EX-A1H6-01B-11D-A230-05	TCGA-EX-A1H6-01B-11R-A22V-13	TCGA-EX-A1H6-01B-11D-A22X-09	TCGA-EX-A1H6-01	7fb5882c-6f15-462f-83e6-8bff997bf16d	46ad10f0-8259-4984-a331-2c004d0e20e4	7fb5882c-6f15-462f-83e6-8bff997bf16d	46ad10f0-8259-4984-a331-2c004d0e20e4	TCGA-EX-A1H6-01B-11D-A22X-09	TCGA-EX-A1H6-01B-11D-A22X-09	TCGA-EX-A1H6-01	TCGA-EX-A1H6-01B-11D-A22W-01	
TCGA-EX-A3L1-01	0	TCGA-EX-A3L1-01	211	0	TCGA-EX-A3L1			211	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					32				Current User					ABSENT							Stage IIA1		-11943					161					0	211																NO		2012-4-19	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma		22			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3								0		3		false			M0	N0	T2a1	TCGA-EX-A3L1.39B5AD4F-9206-4AE5-96EF-AC8E5B2B10E5.pdf							0		0		0		0		0		5		95		60			TUMOR FREE			YES		No								Primary Tumor	01			2009		YES	NO	EX	Lifelong Non-smoker	3	Complete response	cervical	A	LIVING	57	2011			TCGA-EX-A3L1-01A-11D-A21Q-09	576cc9e7-f32b-4478-a8a6-e77c16a07e35	TCGA-EX-A3L1-01A-11D-A21P-01	576cc9e7-f32b-4478-a8a6-e77c16a07e35	TCGA-EX-A3L1-01A-11D-A21R-05	TCGA-EX-A3L1-01A-11R-A21U-13	TCGA-EX-A3L1-01A-11D-A21Q-09	TCGA-EX-A3L1-01	576cc9e7-f32b-4478-a8a6-e77c16a07e35	dfbd84c5-f686-4471-b02f-61f961882fcd	576cc9e7-f32b-4478-a8a6-e77c16a07e35	dfbd84c5-f686-4471-b02f-61f961882fcd	TCGA-EX-A3L1-01A-11D-A21Q-09	TCGA-EX-A3L1-01A-11D-A21Q-09	TCGA-EX-A3L1-01	TCGA-EX-A3L1-01A-11D-A21P-01	
TCGA-EX-A449-01	0	TCGA-EX-A449-01	447	0	TCGA-EX-A449	447	0	447	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		42		4	TCGA-EX-A449-F47567						ABSENT			Macroscopic parametrial involvement			Cisplatin	Stage IVB		-15559					79		-12			0	447								Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent		Once weekly								2013-8-27	FEMALE	168	Endocervical Type of Adenocarcinoma	No					Total Abdominal	Other	C53.9	8384/3	C53.9	YES	Total Abdominal Hysterectomy	Other method, specify:	360	NO		NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			1		false			M1	NX	T1b1	TCGA-EX-A449.C758E08B-3903-4C72-8F2D-5B064F24BCC1.pdf					1		2		1		10		0		0		0		90		80			TUMOR FREE	YES	1	NO	Complete Remission/Response	Yes	YES					External beam radiation	5040	Primary Tumor	01			7th	YES	YES	NO	EX		3		cervical	A	LIVING	107	2012		4F8CD975-7A4D-43CD-A503-7ADE21803B47	TCGA-EX-A449-01A-11D-A243-09	028824a6-0890-43c9-a46f-48a23483d205	TCGA-EX-A449-01A-11D-A242-01	028824a6-0890-43c9-a46f-48a23483d205	TCGA-EX-A449-01A-11D-A244-05	TCGA-EX-A449-01A-11R-A24J-13	TCGA-EX-A449-01A-11D-A243-09	TCGA-EX-A449-01	028824a6-0890-43c9-a46f-48a23483d205	14c6cf34-5659-4fd6-a745-b788214a378a	028824a6-0890-43c9-a46f-48a23483d205	14c6cf34-5659-4fd6-a745-b788214a378a	TCGA-EX-A449-01A-11D-A243-09	TCGA-EX-A449-01A-11D-A243-09	TCGA-EX-A449-01	TCGA-EX-A449-01A-11D-A242-01	
TCGA-EX-A69L-01	0	TCGA-EX-A69L-01	602	0	TCGA-EX-A69L	602	0	602	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		41			TCGA-EX-A69L-F63787	Never Used										Not done per treating physicians discretion		Stage IB1		-15121					148		11			0	602								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|										2014-8-18	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	530	NO	Non-keratinizing squamous cell carcinoma	NO	26				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0		1		false			M0	N0	T1b1	TCGA-EX-A69L.6B157876-04F4-49D6-BACB-87F8E2B921CE.pdf				1			10		0		0		1		0		0		100		70			TUMOR FREE	NO		YES	Complete Remission/Response	No	NO	Participant refusal						Primary Tumor	01			2009	NO	YES	NO	EX	Lifelong Non-smoker	2		cervical	A	LIVING	73	2012		A34C4C91-F909-4102-95A8-2DCE367AEDA8	TCGA-EX-A69L-01A-11D-A32I-09	c51e3133-d702-41cd-af51-094a31f449d4	TCGA-EX-A69L-01A-11D-A32H-01	c51e3133-d702-41cd-af51-094a31f449d4	TCGA-EX-A69L-01A-11D-A32T-05	TCGA-EX-A69L-01A-11R-A32K-13	TCGA-EX-A69L-01A-11D-A32I-09	TCGA-EX-A69L-01	c51e3133-d702-41cd-af51-094a31f449d4	bc0eecec-0579-459b-aeff-3c6e408b149d	c51e3133-d702-41cd-af51-094a31f449d4	bc0eecec-0579-459b-aeff-3c6e408b149d	TCGA-EX-A69L-01A-11D-A32I-09	TCGA-EX-A69L-01A-11D-A32I-09	TCGA-EX-A69L-01	TCGA-EX-A69L-01A-11D-A32H-01	
TCGA-EX-A69M-01	1	TCGA-EX-A69M-01	253	1	TCGA-EX-A69M			253	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		62			TCGA-EX-A69M-F59393	Never Used										Not done per treating physicians discretion		Stage IB2		-22917					148	253			18	0	186							Lung Cancer				1	1			Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-5-12	FEMALE	158	Cervical Squamous Cell Carcinoma	No	Other, specify	Immunostain	HPV 63	HPV 16|Other HPV type(s)			C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	690	NO	Non-keratinizing squamous cell carcinoma	NO	11				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES	0		3		false			M0	N0	T1b2	TCGA-EX-A69M.808A38A8-4E74-42A4-8258-C883A7F6CA0C.pdf	Other, specify						5		0		1		1		0		0		99		75		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	Yes	NO	Not done per treating physician discretion						Primary Tumor	01		2012	2009	NO	YES	NO	EX	Current reformed smoker for < or = 15 years	4		cervical	A	DECEASED	58	2012		E473C4E8-6073-41A2-9ABD-7E02564303CB	TCGA-EX-A69M-01A-11D-A32I-09	81417e28-9132-4081-a85f-ed63396427c3	TCGA-EX-A69M-01A-11D-A32H-01	81417e28-9132-4081-a85f-ed63396427c3	TCGA-EX-A69M-01A-11D-A32T-05	TCGA-EX-A69M-01A-11R-A32K-13	TCGA-EX-A69M-01A-11D-A32I-09	TCGA-EX-A69M-01	81417e28-9132-4081-a85f-ed63396427c3	51ad22d6-dde9-4e8f-bf6d-cd8e02040e66	81417e28-9132-4081-a85f-ed63396427c3	51ad22d6-dde9-4e8f-bf6d-cd8e02040e66	TCGA-EX-A69M-01A-11D-A32I-09	TCGA-EX-A69M-01A-11D-A32I-09	TCGA-EX-A69M-01	TCGA-EX-A69M-01A-11D-A32H-01	
TCGA-EX-A8YF-01	0	TCGA-EX-A8YF-01	473	0	TCGA-EX-A8YF	396	1	473	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES		Progressive Disease		44			TCGA-EX-A8YF-F68767													Stage IB1		-16258					111		21			0	473		396						Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent										2014-12-15	FEMALE	168	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	950	NO	Non-keratinizing squamous cell carcinoma	NO	37			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Other, specify	Dx biopsy		Locoregional Recurrence	Vagina	NO	YES	0		2		false			M0	N0	T2a1	TCGA-EX-A8YF.AD08339B-E984-4E09-A8BF-C9FFE92E83F2.pdf							10		0		0		0		0		20		80		80			WITH TUMOR	NO		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009		YES	NO	EX	Lifelong Non-smoker	3		cervical	A	LIVING	57	2013		25907BD2-AF9F-4497-8B88-8E0E47BC3C33		1c3b1633-b318-486c-9d82-101c4a0364cd	TCGA-EX-A8YF-01A-11D-A37M-01	1c3b1633-b318-486c-9d82-101c4a0364cd	TCGA-EX-A8YF-01A-11D-A37Q-05	TCGA-EX-A8YF-01A-11R-A37P-13		TCGA-EX-A8YF-01	1c3b1633-b318-486c-9d82-101c4a0364cd	f171f298-c501-4ad7-bbb9-00e76701ccc1	1c3b1633-b318-486c-9d82-101c4a0364cd	f171f298-c501-4ad7-bbb9-00e76701ccc1			TCGA-EX-A8YF-01	TCGA-EX-A8YF-01A-11D-A37M-01	
TCGA-FU-A23K-01	0	TCGA-FU-A23K-01	37	0	TCGA-FU-A23K			37	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					28																Stage IIIB		-10551					192		6			0	37								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent								NO		2011-7-18	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8083/3	C53.9	YES	Cervical biopsy, not otherwise specified.	Other method, specify:	100	NO	Non-keratinizing squamous cell carcinoma		24	Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3								1		2		false			MX	N1	T1b1	TCGA-FU-A23K.D5E65FAE-5BC9-43A9-89D0-AA7D266F3C06.pdf							40		20		5		20		0		15		80		80						YES		No								Primary Tumor	01			2009		NO	YES	FU	Lifelong Non-smoker	2		cervical	A	LIVING	91	2010	TCGA-FU-A23K-01A-11D-A16O-08	1533008F-A3B8-4B50-A280-0A1C1FFACEFD	TCGA-FU-A23K-01A-11D-A16O-08	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01A-11D-A16M-01	0375a538-64dc-4f7b-807e-d765c8d88c23	TCGA-FU-A23K-01A-11D-A16P-05	TCGA-FU-A23K-01A-11R-A16Q-13	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01	0375a538-64dc-4f7b-807e-d765c8d88c23	4451bd7f-1d05-423d-879b-9a168a50afe3	0375a538-64dc-4f7b-807e-d765c8d88c23	4451bd7f-1d05-423d-879b-9a168a50afe3	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01A-11D-A16O-08	TCGA-FU-A23K-01	TCGA-FU-A23K-01A-11D-A16M-01	TCGA-FU-A23K-01A-11D-A16O-08
TCGA-FU-A23L-01	0	TCGA-FU-A23L-01	725	0	TCGA-FU-A23L	725	0	725	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		60			TCGA-FU-A23L-F56151			1500		Other	PRESENT						Cisplatin	Stage IIA1		-21962					165					0	725			725								0					NO		2014-1-29	FEMALE	163	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	150	NO		NO	11			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		4		false			MX	N0	T2a1	TCGA-FU-A23L.717358E4-EB69-4232-B0AE-36C7058531A9.pdf							40		20		0		20		0		10		90		90		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01			2009	YES	NO	YES	FU	Lifelong Non-smoker			cervical	A	LIVING	56	2010	TCGA-FU-A23L-01A-11D-A16O-08	179BC59D-8509-4989-8D44-D7C6EB2CCF8B	TCGA-FU-A23L-01A-11D-A16O-08	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01A-11D-A16M-01	58ccb54d-2d23-4bce-b05d-02e543d83306	TCGA-FU-A23L-01A-11D-A16P-05	TCGA-FU-A23L-01A-11R-A16Q-13	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01	58ccb54d-2d23-4bce-b05d-02e543d83306	6e084af6-abdb-4c50-9adf-49089dcf9276	58ccb54d-2d23-4bce-b05d-02e543d83306	6e084af6-abdb-4c50-9adf-49089dcf9276	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01A-11D-A16O-08	TCGA-FU-A23L-01	TCGA-FU-A23L-01A-11D-A16M-01	TCGA-FU-A23L-01A-11D-A16O-08
TCGA-FU-A2QG-01	0	TCGA-FU-A2QG-01	28	0	TCGA-FU-A2QG			28	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					29	14			Former User												Stage IB1		-10865					77					0	28											1	0				NO		2011-10-18	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Keratinizing squamous cell carcinoma		32			ABSENT	Peri (6-12 months since last menstrual period)	G2								0	0	1	15	false				N0	T1b1	TCGA-FU-A2QG.9616EC35-D8F6-4EE1-AF0A-BF955C6A4C14.pdf				0	0		40		20		10		20		0		20		70		70		Preoperative	TUMOR FREE		0	YES		No								Primary Tumor	01		2011	2009		YES	NO	FU	Current reformed smoker for < or = 15 years	1		cervical	A	LIVING	138	2011		BF0B2734-8B91-46D0-BC54-D21D1EB1C035	TCGA-FU-A2QG-01A-11D-A18J-09	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	TCGA-FU-A2QG-01A-11D-A18H-01	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	TCGA-FU-A2QG-01A-11D-A18K-05	TCGA-FU-A2QG-01A-11R-A18L-13	TCGA-FU-A2QG-01A-11D-A18J-09	TCGA-FU-A2QG-01	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	c3bd6fd5-3c2d-431c-bffb-91c637fa80de	7e7e0d0f-aa97-4c0d-bffc-7d8977288836	c3bd6fd5-3c2d-431c-bffb-91c637fa80de	TCGA-FU-A2QG-01A-11D-A18J-09	TCGA-FU-A2QG-01A-11D-A18J-09	TCGA-FU-A2QG-01	TCGA-FU-A2QG-01A-11D-A18H-01	
TCGA-FU-A3EO-01	0	TCGA-FU-A3EO-01	66	0	TCGA-FU-A3EO			66	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					55	15			Former User					ABSENT			Positive vaginal margin				Stage IIB		-20207					137					0	66			14								1	0				NO		2012-2-15	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO			23			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								0	0	2	40	false			MX	N0	T2b	TCGA-FU-A3EO.FA82B92B-202A-44B2-B186-F38F2C33E062.pdf				0	0		0		0		0		0		0		25		75		60		Preoperative	TUMOR FREE		0	YES		No								Primary Tumor	01			2009		YES	NO	FU	Current smoker	2	Complete response	cervical	A	LIVING	64	2011			TCGA-FU-A3EO-01A-11D-A20U-09	d7954ccb-a03f-45cb-a059-88fc217cb753	TCGA-FU-A3EO-01A-11D-A20T-01	d7954ccb-a03f-45cb-a059-88fc217cb753	TCGA-FU-A3EO-01A-11D-A212-05	TCGA-FU-A3EO-01A-11R-A214-13	TCGA-FU-A3EO-01A-11D-A20U-09	TCGA-FU-A3EO-01	d7954ccb-a03f-45cb-a059-88fc217cb753	02b4b7bf-3871-4c41-88fc-59ae939d46d6	d7954ccb-a03f-45cb-a059-88fc217cb753	02b4b7bf-3871-4c41-88fc-59ae939d46d6	TCGA-FU-A3EO-01A-11D-A20U-09	TCGA-FU-A3EO-01A-11D-A20U-09	TCGA-FU-A3EO-01	TCGA-FU-A3EO-01A-11D-A20T-01	
TCGA-FU-A3EO-11	0	TCGA-FU-A3EO-11	66	0	TCGA-FU-A3EO			66	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					55	15			Former User					ABSENT			Positive vaginal margin				Stage IIB		-20207					137					0	66			14								1	0				NO		2012-2-15	FEMALE	165	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8140/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO			23			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								0	0	2	40	false			MX	N0	T2b					0	0		0		0		0		0		100		0		0		0		Preoperative	TUMOR FREE		0	YES		No								Solid Tissue Normal	11			2009		YES	NO	FU	Current smoker	2	Complete response	cervical	A	LIVING	64	2011				3349e197-7ef8-4cfd-b365-1dbf5c7db58d		3349e197-7ef8-4cfd-b365-1dbf5c7db58d	TCGA-FU-A3EO-11A-13D-A212-05	TCGA-FU-A3EO-11A-13R-A214-13			3349e197-7ef8-4cfd-b365-1dbf5c7db58d		3349e197-7ef8-4cfd-b365-1dbf5c7db58d						
TCGA-FU-A3HY-01	0	TCGA-FU-A3HY-01	954	0	TCGA-FU-A3HY	954	0	954	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		47	16		TCGA-FU-A3HY-F64205	Former User		2400		HDR							Cisplatin	Stage IB2		-17228					77					0	954												0				NO		2014-8-27	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	15	NO	Non-keratinizing squamous cell carcinoma	NO	39	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		6	5	false			MX	N1	T1b2	TCGA-FU-A3HY.4048896F-495E-434F-8849-1DA13FD6C2A2.pdf				0	0		0		0		5		0		0		15				75			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	FU	Current smoker	6	Complete response	cervical	A	LIVING	74	2011			TCGA-FU-A3HY-01A-11D-A21Q-09	8724d94d-c194-491b-8c0e-38675b59c2e8	TCGA-FU-A3HY-01A-11D-A21P-01	8724d94d-c194-491b-8c0e-38675b59c2e8	TCGA-FU-A3HY-01A-11D-A21R-05	TCGA-FU-A3HY-01A-11R-A21U-13	TCGA-FU-A3HY-01A-11D-A21Q-09	TCGA-FU-A3HY-01	8724d94d-c194-491b-8c0e-38675b59c2e8	b87ce610-95ab-4fd5-a4f7-0a3c9e27e42a	8724d94d-c194-491b-8c0e-38675b59c2e8	b87ce610-95ab-4fd5-a4f7-0a3c9e27e42a	TCGA-FU-A3HY-01A-11D-A21Q-09	TCGA-FU-A3HY-01A-11D-A21Q-09	TCGA-FU-A3HY-01	TCGA-FU-A3HY-01A-11D-A21P-01	
TCGA-FU-A3HZ-01	0	TCGA-FU-A3HZ-01	1103	0	TCGA-FU-A3HZ	1103	0	1103	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		64			TCGA-FU-A3HZ-F64224			1500		HDR	PRESENT						Cisplatin	Stage IIA2		-23565					465		-7			0	1103			758					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Pelvic Nodes Absent			0	0				NO		2014-8-27	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES	curettage	Other method, specify:	16	NO	Non-keratinizing squamous cell carcinoma	NO	9			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	0		false			M0	N0	T2a2	TCGA-FU-A3HZ.5A91D73E-6F08-4439-AA0D-E73186C81DCB.pdf				0	0		0		0		10		0		0		15		75		80	Follow-up Office Visit	Other	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	FU	Lifelong Non-smoker	0	Complete response	cervical	A	LIVING	66	2010			TCGA-FU-A3HZ-01A-11D-A20U-09	a886bebc-9578-424a-910c-43ebff0d5696	TCGA-FU-A3HZ-01A-11D-A20T-01	a886bebc-9578-424a-910c-43ebff0d5696	TCGA-FU-A3HZ-01A-11D-A212-05	TCGA-FU-A3HZ-01A-11R-A214-13	TCGA-FU-A3HZ-01A-11D-A20U-09	TCGA-FU-A3HZ-01	a886bebc-9578-424a-910c-43ebff0d5696	3338de0f-9a22-4f28-be75-d94a89ade2f6	a886bebc-9578-424a-910c-43ebff0d5696	3338de0f-9a22-4f28-be75-d94a89ade2f6	TCGA-FU-A3HZ-01A-11D-A20U-09	TCGA-FU-A3HZ-01A-11D-A20U-09	TCGA-FU-A3HZ-01	TCGA-FU-A3HZ-01A-11D-A20T-01	
TCGA-FU-A3NI-01	0	TCGA-FU-A3NI-01	44	0	TCGA-FU-A3NI			44	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45																Stage IB1		-16533					466		14			0	44								Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent								NO		2012-4-17	FEMALE	162	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Keratinizing squamous cell carcinoma		29	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								2		2		false			MX	N1	T1b1	TCGA-FU-A3NI.3FD96F22-8669-4908-8DEC-9B9A82A8D5D5.pdf							0		0		5		0		0		5		90		80			TUMOR FREE			YES		No								Primary Tumor	01			2009		NO	YES	FU	Current smoker		Complete response	cervical	A	LIVING	57	2010			TCGA-FU-A3NI-01A-11D-A21Q-09	38948bd8-bc9a-4e38-9f7a-f72d3531050e	TCGA-FU-A3NI-01A-11D-A21P-01	38948bd8-bc9a-4e38-9f7a-f72d3531050e	TCGA-FU-A3NI-01A-11D-A21R-05	TCGA-FU-A3NI-01A-11R-A21U-13	TCGA-FU-A3NI-01A-11D-A21Q-09	TCGA-FU-A3NI-01	38948bd8-bc9a-4e38-9f7a-f72d3531050e	05f8d093-260b-4a94-bd96-9eae3763b553	38948bd8-bc9a-4e38-9f7a-f72d3531050e	05f8d093-260b-4a94-bd96-9eae3763b553	TCGA-FU-A3NI-01A-11D-A21Q-09	TCGA-FU-A3NI-01A-11D-A21Q-09	TCGA-FU-A3NI-01	TCGA-FU-A3NI-01A-11D-A21P-01	
TCGA-FU-A3TQ-01	0	TCGA-FU-A3TQ-01	48	0	TCGA-FU-A3TQ			48	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					55	30								PRESENT							Stage IIIB		-20302					561					0	48												0						2012-8-6	FEMALE	152	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	200	NO	Non-keratinizing squamous cell carcinoma		12	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2								2		3	50	false			MX	N1	T2b	TCGA-FU-A3TQ.76E32FF4-F62D-4ECD-87DF-5C9D9506B3EC.pdf				0	0		60		5		5		20		0		35		60		60			TUMOR FREE		0	YES		No								Primary Tumor	01			2009		NO	YES	FU	Current smoker	3		cervical	A	LIVING	59	2010		ED4A2082-B683-4D56-A7D3-1136F0F1764F	TCGA-FU-A3TQ-01A-11D-A22X-09	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	TCGA-FU-A3TQ-01A-11D-A22W-01	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	TCGA-FU-A3TQ-01A-11D-A230-05	TCGA-FU-A3TQ-01A-11R-A22V-13	TCGA-FU-A3TQ-01A-11D-A22X-09	TCGA-FU-A3TQ-01	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	5aad9b64-a2eb-420f-91cb-8885b1fe5a46	aab8ae6f-ae54-4203-b2e6-2b86b9ca0337	5aad9b64-a2eb-420f-91cb-8885b1fe5a46	TCGA-FU-A3TQ-01A-11D-A22X-09	TCGA-FU-A3TQ-01A-11D-A22X-09	TCGA-FU-A3TQ-01	TCGA-FU-A3TQ-01A-11D-A22W-01	
TCGA-FU-A3TX-01	0	TCGA-FU-A3TX-01	45	0	TCGA-FU-A3TX	45	0	45	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					78	20															Stage IB2		-28825					78		8		8	0	45																		2012-8-6	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	140	NO	Keratinizing squamous cell carcinoma		30			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		3		false			M0	N0	T1b2	TCGA-FU-A3TX.8206742A-1778-4B5F-AD56-32D9501EDA3C.pdf							60		10		5		10		0		25		70		70						YES		Yes								Primary Tumor	01		1993	2009		YES	NO	FU	Current reformed smoker for < or = 15 years	3		cervical	A	LIVING	67	2012		ADB7A8CB-073E-42FE-8219-650EDE7B72DF	TCGA-FU-A3TX-01A-11D-A22X-09	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	TCGA-FU-A3TX-01A-11D-A22W-01	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	TCGA-FU-A3TX-01A-11D-A230-05	TCGA-FU-A3TX-01A-11R-A22V-13	TCGA-FU-A3TX-01A-11D-A22X-09	TCGA-FU-A3TX-01	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	40baece3-2fec-4e90-83ec-02600c9080bb	d1f596d6-1f2c-4728-be8c-0ef9cc402f88	40baece3-2fec-4e90-83ec-02600c9080bb	TCGA-FU-A3TX-01A-11D-A22X-09	TCGA-FU-A3TX-01A-11D-A22X-09	TCGA-FU-A3TX-01	TCGA-FU-A3TX-01A-11D-A22W-01	
TCGA-FU-A3WB-01	0	TCGA-FU-A3WB-01	25	0	TCGA-FU-A3WB	25	0	25	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					43	16			Former User					ABSENT							Stage IIA2		-15833					66					0	25			0								2							2012-9-24	FEMALE	167	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	D&C	Other method, specify:	20	NO	Non-keratinizing squamous cell carcinoma		43			ABSENT		G2							NO	0		1	25	false			MX	N0	T2a2	TCGA-FU-A3WB.20136CDC-19AA-480A-B19C-B4EE219D8903.pdf							0		0		0		0		0		15		85		75		Preoperative	TUMOR FREE			YES	Complete Remission/Response	No								Primary Tumor	01		2012	2009		YES	NO	FU	Current reformed smoker for < or = 15 years	3		cervical	A	LIVING	89	2012			TCGA-FU-A3WB-01A-11D-A22X-09	a1dbd227-73b7-466f-b766-063a3006a206	TCGA-FU-A3WB-01A-11D-A22W-01	a1dbd227-73b7-466f-b766-063a3006a206	TCGA-FU-A3WB-01A-11D-A230-05	TCGA-FU-A3WB-01A-11R-A22V-13	TCGA-FU-A3WB-01A-11D-A22X-09	TCGA-FU-A3WB-01	a1dbd227-73b7-466f-b766-063a3006a206	5d7a33a9-dd10-4b25-a602-6e66fde578b7	a1dbd227-73b7-466f-b766-063a3006a206	5d7a33a9-dd10-4b25-a602-6e66fde578b7	TCGA-FU-A3WB-01A-11D-A22X-09	TCGA-FU-A3WB-01A-11D-A22X-09	TCGA-FU-A3WB-01	TCGA-FU-A3WB-01A-11D-A22W-01	
TCGA-FU-A3YQ-01	0	TCGA-FU-A3YQ-01	107	0	TCGA-FU-A3YQ	107	0	107	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					35	23			Former User												Stage IB1		-12816					139					0	107																		2012-10-4	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		24				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0		3	10	false			MX	N0	T1b1	TCGA-FU-A3YQ.6BF77930-F8F4-41C5-86EF-EF43157BA6B5.pdf				1			3		0		5		0		92		0				60						YES		No								Primary Tumor	01			2009		YES	NO	FU	Current smoker	4		cervical	A	LIVING	101	2012			TCGA-FU-A3YQ-01A-11D-A22X-09	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	TCGA-FU-A3YQ-01A-11D-A22W-01	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	TCGA-FU-A3YQ-01A-11D-A230-05	TCGA-FU-A3YQ-01A-11R-A22V-13	TCGA-FU-A3YQ-01A-11D-A22X-09	TCGA-FU-A3YQ-01	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	3fa6dafd-63bb-44e9-bd30-ffa925c93c84	622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11	3fa6dafd-63bb-44e9-bd30-ffa925c93c84	TCGA-FU-A3YQ-01A-11D-A22X-09	TCGA-FU-A3YQ-01A-11D-A22X-09	TCGA-FU-A3YQ-01	TCGA-FU-A3YQ-01A-11D-A22W-01	
TCGA-FU-A40J-01	0	TCGA-FU-A40J-01	41	0	TCGA-FU-A40J	41	0	41	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					38									ABSENT							Stage IIIB		-14182					76			10		0	41									Extra-Pelvic Metastatic Disease Absent|Parametrium Absent									2012-10-4	FEMALE	160	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO			28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	4		3		false			MX	N1	T2a1	TCGA-FU-A40J.7C1993F0-1B9B-4C33-B644-ED3FC16F3A7F.pdf							3		0		1		0		0		0		99		75			TUMOR FREE			YES		No								Primary Tumor	01			2009		YES	NO	FU	Lifelong Non-smoker	3		cervical	A	LIVING	78	2012		70D677F9-4C07-4C10-BC21-D75784B8AFA4	TCGA-FU-A40J-01A-11D-A243-09	26cdb816-44f0-4ff6-a674-93ec31d64fed	TCGA-FU-A40J-01A-11D-A242-01	26cdb816-44f0-4ff6-a674-93ec31d64fed	TCGA-FU-A40J-01A-11D-A244-05	TCGA-FU-A40J-01A-11R-A24J-13	TCGA-FU-A40J-01A-11D-A243-09	TCGA-FU-A40J-01	26cdb816-44f0-4ff6-a674-93ec31d64fed	2ff5e946-5983-449d-8c74-9aff16bcf243	26cdb816-44f0-4ff6-a674-93ec31d64fed	2ff5e946-5983-449d-8c74-9aff16bcf243	TCGA-FU-A40J-01A-11D-A243-09	TCGA-FU-A40J-01A-11D-A243-09	TCGA-FU-A40J-01	TCGA-FU-A40J-01A-11D-A242-01	
TCGA-FU-A57G-01	0	TCGA-FU-A57G-01	40	0	TCGA-FU-A57G	40	0	40	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					49				Former User					ABSENT							Stage IB2		-17905					684					0	40			40								1							2013-5-31	FEMALE	160	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.0	8384/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	70	NO			26			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0		2		false			MX	N0	T1b2	TCGA-FU-A57G.39B03354-F9B3-4FBA-8D7E-126E3AE752DA.pdf				1			20		20		10		40		0		15		75		75		Preoperative	TUMOR FREE			YES		No								Primary Tumor	01			2009		YES	NO	FU	Lifelong Non-smoker	3		cervical	A	LIVING	57	2011		03EE5C70-AD05-49F8-83F9-AB7C4A1F323A	TCGA-FU-A57G-01A-11D-A26G-09	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	TCGA-FU-A57G-01A-11D-A26F-01	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	TCGA-FU-A57G-01A-11D-A26S-05	TCGA-FU-A57G-01A-11R-A26X-13	TCGA-FU-A57G-01A-11D-A26G-09	TCGA-FU-A57G-01	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	e7808f4d-8cc1-4efa-84a5-cd2cec9124f4	93bf6de4-c67e-4d0b-8fe6-2431a0e0d342	e7808f4d-8cc1-4efa-84a5-cd2cec9124f4	TCGA-FU-A57G-01A-11D-A26G-09	TCGA-FU-A57G-01A-11D-A26G-09	TCGA-FU-A57G-01	TCGA-FU-A57G-01A-11D-A26F-01	
TCGA-FU-A5XV-01	0	TCGA-FU-A5XV-01	60	0	TCGA-FU-A5XV	60	0	60	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					32	14															Stage IIIB		-11692					105					0	60			55								1	1						2013-7-12	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.0	YES		Cone Biopsy / LEEP	70	NO	Non-keratinizing squamous cell carcinoma		63	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2		2	18	false			MX	N1	T1b2	TCGA-FU-A5XV.650F9C07-D8FB-46BD-8565-D03E83F049D6.pdf							80		0		0		20		0		10		90		90		Preoperative				YES		No								Primary Tumor	01			2009		YES	NO	FU	Current smoker			cervical	A	LIVING	69	2012			TCGA-FU-A5XV-01A-11D-A28B-09	97a13a19-7b9b-4e53-9dfe-6a5836a44510	TCGA-FU-A5XV-01A-11D-A28A-01	97a13a19-7b9b-4e53-9dfe-6a5836a44510	TCGA-FU-A5XV-01A-11D-A28C-05	TCGA-FU-A5XV-01A-11R-A28L-13	TCGA-FU-A5XV-01A-11D-A28B-09	TCGA-FU-A5XV-01	97a13a19-7b9b-4e53-9dfe-6a5836a44510	aa770913-8c85-43eb-b846-550bc2cfd351	97a13a19-7b9b-4e53-9dfe-6a5836a44510	aa770913-8c85-43eb-b846-550bc2cfd351	TCGA-FU-A5XV-01A-11D-A28B-09	TCGA-FU-A5XV-01A-11D-A28B-09	TCGA-FU-A5XV-01	TCGA-FU-A5XV-01A-11D-A28A-01	
TCGA-FU-A770-01	0	TCGA-FU-A770-01	34	0	TCGA-FU-A770	34	0	34	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					33	16			Former User					ABSENT	Tumor extends 1.0cm into 1.3 cm thick cervical/lower uterine segment wall						Stage IIIB		-12248					139				0	0	34			30								1	0						2014-2-26	FEMALE	175	Endocervical Adenocarcinoma of the Usual Type	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	D&C	Other method, specify:	40	NO			10	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		1	7	true			MX	N1	T2a2	TCGA-FU-A770.23DD976D-0D35-4BFF-89FF-94D9160F2228.pdf				1	0		40		20		0		20		0		20		80		80		Preoperative	TUMOR FREE		0	YES		No								Primary Tumor	01			2009		YES	NO	FU	Current smoker	2		cervical	A	LIVING	67	2013			TCGA-FU-A770-01A-11D-A33O-09	75aa1caf-bfa3-4365-a066-31a968ad3d9b	TCGA-FU-A770-01A-11D-A33N-01	75aa1caf-bfa3-4365-a066-31a968ad3d9b	TCGA-FU-A770-01A-11D-A340-05	TCGA-FU-A770-01A-11R-A342-13	TCGA-FU-A770-01A-11D-A33O-09	TCGA-FU-A770-01	75aa1caf-bfa3-4365-a066-31a968ad3d9b	85dfbe02-2b90-4626-a12f-fd0b513f223d	75aa1caf-bfa3-4365-a066-31a968ad3d9b	85dfbe02-2b90-4626-a12f-fd0b513f223d	TCGA-FU-A770-01A-11D-A33O-09	TCGA-FU-A770-01A-11D-A33O-09	TCGA-FU-A770-01	TCGA-FU-A770-01A-11D-A33N-01	
TCGA-GH-A9DA-01	0	TCGA-GH-A9DA-01	274	0	TCGA-GH-A9DA	274	0	274	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					27	14								ABSENT					Not done per treating physicians discretion		Stage IB1		-10160					174				42	0	274															Pelvic Nodes Present			2014-5-7	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma		15			ABSENT		G3							NO	0	0	3	6.5	false			MX	N0	T1b	TCGA-GH-A9DA.AAB3DEEA-D415-4495-A42E-E9A6B7AD0D33.pdf				2			10		0		2		2		15		13		70		70			TUMOR FREE	NO		YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01	11.6		2009	NO	YES	NO	GH	Current smoker	5		cervical	A	LIVING		2013		9D9F055F-E99A-472E-8A9A-660B8BA451D5		6977f6c7-f4cf-4669-81fd-7740fd5e64f1	TCGA-GH-A9DA-01A-21D-A37M-01	6977f6c7-f4cf-4669-81fd-7740fd5e64f1	TCGA-GH-A9DA-01A-21D-A37Q-05	TCGA-GH-A9DA-01A-21R-A37P-13		TCGA-GH-A9DA-01	6977f6c7-f4cf-4669-81fd-7740fd5e64f1	12c566be-6459-4999-9873-7db6a997064b	6977f6c7-f4cf-4669-81fd-7740fd5e64f1	12c566be-6459-4999-9873-7db6a997064b			TCGA-GH-A9DA-01	TCGA-GH-A9DA-01A-21D-A37M-01	
TCGA-HG-A2PA-01	1	TCGA-HG-A2PA-01	773	1	TCGA-HG-A2PA			773	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Partial Response		38			TCGA-HG-A2PA-F33511						PRESENT					Not done per treating physicians discretion		Stage IB2		-14025					729	773	2			0	773			21					Bladder Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			0	0				NO		2012-7-5	FEMALE	164	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma	NO	30			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Locoregional Recurrence			YES	0		4		true			M0	N0	T1b2	TCGA-HG-A2PA.63D65B11-EE47-4B19-A811-56D61DB0D7EC.pdf				1	0		7		1		1		0		15		4		80		90		Preoperative	WITH TUMOR	YES	0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			2009	NO	NO	YES	HG	Current smoker	5	Partial response	cervical	A	DECEASED	95	2009		265071B8-67FE-4D9C-BA29-34AF6E92F53D	TCGA-HG-A2PA-01A-11D-A20U-09	cf0a3802-710c-4ec7-9778-2d8150656ab7	TCGA-HG-A2PA-01A-11D-A20T-01	cf0a3802-710c-4ec7-9778-2d8150656ab7	TCGA-HG-A2PA-01A-11D-A212-05	TCGA-HG-A2PA-01A-11R-A214-13	TCGA-HG-A2PA-01A-11D-A20U-09	TCGA-HG-A2PA-01	cf0a3802-710c-4ec7-9778-2d8150656ab7	6789b31f-37e7-4b61-9467-4599fbf6abdf	cf0a3802-710c-4ec7-9778-2d8150656ab7	6789b31f-37e7-4b61-9467-4599fbf6abdf	TCGA-HG-A2PA-01A-11D-A20U-09	TCGA-HG-A2PA-01A-11D-A20U-09	TCGA-HG-A2PA-01	TCGA-HG-A2PA-01A-11D-A20T-01	
TCGA-HG-A9SC-01	0	TCGA-HG-A9SC-01	329	0	TCGA-HG-A9SC	329	0	329	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		49		5	TCGA-HG-A9SC-F67183	Former User											Cisplatin	Stage IIB	40 mg/m2	-17963					98		3			0	329			318							Once weekly	0							2014-10-31	FEMALE	173	Adenosquamous	No						Radical Hysterectomy		8560/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO		NO	21			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO					true			MX	N0	T2b	TCGA-HG-A9SC.288F7530-84F0-40F6-93F6-517DE1A481E0.pdf							5		2		2		2		8		20		70		70		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	YES	NO	YES	HG	Lifelong Non-smoker	0		cervical	A	LIVING	68	2013		6F7ABE28-0E7B-48F7-9713-F18E9D295340			TCGA-HG-A9SC-01A-21D-A42N-01		TCGA-HG-A9SC-01A-21D-A42P-05	TCGA-HG-A9SC-01A-21R-A42V-13				92b0bbac-94de-44cd-afe9-6cdcbd67eb3d		92b0bbac-94de-44cd-afe9-6cdcbd67eb3d				TCGA-HG-A9SC-01A-21D-A42N-01	
TCGA-HM-A3JJ-01	1	TCGA-HM-A3JJ-01	659	1	TCGA-HM-A3JJ	385	1	659	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	YES	Progressive Disease	YES	40		5	TCGA-HM-A3JJ-F29259	Former User											Cisplatin	Stage IB1	70 mg	-14736			138	110	629	659	13			0			385	26		150	110		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0		Completed as Planned			NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	173	Cervical Squamous Cell Carcinoma	No			18,31,33,35,39,45,51,52,56,58,59,68	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	680	NO	Non-keratinizing squamous cell carcinoma		41			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3		FINE NEEDLE ASPIRATION BIOPSY	Other, specify	Distant Metastasis			YES	4		5		false			MX	N1	T1b1	TCGA-HM-A3JJ.5F8358A7-34EB-4DAA-81F0-18B27BDCDF65.pdf	Cervical Cancer				1		5		0		0		1		10		10		80		60		Preoperative	WITH TUMOR			YES	Complete Remission/Response	No	YES						5040	Primary Tumor	01			2009	YES	YES	NO	HM		6	Complete response	cervical	A	DECEASED	72	2010		8AE5BF11-9C43-4107-81B3-B4033B96D0F5	TCGA-HM-A3JJ-01A-21D-A21Q-09	4811ba43-5130-4cd4-8317-6d4495144c9e	TCGA-HM-A3JJ-01A-21D-A21P-01	4811ba43-5130-4cd4-8317-6d4495144c9e	TCGA-HM-A3JJ-01A-21D-A21R-05	TCGA-HM-A3JJ-01A-21R-A21U-13	TCGA-HM-A3JJ-01A-21D-A21Q-09	TCGA-HM-A3JJ-01	4811ba43-5130-4cd4-8317-6d4495144c9e	6d671137-cc39-4651-bfcd-a6e36466a963	4811ba43-5130-4cd4-8317-6d4495144c9e	6d671137-cc39-4651-bfcd-a6e36466a963	TCGA-HM-A3JJ-01A-21D-A21Q-09	TCGA-HM-A3JJ-01A-21D-A21Q-09	TCGA-HM-A3JJ-01	TCGA-HM-A3JJ-01A-21D-A21P-01	
TCGA-HM-A3JJ-11	1	TCGA-HM-A3JJ-11	659	1	TCGA-HM-A3JJ	385	1	659	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	NO	YES	Progressive Disease	YES	40		5	TCGA-HM-A3JJ-F29259	Former User											Cisplatin	Stage IB1	70 mg	-14736			138	110	629	659	13			0			385	26		150	110		Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0		Completed as Planned			NO	Scheduled Follow-up Submission	2012-3-13	FEMALE	173	Cervical Squamous Cell Carcinoma	No			18,31,33,35,39,45,51,52,56,58,59,68	Other HPV type(s)		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	950	NO	Non-keratinizing squamous cell carcinoma		41			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3		FINE NEEDLE ASPIRATION BIOPSY	Other, specify	Distant Metastasis			YES	4		5		false			MX	N1	T1b1		Cervical Cancer				1		1		0		0		0		100		0		0		0		Preoperative	WITH TUMOR			YES	Complete Remission/Response	No	YES						5040	Solid Tissue Normal	11			2009	YES	YES	NO	HM		6	Complete response	cervical	A	DECEASED	72	2010				0a78e78c-f31a-488a-bf37-c47b108954fd		0a78e78c-f31a-488a-bf37-c47b108954fd	TCGA-HM-A3JJ-11A-12D-A21R-05	TCGA-HM-A3JJ-11A-12R-A21U-13			0a78e78c-f31a-488a-bf37-c47b108954fd		0a78e78c-f31a-488a-bf37-c47b108954fd						
TCGA-HM-A3JK-01	0	TCGA-HM-A3JK-01	351	0	TCGA-HM-A3JK	351	0	351	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		64		5	TCGA-HM-A3JK-F33102	Never Used						carcinoma involves all sections of the cervix with direct extension into the myometrial wall, parametrial tissues and upper vagina.					Cisplatin	Stage IIA2	70 mg	-23618							17		17	0	351			21					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	NO		2012-6-21	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	51	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1		0					MX	N1	T2b					0	0																		Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01	13.8	2008	2009	YES	YES	NO	HM	Current reformed smoker for < or = 15 years	0		cervical		LIVING	94	2011			TCGA-HM-A3JK-01A-11D-A21Q-09	beb89362-12a9-41bd-a1a2-b597138c16fb	TCGA-HM-A3JK-01A-11D-A21P-01	beb89362-12a9-41bd-a1a2-b597138c16fb	TCGA-HM-A3JK-01A-11D-A21R-05	TCGA-HM-A3JK-01A-11R-A21U-13	TCGA-HM-A3JK-01A-11D-A21Q-09	TCGA-HM-A3JK-01	beb89362-12a9-41bd-a1a2-b597138c16fb	ba0bf34a-6ce9-46a2-8f23-9562eb8b8071	beb89362-12a9-41bd-a1a2-b597138c16fb	ba0bf34a-6ce9-46a2-8f23-9562eb8b8071	TCGA-HM-A3JK-01A-11D-A21Q-09	TCGA-HM-A3JK-01A-11D-A21Q-09	TCGA-HM-A3JK-01	TCGA-HM-A3JK-01A-11D-A21P-01	
TCGA-HM-A4S6-01	0	TCGA-HM-A4S6-01	454	0	TCGA-HM-A4S6	454	0	454	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		51	14	4	TCGA-HM-A4S6-F49848	Former User		2100		HDR	ABSENT		Squamous cell carcinoma in situ focallly extends to the cervical cuff margin(6-9 oclock	Other Location, specify	Concurent chemo RT Ongoing-treatment delayed due to postoperative complications.	Adverse event/ complications	Cisplatin	Stage IIIB	70 mg	-18903					117		11		24	0	454			38					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|		Once weekly	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2013-10-11	FEMALE	152	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Tissue in the cervix during pelvic exam was passed ans sent for pathology	Other method, specify:	390	NO		NO	13	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2		5	10	false			MX	N1	T1b2	TCGA-HM-A4S6.B4118FB2-3A61-44B4-BC2F-020EB53542A1.pdf				1			3		0		0		0		0		0		100		75		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES	Other	Radiation currently ongoing- treatment delayed due to postoperative complication			IMRT	4500	Primary Tumor	01		1995	2009	YES	YES	NO	HM	Current reformed smoker for > 15 years	6		cervical	A	LIVING	101	2012		0BB4A1E7-3861-4E40-895F-0C25B47E8E57	TCGA-HM-A4S6-01A-11D-A26G-09	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	TCGA-HM-A4S6-01A-11D-A26F-01	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	TCGA-HM-A4S6-01A-11D-A26S-05	TCGA-HM-A4S6-01A-11R-A26X-13	TCGA-HM-A4S6-01A-11D-A26G-09	TCGA-HM-A4S6-01	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	ddedf815-7dc4-472f-8433-91df6391a9ee	a27551cc-4bbf-495c-9fc2-7cf6108ed1bf	ddedf815-7dc4-472f-8433-91df6391a9ee	TCGA-HM-A4S6-01A-11D-A26G-09	TCGA-HM-A4S6-01A-11D-A26G-09	TCGA-HM-A4S6-01	TCGA-HM-A4S6-01A-11D-A26F-01	
TCGA-HM-A6W2-01	0	TCGA-HM-A6W2-01	287	0	TCGA-HM-A6W2	287	0	287	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		34	27	6	TCGA-HM-A6W2-F57139	Former User						Metastases to Right Ovary					Cisplatin	Stage IVB	70mg	-12775					51		9		62	0	287			28					|Paraaortic Nodes Absent|Pelvic Nodes Absent		Once weekly	0				Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-3-27	FEMALE	160	Adenosquamous	No						Radical Hysterectomy		8070/3	C56.9	YES		Biopsy (cervical / CT-guided / Other)	1280	NO		NO	7			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	8	false			M1	N0	T2a	TCGA-HM-A6W2.611A1962-1D19-48DF-B086-4FBA139822FF.pdf							4		1		5		0		10		5		80		80		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					IMRT	4500	Primary Tumor	01			2009	YES	YES	NO	HM	Current smoker	2		cervical	A	LIVING	89	2013			TCGA-HM-A6W2-01A-21D-A33O-09	459f5e07-fffc-4f47-904b-3c51367c83f1	TCGA-HM-A6W2-01A-21D-A33N-01	459f5e07-fffc-4f47-904b-3c51367c83f1	TCGA-HM-A6W2-01A-21D-A340-05	TCGA-HM-A6W2-01A-21R-A342-13	TCGA-HM-A6W2-01A-21D-A33O-09	TCGA-HM-A6W2-01	459f5e07-fffc-4f47-904b-3c51367c83f1	08c9601e-983c-4fc3-960f-df202b944ae9	459f5e07-fffc-4f47-904b-3c51367c83f1	08c9601e-983c-4fc3-960f-df202b944ae9	TCGA-HM-A6W2-01A-21D-A33O-09	TCGA-HM-A6W2-01A-21D-A33O-09	TCGA-HM-A6W2-01	TCGA-HM-A6W2-01A-21D-A33N-01	
TCGA-HM-A6W2-06	0	TCGA-HM-A6W2-06	287	0	TCGA-HM-A6W2	287	0	287	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		34	27	6	TCGA-HM-A6W2-F57139	Former User						Metastases to Right Ovary					Cisplatin	Stage IVB	70mg	-12775					51		9		62	0	287			28					|Paraaortic Nodes Absent|Pelvic Nodes Absent		Once weekly	0				Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-3-27	FEMALE	160	Adenosquamous	No						Radical Hysterectomy		8070/3	C56.9	YES		Biopsy (cervical / CT-guided / Other)	1340	NO		NO	7			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			2	8	false			M1	N0	T2a	TCGA-HM-A6W2.FD13C302-78F0-4FEE-B90A-95A10C236CE9.pdf							5		2		5		2		15		20		60		60		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					IMRT	4500	Metastatic	06			2009	YES	YES	NO	HM	Current smoker	2		cervical	A	LIVING	89	2013			TCGA-HM-A6W2-06A-22D-A33O-09	386214f6-caab-4e0f-b3ed-e6103110c3bb		386214f6-caab-4e0f-b3ed-e6103110c3bb	TCGA-HM-A6W2-06A-22D-A340-05	TCGA-HM-A6W2-06A-22R-A342-13	TCGA-HM-A6W2-06A-22D-A33O-09		386214f6-caab-4e0f-b3ed-e6103110c3bb	ec15fb74-a4dc-44a2-a11b-990627da774a	386214f6-caab-4e0f-b3ed-e6103110c3bb	ec15fb74-a4dc-44a2-a11b-990627da774a	TCGA-HM-A6W2-06A-22D-A33O-09				
TCGA-IR-A3L7-01	0	TCGA-IR-A3L7-01	4483	0	TCGA-IR-A3L7	4483	0	4483	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		37	17	5	TCGA-IR-A3L7-F38287	Former User					ABSENT						Cisplatin	Stage IB1	40mg/m2	-13559					4286					0	4483										Once weekly		0		0		NO		2012-12-14	FEMALE	177	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	110	NO		NO	20			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	3	10	true			M0	N0	T1b1	TCGA-IR-A3L7.411A8FF2-4778-43AD-99F7-FD5BD23559DD.pdf				0	0		5		0		0		0		40		0		60		60			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1990	2009	YES	NO	YES	IR	Current reformed smoker for < or = 15 years	3	Complete response	cervical	A	LIVING	89	2000		05FAF119-1842-40FE-9B3D-A97D8E6B9662	TCGA-IR-A3L7-01A-21D-A20U-09	953f918b-a82a-408f-b080-d0cb4441e1ef	TCGA-IR-A3L7-01A-21D-A20T-01	953f918b-a82a-408f-b080-d0cb4441e1ef	TCGA-IR-A3L7-01A-21D-A212-05	TCGA-IR-A3L7-01A-21R-A214-13	TCGA-IR-A3L7-01A-21D-A20U-09	TCGA-IR-A3L7-01	953f918b-a82a-408f-b080-d0cb4441e1ef	4720f00e-9441-4cf9-b80b-8616d2e8a4d2	953f918b-a82a-408f-b080-d0cb4441e1ef	4720f00e-9441-4cf9-b80b-8616d2e8a4d2	TCGA-IR-A3L7-01A-21D-A20U-09	TCGA-IR-A3L7-01A-21D-A20U-09	TCGA-IR-A3L7-01	TCGA-IR-A3L7-01A-21D-A20T-01	
TCGA-IR-A3LA-01	0	TCGA-IR-A3LA-01	4078	0	TCGA-IR-A3LA	4078	0	4078	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		60		4|4	TCGA-IR-A3LA-F53750	Never Used					ABSENT						Cisplatin|Other	Stage IB1	70 mg/m2|750 mg/m2	-21949					3401					0	4078														0				2013-12-13	FEMALE	157	Endometrioid Adenocarcinoma of Endocervix	No						Simple Hysterectomy	C53.9	8384/3	C53.9	YES	Dilation & curettage	Other method, specify:	170	NO		NO	18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0	0	0		true		|Fluorouracil (5-FU)	M0	N0	T1b1	TCGA-IR-A3LA.65E053F4-BCDB-40E2-A76B-1CA62FD61E1B.pdf							0		0		0		0		0		0		100		80			TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	NO	YES	IR	Lifelong Non-smoker	2		cervical	A	LIVING	101	2002		23FD746E-B0D7-4779-BF26-BB319461F879	TCGA-IR-A3LA-01A-11D-A22X-09	249a179f-25d7-4508-b64c-be08aaafc82a	TCGA-IR-A3LA-01A-11D-A22W-01	249a179f-25d7-4508-b64c-be08aaafc82a	TCGA-IR-A3LA-01A-11D-A230-05	TCGA-IR-A3LA-01A-11R-A22V-13	TCGA-IR-A3LA-01A-11D-A22X-09	TCGA-IR-A3LA-01	249a179f-25d7-4508-b64c-be08aaafc82a	b527188b-4601-4037-ab58-c5f4e21602aa	249a179f-25d7-4508-b64c-be08aaafc82a	b527188b-4601-4037-ab58-c5f4e21602aa	TCGA-IR-A3LA-01A-11D-A22X-09	TCGA-IR-A3LA-01A-11D-A22X-09	TCGA-IR-A3LA-01	TCGA-IR-A3LA-01A-11D-A22W-01	
TCGA-IR-A3LB-01	1	TCGA-IR-A3LB-01	2032	1	TCGA-IR-A3LB			2032	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					53	17	4|4		Never Used					ABSENT						Cisplatin|Other	Stage IB1	70mg/m2|1000mg/m2	-19374					3385	2032				0															0				2013-1-24	FEMALE	168	Endocervical Type of Adenocarcinoma	No					Radical trachelectomy	Other	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO			29			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES	0	0	2	2.5	true		|Fluorouracil (5-FU)	M0	N0	T1b1	TCGA-IR-A3LB.8E99E100-EB4F-472A-BB28-36592B1AA26E.pdf							1		0		1		0		0		0		99		90			WITH TUMOR	YES		YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01		1972	2009	YES	NO	YES	IR	Current reformed smoker for > 15 years	4		cervical	A	DECEASED	94	2002		512D1B08-402F-433F-974C-B134628CBA33	TCGA-IR-A3LB-01A-11D-A243-09	135d2983-9bfc-476a-8313-661f8bde6d06	TCGA-IR-A3LB-01A-11D-A242-01	135d2983-9bfc-476a-8313-661f8bde6d06	TCGA-IR-A3LB-01A-11D-A244-05	TCGA-IR-A3LB-01A-11R-A24J-13	TCGA-IR-A3LB-01A-11D-A243-09	TCGA-IR-A3LB-01	135d2983-9bfc-476a-8313-661f8bde6d06	a9d3d5d7-a94a-440f-800c-68511d3a9c1f	135d2983-9bfc-476a-8313-661f8bde6d06	a9d3d5d7-a94a-440f-800c-68511d3a9c1f	TCGA-IR-A3LB-01A-11D-A243-09	TCGA-IR-A3LB-01A-11D-A243-09	TCGA-IR-A3LB-01	TCGA-IR-A3LB-01A-11D-A242-01	
TCGA-IR-A3LC-01	0	TCGA-IR-A3LC-01	3571	0	TCGA-IR-A3LC	3571	0	3571	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		40		6	TCGA-IR-A3LC-F38289	Current User					ABSENT						Cisplatin	Stage IB1		-14697					3214					0	3571												0		0		NO		2012-12-14	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO	48			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	3		true			M0	N0	T1b1	TCGA-IR-A3LC.97FF892D-6CAD-4376-BB48-082EC5BC4C39.pdf				0	0		5		0		0		0		0		0		100		85			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES						4500	Primary Tumor	01			2009	YES	NO	YES	IR	Lifelong Non-smoker	3	Complete response	cervical	A	LIVING	64	2003		ED5836F8-2919-4EC1-85ED-0859F071B5A9	TCGA-IR-A3LC-01A-11D-A20U-09	50b34335-7e00-417a-8e0d-c50a4384b4c9	TCGA-IR-A3LC-01A-11D-A20T-01	50b34335-7e00-417a-8e0d-c50a4384b4c9	TCGA-IR-A3LC-01A-11D-A212-05	TCGA-IR-A3LC-01A-11R-A214-13	TCGA-IR-A3LC-01A-11D-A20U-09	TCGA-IR-A3LC-01	50b34335-7e00-417a-8e0d-c50a4384b4c9	ba3ab0e2-9734-485f-9836-b38f75a72469	50b34335-7e00-417a-8e0d-c50a4384b4c9	ba3ab0e2-9734-485f-9836-b38f75a72469	TCGA-IR-A3LC-01A-11D-A20U-09	TCGA-IR-A3LC-01A-11D-A20U-09	TCGA-IR-A3LC-01	TCGA-IR-A3LC-01A-11D-A20T-01	
TCGA-IR-A3LF-01	0	TCGA-IR-A3LF-01	2949	0	TCGA-IR-A3LF	2949	0	2949	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		64			TCGA-IR-A3LF-F60818	Never Used		2500		HDR	ABSENT					Not done per treating physicians discretion		Stage IB1		-23721					2814					0	2949												0		0				2014-6-17	FEMALE	155	Endocervical Adenocarcinoma of the Usual Type	No						Simple Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	240	NO		YES	16			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			M0	N0	T1b1	TCGA-IR-A3LF.8F0D0E63-D4E5-49A9-AC56-7D538284E917.pdf				1	0		0		0		0		0		30		0		70		60			TUMOR FREE	NO	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	NO	NO	YES	IR	Lifelong Non-smoker	3		cervical	A	LIVING	86	2004		B65F36C5-75E0-45AA-B254-16ABC4C5DF64	TCGA-IR-A3LF-01A-21D-A22X-09	851064c8-582a-414a-bfcc-e1042bb9ff7b	TCGA-IR-A3LF-01A-21D-A22W-01	851064c8-582a-414a-bfcc-e1042bb9ff7b	TCGA-IR-A3LF-01A-21D-A230-05	TCGA-IR-A3LF-01A-21R-A22V-13	TCGA-IR-A3LF-01A-21D-A22X-09	TCGA-IR-A3LF-01	851064c8-582a-414a-bfcc-e1042bb9ff7b	9bc5af60-bf34-4766-9a7b-7a706e970823	851064c8-582a-414a-bfcc-e1042bb9ff7b	9bc5af60-bf34-4766-9a7b-7a706e970823	TCGA-IR-A3LF-01A-21D-A22X-09	TCGA-IR-A3LF-01A-21D-A22X-09	TCGA-IR-A3LF-01	TCGA-IR-A3LF-01A-21D-A22W-01	
TCGA-IR-A3LH-01	0	TCGA-IR-A3LH-01	2394	0	TCGA-IR-A3LH	2394	0	2394	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		49	24	6	TCGA-IR-A3LH-F38298	Former User		2000		HDR	ABSENT			Positive vaginal margin			Cisplatin	Stage IIA1	40mg/m2	-18118					2501					0	2394										Once weekly		1		0		NO		2012-12-14	FEMALE	154	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	340	NO		NO	40			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G4							NO	0	0	1	20	true			M0	N0	T2a1	TCGA-IR-A3LH.7204DF29-2167-48A0-AA56-51E9AFFBB0D5.pdf				0	0		1		1		5		0		0		0		95		95			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01		2000	2009	YES	NO	YES	IR	Current reformed smoker for < or = 15 years	2	Complete response	cervical	A	LIVING	74	2005		321A85A8-BC4A-4D64-B8E6-89FC29A338CB	TCGA-IR-A3LH-01A-21D-A20U-09	2cdcd676-9056-4b42-8029-5b8dc44d3b57	TCGA-IR-A3LH-01A-21D-A20T-01	2cdcd676-9056-4b42-8029-5b8dc44d3b57	TCGA-IR-A3LH-01A-21D-A212-05	TCGA-IR-A3LH-01A-21R-A214-13	TCGA-IR-A3LH-01A-21D-A20U-09	TCGA-IR-A3LH-01	2cdcd676-9056-4b42-8029-5b8dc44d3b57	db86d02e-bdf5-42a6-b6dc-20825d86b3af	2cdcd676-9056-4b42-8029-5b8dc44d3b57	db86d02e-bdf5-42a6-b6dc-20825d86b3af	TCGA-IR-A3LH-01A-21D-A20U-09	TCGA-IR-A3LH-01A-21D-A20U-09	TCGA-IR-A3LH-01	TCGA-IR-A3LH-01A-21D-A20T-01	
TCGA-IR-A3LI-01	0	TCGA-IR-A3LI-01	2493	0	TCGA-IR-A3LI	2493	0	2493	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		48		4|4|4|4	TCGA-IR-A3LI-F38327	Never Used					ABSENT			Microscopic parametrial involvement			Cisplatin|Other|Other|Cisplatin	Stage IVB	40mg/m2|40mg/m2|0.75mg/m2|50mg/m2	-17741					2326					0	2493										Once weekly|Once weekly		0		0		NO		2012-12-14	FEMALE	169	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES	Surgical resection	Other method, specify:	180	NO		NO	25	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Peri (6-12 months since last menstrual period)	G2							NO	1	0	2		true		|Paclitaxel|Topotecan HCl|	M1	N1	T2b	TCGA-IR-A3LI.203CED2B-3E76-4539-9B52-D6F8FBF7E642.pdf				0	2		1		0		0		0		0		0		100		95			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					IMRT	5040	Primary Tumor	01			2009	YES	NO	YES	IR	Lifelong Non-smoker	4	Complete response	cervical	A	LIVING	71	2005		CAC8649C-9172-4F4F-8083-62EFF39FB4D6	TCGA-IR-A3LI-01A-11D-A20U-09	e77c56f5-7575-46f0-9751-723085dbd6fc	TCGA-IR-A3LI-01A-11D-A20T-01	e77c56f5-7575-46f0-9751-723085dbd6fc	TCGA-IR-A3LI-01A-11D-A212-05	TCGA-IR-A3LI-01A-11R-A214-13	TCGA-IR-A3LI-01A-11D-A20U-09	TCGA-IR-A3LI-01	e77c56f5-7575-46f0-9751-723085dbd6fc	157bebd4-083b-424d-aa5a-a08e13369b9d	e77c56f5-7575-46f0-9751-723085dbd6fc	157bebd4-083b-424d-aa5a-a08e13369b9d	TCGA-IR-A3LI-01A-11D-A20U-09	TCGA-IR-A3LI-01A-11D-A20U-09	TCGA-IR-A3LI-01	TCGA-IR-A3LI-01A-11D-A20T-01	
TCGA-IR-A3LK-01	1	TCGA-IR-A3LK-01	908	1	TCGA-IR-A3LK	574	1	908	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease		69		5	TCGA-IR-A3LK-F38333	Never Used					ABSENT			Microscopic parametrial involvement			Cisplatin	Stage IB2	30mg/m2	-25440					779	908				0	808		574								Once weekly		0		0		NO		2012-12-14	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO		NO	17				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Other, specify	Needle biopsy		Distant Metastasis	thoracic lymph nodes, liver, abdominal wall	NO	YES	0	0	1		true			M0	N0	T1b2	TCGA-IR-A3LK.3AE8F93E-83B7-4501-B916-EC4EA9959F99.pdf	Cervical Cancer			0	0		2		0		0		0		0		0		100		90			WITH TUMOR	YES	0	YES	Complete Remission/Response	No	YES					IMRT	5040	Primary Tumor	01			2009	YES	NO	YES	IR	Lifelong Non-smoker	1	Complete response	cervical	A	DECEASED	96	2009		9F4623A9-D7C2-4EB5-8CA9-6F0C67828AEB	TCGA-IR-A3LK-01A-12D-A20U-09	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	TCGA-IR-A3LK-01A-12D-A20T-01	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	TCGA-IR-A3LK-01A-12D-A212-05	TCGA-IR-A3LK-01A-12R-A214-13	TCGA-IR-A3LK-01A-12D-A20U-09	TCGA-IR-A3LK-01	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	1fab1cc0-f289-4907-a87d-4cd800ced71a	9fd5309d-03cc-4123-8bc8-d7dfba4955d2	1fab1cc0-f289-4907-a87d-4cd800ced71a	TCGA-IR-A3LK-01A-12D-A20U-09	TCGA-IR-A3LK-01A-12D-A20U-09	TCGA-IR-A3LK-01	TCGA-IR-A3LK-01A-12D-A20T-01	
TCGA-IR-A3LL-01	0	TCGA-IR-A3LL-01	957	0	TCGA-IR-A3LL	957	0	957	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		60		5	TCGA-IR-A3LL-F38232						ABSENT						Cisplatin	Stage IB1	30mg/m2	-22123					614					0	957										Once weekly		0		0		NO		2012-12-14	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	370	NO		NO	15			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	2		true			M0	N0	T1b1	TCGA-IR-A3LL.CF29FB41-6E3C-4798-A958-37A1B1F9E7AD.pdf				0	0		2		0		0		0		20		0		80		90			TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES					External beam radiation	5040	Primary Tumor	01			2009	YES	NO	YES	IR	Lifelong Non-smoker	2	Complete response	cervical	A	LIVING	92	2010		4157E44A-BFC9-479E-B2DE-D7B6A8C373B9	TCGA-IR-A3LL-01A-11D-A20U-09	386fbf20-f41e-41e1-96de-578066c35560	TCGA-IR-A3LL-01A-11D-A20T-01	386fbf20-f41e-41e1-96de-578066c35560	TCGA-IR-A3LL-01A-11D-A212-05	TCGA-IR-A3LL-01A-11R-A214-13	TCGA-IR-A3LL-01A-11D-A20U-09	TCGA-IR-A3LL-01	386fbf20-f41e-41e1-96de-578066c35560	70d9c94b-3472-4005-bb37-71965c1746c7	386fbf20-f41e-41e1-96de-578066c35560	70d9c94b-3472-4005-bb37-71965c1746c7	TCGA-IR-A3LL-01A-11D-A20U-09	TCGA-IR-A3LL-01A-11D-A20U-09	TCGA-IR-A3LL-01	TCGA-IR-A3LL-01A-11D-A20T-01	
TCGA-JW-A5VG-01	0	TCGA-JW-A5VG-01	834	0	TCGA-JW-A5VG	834	0	834	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		35		5	TCGA-JW-A5VG-F58243	Never Used		4500		LDR							Cisplatin	Stage IIA	40mg/m2	-13109					342		-8			0	834			834					Pelvic Nodes Present		Once weekly	0	0		0				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			5		false			MX	NX	T2a	TCGA-JW-A5VG.679E2EDC-A950-49A4-AC1A-9472CCB3447D.pdf				0	0		40		20		0		20		0		5		95		95		Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	No	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	JW	Lifelong Non-smoker	5		cervical	A	LIVING	110	2012			TCGA-JW-A5VG-01A-11D-A28B-09	40eb69ac-5c96-42c7-adfc-877580c58cc5	TCGA-JW-A5VG-01A-11D-A28A-01	40eb69ac-5c96-42c7-adfc-877580c58cc5	TCGA-JW-A5VG-01A-11D-A28C-05	TCGA-JW-A5VG-01A-11R-A28L-13	TCGA-JW-A5VG-01A-11D-A28B-09	TCGA-JW-A5VG-01	40eb69ac-5c96-42c7-adfc-877580c58cc5	c10abe2e-3ff3-4be5-a585-20fba382ef62	40eb69ac-5c96-42c7-adfc-877580c58cc5	c10abe2e-3ff3-4be5-a585-20fba382ef62	TCGA-JW-A5VG-01A-11D-A28B-09	TCGA-JW-A5VG-01A-11D-A28B-09	TCGA-JW-A5VG-01	TCGA-JW-A5VG-01A-11D-A28A-01	
TCGA-JW-A5VH-01	1	TCGA-JW-A5VH-01	100	1	TCGA-JW-A5VH			100	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					53		2												Not done per treating physicians discretion	Carboplatin	Stage IVB		-19423					405	100	7			0				5					Extra-Pelvic Metastatic Disease Present|Pelvic Nodes Present		Once weekly	2	0		0				2013-5-31	FEMALE	163	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO	Non-keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES			2		false			M1	NX	T4	TCGA-JW-A5VH.D5B62718-1D34-45F7-8DDB-B106AC85B102.pdf	Cervical Cancer			0	0		40		20		5		20		0		5		90		90	N/A	Other	WITH TUMOR	NO	0	NO	Progressive Disease	No	NO	Other	Brain and Pulmonary Metastases leading to death			External beam radiation	1900	Primary Tumor	01			2009	NO	NO	YES	JW	Lifelong Non-smoker	2		cervical	A	DECEASED	80	2012			TCGA-JW-A5VH-01A-11D-A28B-09	87bab535-6f15-4b0f-a274-571a4a81d1be	TCGA-JW-A5VH-01A-11D-A28A-01	87bab535-6f15-4b0f-a274-571a4a81d1be	TCGA-JW-A5VH-01A-11D-A28C-05	TCGA-JW-A5VH-01A-11R-A28L-13	TCGA-JW-A5VH-01A-11D-A28B-09	TCGA-JW-A5VH-01	87bab535-6f15-4b0f-a274-571a4a81d1be	b0182f43-014f-4a53-a40c-de5600015bce	87bab535-6f15-4b0f-a274-571a4a81d1be	b0182f43-014f-4a53-a40c-de5600015bce	TCGA-JW-A5VH-01A-11D-A28B-09	TCGA-JW-A5VH-01A-11D-A28B-09	TCGA-JW-A5VH-01	TCGA-JW-A5VH-01A-11D-A28A-01	
TCGA-JW-A5VI-01	0	TCGA-JW-A5VI-01	747	0	TCGA-JW-A5VI	558	1	747	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Partial Response		45	26	5	TCGA-JW-A5VI-F58233	Former User		4644		LDR							Cisplatin	Stage IIB	40 mg/m2	-16444					406		6			0	747		558	747					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Pelvic Nodes Present		Once weekly	1	0		0				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3	Lung	Lung Biopsy		Distant Metastasis		NO	YES			2	10	false			MX	NX	T2b	TCGA-JW-A5VI.4ADC462C-2D78-4CAA-B865-5D954A080801.pdf				0	0		40		20		5		20		0		5		90		90		Post-Adjuvant Therapy	WITH TUMOR	NO	0	NO	Progressive Disease	No	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	NO	YES	JW	Current smoker	2		cervical	A	LIVING	59	2012			TCGA-JW-A5VI-01A-11D-A28B-09	e5bafefb-df41-4686-9bbe-b176f954d131	TCGA-JW-A5VI-01A-11D-A28A-01	e5bafefb-df41-4686-9bbe-b176f954d131	TCGA-JW-A5VI-01A-11D-A28C-05	TCGA-JW-A5VI-01A-11R-A28L-13	TCGA-JW-A5VI-01A-11D-A28B-09	TCGA-JW-A5VI-01	e5bafefb-df41-4686-9bbe-b176f954d131	973894f5-c3ef-487d-8ee7-e8b0115c0839	e5bafefb-df41-4686-9bbe-b176f954d131	973894f5-c3ef-487d-8ee7-e8b0115c0839	TCGA-JW-A5VI-01A-11D-A28B-09	TCGA-JW-A5VI-01A-11D-A28B-09	TCGA-JW-A5VI-01	TCGA-JW-A5VI-01A-11D-A28A-01	
TCGA-JW-A5VJ-01	0	TCGA-JW-A5VJ-01	588	0	TCGA-JW-A5VJ	267	1	588	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	YES	Progressive Disease		56		5	TCGA-JW-A5VJ-F58231	Never Used		4200		LDR							Carboplatin	Stage IIB	40mg/m2	-20714							0			0	588		267	258					Paraaortic Nodes Present|Pelvic Nodes Present		Once weekly	3	1						2014-4-3	FEMALE	155	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3	Head and Neck	F of supraclavicular LN positive for malignancy		Distant Metastasis		NO	YES			2					MX	NX	T2b					0	0																		Post-Adjuvant Therapy	WITH TUMOR	NO	0	NO	Partial Remission/Response	No	NO					External beam radiation	5040	Primary Tumor	01			2009	YES	YES	NO	JW	Lifelong Non-smoker	3		cervical		LIVING	57	2012			TCGA-JW-A5VJ-01A-11D-A28B-09	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	TCGA-JW-A5VJ-01A-11D-A28A-01	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	TCGA-JW-A5VJ-01A-11D-A28C-05	TCGA-JW-A5VJ-01A-11R-A28L-13	TCGA-JW-A5VJ-01A-11D-A28B-09	TCGA-JW-A5VJ-01	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	bcf45ae5-15fc-466a-a9f8-ca9296694025	fef94ae2-4cd8-4e24-9220-3fa17ef1230a	bcf45ae5-15fc-466a-a9f8-ca9296694025	TCGA-JW-A5VJ-01A-11D-A28B-09	TCGA-JW-A5VJ-01A-11D-A28B-09	TCGA-JW-A5VJ-01	TCGA-JW-A5VJ-01A-11D-A28A-01	
TCGA-JW-A5VK-01	0	TCGA-JW-A5VK-01	623	0	TCGA-JW-A5VK	623	0	623	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					43	33	5	TCGA-JW-A5VK-F58232	Never Used		4725		LDR							Cisplatin	Stage IB2	40 mg/m2	-15965					219		16			0	623			623					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	0	0		4500				2014-4-3	FEMALE	158	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8052/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			1	1	false			MX	NX	T1b2	TCGA-JW-A5VK.00E96283-50FE-4604-A268-FF2A65B58B7F.pdf				0	0		40		20		5		20		0		5		90		90		Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	No	NO					External beam radiation	5500	Primary Tumor	01			2009	YES	YES	NO	JW	Current reformed smoker for > 15 years	1		cervical	A	LIVING	68	2012			TCGA-JW-A5VK-01A-11D-A28B-09	d8e69719-3717-4c5d-8928-6b921d6ac187	TCGA-JW-A5VK-01A-11D-A28A-01	d8e69719-3717-4c5d-8928-6b921d6ac187	TCGA-JW-A5VK-01A-11D-A28C-05	TCGA-JW-A5VK-01A-11R-A28L-13	TCGA-JW-A5VK-01A-11D-A28B-09	TCGA-JW-A5VK-01	d8e69719-3717-4c5d-8928-6b921d6ac187	14f0047a-2f4d-430c-8988-e3cb5bf616e1	d8e69719-3717-4c5d-8928-6b921d6ac187	14f0047a-2f4d-430c-8988-e3cb5bf616e1	TCGA-JW-A5VK-01A-11D-A28B-09	TCGA-JW-A5VK-01A-11D-A28B-09	TCGA-JW-A5VK-01	TCGA-JW-A5VK-01A-11D-A28A-01	
TCGA-JW-A5VL-01	0	TCGA-JW-A5VL-01	474	0	TCGA-JW-A5VL	474	0	474	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		37		4	TCGA-JW-A5VL-F58247			4620		LDR							Cisplatin	Stage IB2	40mg/m2	-13604					114		14			0	474			474					Pelvic Nodes Present		Once weekly	0	0		540				2014-4-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			2		false			MX	NX	T1b2	TCGA-JW-A5VL.7C385D8F-CFDF-48DC-B421-4B2483CE9B25.pdf				0	0		40		20		5		20		0		5		90		90	N/A	Post-Adjuvant Therapy	TUMOR FREE	NO	0		Complete Remission/Response	No	NO					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	JW	Lifelong Non-smoker	2		cervical	A	LIVING	71	2012		9180D48E-36DA-421A-933F-FD75E6515174	TCGA-JW-A5VL-01A-11D-A28B-09	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	TCGA-JW-A5VL-01A-11D-A28A-01	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	TCGA-JW-A5VL-01A-11D-A28C-05	TCGA-JW-A5VL-01A-11R-A28L-13	TCGA-JW-A5VL-01A-11D-A28B-09	TCGA-JW-A5VL-01	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	05cec78c-1a12-4e5f-beb8-bf55d9c263d2	bd76ebed-0575-46c8-8c8a-f02fdcffc2e9	05cec78c-1a12-4e5f-beb8-bf55d9c263d2	TCGA-JW-A5VL-01A-11D-A28B-09	TCGA-JW-A5VL-01A-11D-A28B-09	TCGA-JW-A5VL-01	TCGA-JW-A5VL-01A-11D-A28A-01	
TCGA-JW-A69B-01	0	TCGA-JW-A69B-01	863	0	TCGA-JW-A69B	863	0	863	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		44		5	TCGA-JW-A69B-F69345	Never Used		4631		LDR						Scheduling problems	Other	Stage IB2	40 mg/m2	-16080					231		34			0	863			863					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	0		0				2015-1-20	FEMALE	155	Endocervical Type of Adenocarcinoma	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			3		true		External Radiation Therapy	MX	NX	T1b2	TCGA-JW-A69B.5C2BA942-7F36-496E-AB8F-0EF8A5DE9669.pdf				1	0		2		0		0		0		0		0		100		80	Follow up Visit	Other	TUMOR FREE	YES	0	NO	Complete Remission/Response	No	YES					External beam radiation	4500	Primary Tumor	01			2009	YES	YES	NO	JW	Lifelong Non-smoker	4		cervical	A	LIVING	69	2012			TCGA-JW-A69B-01A-11D-A32I-09	0697ab9a-88cc-4428-b02a-7666f0a772fa	TCGA-JW-A69B-01A-11D-A32H-01	0697ab9a-88cc-4428-b02a-7666f0a772fa	TCGA-JW-A69B-01A-11D-A32T-05	TCGA-JW-A69B-01A-11R-A32K-13	TCGA-JW-A69B-01A-11D-A32I-09	TCGA-JW-A69B-01	0697ab9a-88cc-4428-b02a-7666f0a772fa	c469f196-797d-44fd-9ed9-434966b47d99	0697ab9a-88cc-4428-b02a-7666f0a772fa	c469f196-797d-44fd-9ed9-434966b47d99	TCGA-JW-A69B-01A-11D-A32I-09	TCGA-JW-A69B-01A-11D-A32I-09	TCGA-JW-A69B-01	TCGA-JW-A69B-01A-11D-A32H-01	
TCGA-JW-A852-01	1	TCGA-JW-A852-01	252	1	TCGA-JW-A852	187	1	252	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		42		4	TCGA-JW-A852-F69374			4105		LDR						Scheduling problems	Cisplatin	Stage IIB	40 mg/m2	-15682					57	252	-1		6	0	156		187	13					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent		Once weekly	1	0		0	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2015-1-20	FEMALE	160	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2	Other, specify			Distant Metastasis	Breast		YES			3		true			MX	N1	T2b	TCGA-JW-A852.7333C03D-0CDA-4BDE-A213-6FD7D3ACB382.pdf	Cervical Cancer			0	0		3		0		0		1		5		5		90		90		Pre-Adjuvant Therapy	WITH TUMOR	YES	0	NO	Complete Remission/Response	No	YES					External beam radiation	5382	Primary Tumor	01	11.1		2009	YES	YES	NO	JW	Lifelong Non-smoker	3		cervical	A	DECEASED	100	2013			TCGA-JW-A852-01A-11D-A351-09	9795c475-908b-40e2-93d3-f07e5b94b91f	TCGA-JW-A852-01A-11D-A350-01	9795c475-908b-40e2-93d3-f07e5b94b91f	TCGA-JW-A852-01A-11D-A357-05	TCGA-JW-A852-01A-11R-A358-13	TCGA-JW-A852-01A-11D-A351-09	TCGA-JW-A852-01	9795c475-908b-40e2-93d3-f07e5b94b91f	68708798-0dcb-402b-bf89-bea09cf548f3	9795c475-908b-40e2-93d3-f07e5b94b91f	68708798-0dcb-402b-bf89-bea09cf548f3	TCGA-JW-A852-01A-11D-A351-09	TCGA-JW-A852-01A-11D-A351-09	TCGA-JW-A852-01	TCGA-JW-A852-01A-11D-A350-01	
TCGA-JW-AAVH-01	0	TCGA-JW-AAVH-01	204	0	TCGA-JW-AAVH	204	0	204	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					46	16															Stage IB1		-16894					104		21			0	204			170					Bladder Present|Extra-Pelvic Metastatic Disease Absent|Pelvic Nodes Present			2							2014-4-3	FEMALE	155	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO	Non-keratinizing squamous cell carcinoma		15			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	4	20	true			M0	N0	T1b1	TCGA-JW-AAVH.DDB7F46F-ABEE-4B05-9993-96E68774AB40.pdf				6			3		0		5		2		5		5		85		85		Pre-Adjuvant Therapy	WITH TUMOR	NO		YES		No	NO	Adverse event/complications						Primary Tumor	01			2009		YES	NO	JW	Current smoker	10		cervical	A	LIVING	165	2013				ab32f0f9-4327-4189-9dd7-6951531c6e16	TCGA-JW-AAVH-01A-11D-A386-01	ab32f0f9-4327-4189-9dd7-6951531c6e16	TCGA-JW-AAVH-01A-11D-A388-05	TCGA-JW-AAVH-01A-11R-A38M-13		TCGA-JW-AAVH-01	ab32f0f9-4327-4189-9dd7-6951531c6e16	8640bbce-49fd-41cb-b0ca-864f4d2e371e	ab32f0f9-4327-4189-9dd7-6951531c6e16	8640bbce-49fd-41cb-b0ca-864f4d2e371e			TCGA-JW-AAVH-01	TCGA-JW-AAVH-01A-11D-A386-01	
TCGA-JX-A3PZ-01	1	TCGA-JX-A3PZ-01	642	1	TCGA-JX-A3PZ			642	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					25				Never Used					ABSENT					Not done per treating physicians discretion		Stage IB		-9303					5922	642	-1			0				538					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Absent|			0	0						2014-4-17	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO	Keratinizing squamous cell carcinoma		22			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0	0	0		true			M0	N0	T1b	TCGA-JX-A3PZ.BE580A02-1AD8-4526-A0FF-042D4AAB6E15.pdf	Cervical Cancer			0	0		1		1		5		0		0		0		95		90		Pre-Adjuvant Therapy	WITH TUMOR	NO	0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			1995	NO	NO	YES	JX	Lifelong Non-smoker	0		cervical	A	DECEASED	58	1995		E8E61B42-4CF6-470E-8067-18CC5A90FDF4	TCGA-JX-A3PZ-01A-11D-A21Q-09	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	TCGA-JX-A3PZ-01A-11D-A21P-01	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	TCGA-JX-A3PZ-01A-11D-A21R-05	TCGA-JX-A3PZ-01A-11R-A21U-13	TCGA-JX-A3PZ-01A-11D-A21Q-09	TCGA-JX-A3PZ-01	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	c8e683bb-a537-4be1-a4b2-08c637caa5fa	e2dbf718-1895-4749-b0aa-5fd8acc2f9bc	c8e683bb-a537-4be1-a4b2-08c637caa5fa	TCGA-JX-A3PZ-01A-11D-A21Q-09	TCGA-JX-A3PZ-01A-11D-A21Q-09	TCGA-JX-A3PZ-01	TCGA-JX-A3PZ-01A-11D-A21P-01	
TCGA-JX-A3Q0-01	0	TCGA-JX-A3Q0-01	5957	0	TCGA-JX-A3Q0	5957	0	5957	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		63	24		TCGA-JX-A3Q0-F60570	Never Used		6545	Implants-tandem and ovoids	LDR						Not done per treating physicians discretion		Stage III		-23313					5251		-1			0	5957			5957					Extra-Pelvic Metastatic Disease Present			0	0						2014-6-11	FEMALE	166	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			2	20	true			M0	N0	T3	TCGA-JX-A3Q0.3CE379FF-5E2B-4DE5-BBD8-51D70E6EFF73.pdf				0	0		0		0		10		0		0		10		80		70	Followup visit	Other	TUMOR FREE	NO	0	NO	Complete Remission/Response	No	YES			Whole pelvis split field		External beam radiation	5040	Primary Tumor	01		1997	1995	NO	NO	YES	JX	Current reformed smoker for < or = 15 years	2		cervical	A	LIVING	57	1997		1DDEE185-E1DE-44AE-AD36-FFCC69B5EE84	TCGA-JX-A3Q0-01A-11D-A21Q-09	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	TCGA-JX-A3Q0-01A-11D-A21P-01	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	TCGA-JX-A3Q0-01A-11D-A21R-05	TCGA-JX-A3Q0-01A-11R-A21U-13	TCGA-JX-A3Q0-01A-11D-A21Q-09	TCGA-JX-A3Q0-01	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	8cbfb811-7663-40f8-9034-07bd3ee558ad	f5380a4f-3678-45b2-bfc2-5b3c0d346dcd	8cbfb811-7663-40f8-9034-07bd3ee558ad	TCGA-JX-A3Q0-01A-11D-A21Q-09	TCGA-JX-A3Q0-01A-11D-A21Q-09	TCGA-JX-A3Q0-01	TCGA-JX-A3Q0-01A-11D-A21P-01	
TCGA-JX-A3Q8-01	0	TCGA-JX-A3Q8-01	922	0	TCGA-JX-A3Q8	922	0	922	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		40			TCGA-JX-A3Q8-F60569	Former User					ABSENT					Not done per treating physicians discretion		Stage IB1		-14839					252				32	0	922			922								0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-6-11	FEMALE	158	Endocervical Type of Adenocarcinoma	No	PCR		31.33, 35.39, 45.51, 52.56.58.59.68	HPV 16|HPV 18|Other HPV type(s)		Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO	14			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	1		true			MX	N0	T1b1	TCGA-JX-A3Q8.0BC4C48F-7EE3-40A4-85AB-44B85DE4EC65.pdf				1	1		1		0		0		0		0		0		100		90	Post-operative follow-up	Other	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01	7.1		2009	NO	NO	YES	JX	Lifelong Non-smoker	3		cervical	A	LIVING	68	2011			TCGA-JX-A3Q8-01A-11D-A21Q-09	21e92dd7-adee-4826-9470-fb7501ad280d	TCGA-JX-A3Q8-01A-11D-A21P-01	21e92dd7-adee-4826-9470-fb7501ad280d	TCGA-JX-A3Q8-01A-11D-A21R-05	TCGA-JX-A3Q8-01A-11R-A21U-13	TCGA-JX-A3Q8-01A-11D-A21Q-09	TCGA-JX-A3Q8-01	21e92dd7-adee-4826-9470-fb7501ad280d	4f3a6d35-d6cb-43ac-b6bb-04f6f1cd9297	21e92dd7-adee-4826-9470-fb7501ad280d	4f3a6d35-d6cb-43ac-b6bb-04f6f1cd9297	TCGA-JX-A3Q8-01A-11D-A21Q-09	TCGA-JX-A3Q8-01A-11D-A21Q-09	TCGA-JX-A3Q8-01	TCGA-JX-A3Q8-01A-11D-A21P-01	
TCGA-JX-A5QV-01	0	TCGA-JX-A5QV-01	243	0	TCGA-JX-A5QV	243	0	243	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		37			TCGA-JX-A5QV-F60568	Never Used		2400		LDR	ABSENT							Stage IB1		-13667					147				8	0	243			243								0	0			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-6-11	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Keratinizing squamous cell carcinoma	NO	13			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0	4		true			M0	N0	T1b1	TCGA-JX-A5QV.6C4DBD4D-8F4E-4680-AE60-1AFE2BF72732.pdf				1	0		5		0		0		5		20		20		60		60		Post-Adjuvant Therapy	TUMOR FREE	NO	0	YES	Complete Remission/Response	No	YES					IMRT	5120	Primary Tumor	01			2009	NO	NO	YES	JX	Lifelong Non-smoker	5		cervical	A	LIVING	61	2012		F32F346E-9E0B-4EDA-AB4D-09FCC54BED28	TCGA-JX-A5QV-01A-22D-A28B-09	5005b96a-a215-43a0-8b55-f212891bca11	TCGA-JX-A5QV-01A-22D-A28A-01	5005b96a-a215-43a0-8b55-f212891bca11	TCGA-JX-A5QV-01A-22D-A28C-05	TCGA-JX-A5QV-01A-22R-A28L-13	TCGA-JX-A5QV-01A-22D-A28B-09	TCGA-JX-A5QV-01	5005b96a-a215-43a0-8b55-f212891bca11	bcaeb46f-3787-4c33-b133-9531887648ff	5005b96a-a215-43a0-8b55-f212891bca11	bcaeb46f-3787-4c33-b133-9531887648ff	TCGA-JX-A5QV-01A-22D-A28B-09	TCGA-JX-A5QV-01A-22D-A28B-09	TCGA-JX-A5QV-01	TCGA-JX-A5QV-01A-22D-A28A-01	
TCGA-LP-A4AU-01	0	TCGA-LP-A4AU-01	343	0	TCGA-LP-A4AU	343	0	343	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		35			TCGA-LP-A4AU-F58081												Cisplatin|Other	Stage IIIB	|750 mg/m2	-13074					272					0	343			343								3							2014-3-31	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	500	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			1		true		|5FU	M0	N1	T2	TCGA-LP-A4AU.A929AD30-1751-4BEB-BB5C-B5D191565385.pdf							2		0		2		0		3		0		95		80	Date of Contact	Other	TUMOR FREE	YES		YES		No	YES					External beam radiation	6500	Primary Tumor	01			2009	YES	YES	NO	LP	Lifelong Non-smoker	1		cervical	A	LIVING	49	2011			TCGA-LP-A4AU-01A-32D-A243-09	9f1118f7-2469-4161-9930-58af9b633b66	TCGA-LP-A4AU-01A-32D-A242-01	9f1118f7-2469-4161-9930-58af9b633b66	TCGA-LP-A4AU-01A-32D-A244-05	TCGA-LP-A4AU-01A-32R-A24J-13	TCGA-LP-A4AU-01A-32D-A243-09	TCGA-LP-A4AU-01	9f1118f7-2469-4161-9930-58af9b633b66	1444132b-8f73-449e-9421-372523791d01	9f1118f7-2469-4161-9930-58af9b633b66	1444132b-8f73-449e-9421-372523791d01	TCGA-LP-A4AU-01A-32D-A243-09	TCGA-LP-A4AU-01A-32D-A243-09	TCGA-LP-A4AU-01	TCGA-LP-A4AU-01A-32D-A242-01	
TCGA-LP-A4AV-01		TCGA-LP-A4AV-01			TCGA-LP-A4AV				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					63																Stage IB							413					0	0																		2013-3-12	FEMALE	153	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO			3					G2							NO			4		true			M0	N0	T1b	TCGA-LP-A4AV.7880E0A0-01B8-4A31-967D-8833B20752BB.pdf							3		0		10		0		0		0		90		80			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			2009		YES	NO	LP	Lifelong Non-smoker	4		cervical	A	LIVING	42	2011		41413CCA-EDCB-4BA1-945E-81C34DBFF006	TCGA-LP-A4AV-01A-11D-A243-09	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	TCGA-LP-A4AV-01A-11D-A242-01	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	TCGA-LP-A4AV-01A-11D-A244-05	TCGA-LP-A4AV-01A-11R-A24J-13	TCGA-LP-A4AV-01A-11D-A243-09	TCGA-LP-A4AV-01	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	7c924fd6-3478-46b2-83a1-f7bd2c768e01	777d3cf0-1f4a-42e9-b88c-cdf2d783b24d	7c924fd6-3478-46b2-83a1-f7bd2c768e01	TCGA-LP-A4AV-01A-11D-A243-09	TCGA-LP-A4AV-01A-11D-A243-09	TCGA-LP-A4AV-01	TCGA-LP-A4AV-01A-11D-A242-01	
TCGA-LP-A4AW-01	0	TCGA-LP-A4AW-01	27	0	TCGA-LP-A4AW	27	0	27	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					52																Stage IA		-19079					259					0	27																		2013-3-12	FEMALE	158	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	420	NO	Keratinizing squamous cell carcinoma		3				Peri (6-12 months since last menstrual period)	G1							NO			2		true			M0	N0	T1b	TCGA-LP-A4AW.6FE2BF04-559B-4650-921B-C1674E76EEEB.pdf							2		0		0		0		0		0		100		80			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01			2009		YES	NO	LP	Lifelong Non-smoker	2		cervical	A	LIVING	52	2011		85E20D48-3D30-4459-BFB5-95F947CED890	TCGA-LP-A4AW-01A-11D-A243-09	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	TCGA-LP-A4AW-01A-11D-A242-01	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	TCGA-LP-A4AW-01A-11D-A244-05	TCGA-LP-A4AW-01A-11R-A24J-13	TCGA-LP-A4AW-01A-11D-A243-09	TCGA-LP-A4AW-01	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	10bb34d6-a98e-4455-8ac8-5f47f6b7bf67	985c5f28-72d3-49f6-bc9b-31e565b2ba7c	10bb34d6-a98e-4455-8ac8-5f47f6b7bf67	TCGA-LP-A4AW-01A-11D-A243-09	TCGA-LP-A4AW-01A-11D-A243-09	TCGA-LP-A4AW-01	TCGA-LP-A4AW-01A-11D-A242-01	
TCGA-LP-A4AX-01	0	TCGA-LP-A4AX-01	380	0	TCGA-LP-A4AX	380	0	380	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		45			TCGA-LP-A4AX-F69765													Stage IB1		-16544					263					0	380			380								1							2015-1-19	FEMALE		Cervical Squamous Cell Carcinoma	No						Simple Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	240	NO		NO	2				Peri (6-12 months since last menstrual period)	G3							NO	0		2		true			M0	N0	T1b1	TCGA-LP-A4AX.06D6C5C2-EE8F-40DF-9F99-05E9DA394840.pdf							2		0		0		0		0		0		100		80		Post-Adjuvant Therapy	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	NO	YES	NO	LP	Lifelong Non-smoker	2		cervical	A	LIVING		2011		D61E568A-FB64-4C66-A46D-B835AB2B7F46	TCGA-LP-A4AX-01A-12D-A243-09	f7e2e36f-3018-4570-9ed2-f256048a9427	TCGA-LP-A4AX-01A-12D-A242-01	f7e2e36f-3018-4570-9ed2-f256048a9427	TCGA-LP-A4AX-01A-12D-A244-05	TCGA-LP-A4AX-01A-12R-A24J-13	TCGA-LP-A4AX-01A-12D-A243-09	TCGA-LP-A4AX-01	f7e2e36f-3018-4570-9ed2-f256048a9427	47174a3a-d374-4f19-b977-be37e5a8d22b	f7e2e36f-3018-4570-9ed2-f256048a9427	47174a3a-d374-4f19-b977-be37e5a8d22b	TCGA-LP-A4AX-01A-12D-A243-09	TCGA-LP-A4AX-01A-12D-A243-09	TCGA-LP-A4AX-01	TCGA-LP-A4AX-01A-12D-A242-01	
TCGA-LP-A5U2-01	0	TCGA-LP-A5U2-01	9	0	TCGA-LP-A5U2	9	0	9	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					30				Never Used					ABSENT							Stage IIIB		-11049					226					0	9			6								1							2014-7-3	FEMALE	160	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	550	NO			7	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	2				true			MX	N1	T2a	TCGA-LP-A5U2.21CF3259-2E5C-48A6-B6BC-094001C4DB87.pdf					1		40		20		0		20		0		20		80		80		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	LP	Lifelong Non-smoker	1		cervical	A	LIVING	51	2012		094DF0CC-0C59-4855-B581-56FB17D71468	TCGA-LP-A5U2-01A-11D-A28B-09	2953ceed-8418-4c63-b260-307aea1d9e63	TCGA-LP-A5U2-01A-11D-A28A-01	2953ceed-8418-4c63-b260-307aea1d9e63	TCGA-LP-A5U2-01A-11D-A28C-05	TCGA-LP-A5U2-01A-11R-A28L-13	TCGA-LP-A5U2-01A-11D-A28B-09	TCGA-LP-A5U2-01	2953ceed-8418-4c63-b260-307aea1d9e63	35d3de60-9a72-491f-aad6-77bd035bdbec	2953ceed-8418-4c63-b260-307aea1d9e63	35d3de60-9a72-491f-aad6-77bd035bdbec	TCGA-LP-A5U2-01A-11D-A28B-09	TCGA-LP-A5U2-01A-11D-A28B-09	TCGA-LP-A5U2-01	TCGA-LP-A5U2-01A-11D-A28A-01	
TCGA-LP-A5U3-01	0	TCGA-LP-A5U3-01	25	0	TCGA-LP-A5U3	25	0	25	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					40				Never Used					ABSENT							Stage IB1		-14698					168					0	25											1							2014-1-3	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	520	NO	Non-keratinizing squamous cell carcinoma					ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		true			M0	N0	T1b1	TCGA-LP-A5U3.153C30F0-1533-4056-9E90-F1568B8130D9.pdf							20		20		0		40		0		30		70		70		Preoperative	TUMOR FREE			NO	Complete Remission/Response	No								Primary Tumor	01			2009		YES	NO	LP	Lifelong Non-smoker	3		cervical	A	LIVING	50	2012		D4F30F80-47CD-44E7-A1C9-419484388AF4	TCGA-LP-A5U3-01A-11D-A28B-09	7db85d66-16a3-4062-b98f-1ebe628d2b13	TCGA-LP-A5U3-01A-11D-A28A-01	7db85d66-16a3-4062-b98f-1ebe628d2b13	TCGA-LP-A5U3-01A-11D-A28C-05	TCGA-LP-A5U3-01A-11R-A28L-13	TCGA-LP-A5U3-01A-11D-A28B-09	TCGA-LP-A5U3-01	7db85d66-16a3-4062-b98f-1ebe628d2b13	b295143c-7132-4848-8c26-b581f6d81d7a	7db85d66-16a3-4062-b98f-1ebe628d2b13	b295143c-7132-4848-8c26-b581f6d81d7a	TCGA-LP-A5U3-01A-11D-A28B-09	TCGA-LP-A5U3-01A-11D-A28B-09	TCGA-LP-A5U3-01	TCGA-LP-A5U3-01A-11D-A28A-01	
TCGA-LP-A7HU-01	0	TCGA-LP-A7HU-01	406	0	TCGA-LP-A7HU	406	0	406	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		53			TCGA-LP-A7HU-F69614	Never Used					ABSENT							Stage II		-19595					141					0	406			406								1							2015-1-15	FEMALE	155	Endocervical Type of Adenocarcinoma	No						Simple Hysterectomy	C53.9	8384/3	C53.0	YES		Biopsy (cervical / CT-guided / Other)	250	NO		NO	2	Pelvic (external iliac, internal iliac, obturator)		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		2		true			M0	N0	T2	TCGA-LP-A7HU.73BE0D97-1598-42A4-905B-3E652FF7D295.pdf							4		1		5		2		10		20		65		65		Post-Adjuvant Therapy	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES					External beam radiation	5000	Primary Tumor	01			2009	NO	YES	NO	LP	Lifelong Non-smoker	3		cervical	A	LIVING	58	2013		BCB3CB2B-4807-4B75-BEBA-8B33C4F18C18	TCGA-LP-A7HU-01A-11D-A33O-09	33849579-965e-47e7-8fbe-016db46b3d77	TCGA-LP-A7HU-01A-11D-A33N-01	33849579-965e-47e7-8fbe-016db46b3d77	TCGA-LP-A7HU-01A-11D-A340-05	TCGA-LP-A7HU-01A-11R-A342-13	TCGA-LP-A7HU-01A-11D-A33O-09	TCGA-LP-A7HU-01	33849579-965e-47e7-8fbe-016db46b3d77	3a0265f2-db94-4e32-bc5c-8c9bc0e9d4c3	33849579-965e-47e7-8fbe-016db46b3d77	3a0265f2-db94-4e32-bc5c-8c9bc0e9d4c3	TCGA-LP-A7HU-01A-11D-A33O-09	TCGA-LP-A7HU-01A-11D-A33O-09	TCGA-LP-A7HU-01	TCGA-LP-A7HU-01A-11D-A33N-01	
TCGA-MA-AA3W-01	0	TCGA-MA-AA3W-01	685	0	TCGA-MA-AA3W	685	0	685	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		54	18	5	TCGA-MA-AA3W-F65477						PRESENT	negative					Cisplatin	Stage IB1	70	-20066					512		5		65	0	685			685					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0	1			Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma	NO	40	Other Location, specify	left parametrium		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	1	0	4	5.7	false			M0	N1	T1b1	TCGA-MA-AA3W.1C91223A-5529-46CD-AA9C-40A974F1843E.pdf				1			10		0		0		0		20		10		70		70		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					IMRT	4500	Primary Tumor	01	0		2009	YES	YES	NO	MA	Current smoker	6		cervical	A	LIVING	84	2012		E9FE952A-0600-4871-B650-997628E6A1C0		52041760-a4d7-43e0-b2be-6b7055fe49ed	TCGA-MA-AA3W-01A-11D-A386-01	52041760-a4d7-43e0-b2be-6b7055fe49ed	TCGA-MA-AA3W-01A-11D-A388-05	TCGA-MA-AA3W-01A-11R-A38M-13		TCGA-MA-AA3W-01	52041760-a4d7-43e0-b2be-6b7055fe49ed	17711746-6187-4c56-b0b5-d4f34e5a8bc5	52041760-a4d7-43e0-b2be-6b7055fe49ed	17711746-6187-4c56-b0b5-d4f34e5a8bc5			TCGA-MA-AA3W-01	TCGA-MA-AA3W-01A-11D-A386-01	
TCGA-MA-AA3X-01	0	TCGA-MA-AA3X-01	595	0	TCGA-MA-AA3X	595	0	595	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		50	12	5	TCGA-MA-AA3X-F65478			2900		HDR							Cisplatin	Stage IIIB	70	-18412					471		83	1	77	0	595			595					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0				Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|			2014-9-23	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			2	9.5	false			MX	NX	T3b	TCGA-MA-AA3X.FE614842-9700-472D-B1D8-F2DFF940D489.pdf				1			10		0		2		0		0		18		80		80		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	5040	Primary Tumor	01			2009	YES	YES	NO	MA	Current smoker	3		cervical	A	LIVING	73	2012				476a57b4-654c-48b3-929b-37996cd93f45	TCGA-MA-AA3X-01A-22D-A42N-01	476a57b4-654c-48b3-929b-37996cd93f45	TCGA-MA-AA3X-01A-22D-A42P-05	TCGA-MA-AA3X-01A-22R-A42U-13			476a57b4-654c-48b3-929b-37996cd93f45	cd6d5682-9e0b-4086-b019-a1012835b66a	476a57b4-654c-48b3-929b-37996cd93f45	cd6d5682-9e0b-4086-b019-a1012835b66a				TCGA-MA-AA3X-01A-22D-A42N-01	
TCGA-MA-AA3Y-01	0	TCGA-MA-AA3Y-01	542	0	TCGA-MA-AA3Y	542	0	542	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		48			TCGA-MA-AA3Y-F65479	Never Used					ABSENT	negative						Stage IB1		-17795					478		20			0	542			542					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			0							2014-9-23	FEMALE	156	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	250	NO	Keratinizing squamous cell carcinoma	NO	29			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	0	0			false			M0	N0	T1b1	TCGA-MA-AA3Y.AA310801-F827-47D4-9A53-9C63D65F12C8.pdf				1			10		0		10		0		10		20		60		60	Post operative	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009	NO	YES	NO	MA	Lifelong Non-smoker	1		cervical	A	LIVING	65	2012		D9039497-FD01-4832-966C-FCE8F17A7971		32de6610-4b6b-443f-bd20-f67d97558cbd	TCGA-MA-AA3Y-01A-11D-A386-01	32de6610-4b6b-443f-bd20-f67d97558cbd	TCGA-MA-AA3Y-01A-11D-A388-05	TCGA-MA-AA3Y-01A-11R-A38M-13		TCGA-MA-AA3Y-01	32de6610-4b6b-443f-bd20-f67d97558cbd	b73e90c0-2a18-4a88-a05d-344d97efb1cf	32de6610-4b6b-443f-bd20-f67d97558cbd	b73e90c0-2a18-4a88-a05d-344d97efb1cf			TCGA-MA-AA3Y-01	TCGA-MA-AA3Y-01A-11D-A386-01	
TCGA-MA-AA3Z-01	0	TCGA-MA-AA3Z-01	595	0	TCGA-MA-AA3Z	595	0	595	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		43		6	TCGA-MA-AA3Z-F65480	Former User		2800		HDR							Cisplatin	Stage IB2	70	-15762					352		41		52	0	595			595					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	160	Cervical Squamous Cell Carcinoma	No	Other, specify	HPV Hybrid Capture II	There are several types of HPV the patient could be positive for.	Other HPV type(s)			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	230	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			5		false			M0	N0	T1b2	TCGA-MA-AA3Z.9CE46816-BE2F-46EA-880C-709BE2D40A1A.pdf							10		0		0		0		0		20		80		80		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	5040	Primary Tumor	01	28.8		2009	YES	YES	NO	MA	Lifelong Non-smoker	5		cervical	A	LIVING	84	2013		58DA0BF4-6F81-404C-B348-29BDA4104BAE		cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	TCGA-MA-AA3Z-01A-11D-A386-01	cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	TCGA-MA-AA3Z-01A-11D-A388-05	TCGA-MA-AA3Z-01A-11R-A38M-13		TCGA-MA-AA3Z-01	cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	3eeef706-d692-4d89-a81c-6d24dc8853a6	cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8	3eeef706-d692-4d89-a81c-6d24dc8853a6			TCGA-MA-AA3Z-01	TCGA-MA-AA3Z-01A-11D-A386-01	
TCGA-MA-AA41-01	0	TCGA-MA-AA41-01	254	0	TCGA-MA-AA41	254	0	254	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		33	14	2|6|6|5	TCGA-MA-AA41-F65481	Former User		6817	pulse dose rate	Other							Cisplatin|Carboplatin|Other|Other	Stage IIB	57|AUC/5|175mg/m2; 135mg/m2|15mg/kg	-12398					197				15	0	254			254							Once weekly|Once weekly|Once weekly|	4				Bladder Absent|Extra-Pelvic Metastatic Disease Present|Parametrium Present|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2014-9-23	FEMALE	159	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	340	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			3	5	false		Paclitaxel|Bevacizumab	M1	N1	T2	TCGA-MA-AA41.3E26B1B5-771B-4F99-BB78-C83C9F6557D2.pdf							5		0		0		0		5		20		75		75		Post-Adjuvant Therapy	WITH TUMOR	YES		NO	Progressive Disease	No	YES					3D conformal	3420	Primary Tumor	01			2009	YES	YES	NO	MA	Current smoker	3		cervical	A	LIVING	47	2013		EAD0873A-0639-48FC-B340-C009F8FC6984		b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	TCGA-MA-AA41-01A-11D-A386-01	b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	TCGA-MA-AA41-01A-11D-A388-05	TCGA-MA-AA41-01A-11R-A38M-13		TCGA-MA-AA41-01	b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	efcfe9c4-debe-4e3a-a606-d11f85ee7a4c	b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e	efcfe9c4-debe-4e3a-a606-d11f85ee7a4c			TCGA-MA-AA41-01	TCGA-MA-AA41-01A-11D-A386-01	
TCGA-MA-AA42-01	0	TCGA-MA-AA42-01	259	0	TCGA-MA-AA42	259	0	259	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		75		5	TCGA-MA-AA42-F65482			3100		HDR							Cisplatin	Stage IIB	62	-27460					57			14	19	0	259			259						Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0				Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2014-9-23	FEMALE	140	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			6		false			M0	N0	T2b	TCGA-MA-AA42.62F4EBB5-6F2F-4D4C-817E-88EEF577BF1C.pdf				2			3		0		18		2		5		2		75		75		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	5040	Primary Tumor	01	18.5		2009	YES	YES	NO	MA	Lifelong Non-smoker	8		cervical	A	LIVING	63	2013		8C54A0B1-1E91-40CE-8BC8-2CC140B4310C		4523956c-5427-45e0-a640-cc5ce875b022	TCGA-MA-AA42-01A-12D-A386-01	4523956c-5427-45e0-a640-cc5ce875b022	TCGA-MA-AA42-01A-12D-A388-05	TCGA-MA-AA42-01A-12R-A38M-13		TCGA-MA-AA42-01	4523956c-5427-45e0-a640-cc5ce875b022	ceac0d66-ae14-4347-ad91-a45f71e894aa	4523956c-5427-45e0-a640-cc5ce875b022	ceac0d66-ae14-4347-ad91-a45f71e894aa			TCGA-MA-AA42-01	TCGA-MA-AA42-01A-12D-A386-01	
TCGA-MA-AA43-01	0	TCGA-MA-AA43-01	346	0	TCGA-MA-AA43	346	0	346	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		48	16	2	TCGA-MA-AA43-F65483	Never Used		8239	pulse dose rate	Other							Cisplatin	Stage IIIB	68	-17658					180			70	66	0	346			346						Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent	Once weekly	0			4500	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Present|Supraclavicular Absent			2014-9-23	FEMALE	152	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO	Non-keratinizing squamous cell carcinoma	NO					Peri (6-12 months since last menstrual period)	G3							NO			6	11.6	false			MX	NX	T3b	TCGA-MA-AA43.662EBBFF-1A0B-4217-8E3D-C453AAA4BDAD.pdf							4		0		5		0		10		5		80		80		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	11400	Primary Tumor	01		2013	2009	YES	YES	NO	MA	Current reformed smoker for < or = 15 years	6		cervical	A	LIVING	72	2013		030704AA-5162-44EE-B68B-7D35FB6DD2A0		eb0b4f03-9121-4c2a-bc13-4d9109d6b894	TCGA-MA-AA43-01A-11D-A42N-01	eb0b4f03-9121-4c2a-bc13-4d9109d6b894	TCGA-MA-AA43-01A-11D-A42P-05	TCGA-MA-AA43-01A-11R-A42V-13			eb0b4f03-9121-4c2a-bc13-4d9109d6b894	5d7ac947-eb86-4118-bd9a-42fbd5aa91f5	eb0b4f03-9121-4c2a-bc13-4d9109d6b894	5d7ac947-eb86-4118-bd9a-42fbd5aa91f5				TCGA-MA-AA43-01A-11D-A42N-01	
TCGA-MU-A51Y-01	0	TCGA-MU-A51Y-01	422	0	TCGA-MU-A51Y	422	0	422	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					27																Stage IIA1		-10199					127				52	0	422																		2012-9-14	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	90	NO	Non-keratinizing squamous cell carcinoma		17				Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1		true			MX	N0	T2a1	TCGA-MU-A51Y.6E5C4ACB-C01C-4AE3-B060-E354CFEF08A0.pdf					3		0		0		5		0		0		15		80		80			TUMOR FREE	NO		YES		No	NO	Not done per treating physician discretion						Primary Tumor	01	6.47		2009		YES	NO	MU	Lifelong Non-smoker			cervical	A	LIVING	31	2012		9D208C1A-C282-49B9-8271-BDDD8D5792A6	TCGA-MU-A51Y-01A-11D-A26G-09	e2f4f6ea-e643-421e-96ec-3618bb46b91d	TCGA-MU-A51Y-01A-11D-A26F-01	e2f4f6ea-e643-421e-96ec-3618bb46b91d	TCGA-MU-A51Y-01A-11D-A26S-05	TCGA-MU-A51Y-01A-11R-A26X-13	TCGA-MU-A51Y-01A-11D-A26G-09	TCGA-MU-A51Y-01	e2f4f6ea-e643-421e-96ec-3618bb46b91d	faf40abd-1ff2-40c9-a482-5c2327184d93	e2f4f6ea-e643-421e-96ec-3618bb46b91d	faf40abd-1ff2-40c9-a482-5c2327184d93	TCGA-MU-A51Y-01A-11D-A26G-09	TCGA-MU-A51Y-01A-11D-A26G-09	TCGA-MU-A51Y-01	TCGA-MU-A51Y-01A-11D-A26F-01	
TCGA-MU-A5YI-01	0	TCGA-MU-A5YI-01	1053	0	TCGA-MU-A5YI	630	1	1053	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	YES	Progressive Disease		60	37	3	TCGA-MU-A5YI-F60258												Cisplatin	Stage IA1		-21927					593					0	1053	662	630	1053							Once weekly	2							2014-6-4	FEMALE	175	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES	Hysterectomy	Other method, specify:	150	NO	Non-keratinizing squamous cell carcinoma	NO	18			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2	Other, specify	CT Guided biopsy		Distant Metastasis	Thoracic Spine	YES	YES	0			10	true			MX	NX	T1a1	TCGA-MU-A5YI.A762F957-1504-4FD5-9862-D7C8DD94A693.pdf							40		20		0		20		0		30		70		70		Post-Adjuvant Therapy	WITH TUMOR	YES		YES		No	YES					External beam radiation	3500	Primary Tumor	01		1991	2009	YES	YES	NO	MU	Current reformed smoker for > 15 years			cervical	A	LIVING	101	2011		2A20CB75-42F9-4895-B3DC-9A6FBC9A1E59	TCGA-MU-A5YI-01A-11D-A32I-09	736a30f9-fb53-422d-b66e-1af964011d15	TCGA-MU-A5YI-01A-11D-A32H-01	736a30f9-fb53-422d-b66e-1af964011d15	TCGA-MU-A5YI-01A-11D-A32T-05	TCGA-MU-A5YI-01A-11R-A32K-13	TCGA-MU-A5YI-01A-11D-A32I-09	TCGA-MU-A5YI-01	736a30f9-fb53-422d-b66e-1af964011d15	84f8bb9b-01d6-452b-a3e1-f658dd0b94d6	736a30f9-fb53-422d-b66e-1af964011d15	84f8bb9b-01d6-452b-a3e1-f658dd0b94d6	TCGA-MU-A5YI-01A-11D-A32I-09	TCGA-MU-A5YI-01A-11D-A32I-09	TCGA-MU-A5YI-01	TCGA-MU-A5YI-01A-11D-A32H-01	
TCGA-MU-A8JM-01	0	TCGA-MU-A8JM-01	165	0	TCGA-MU-A8JM	165	0	165	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					46	16											Microscopic parametrial involvement				Stage IB1		-17156					278				28	0	165																		2013-10-9	FEMALE	165	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	210	NO	Non-keratinizing squamous cell carcinoma		29	Pelvic (external iliac, internal iliac, obturator)|Common iliac				G2							NO	0		1	30	true			MX	N0	T1b	TCGA-MU-A8JM.A70CA320-58BF-4165-BD92-D791A4385247.pdf				1			10		0		0		0		10		20		70		70			TUMOR FREE	NO		YES		No	NO							Primary Tumor	01	6.0	2012	2009	NO	YES	NO	MU	Current reformed smoker for < or = 15 years	2		cervical	A	LIVING	86	2013		6DEA112A-68FE-4D44-A1D3-94F52FA9D333		78fd9869-2ed5-40a6-a846-07d5089dd810	TCGA-MU-A8JM-01A-11D-A36I-01	78fd9869-2ed5-40a6-a846-07d5089dd810	TCGA-MU-A8JM-01A-11D-A36K-05	TCGA-MU-A8JM-01A-11R-A36A-13		TCGA-MU-A8JM-01	78fd9869-2ed5-40a6-a846-07d5089dd810	2eb90697-a948-4adf-84ed-c3d05b04b2e4	78fd9869-2ed5-40a6-a846-07d5089dd810	2eb90697-a948-4adf-84ed-c3d05b04b2e4			TCGA-MU-A8JM-01	TCGA-MU-A8JM-01A-11D-A36I-01	
TCGA-MY-A5BD-01	0	TCGA-MY-A5BD-01	1667	0	TCGA-MY-A5BD	1667	0	1667	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		62		6	TCGA-MY-A5BD-F67085						PRESENT						Cisplatin	Stage IIB	40mg	-22901					983					0	1667										Once weekly	0			15				2014-10-30	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	10	NO		NO	26			PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	0			true			M0	N0	T2b	TCGA-MY-A5BD.4BCA8C55-997E-4700-A12C-B520575C3608.pdf							40		10		0		20		0		10		90		90		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Stable Disease	No	YES					External beam radiation	45	Primary Tumor	01			2009	YES	NO	YES	MY	Lifelong Non-smoker			cervical	A	LIVING	91	2010			TCGA-MY-A5BD-01A-11D-A26G-09	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	TCGA-MY-A5BD-01A-11D-A26F-01	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	TCGA-MY-A5BD-01A-11D-A26S-05	TCGA-MY-A5BD-01A-11R-A26X-13	TCGA-MY-A5BD-01A-11D-A26G-09	TCGA-MY-A5BD-01	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	79f5965d-61e9-4225-a192-878f5d1ebe6a	6cf2bd67-93bd-449e-9204-5ac5f75cbfd1	79f5965d-61e9-4225-a192-878f5d1ebe6a	TCGA-MY-A5BD-01A-11D-A26G-09	TCGA-MY-A5BD-01A-11D-A26G-09	TCGA-MY-A5BD-01	TCGA-MY-A5BD-01A-11D-A26F-01	
TCGA-MY-A5BE-01	0	TCGA-MY-A5BE-01	1066	0	TCGA-MY-A5BE	1066	0	1066	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		42			TCGA-MY-A5BE-F67177											Not done per treating physicians discretion		Stage IB1		-15466					386					0	1066																		2014-10-31	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO		Pelvic (external iliac, internal iliac, obturator)|Common iliac		ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO					true			MX	N0	T1b1	TCGA-MY-A5BE.8D0A3856-45BE-458D-996A-49B5C255296C.pdf							3		0		5		0		0		0		95		80			TUMOR FREE	NO		YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			2009	NO	NO	YES	MY	Lifelong Non-smoker			cervical	A	LIVING	84	2011			TCGA-MY-A5BE-01A-21D-A26G-09	8e7c9d3f-137c-4f4d-829d-76f11c133267	TCGA-MY-A5BE-01A-21D-A26F-01	8e7c9d3f-137c-4f4d-829d-76f11c133267	TCGA-MY-A5BE-01A-21D-A26S-05	TCGA-MY-A5BE-01A-21R-A26X-13	TCGA-MY-A5BE-01A-21D-A26G-09	TCGA-MY-A5BE-01	8e7c9d3f-137c-4f4d-829d-76f11c133267	9c8f045d-4441-4f51-a348-8a0b38fc5215	8e7c9d3f-137c-4f4d-829d-76f11c133267	9c8f045d-4441-4f51-a348-8a0b38fc5215	TCGA-MY-A5BE-01A-21D-A26G-09	TCGA-MY-A5BE-01A-21D-A26G-09	TCGA-MY-A5BE-01	TCGA-MY-A5BE-01A-21D-A26F-01	
TCGA-MY-A5BF-01	0	TCGA-MY-A5BF-01	634	0	TCGA-MY-A5BF	634	0	634	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		68		5	TCGA-MY-A5BF-F67160												Cisplatin	Stage IIA2	40mg	-25082					97					0	634										Once weekly								2014-10-31	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable	robotic	Other	C53.9	8071/3	C53.9	YES		Lymph node sampling or dissection	190	NO		NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	6			true			MX	N0	T2a2	TCGA-MY-A5BF.1BFC6DC1-D8FF-4C55-8925-BA52DEB3ECD3.pdf							3		0		2		0		0		0		98		80			TUMOR FREE	YES		YES	Stable Disease	No	YES					IMRT	45	Primary Tumor	01			2009	YES	YES	NO	MY	Lifelong Non-smoker			cervical	A	LIVING	74	2012		C4584FD2-F3A6-4475-96F1-7897310781FA	TCGA-MY-A5BF-01A-11D-A26G-09	77019674-09ef-416d-a02a-8135b048af91	TCGA-MY-A5BF-01A-11D-A26F-01	77019674-09ef-416d-a02a-8135b048af91	TCGA-MY-A5BF-01A-11D-A26S-05	TCGA-MY-A5BF-01A-11R-A26X-13	TCGA-MY-A5BF-01A-11D-A26G-09	TCGA-MY-A5BF-01	77019674-09ef-416d-a02a-8135b048af91	a8c2bf57-91e1-41fc-a694-8a8e0a8ad55d	77019674-09ef-416d-a02a-8135b048af91	a8c2bf57-91e1-41fc-a694-8a8e0a8ad55d	TCGA-MY-A5BF-01A-11D-A26G-09	TCGA-MY-A5BF-01A-11D-A26G-09	TCGA-MY-A5BF-01	TCGA-MY-A5BF-01A-11D-A26F-01	
TCGA-MY-A5BF-11	0	TCGA-MY-A5BF-11	634	0	TCGA-MY-A5BF	634	0	634	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		68		5	TCGA-MY-A5BF-F67160												Cisplatin	Stage IIA2	40mg	-25082					97					0	634										Once weekly								2014-10-31	FEMALE	170	Cervical Squamous Cell Carcinoma	No				Not applicable	robotic	Other	C53.9	8071/3	C53.9	YES		Lymph node sampling or dissection	220	NO		NO	6	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G1							NO	0	6			true			MX	N0	T2a2								1		0		0		0		100		0		0		0			TUMOR FREE	YES		YES	Stable Disease	No	YES					IMRT	45	Solid Tissue Normal	11			2009	YES	YES	NO	MY	Lifelong Non-smoker			cervical	A	LIVING	74	2012				ea52408f-b5e1-4a15-80bc-945cc74135e4		ea52408f-b5e1-4a15-80bc-945cc74135e4	TCGA-MY-A5BF-11A-11D-A26S-05	TCGA-MY-A5BF-11A-11R-A26X-13			ea52408f-b5e1-4a15-80bc-945cc74135e4		ea52408f-b5e1-4a15-80bc-945cc74135e4						
TCGA-MY-A913-01	0	TCGA-MY-A913-01	167	0	TCGA-MY-A913	167	0	167	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					28		5				50		HDR							Cisplatin	Stage IIA	40mg	-10379					107		166	21	-7	0	167			152					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	0				Bladder AbsentPelvic Nodes Present|			2014-4-23	FEMALE	163	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	210	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			5		true			M1	N0	Tis	TCGA-MY-A913.E17EECA7-26DE-4456-94B2-6B5A9F4931AD.pdf				1	1		10		0		10		0		10		10		70		70		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					External beam radiation	50	Primary Tumor	01	26.1		2009	YES	YES	NO	MY	Current Reformed Smoker, Duration Not Specified	7		cervical	A	LIVING	76	2013		263D2292-E1D0-4937-90C2-C733495AFF02		4b1da384-ab8a-4c6f-a76a-54ddc5314594	TCGA-MY-A913-01A-11D-A37M-01	4b1da384-ab8a-4c6f-a76a-54ddc5314594	TCGA-MY-A913-01A-11D-A37Q-05	TCGA-MY-A913-01A-11R-A37P-13		TCGA-MY-A913-01	4b1da384-ab8a-4c6f-a76a-54ddc5314594	ddfd22d5-31ef-4a04-bcd6-c84700484c67	4b1da384-ab8a-4c6f-a76a-54ddc5314594	ddfd22d5-31ef-4a04-bcd6-c84700484c67			TCGA-MY-A913-01	TCGA-MY-A913-01A-11D-A37M-01	
TCGA-PN-A8M9-01		TCGA-PN-A8M9-01			TCGA-PN-A8M9				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					34				Never Used												Stage IIA2		-12664					232					0	0			0								0							2014-3-25	FEMALE	171	Endometrioid Adenocarcinoma of Endocervix	No				Not applicable						YES		Biopsy (cervical / CT-guided / Other)	430	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			3		false			M0	N0	T2a2			HIV			1		2		0		5		0		20		15		60		60		Pre-Adjuvant Therapy	WITH TUMOR	NO		NO		No	NO							Primary Tumor	01			2009	NO	YES	NO	PN		4		cervical	A	LIVING	75	2013				c9ccb91c-8643-4642-8fa7-e49a945dd938		c9ccb91c-8643-4642-8fa7-e49a945dd938		TCGA-PN-A8M9-01A-21R-A36A-13			c9ccb91c-8643-4642-8fa7-e49a945dd938	3ab0755c-2d40-4d70-b197-eae74536d65c	c9ccb91c-8643-4642-8fa7-e49a945dd938	3ab0755c-2d40-4d70-b197-eae74536d65c					
TCGA-PN-A8MA-01	0	TCGA-PN-A8MA-01	90	0	TCGA-PN-A8MA			90	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Stable Disease		43		3	TCGA-PN-A8MA-F64853	Former User											Cisplatin	Stage IIB	50mg	-15918										0	90			90							Once weekly	1							2014-10-17	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	YES					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3										8					M0	N0	T2b					1																		during adjuvant therapy	Other	WITH TUMOR	YES		NO	Stable Disease	No	YES	Adverse event/complications				External beam radiation		Primary Tumor	01			2009	YES	YES	NO	PN		9		cervical		LIVING	71	2013				fa2cdebd-8b7c-452a-8191-994ceeb1e763	TCGA-PN-A8MA-01A-11D-A36I-01	fa2cdebd-8b7c-452a-8191-994ceeb1e763	TCGA-PN-A8MA-01A-11D-A36K-05	TCGA-PN-A8MA-01A-11R-A36A-13		TCGA-PN-A8MA-01	fa2cdebd-8b7c-452a-8191-994ceeb1e763	f22d5b86-dfd8-420a-8a41-66fe70c320ba	fa2cdebd-8b7c-452a-8191-994ceeb1e763	f22d5b86-dfd8-420a-8a41-66fe70c320ba			TCGA-PN-A8MA-01	TCGA-PN-A8MA-01A-11D-A36I-01	
TCGA-Q1-A5R1-01	0	TCGA-Q1-A5R1-01	474	0	TCGA-Q1-A5R1	474	0	474	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		32			TCGA-Q1-A5R1-F56897	Current User					ABSENT					Not done per treating physicians discretion		Stage IB1		-11705										0	474			474								0							2014-2-25	FEMALE	183	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C3.9	8482/3	C53.1	YES		Cytology (e.g. Peritoneal or pleural fluid)			Non-keratinizing squamous cell carcinoma	NO	4			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0	1					MX	N0	T1b1																							Post-operative	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO	Not done per treating physician discretion						Primary Tumor	01			2009	NO	YES	NO	Q1	Lifelong Non-smoker	2		cervical		LIVING	92	2012			TCGA-Q1-A5R1-01A-11D-A28B-09	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	TCGA-Q1-A5R1-01A-11D-A28A-01	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	TCGA-Q1-A5R1-01A-11D-A28C-05	TCGA-Q1-A5R1-01A-11R-A28L-13	TCGA-Q1-A5R1-01A-11D-A28B-09	TCGA-Q1-A5R1-01	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	af1e6e2f-12e4-4f0c-aac0-05889e0053f6	ca1c37f0-52c9-4702-87ea-1a81a09c12e8	af1e6e2f-12e4-4f0c-aac0-05889e0053f6	TCGA-Q1-A5R1-01A-11D-A28B-09	TCGA-Q1-A5R1-01A-11D-A28B-09	TCGA-Q1-A5R1-01	TCGA-Q1-A5R1-01A-11D-A28A-01	
TCGA-Q1-A5R2-01	0	TCGA-Q1-A5R2-01	499	0	TCGA-Q1-A5R2	499	0	499	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		64		6	TCGA-Q1-A5R2-F56898	Former User		300		HDR							Cisplatin			-23523					57					0	499			406							Once weekly	0							2014-2-25	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2		true			MX	NX	TX	TCGA-Q1-A5R2.D5BD3FE8-6CE0-41A1-A9CB-FE8874C4A16F.pdf							3		0		0		0		0		0		100		80	Post-operative	Other	TUMOR FREE	YES		NO		No	YES							Primary Tumor	01			7th	YES	YES	NO	Q1	Lifelong Non-smoker	2		cervical	A	LIVING	76	2012			TCGA-Q1-A5R2-01A-11D-A28B-09	e0dc1957-256a-4ffe-9521-66dd3970639c	TCGA-Q1-A5R2-01A-11D-A28A-01	e0dc1957-256a-4ffe-9521-66dd3970639c	TCGA-Q1-A5R2-01A-11D-A28C-05	TCGA-Q1-A5R2-01A-11R-A28L-13	TCGA-Q1-A5R2-01A-11D-A28B-09	TCGA-Q1-A5R2-01	e0dc1957-256a-4ffe-9521-66dd3970639c	2fad7360-d74b-426a-8f35-ceb215226c38	e0dc1957-256a-4ffe-9521-66dd3970639c	2fad7360-d74b-426a-8f35-ceb215226c38	TCGA-Q1-A5R2-01A-11D-A28B-09	TCGA-Q1-A5R2-01A-11D-A28B-09	TCGA-Q1-A5R2-01	TCGA-Q1-A5R2-01A-11D-A28A-01	
TCGA-Q1-A5R3-01	0	TCGA-Q1-A5R3-01	485	0	TCGA-Q1-A5R3	485	0	485	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		56			TCGA-Q1-A5R3-F56894	Former User		3000		HDR							Cisplatin			-20574					115					0	485			485								0							2014-2-25	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	420	NO	Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			3		true			MX	NX	TX	TCGA-Q1-A5R3.1E8B41FC-2317-4EEA-BDD8-40BC40D36BA6.pdf							4		0		0		0		0		0		100		80		Post-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES							Primary Tumor	01			7th	YES	YES	NO	Q1	Lifelong Non-smoker	5		cervical	A	LIVING	50	2012		677D93FA-9BC4-4BDC-A8E7-EC89133566BD	TCGA-Q1-A5R3-01A-11D-A28B-09	2807ba60-128f-49fc-9e15-bb3678c12f56	TCGA-Q1-A5R3-01A-11D-A28A-01	2807ba60-128f-49fc-9e15-bb3678c12f56	TCGA-Q1-A5R3-01A-11D-A28C-05	TCGA-Q1-A5R3-01A-11R-A28L-13	TCGA-Q1-A5R3-01A-11D-A28B-09	TCGA-Q1-A5R3-01	2807ba60-128f-49fc-9e15-bb3678c12f56	8e5da6ef-001a-4766-929e-c2d191616f06	2807ba60-128f-49fc-9e15-bb3678c12f56	8e5da6ef-001a-4766-929e-c2d191616f06	TCGA-Q1-A5R3-01A-11D-A28B-09	TCGA-Q1-A5R3-01A-11D-A28B-09	TCGA-Q1-A5R3-01	TCGA-Q1-A5R3-01A-11D-A28A-01	
TCGA-Q1-A6DT-01	1	TCGA-Q1-A6DT-01	275	1	TCGA-Q1-A6DT	275	0	275	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		55			TCGA-Q1-A6DT-F62826													Stage I		-20286						275				0	103																		2014-7-25	FEMALE		Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)			Non-keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO								MX	NX	TX		Cervical Cancer																							WITH TUMOR	NO		NO		No	NO							Primary Tumor	01			2009		YES	NO	Q1	Lifelong Non-smoker			cervical		DECEASED		2013			TCGA-Q1-A6DT-01A-11D-A32I-09	a11fe2cb-92b2-463c-873c-b179e1d352cd	TCGA-Q1-A6DT-01A-11D-A32H-01	a11fe2cb-92b2-463c-873c-b179e1d352cd	TCGA-Q1-A6DT-01A-11D-A32T-05	TCGA-Q1-A6DT-01A-11R-A32K-13	TCGA-Q1-A6DT-01A-11D-A32I-09	TCGA-Q1-A6DT-01	a11fe2cb-92b2-463c-873c-b179e1d352cd	ea7c33ff-961d-49c7-a6cc-4d9bdeaa251a	a11fe2cb-92b2-463c-873c-b179e1d352cd	ea7c33ff-961d-49c7-a6cc-4d9bdeaa251a	TCGA-Q1-A6DT-01A-11D-A32I-09	TCGA-Q1-A6DT-01A-11D-A32I-09	TCGA-Q1-A6DT-01	TCGA-Q1-A6DT-01A-11D-A32H-01	
TCGA-Q1-A6DV-01	0	TCGA-Q1-A6DV-01	491	0	TCGA-Q1-A6DV	491	0	491	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		36			TCGA-Q1-A6DV-F62827	Current User					ABSENT							Stage IB1		-13166					79					0	491			-12								0							2014-7-25	FEMALE	152	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C53.0	8482/3	C53.0	YES	Hysterectomy	Other method, specify:	80	NO	Non-keratinizing squamous cell carcinoma	NO	2			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	0	0			true			M0	N0	T1b1	TCGA-Q1-A6DV.B42DEC07-001A-4766-BFD6-DE67D04ABA65.pdf							15		5		0		5		10		30		60		60		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009	NO	YES	NO	Q1	Lifelong Non-smoker	0		cervical	A	LIVING	60	2013			TCGA-Q1-A6DV-01A-11D-A32I-09	432d3081-de85-448f-8499-2446b25af20c	TCGA-Q1-A6DV-01A-11D-A32H-01	432d3081-de85-448f-8499-2446b25af20c	TCGA-Q1-A6DV-01A-11D-A32T-05	TCGA-Q1-A6DV-01A-11R-A32K-13	TCGA-Q1-A6DV-01A-11D-A32I-09	TCGA-Q1-A6DV-01	432d3081-de85-448f-8499-2446b25af20c	afb2291e-8cf6-4040-b144-ef9368760171	432d3081-de85-448f-8499-2446b25af20c	afb2291e-8cf6-4040-b144-ef9368760171	TCGA-Q1-A6DV-01A-11D-A32I-09	TCGA-Q1-A6DV-01A-11D-A32I-09	TCGA-Q1-A6DV-01	TCGA-Q1-A6DV-01A-11D-A32H-01	
TCGA-Q1-A6DW-01	0	TCGA-Q1-A6DW-01	534	0	TCGA-Q1-A6DW	534	0	534	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44	35	5	TCGA-Q1-A6DW-F62829			2900		HDR	ABSENT						Cisplatin	Stage I	40mg	-16200					100					0	534			114							Once weekly	0							2014-7-25	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	2.5	true			MX	NX	TX	TCGA-Q1-A6DW.5C7158E0-E120-4D7C-A68D-FA3853507A83.pdf							5		5		5		5		0		35		60		60		Post-Adjuvant Therapy		YES		NO		No	YES							Primary Tumor	01		2009	2009	YES	YES	NO	Q1	Current reformed smoker for < or = 15 years	1		cervical	A	LIVING	62	2013		D724F57C-3058-4E1F-9B5F-F899F7388CF2	TCGA-Q1-A6DW-01A-11D-A32I-09	c564836c-e7fd-48cc-8896-7d18028039f7	TCGA-Q1-A6DW-01A-11D-A32H-01	c564836c-e7fd-48cc-8896-7d18028039f7	TCGA-Q1-A6DW-01A-11D-A32T-05	TCGA-Q1-A6DW-01A-11R-A32K-13	TCGA-Q1-A6DW-01A-11D-A32I-09	TCGA-Q1-A6DW-01	c564836c-e7fd-48cc-8896-7d18028039f7	51ac04d8-52fc-434c-861f-1dffa8e893b0	c564836c-e7fd-48cc-8896-7d18028039f7	51ac04d8-52fc-434c-861f-1dffa8e893b0	TCGA-Q1-A6DW-01A-11D-A32I-09	TCGA-Q1-A6DW-01A-11D-A32I-09	TCGA-Q1-A6DW-01	TCGA-Q1-A6DW-01A-11D-A32H-01	
TCGA-Q1-A73O-01	0	TCGA-Q1-A73O-01	428	0	TCGA-Q1-A73O	428	0	428	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		37		6	TCGA-Q1-A73O-F62831						ABSENT						Cisplatin	Stage IB2	40mg/m2	-13601					77					0	428			425							Once weekly	0							2014-7-25	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma	NO				ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					true			MX	NX	TX	TCGA-Q1-A73O.2D4BBE0A-11E4-46C1-8416-FA0E724B53FC.pdf							40		20		10		20		0		20		70		70	Post-surgery	Other	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES							Primary Tumor	01			2009	YES	YES	NO	Q1	Lifelong Non-smoker			cervical	A	LIVING	76	2013		FA37518B-8DC1-4510-8DF4-6E7021ECC8B5	TCGA-Q1-A73O-01A-11D-A32I-09	48ad4bbc-d720-43da-98a8-e002c69ff5aa	TCGA-Q1-A73O-01A-11D-A32H-01	48ad4bbc-d720-43da-98a8-e002c69ff5aa	TCGA-Q1-A73O-01A-11D-A32T-05	TCGA-Q1-A73O-01A-11R-A32K-13	TCGA-Q1-A73O-01A-11D-A32I-09	TCGA-Q1-A73O-01	48ad4bbc-d720-43da-98a8-e002c69ff5aa	fcacef72-32c4-45c5-832b-27050029bc36	48ad4bbc-d720-43da-98a8-e002c69ff5aa	fcacef72-32c4-45c5-832b-27050029bc36	TCGA-Q1-A73O-01A-11D-A32I-09	TCGA-Q1-A73O-01A-11D-A32I-09	TCGA-Q1-A73O-01	TCGA-Q1-A73O-01A-11D-A32H-01	
TCGA-Q1-A73P-01	0	TCGA-Q1-A73P-01	483	0	TCGA-Q1-A73P	483	0	483	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		45			TCGA-Q1-A73P-F62731	Former User					ABSENT							Stage IB1		-16450					92					0	483			295								0							2014-7-23	FEMALE	173	Endocervical Type of Adenocarcinoma	No						Radical Hysterectomy	C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	110	NO		NO	17			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	0	0	5		true			MX	N0	T1b	TCGA-Q1-A73P.5269DE35-6DEC-417C-B618-6F7717FFA55A.pdf							40		20		10		20		0		20		70		70	Post-surgery	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		YES	NO	Q1	Lifelong Non-smoker	6		cervical	A	LIVING	82	2013		0095AB4C-70E1-460B-AFEB-74AAB65D1E95	TCGA-Q1-A73P-01A-11D-A32I-09	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	TCGA-Q1-A73P-01A-11D-A32H-01	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	TCGA-Q1-A73P-01A-11D-A32T-05	TCGA-Q1-A73P-01A-11R-A32K-13	TCGA-Q1-A73P-01A-11D-A32I-09	TCGA-Q1-A73P-01	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	94f16ad1-b80c-4d2e-8711-3a6d0ff3eebf	265dd9bb-8b5e-4cad-a43e-f21ae0953f22	94f16ad1-b80c-4d2e-8711-3a6d0ff3eebf	TCGA-Q1-A73P-01A-11D-A32I-09	TCGA-Q1-A73P-01A-11D-A32I-09	TCGA-Q1-A73P-01	TCGA-Q1-A73P-01A-11D-A32H-01	
TCGA-Q1-A73Q-01	0	TCGA-Q1-A73Q-01	179	0	TCGA-Q1-A73Q	179	0	179	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					46	13	5				2900		HDR							Cisplatin	Stage I	40mg/m2	-16851					96					0	179			179							Once weekly	0	1						2013-10-31	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	1260	NO	Keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	3.3	true			MX	NX	TX	TCGA-Q1-A73Q.C29EC084-5A50-4007-B281-391965A67F43.pdf							40		20		10		20		0		20		70		70		Post-Adjuvant Therapy		YES		NO		No	YES							Primary Tumor	01			2009	YES	YES	NO	Q1	Current smoker	2		cervical	A	LIVING	87	2013		E7F7A921-F39C-4DB0-AC65-0A6AE9578FC6	TCGA-Q1-A73Q-01A-21D-A32I-09	c7f8cb76-3d15-41f0-8217-908db558eedc	TCGA-Q1-A73Q-01A-21D-A32H-01	c7f8cb76-3d15-41f0-8217-908db558eedc	TCGA-Q1-A73Q-01A-21D-A32T-05	TCGA-Q1-A73Q-01A-21R-A32K-13	TCGA-Q1-A73Q-01A-21D-A32I-09	TCGA-Q1-A73Q-01	c7f8cb76-3d15-41f0-8217-908db558eedc	570debcf-ac39-4d93-9cd7-e9f65f7ac8d0	c7f8cb76-3d15-41f0-8217-908db558eedc	570debcf-ac39-4d93-9cd7-e9f65f7ac8d0	TCGA-Q1-A73Q-01A-21D-A32I-09	TCGA-Q1-A73Q-01A-21D-A32I-09	TCGA-Q1-A73Q-01	TCGA-Q1-A73Q-01A-21D-A32H-01	
TCGA-Q1-A73R-01	0	TCGA-Q1-A73R-01	190	0	TCGA-Q1-A73R	190	0	190	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					45																Stage I		-16701					118					0	190			190								0							2013-10-31	FEMALE	155	Endocervical Type of Adenocarcinoma	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	580	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					true			MX	NX	TX	TCGA-Q1-A73R.2294E1F2-FA18-4E80-A7C8-F7089B24298A.pdf							1		1		5		1		20		15		60		60		Post-Adjuvant Therapy		NO		NO		No	NO							Primary Tumor	01			2009		YES	NO	Q1	Lifelong Non-smoker			cervical	A	LIVING	95	2013		6922055B-2C39-4A60-80D9-ADF3269CD2DB	TCGA-Q1-A73R-01A-11D-A33O-09	a661f07b-e207-4221-b9f2-a5704be3650b	TCGA-Q1-A73R-01A-11D-A33N-01	a661f07b-e207-4221-b9f2-a5704be3650b	TCGA-Q1-A73R-01A-11D-A340-05	TCGA-Q1-A73R-01A-11R-A342-13	TCGA-Q1-A73R-01A-11D-A33O-09	TCGA-Q1-A73R-01	a661f07b-e207-4221-b9f2-a5704be3650b	518aba19-7e1c-4de6-8a19-546756ccd479	a661f07b-e207-4221-b9f2-a5704be3650b	518aba19-7e1c-4de6-8a19-546756ccd479	TCGA-Q1-A73R-01A-11D-A33O-09	TCGA-Q1-A73R-01A-11D-A33O-09	TCGA-Q1-A73R-01	TCGA-Q1-A73R-01A-11D-A33N-01	
TCGA-Q1-A73S-01	0	TCGA-Q1-A73S-01	316	0	TCGA-Q1-A73S	316	0	316	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					33	19	6		Former User					PRESENT						Cisplatin	Stage IB1	40mg/m2	-12229					232					0	316			316							Once weekly	0							2013-10-31	FEMALE	160	Adenosquamous	No						Radical Hysterectomy		8560/3	C53.9	YES	Hysterectomy	Other method, specify:	490	NO	Non-keratinizing squamous cell carcinoma		18	Other Location, specify	Obturator	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	2	0	2	7.5	true			MX	N1	T1b1	TCGA-Q1-A73S.264F3D75-C462-4904-8AFB-2D18B0A59CB7.pdf							1		1		5		1		0		15		80		80		Post-Adjuvant Therapy		YES		YES		No	YES							Primary Tumor	01		2012	2009	YES	YES	NO	Q1	Current reformed smoker for < or = 15 years	4		cervical	A	LIVING	68	2012		8338B88E-C70C-435A-B4A1-F7D869485F60	TCGA-Q1-A73S-01A-11D-A33O-09	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	TCGA-Q1-A73S-01A-11D-A33N-01	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	TCGA-Q1-A73S-01A-11D-A340-05	TCGA-Q1-A73S-01A-11R-A342-13	TCGA-Q1-A73S-01A-11D-A33O-09	TCGA-Q1-A73S-01	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	8c9646ab-ac17-4f4b-8d17-65d8b9f3d784	22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20	8c9646ab-ac17-4f4b-8d17-65d8b9f3d784	TCGA-Q1-A73S-01A-11D-A33O-09	TCGA-Q1-A73S-01A-11D-A33O-09	TCGA-Q1-A73S-01	TCGA-Q1-A73S-01A-11D-A33N-01	
TCGA-R2-A69V-01	0	TCGA-R2-A69V-01	596	0	TCGA-R2-A69V	596	0	596	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					42						4500		HDR	ABSENT						Cisplatin	Stage IB		-15479					548				15	0	596															Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2013-7-15	FEMALE	157	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cytology (e.g. Peritoneal or pleural fluid)	780	NO	Non-keratinizing squamous cell carcinoma		18			PRESENT	Peri (6-12 months since last menstrual period)	G3							NO	0	0	1		false			M0	N0	T1b	TCGA-R2-A69V.13EE4EE8-9C51-4EBC-9562-7233A148810B.pdf							40		20		10		20		0		30		60		60			TUMOR FREE	YES		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	YES	YES	NO	R2	Lifelong Non-smoker			cervical	A	LIVING	116	2011		C070ECB0-DB6E-46BD-8B6F-80795F0B65E2	TCGA-R2-A69V-01A-11D-A32I-09	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	TCGA-R2-A69V-01A-11D-A32H-01	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	TCGA-R2-A69V-01A-11D-A32T-05	TCGA-R2-A69V-01A-11R-A32K-13	TCGA-R2-A69V-01A-11D-A32I-09	TCGA-R2-A69V-01	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	fb03a12d-6050-49b1-86df-3c6a02b3421f	74b2fff7-243f-4eb5-9c67-2ab77b3ca059	fb03a12d-6050-49b1-86df-3c6a02b3421f	TCGA-R2-A69V-01A-11D-A32I-09	TCGA-R2-A69V-01A-11D-A32I-09	TCGA-R2-A69V-01	TCGA-R2-A69V-01A-11D-A32H-01	
TCGA-RA-A741-01	0	TCGA-RA-A741-01	118	0	TCGA-RA-A741	118	0	118	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					34	21	6				5500		HDR							Cisplatin	Stage IIB	40 MG/M2	-12607					22		-15	14		0	118			0					Pelvic Nodes Absent|	Bladder AbsentParametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|	Once weekly	0	0						2013-11-13	FEMALE	165	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	180	NO	Non-keratinizing squamous cell carcinoma		4	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO	0	0	0	10	false						TCGA-RA-A741.4CC49B26-FA09-4B3C-BB2F-236914852C7A.pdf				0	0		40		20		10		20		0		5		85		85		Preoperative		YES	0	YES		No	YES					IMRT	4500	Primary Tumor	01		2013	2009	YES	YES	NO	RA	Current reformed smoker for < or = 15 years	0		cervical	A	LIVING	86	2013		B1B3C261-B418-4B28-AAEA-749C4370A347	TCGA-RA-A741-01A-11D-A33O-09	58e01e27-fe36-4ee7-9560-f668bf6dcb48	TCGA-RA-A741-01A-11D-A33N-01	58e01e27-fe36-4ee7-9560-f668bf6dcb48	TCGA-RA-A741-01A-11D-A340-05	TCGA-RA-A741-01A-11R-A342-13	TCGA-RA-A741-01A-11D-A33O-09	TCGA-RA-A741-01	58e01e27-fe36-4ee7-9560-f668bf6dcb48	6d2ffa68-2020-4d96-831d-b164f95cc439	58e01e27-fe36-4ee7-9560-f668bf6dcb48	6d2ffa68-2020-4d96-831d-b164f95cc439	TCGA-RA-A741-01A-11D-A33O-09	TCGA-RA-A741-01A-11D-A33O-09	TCGA-RA-A741-01	TCGA-RA-A741-01A-11D-A33N-01	
TCGA-UC-A7PD-01	1	TCGA-UC-A7PD-01	355	1	TCGA-UC-A7PD			355	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					21	13			Former User			vaginal implant	Other			perineural space invasion	Other Location, specify				Stage IB		-7855					6036	355				0				-1								1	0						2014-2-4	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES	tumor resection	Other method, specify:	40	NO	Keratinizing squamous cell carcinoma		11			PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0	0	4	1.75	true			M0	N0	T1b	TCGA-UC-A7PD.E48CD4E1-FBC6-48AB-BACD-26AA3BC252D9.pdf	Cervical Cancer			0	1		2		0		0		0		5		10		85		85		Preoperative	WITH TUMOR	NO	0	YES	Complete Remission/Response	No	YES					External beam radiation		Primary Tumor	01			1995	NO	NO	YES	UC	Current smoker	5		cervical	A	DECEASED		1997			TCGA-UC-A7PD-01A-11D-A351-09	be979660-2d11-4707-9c74-b1222c7cb56e	TCGA-UC-A7PD-01A-11D-A350-01	be979660-2d11-4707-9c74-b1222c7cb56e	TCGA-UC-A7PD-01A-11D-A357-05	TCGA-UC-A7PD-01A-11R-A358-13	TCGA-UC-A7PD-01A-11D-A351-09	TCGA-UC-A7PD-01	be979660-2d11-4707-9c74-b1222c7cb56e	04f4e35d-a0d5-4254-9407-0b42427c4a4e	be979660-2d11-4707-9c74-b1222c7cb56e	04f4e35d-a0d5-4254-9407-0b42427c4a4e	TCGA-UC-A7PD-01A-11D-A351-09	TCGA-UC-A7PD-01A-11D-A351-09	TCGA-UC-A7PD-01	TCGA-UC-A7PD-01A-11D-A350-01	
TCGA-UC-A7PF-01	1	TCGA-UC-A7PF-01	2859	1	TCGA-UC-A7PF			2859	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44									PRESENT							Stage IB1		-16412					5050	2859				0													2						2014-2-4	FEMALE		Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Cone Biopsy / LEEP	210	NO			30	Pelvic (external iliac, internal iliac, obturator)|Other Location, specify	anterior parametrium	PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2								5		2		true			M0	N1	T1b1	TCGA-UC-A7PF.EF390F2F-A13F-4661-86C6-2679E4FAEE72.pdf				0	0		70		10		10		10		0		30		60		60					0	YES		No								Primary Tumor	01			2009		NO	YES	UC	Current smoker	4		cervical	A	DECEASED	210	1999		1F3D85EE-2B7F-4EDF-B976-4471D4AE5C08	TCGA-UC-A7PF-01A-11D-A351-09	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	TCGA-UC-A7PF-01A-11D-A350-01	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	TCGA-UC-A7PF-01A-11D-A357-05	TCGA-UC-A7PF-01A-11R-A358-13	TCGA-UC-A7PF-01A-11D-A351-09	TCGA-UC-A7PF-01	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	7cca71cd-228c-4af7-9dd9-4edf5635e8fb	abb75efe-7d8f-4d43-a04b-8a97f2eda7b8	7cca71cd-228c-4af7-9dd9-4edf5635e8fb	TCGA-UC-A7PF-01A-11D-A351-09	TCGA-UC-A7PF-01A-11D-A351-09	TCGA-UC-A7PF-01	TCGA-UC-A7PF-01A-11D-A350-01	
TCGA-UC-A7PG-01	1	TCGA-UC-A7PG-01	370	1	TCGA-UC-A7PG	370	0	370	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44	18	6				4400		HDR							Cisplatin	Stage IIIB		-16231					3610	370	-54			0				-10					|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2014-7-17	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	20	NO	Non-keratinizing squamous cell carcinoma		9	Pelvic (external iliac, internal iliac, obturator)|Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	8	0	3	52	true			MX	N1	T3b	TCGA-UC-A7PG.AB821E7F-7CED-4191-A82D-B411A7C1AA45.pdf	Cervical Cancer			0	2		40		20		0		20		20		20		60		60		Preoperative	WITH TUMOR	YES	0	YES	Progressive Disease	No	YES			external beam and bilateral parametrial boost		Other	5400	Primary Tumor	01			1995	YES	NO	YES	UC	Current smoker	5		cervical	A	DECEASED	82	2003				13b94e1c-6bd0-420f-bf57-c14c91e8f28e	TCGA-UC-A7PG-01A-11D-A42N-01	13b94e1c-6bd0-420f-bf57-c14c91e8f28e	TCGA-UC-A7PG-01A-11D-A42P-05	TCGA-UC-A7PG-01A-11R-A42U-13			13b94e1c-6bd0-420f-bf57-c14c91e8f28e	c6364b2e-7fb9-4c8e-b819-b28934b68a81	13b94e1c-6bd0-420f-bf57-c14c91e8f28e	c6364b2e-7fb9-4c8e-b819-b28934b68a81				TCGA-UC-A7PG-01A-11D-A42N-01	
TCGA-UC-A7PG-06	1	TCGA-UC-A7PG-06	370	1	TCGA-UC-A7PG	370	0	370	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					44	18	6				4400		HDR							Cisplatin	Stage IIIB		-16231					3610	370	-54			0				-10					|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2014-7-17	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO	Non-keratinizing squamous cell carcinoma		9	Pelvic (external iliac, internal iliac, obturator)|Common iliac		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO	8	0	3	52	true			MX	N1	T3b		Cervical Cancer			0	2		40		20		0		20		0		20		80		80		Preoperative	WITH TUMOR	YES	0	YES	Progressive Disease	No	YES			external beam and bilateral parametrial boost		Other	5400	Metastatic	06			1995	YES	NO	YES	UC	Current smoker	5		cervical	A	DECEASED	82	2003				22727b4c-d2ab-4ebf-a681-d2dd20eb4f43		22727b4c-d2ab-4ebf-a681-d2dd20eb4f43	TCGA-UC-A7PG-06A-11D-A42P-05	TCGA-UC-A7PG-06A-11R-A42U-13			22727b4c-d2ab-4ebf-a681-d2dd20eb4f43	caf81b43-15ba-4755-a146-ae86ee8fbca9	22727b4c-d2ab-4ebf-a681-d2dd20eb4f43	caf81b43-15ba-4755-a146-ae86ee8fbca9					
TCGA-UC-A7PI-01	0	TCGA-UC-A7PI-01	2009	0	TCGA-UC-A7PI	737	1	2009	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	YES	Complete Response		45		6	TCGA-UC-A7PI-F66695	Former User					ABSENT						Cisplatin	Stage IB1	40 mg/m(2)	-16468					1606		-16			0	2009	758	737	-14					|Extra-Pelvic Metastatic Disease AbsentParaaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent		Once weekly	1	0						2014-10-27	FEMALE		Endometrioid Adenocarcinoma of Endocervix	No						Radical Hysterectomy		8380/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO		NO	47			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1	Other, specify			Locoregional Recurrence		YES	YES	0		0		true			MX	N0	T1b1	TCGA-UC-A7PI.9FA775F9-4A52-498E-93B3-BAEE344324CC.pdf				0	1		3		0		0		0		0		0		100		65		Preoperative	TUMOR FREE	YES	0	YES	Complete Remission/Response	No	YES				R0	External beam radiation	5400	Primary Tumor	01			2009	YES	NO	YES	UC	Lifelong Non-smoker	1		cervical	A	LIVING	64	2009				110bcd0d-95b5-4387-bfa3-837fbde32085	TCGA-UC-A7PI-01A-11D-A42N-01	110bcd0d-95b5-4387-bfa3-837fbde32085	TCGA-UC-A7PI-01A-11D-A42P-05	TCGA-UC-A7PI-01A-11R-A42U-13			110bcd0d-95b5-4387-bfa3-837fbde32085	6f139966-c340-4006-a32e-455bfa6d1c71	110bcd0d-95b5-4387-bfa3-837fbde32085	6f139966-c340-4006-a32e-455bfa6d1c71				TCGA-UC-A7PI-01A-11D-A42N-01	
TCGA-VS-A8EB-01	1	TCGA-VS-A8EB-01	305	1	TCGA-VS-A8EB	305	0	305	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					41		4		Never Used											Cisplatin	Stage IIIB		-15215					1189	305				0				28							Once weekly	1							2014-4-22	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			3		false			M1	NX	T3b	TCGA-VS-A8EB.ED146C1D-315F-4628-A529-62D235938DFF.pdf	Cervical Cancer			1			5		0		0		0		10		10		80		80		Pre-Adjuvant Therapy	WITH TUMOR	NO			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	4		cervical	A	DECEASED	64	2010				69e3b16b-5515-416b-808a-0321a107e5c0	TCGA-VS-A8EB-01A-11D-A36I-01	69e3b16b-5515-416b-808a-0321a107e5c0	TCGA-VS-A8EB-01A-11D-A36K-05	TCGA-VS-A8EB-01A-11R-A36A-13		TCGA-VS-A8EB-01	69e3b16b-5515-416b-808a-0321a107e5c0	37639acb-158f-4ab2-b915-13511bffae44	69e3b16b-5515-416b-808a-0321a107e5c0	37639acb-158f-4ab2-b915-13511bffae44			TCGA-VS-A8EB-01	TCGA-VS-A8EB-01A-11D-A36I-01	
TCGA-VS-A8EC-01	0	TCGA-VS-A8EC-01	1232	0	TCGA-VS-A8EC	1232	0	1232	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		55			TCGA-VS-A8EC-F67671	Former User												Stage IIIB		-20286										0	1232			46								1							2014-11-9	FEMALE	154	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	G2							NO			3					M0	NX	T3b					1																				TUMOR FREE	YES			Partial Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS		4		cervical		LIVING	46	2011				f00b3401-8432-4748-8d19-267e945cd3c0	TCGA-VS-A8EC-01A-11D-A36I-01	f00b3401-8432-4748-8d19-267e945cd3c0	TCGA-VS-A8EC-01A-11D-A36K-05	TCGA-VS-A8EC-01A-11R-A36A-13		TCGA-VS-A8EC-01	f00b3401-8432-4748-8d19-267e945cd3c0	bee1084d-680e-452b-8eb6-25b2235c570f	f00b3401-8432-4748-8d19-267e945cd3c0	bee1084d-680e-452b-8eb6-25b2235c570f			TCGA-VS-A8EC-01	TCGA-VS-A8EC-01A-11D-A36I-01	
TCGA-VS-A8EG-01	0	TCGA-VS-A8EG-01	1149	0	TCGA-VS-A8EG	1149	0	1149	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		36			TCGA-VS-A8EG-F67670	Current User		2800		HDR								Stage IB1		-13166										0	1149			76								0							2014-11-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Peri (6-12 months since last menstrual period)	GX							NO			4					M0	NX	T1b1					1																			Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	5		cervical		LIVING	66	2011				aa91c19b-008d-497a-8121-a06cf9dc7b29	TCGA-VS-A8EG-01A-11D-A36I-01	aa91c19b-008d-497a-8121-a06cf9dc7b29	TCGA-VS-A8EG-01A-11D-A36K-05	TCGA-VS-A8EG-01A-11R-A36A-13		TCGA-VS-A8EG-01	aa91c19b-008d-497a-8121-a06cf9dc7b29	a07ed44e-0a4b-4b1a-b70e-ce68c1cb4231	aa91c19b-008d-497a-8121-a06cf9dc7b29	a07ed44e-0a4b-4b1a-b70e-ce68c1cb4231			TCGA-VS-A8EG-01	TCGA-VS-A8EG-01A-11D-A36I-01	
TCGA-VS-A8EH-01	0	TCGA-VS-A8EH-01	804	0	TCGA-VS-A8EH	804	0	804	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		56	39	4	TCGA-VS-A8EH-F67675	Never Used		2400		HDR						Adverse event/ complications	Cisplatin	Stage IIIB		-20728					507					0	804			804							Once weekly	1							2014-11-9	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Peri (6-12 months since last menstrual period)	G2							NO			4	3	false			M0	NX	T3b	TCGA-VS-A8EH.0CC29204-715D-465B-8F93-7DE27B85FD5F.pdf							5		0		0		0		0		15		85		85	Follow up	Other	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	4		cervical	A	LIVING	44	2012				9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	TCGA-VS-A8EH-01A-11D-A36I-01	9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	TCGA-VS-A8EH-01A-11D-A36K-05	TCGA-VS-A8EH-01A-11R-A36A-13		TCGA-VS-A8EH-01	9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	9eb3a0d7-db6a-4927-9c85-6194086f4fb7	9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a	9eb3a0d7-db6a-4927-9c85-6194086f4fb7			TCGA-VS-A8EH-01	TCGA-VS-A8EH-01A-11D-A36I-01	
TCGA-VS-A8EI-01	0	TCGA-VS-A8EI-01	549	0	TCGA-VS-A8EI	549	0	549	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		38		6	TCGA-VS-A8EI-F67687	Never Used		2800		HDR							Cisplatin	Stage IIB		-14129										0	549			549							Once weekly	0							2014-11-9	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			4					M0	NX	T3b																							Follow up	Other	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical		LIVING	58	2012				a32d716b-4fc9-4451-9106-b4c7cda9bfc1	TCGA-VS-A8EI-01A-11D-A37M-01	a32d716b-4fc9-4451-9106-b4c7cda9bfc1	TCGA-VS-A8EI-01A-11D-A37Q-05	TCGA-VS-A8EI-01A-11R-A37P-13		TCGA-VS-A8EI-01	a32d716b-4fc9-4451-9106-b4c7cda9bfc1	eededb2a-6f5f-4b5d-b6ba-425871c7ac13	a32d716b-4fc9-4451-9106-b4c7cda9bfc1	eededb2a-6f5f-4b5d-b6ba-425871c7ac13			TCGA-VS-A8EI-01	TCGA-VS-A8EI-01A-11D-A37M-01	
TCGA-VS-A8EJ-01	1	TCGA-VS-A8EJ-01	607	1	TCGA-VS-A8EJ	607	0	607	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					60		4				2700		HDR							Cisplatin	Stage IIB		-22000					1771	607				0				0							Once weekly	0							2014-4-22	FEMALE	167	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			3		false			M1	NX	T2b	TCGA-VS-A8EJ.92D067E8-1E5A-46B6-90BD-4DF9782CCA32.pdf	Cervical Cancer						20		20		20		40		0		10		70		70		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	DECEASED	113	2008				fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	TCGA-VS-A8EJ-01A-11D-A37M-01	fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	TCGA-VS-A8EJ-01A-11D-A37Q-05	TCGA-VS-A8EJ-01A-11R-A37P-13		TCGA-VS-A8EJ-01	fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	7bd324d6-ed82-4278-a102-5f0008b57ae1	fc6c05b9-e904-4c4e-b26a-65b4ac455cf1	7bd324d6-ed82-4278-a102-5f0008b57ae1			TCGA-VS-A8EJ-01	TCGA-VS-A8EJ-01A-11D-A37M-01	
TCGA-VS-A8EK-01	1	TCGA-VS-A8EK-01	829	1	TCGA-VS-A8EK	829	0	829	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					65		7													Cisplatin	Stage IVA		-23817					1784	829				0				58							Once weekly	0							2014-4-22	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO								G2							NO			5		false			M0	NX	T4	TCGA-VS-A8EK.C5B99AC6-E318-4608-8E70-96176F97EF90.pdf	Cervical Cancer			1			40		20		10		20		0		30		60		60		Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS		6		cervical	A	DECEASED	50	2008		18D2E64E-B473-4594-BECE-25C028266FA4		8d5e2fac-878b-440c-a19b-09c972b840ac		8d5e2fac-878b-440c-a19b-09c972b840ac	TCGA-VS-A8EK-01A-12D-A37Q-05	TCGA-VS-A8EK-01A-12R-A37P-13			8d5e2fac-878b-440c-a19b-09c972b840ac		8d5e2fac-878b-440c-a19b-09c972b840ac				TCGA-VS-A8EK-01		
TCGA-VS-A8EL-01	0	TCGA-VS-A8EL-01	1810	0	TCGA-VS-A8EL	1810	0	1810	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		38		5	TCGA-VS-A8EL-F67669	Former User		2800		HDR							Cisplatin	Stage IIB		-14162					1589					0	1810			-9							Once weekly	1							2014-11-9	FEMALE	166	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		false			M0	NX	T2b	TCGA-VS-A8EL.14765542-0003-41A9-8863-BDC90E87594D.pdf							20		20		10		40		0		10		80		80		Preoperative	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING	78	2009				79a31785-793f-4878-8c09-64c8fb0c53e3	TCGA-VS-A8EL-01A-11D-A37M-01	79a31785-793f-4878-8c09-64c8fb0c53e3	TCGA-VS-A8EL-01A-11D-A37Q-05	TCGA-VS-A8EL-01A-11R-A37P-13		TCGA-VS-A8EL-01	79a31785-793f-4878-8c09-64c8fb0c53e3	351d7039-1d0c-4fb1-9834-c2b3aad2fcbb	79a31785-793f-4878-8c09-64c8fb0c53e3	351d7039-1d0c-4fb1-9834-c2b3aad2fcbb			TCGA-VS-A8EL-01	TCGA-VS-A8EL-01A-11D-A37M-01	
TCGA-VS-A8Q8-01	1	TCGA-VS-A8Q8-01	978	1	TCGA-VS-A8Q8			978	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					26				Former User												Stage IB		-9571					1348	978				0				-84								0							2014-3-31	FEMALE	166	Cervical Squamous Cell Carcinoma	No					Radical trachelectomy and pelvic lymphadenectomy	Other	C53.9	8070/3	C53.9	YES	Surgery	Other method, specify:	60	NO			11			ABSENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES	0				false			MX	N0	T1b	TCGA-VS-A8Q8.DF0B7CA7-20B3-45CE-A25D-D4F622AF9C9B.pdf	Cervical Cancer						40		20		5		20		0		25		70		70		Preoperative	WITH TUMOR	NO		YES	Progressive Disease	No	YES					3D conformal		Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	0		cervical	A	DECEASED	92	2010				4601c9ab-da58-46f4-a875-5ef03727b756	TCGA-VS-A8Q8-01A-11D-A37M-01	4601c9ab-da58-46f4-a875-5ef03727b756	TCGA-VS-A8Q8-01A-11D-A37Q-05	TCGA-VS-A8Q8-01A-11R-A37P-13		TCGA-VS-A8Q8-01	4601c9ab-da58-46f4-a875-5ef03727b756	31d054fb-991f-40f3-80e6-4b464a97be9e	4601c9ab-da58-46f4-a875-5ef03727b756	31d054fb-991f-40f3-80e6-4b464a97be9e			TCGA-VS-A8Q8-01	TCGA-VS-A8Q8-01A-11D-A37M-01	
TCGA-VS-A8Q9-01	0	TCGA-VS-A8Q9-01	1400	0	TCGA-VS-A8Q9	1400	0	1400	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					79						2700		HDR								Stage IB1		-28881										0	1400			90								1							2014-3-30	FEMALE	150	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			8					MX	NX	TX					4																			Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	12		cervical		LIVING	49	2010				c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	TCGA-VS-A8Q9-01A-12D-A37M-01	c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	TCGA-VS-A8Q9-01A-12D-A37Q-05	TCGA-VS-A8Q9-01A-12R-A37P-13		TCGA-VS-A8Q9-01	c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	bb6746e5-effc-46fa-8da2-13d813de6047	c43ed784-3bfe-4485-8dd9-cee08f8c0fa8	bb6746e5-effc-46fa-8da2-13d813de6047			TCGA-VS-A8Q9-01	TCGA-VS-A8Q9-01A-12D-A37M-01	
TCGA-VS-A8QA-01	0	TCGA-VS-A8QA-01	1099	0	TCGA-VS-A8QA	1099	0	1099	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		44			TCGA-VS-A8QA-F67672									Positive vaginal margin				Stage IB1		-16072										0	1099			0								0							2014-11-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8070/3	C55.9	YES		Biopsy (cervical / CT-guided / Other)				NO	26				Peri (6-12 months since last menstrual period)	GX							NO	0	0	2					MX	N0	T1b1																								Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	2		cervical		LIVING	67	2011				ca559bd7-454b-463c-9751-1f772f738599	TCGA-VS-A8QA-01A-11D-A37M-01	ca559bd7-454b-463c-9751-1f772f738599	TCGA-VS-A8QA-01A-11D-A37Q-05	TCGA-VS-A8QA-01A-11R-A37P-13		TCGA-VS-A8QA-01	ca559bd7-454b-463c-9751-1f772f738599	a516f3f7-5d71-4e60-aada-90661d995b72	ca559bd7-454b-463c-9751-1f772f738599	a516f3f7-5d71-4e60-aada-90661d995b72			TCGA-VS-A8QA-01	TCGA-VS-A8QA-01A-11D-A37M-01	
TCGA-VS-A8QC-01	1	TCGA-VS-A8QC-01	350	1	TCGA-VS-A8QC			350	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51		5													Cisplatin	Stage IVA		-18743					1768	350				0				-1							Once weekly	2							2014-3-30	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO							Peri (6-12 months since last menstrual period)	G2							YES			7		false			MX	NX	TX	TCGA-VS-A8QC.2A1AB5DB-9963-41C6-B28F-1A26D149930C.pdf	Cervical Cancer						40		20		5		20		0		25		70		70		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	7		cervical	A	DECEASED	90	2009				cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	TCGA-VS-A8QC-01A-11D-A37M-01	cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	TCGA-VS-A8QC-01A-11D-A37Q-05	TCGA-VS-A8QC-01A-11R-A37P-13		TCGA-VS-A8QC-01	cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	0d42ae63-dbd7-4cb7-93e0-d50c61b7cda9	cad09fcd-1d43-4fb4-8d65-6f52c9a17d86	0d42ae63-dbd7-4cb7-93e0-d50c61b7cda9			TCGA-VS-A8QC-01	TCGA-VS-A8QC-01A-11D-A37M-01	
TCGA-VS-A8QF-01	0	TCGA-VS-A8QF-01	1617	0	TCGA-VS-A8QF	1617	0	1617	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		42	12	4	TCGA-VS-A8QF-F67683			2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-15374					1399					0	1617			92							Once weekly	0							2014-11-9	FEMALE	159	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			5		false			MX	NX	TX	TCGA-VS-A8QF.9E014162-B8BD-4DDD-9E8C-A1D18A6A8A7A.pdf							5		0		0		2		10		10		80		80		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01		2010	2009	YES	NO	YES	VS	Current reformed smoker for < or = 15 years	5		cervical	A	LIVING	68	2010		AFE9BCB4-EE5E-426D-87FF-0F823DDF7351		151ea5c1-80f3-473f-af58-f43df84879f2	TCGA-VS-A8QF-01A-21D-A37M-01	151ea5c1-80f3-473f-af58-f43df84879f2	TCGA-VS-A8QF-01A-21D-A37Q-05	TCGA-VS-A8QF-01A-21R-A37P-13		TCGA-VS-A8QF-01	151ea5c1-80f3-473f-af58-f43df84879f2	a94dc00e-54ef-4523-8df1-d077dabaa0f7	151ea5c1-80f3-473f-af58-f43df84879f2	a94dc00e-54ef-4523-8df1-d077dabaa0f7			TCGA-VS-A8QF-01	TCGA-VS-A8QF-01A-21D-A37M-01	
TCGA-VS-A8QH-01	1	TCGA-VS-A8QH-01	1210	1	TCGA-VS-A8QH	1210	0	1210	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					76		3|3						HDR						Adverse event/ complications	Other|Other	Stage IB1		-27909						1210				0				-1							Once weekly|Once weekly	0							2014-3-30	FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)									Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			3				Cisplatin|Gemcitabine	MX	NX	TX		Cervical Cancer			1																			Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical		DECEASED	73	2010				b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	TCGA-VS-A8QH-01A-11D-A37M-01	b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	TCGA-VS-A8QH-01A-11D-A37Q-05	TCGA-VS-A8QH-01A-11R-A37P-13		TCGA-VS-A8QH-01	b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	c4fcdeaf-b845-4eaa-9303-b2bc89b8a0d1	b21b7604-5292-4f80-b0d9-8a99b9c0c1a6	c4fcdeaf-b845-4eaa-9303-b2bc89b8a0d1			TCGA-VS-A8QH-01	TCGA-VS-A8QH-01A-11D-A37M-01	
TCGA-VS-A8QM-01	1	TCGA-VS-A8QM-01	951	1	TCGA-VS-A8QM	951	0	951	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					47	15	3|3												Adverse event/ complications	Cisplatin|Other	Stage IVB		-17168					1422	951				0				-334							Once weekly|Once weekly	0							2014-4-1	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO								GX							NO			3	16	false		|Fluorouracil	M1	NX	TX	TCGA-VS-A8QM.83522ECF-2552-4708-9311-A15C53D436C9.pdf	Cervical Cancer			1			8		1		5		2		15		20		60		60		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	4		cervical	A	DECEASED	53	2009				babc730d-6170-4503-8502-d794575fe993	TCGA-VS-A8QM-01A-11D-A37M-01	babc730d-6170-4503-8502-d794575fe993	TCGA-VS-A8QM-01A-11D-A37Q-05	TCGA-VS-A8QM-01A-11R-A37P-13		TCGA-VS-A8QM-01	babc730d-6170-4503-8502-d794575fe993	26653bdc-9081-45ed-a02c-c6be410e85f9	babc730d-6170-4503-8502-d794575fe993	26653bdc-9081-45ed-a02c-c6be410e85f9			TCGA-VS-A8QM-01	TCGA-VS-A8QM-01A-11D-A37M-01	
TCGA-VS-A94W-01	0	TCGA-VS-A94W-01	1103	0	TCGA-VS-A94W	1103	0	1103	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		39		5	TCGA-VS-A94W-F67673	Never Used		2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-14399										0	1103			1103							Once weekly	1							2014-11-9	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO	47	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO	1		2					MX	N1	T2b																							Last contact	Other	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	2		cervical		LIVING	79	2011				f99240d0-32ea-438a-b350-862202b18a30	TCGA-VS-A94W-01A-12D-A37M-01	f99240d0-32ea-438a-b350-862202b18a30	TCGA-VS-A94W-01A-12D-A37Q-05	TCGA-VS-A94W-01A-12R-A37P-13		TCGA-VS-A94W-01	f99240d0-32ea-438a-b350-862202b18a30	f2642857-0764-41e4-8261-719b7c227b36	f99240d0-32ea-438a-b350-862202b18a30	f2642857-0764-41e4-8261-719b7c227b36			TCGA-VS-A94W-01	TCGA-VS-A94W-01A-12D-A37M-01	
TCGA-VS-A94X-01	1	TCGA-VS-A94X-01	506	1	TCGA-VS-A94X	506	0	506	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					40		5				2800		HDR							Cisplatin	Stage IIB		-14955					1281	506				0				0							Once weekly	0							2014-5-21	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO								G2							NO			3		false			MX	NX	T2b	TCGA-VS-A94X.434AA106-443D-4A8E-93AD-14DFFD8A2B76.pdf	Cervical Cancer						40		20		10		20		0		20		70		70		Pre-Adjuvant Therapy	WITH TUMOR	YES		NO	Partial Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	DECEASED	42	2010		94F1E446-754F-4DBB-A416-2551278C763F		7626194c-9fc3-4b7f-a759-2834583f3890	TCGA-VS-A94X-01A-11D-A386-01	7626194c-9fc3-4b7f-a759-2834583f3890	TCGA-VS-A94X-01A-11D-A388-05	TCGA-VS-A94X-01A-11R-A38M-13		TCGA-VS-A94X-01	7626194c-9fc3-4b7f-a759-2834583f3890	1a939a8d-16d6-4edb-8661-76fa94015f80	7626194c-9fc3-4b7f-a759-2834583f3890	1a939a8d-16d6-4edb-8661-76fa94015f80			TCGA-VS-A94X-01	TCGA-VS-A94X-01A-11D-A386-01	
TCGA-VS-A94Y-01	1	TCGA-VS-A94Y-01	144	1	TCGA-VS-A94Y	144	0	144	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					47	44			Current User										Adverse event/ complications		Stage IIB		-17465					1306	144				0				1								1							2014-5-27	FEMALE	154	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO			1	1	false			MX	NX	T2b	TCGA-VS-A94Y.CBBFD564-A58A-42D3-89B8-682858D13B50.pdf	Cervical Cancer						40		20		5		20		0		15		80		80		Pre-Adjuvant Therapy	WITH TUMOR	YES		NO	Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Current smoker	1		cervical	A	DECEASED	44	2010				b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	TCGA-VS-A94Y-01A-11D-A386-01	b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	TCGA-VS-A94Y-01A-11D-A388-05	TCGA-VS-A94Y-01A-11R-A38M-13		TCGA-VS-A94Y-01	b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	1a36ceb6-8a9f-4f43-b923-9dfba950bdad	b52d5d7a-3104-4d2a-a36b-aa9ac75e341d	1a36ceb6-8a9f-4f43-b923-9dfba950bdad			TCGA-VS-A94Y-01	TCGA-VS-A94Y-01A-11D-A386-01	
TCGA-VS-A94Z-01	0	TCGA-VS-A94Z-01	742	0	TCGA-VS-A94Z	742	0	742	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		38	27	5	TCGA-VS-A94Z-F67676	Never Used		2800		HDR							Cisplatin	Stage IIB		-14046										0	742			39							Once weekly	1							2014-11-9	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)				NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			3	2				MX	NX	T2b					1																			Pre-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01		2010	2009	YES	NO	YES	VS	Current reformed smoker for < or = 15 years	4		cervical		LIVING	96	2012				c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	TCGA-VS-A94Z-01A-11D-A386-01	c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	TCGA-VS-A94Z-01A-11D-A388-05	TCGA-VS-A94Z-01A-11R-A38M-13		TCGA-VS-A94Z-01	c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	f1a9cba8-481b-4dd8-b66e-b0be36e0968b	c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4	f1a9cba8-481b-4dd8-b66e-b0be36e0968b			TCGA-VS-A94Z-01	TCGA-VS-A94Z-01A-11D-A386-01	
TCGA-VS-A950-01	0	TCGA-VS-A950-01	1210	0	TCGA-VS-A950	1210	0	1210	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Partial Response		42			TCGA-VS-A950-F67689	Never Used		2600		HDR								Stage IIIA		-15365					874					0	1210			0								0							2014-11-9	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			3		false			MX	NX	T3a	TCGA-VS-A950.F095B0C9-4855-495D-89C9-B303D7756BFB.pdf							40		20		10		20		0		20		70		70		Pre-Adjuvant Therapy	WITH TUMOR	NO			Partial Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING	57	2011				1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	TCGA-VS-A950-01A-11D-A42N-01	1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	TCGA-VS-A950-01A-11D-A42P-05	TCGA-VS-A950-01A-11R-A42V-13			1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	56a6ef36-33c4-4b71-80b7-6ff51f05b8c0	1560b26a-bc8d-4bdd-b317-f04b66c2ce5b	56a6ef36-33c4-4b71-80b7-6ff51f05b8c0				TCGA-VS-A950-01A-11D-A42N-01	
TCGA-VS-A952-01	0	TCGA-VS-A952-01	1547	0	TCGA-VS-A952	1547	0	1547	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		66			TCGA-VS-A952-F67682	Never Used												Stage IB1		-24345					1288					0	1547			1547								0							2014-11-9	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No						Radical Hysterectomy	C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO	15			ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO	0	0	3		false			MX	N0	T1b	TCGA-VS-A952.B7893751-3A8F-4FD8-996F-D8C93C108336.pdf							40		20		0		20		0		30		70		70	Follow up	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	NO							Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING	65	2010				01a6c838-ea9c-488c-8dcb-8bac73253a33	TCGA-VS-A952-01A-11D-A386-01	01a6c838-ea9c-488c-8dcb-8bac73253a33	TCGA-VS-A952-01A-11D-A388-05	TCGA-VS-A952-01A-11R-A38M-13		TCGA-VS-A952-01	01a6c838-ea9c-488c-8dcb-8bac73253a33	ce9c68e7-7eed-4f31-9a55-39d198587a50	01a6c838-ea9c-488c-8dcb-8bac73253a33	ce9c68e7-7eed-4f31-9a55-39d198587a50			TCGA-VS-A952-01	TCGA-VS-A952-01A-11D-A386-01	
TCGA-VS-A953-01	1	TCGA-VS-A953-01	477	1	TCGA-VS-A953	477	0	477	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					63				Never Used										Adverse event/ complications		Stage IVA		-23277					1274	477				0				0								0							2014-10-17	FEMALE	155	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			11		false			MX	NX	T4	TCGA-VS-A953.C5CCCB76-671A-4498-BA9F-A5D5AF6DD215.pdf	Cervical Cancer						40		20		10		20		0		10		80		80		Pre-Adjuvant Therapy	WITH TUMOR	YES			Partial Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	11		cervical	A	DECEASED	47	2010				1893be96-6727-4bfa-aa28-2a2df326c464	TCGA-VS-A953-01A-11D-A386-01	1893be96-6727-4bfa-aa28-2a2df326c464	TCGA-VS-A953-01A-11D-A388-05	TCGA-VS-A953-01A-11R-A38M-13		TCGA-VS-A953-01	1893be96-6727-4bfa-aa28-2a2df326c464	c4d488bf-d211-45e2-933a-807ba0d7d35a	1893be96-6727-4bfa-aa28-2a2df326c464	c4d488bf-d211-45e2-933a-807ba0d7d35a			TCGA-VS-A953-01	TCGA-VS-A953-01A-11D-A386-01	
TCGA-VS-A954-01	0	TCGA-VS-A954-01	1540	0	TCGA-VS-A954	1540	0	1540	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		67		5	TCGA-VS-A954-F67678	Never Used		2700		HDR							Cisplatin	Stage IIIB		-24498					1259					0	1540			92							Once weekly	1							2014-11-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			10		false			MX	NX	T3b	TCGA-VS-A954.5A62ACAB-9170-49CB-AA5A-82E90CA3A200.pdf							0		0		0		0		0		15		85		90		Pre-Adjuvant Therapy	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	10		cervical	A	LIVING	58	2010				01ab5f23-487f-4a57-97b3-6a110a789124	TCGA-VS-A954-01A-11D-A386-01	01ab5f23-487f-4a57-97b3-6a110a789124	TCGA-VS-A954-01A-11D-A388-05	TCGA-VS-A954-01A-11R-A38M-13		TCGA-VS-A954-01	01ab5f23-487f-4a57-97b3-6a110a789124	6f64c2fd-c11f-439f-97ad-ddde35c93226	01ab5f23-487f-4a57-97b3-6a110a789124	6f64c2fd-c11f-439f-97ad-ddde35c93226			TCGA-VS-A954-01	TCGA-VS-A954-01A-11D-A386-01	
TCGA-VS-A957-01	0	TCGA-VS-A957-01	1462	0	TCGA-VS-A957	1462	0	1462	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		64		4	TCGA-VS-A957-F67668	Never Used										Adverse event/ complications	Cisplatin	Stage IB1		-23585					1210					0	1462			118							Once weekly	0							2014-11-9	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			4		false			MX	NX	T1b1	TCGA-VS-A957.A1599777-E100-4429-8872-764AE82C9258.pdf							0		0		0		0		0		15		85		90		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	LIVING	91	2010				78879d70-1eb8-4677-869c-a4c51e537062	TCGA-VS-A957-01A-11D-A42N-01	78879d70-1eb8-4677-869c-a4c51e537062	TCGA-VS-A957-01A-11D-A42P-05	TCGA-VS-A957-01A-11R-A42V-13			78879d70-1eb8-4677-869c-a4c51e537062	a70b66b9-eb69-4fa0-aec4-c35ed63a67fd	78879d70-1eb8-4677-869c-a4c51e537062	a70b66b9-eb69-4fa0-aec4-c35ed63a67fd				TCGA-VS-A957-01A-11D-A42N-01	
TCGA-VS-A958-01	0	TCGA-VS-A958-01	1525	0	TCGA-VS-A958	1525	0	1525	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		46		4	TCGA-VS-A958-F68144	Never Used		2800		HDR						Adverse event/ complications	Cisplatin	Stage IIB		-16905					1189					0	1525			0							Once weekly	1							2014-11-13	FEMALE	151	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			4		false			MX	NX	T2b	TCGA-VS-A958.643CD93E-47D0-4D40-96C8-DDF836EEF501.pdf							0		0		0		0		0		15		85		90		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	LIVING	61	2010				5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	TCGA-VS-A958-01A-11D-A42N-01	5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	TCGA-VS-A958-01A-11D-A42P-05	TCGA-VS-A958-01A-11R-A42V-13			5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	1f8efe9c-6f82-4894-a5e9-0771470c1c0d	5fd1a695-76a4-4ccb-8623-6b1e65e7de3a	1f8efe9c-6f82-4894-a5e9-0771470c1c0d				TCGA-VS-A958-01A-11D-A42N-01	
TCGA-VS-A959-01	0	TCGA-VS-A959-01	1379	0	TCGA-VS-A959	1379	0	1379	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		76			TCGA-VS-A959-F67680	Never Used		2700		HDR								Stage IIB		-27897					1181					0	1379																		2014-11-9	FEMALE	145	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			11		false			MX	NX	T2b	TCGA-VS-A959.10A6CADD-C99B-4A34-9D5D-02AD37C1AB80.pdf							0		0		0		0		0		20		80		60			TUMOR FREE	NO			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	11		cervical	A	LIVING	47	2010				33be2852-1252-432d-9f4e-2d0749f2563a	TCGA-VS-A959-01A-11D-A42N-01	33be2852-1252-432d-9f4e-2d0749f2563a	TCGA-VS-A959-01A-11D-A42P-05	TCGA-VS-A959-01A-11R-A42V-13			33be2852-1252-432d-9f4e-2d0749f2563a	ee3811ca-e256-46bf-a9c4-b3626536a674	33be2852-1252-432d-9f4e-2d0749f2563a	ee3811ca-e256-46bf-a9c4-b3626536a674				TCGA-VS-A959-01A-11D-A42N-01	
TCGA-VS-A9U5-01	0	TCGA-VS-A9U5-01	1367	0	TCGA-VS-A9U5	1367	0	1367	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		57		5	TCGA-VS-A9U5-F67679	Never Used		2800		HDR							Cisplatin	Stage IIB		-21149					1114					0	1367			-3							Once weekly	0							2014-11-9	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	300	NO		NO					Peri (6-12 months since last menstrual period)	G3							NO			3		false			MX	NX	T2b	TCGA-VS-A9U5.4DCCBB92-3E31-4B62-8F8E-00264488ADD0.pdf							35		0		0		0		35		5		60		60		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING	74	2010		FF774297-756E-40BC-910D-6702417510C2		e5241411-aec5-4822-8522-8e74c51a0d79	TCGA-VS-A9U5-01A-11D-A42N-01	e5241411-aec5-4822-8522-8e74c51a0d79	TCGA-VS-A9U5-01A-11D-A42P-05	TCGA-VS-A9U5-01A-11R-A42V-13			e5241411-aec5-4822-8522-8e74c51a0d79	d631dcba-6d88-40d0-bf0a-d9854e72ed83	e5241411-aec5-4822-8522-8e74c51a0d79	d631dcba-6d88-40d0-bf0a-d9854e72ed83				TCGA-VS-A9U5-01A-11D-A42N-01	
TCGA-VS-A9U6-01	0	TCGA-VS-A9U6-01	1320	0	TCGA-VS-A9U6	1311	1	1320	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer	YES	NO	Progressive Disease		52		4	TCGA-VS-A9U6-F68123	Never Used		2600		HDR							Cisplatin	Stage IVB		-19109					1058					0	1320		1311	0							Once weekly	1							2014-11-13	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Non-keratinizing squamous cell carcinoma	NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX	Other, specify			Distant Metastasis	Ovary	NO	YES			1		false			M1	NX	T4	TCGA-VS-A9U6.BB78B2C7-E9AF-47D4-AAA2-354D1CFC2F76.pdf				1			2		0		0		0		5		15		80		80		Preoperative	WITH TUMOR	YES			Stable Disease	No	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	2		cervical	A	LIVING	66	2011					TCGA-VS-A9U6-01A-11D-A42N-01		TCGA-VS-A9U6-01A-11D-A42P-05	TCGA-VS-A9U6-01A-11R-A42V-13				c3ff93f6-e8c7-40c8-88f6-d0e3cfe6552f		c3ff93f6-e8c7-40c8-88f6-d0e3cfe6552f				TCGA-VS-A9U6-01A-11D-A42N-01	
TCGA-VS-A9U7-01	0	TCGA-VS-A9U7-01	1290	0	TCGA-VS-A9U7	1290	0	1290	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		30		5	TCGA-VS-A9U7-F67667	Current User		2800		HDR							Cisplatin	Stage IB1		-11210					1029					0	1290			0							Once weekly	0							2014-11-9	FEMALE	157	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO	18	Pelvic (external iliac, internal iliac, obturator)			Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	3	0	1		false			M0	N1	T1b	TCGA-VS-A9U7.3FB4D6F8-6625-49A7-AA2C-533FB9EC9310.pdf				2			5		0		0		0		5		5		90		90		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING	82	2011				78f72cda-30eb-41f6-8713-795ced251abb	TCGA-VS-A9U7-01A-11D-A42N-01	78f72cda-30eb-41f6-8713-795ced251abb	TCGA-VS-A9U7-01A-11D-A42P-05	TCGA-VS-A9U7-01A-11R-A42V-13			78f72cda-30eb-41f6-8713-795ced251abb	6f8e775b-700b-4f49-87cf-67a827c1b2a1	78f72cda-30eb-41f6-8713-795ced251abb	6f8e775b-700b-4f49-87cf-67a827c1b2a1				TCGA-VS-A9U7-01A-11D-A42N-01	
TCGA-VS-A9UA-01	0	TCGA-VS-A9UA-01	648	0	TCGA-VS-A9UA	648	0	648	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		60		4	TCGA-VS-A9UA-F67688	Never Used		2400		HDR							Cisplatin	Stage IIIA		-22221					455					0	648			648							Once weekly	0							2014-11-9	FEMALE	134	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO			2		false			MX	NX	T3	TCGA-VS-A9UA.36B3C85C-699D-4C72-B0FD-45480AC0A41B.pdf							15		0		10		0		20		10		60		60	Follow up	Other	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	2		cervical	A	LIVING	88	2012					TCGA-VS-A9UA-01A-11D-A42N-01		TCGA-VS-A9UA-01A-11D-A42P-05	TCGA-VS-A9UA-01A-11R-A42V-13				8b115d16-51ff-4bb3-8aa3-d6a95b92da8b		8b115d16-51ff-4bb3-8aa3-d6a95b92da8b				TCGA-VS-A9UA-01A-11D-A42N-01	
TCGA-VS-A9UB-01	0	TCGA-VS-A9UB-01	648	0	TCGA-VS-A9UB	648	0	648	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		54		6	TCGA-VS-A9UB-F67692	Never Used		2800		HDR							Cisplatin	Stage IIB		-19737					435					0	648			648							Once weekly	2							2014-11-9	FEMALE	166	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO	51				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							NO	0		11		false			MX	N0	T2b	TCGA-VS-A9UB.73D61A64-9435-4E72-898C-3A4E7C109CF3.pdf							30		0		20		70		0		10		70		70	Follow up	Other	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	11		cervical	A	LIVING	79	2012		F54758E3-15BA-49F2-8F6A-B68B540D499C		389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	TCGA-VS-A9UB-01A-22D-A42N-01	389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	TCGA-VS-A9UB-01A-22D-A42P-05	TCGA-VS-A9UB-01A-22R-A42V-13			389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	5ed71bad-4cba-4dc4-b9c7-6069c928b263	389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a	5ed71bad-4cba-4dc4-b9c7-6069c928b263				TCGA-VS-A9UB-01A-22D-A42N-01	
TCGA-VS-A9UC-01	0	TCGA-VS-A9UC-01	691	0	TCGA-VS-A9UC	691	0	691	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Stable Disease		32		5	TCGA-VS-A9UC-F68147	Never Used											Cisplatin	Stage IIB		-11790					370					0	691			-2							Once weekly	1							2014-11-13	FEMALE	153	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO					Peri (6-12 months since last menstrual period)	G2							NO			4		false			MX	NX	T2b	TCGA-VS-A9UC.F7CE1EAA-6332-4A64-88C8-3BB5905380AA.pdf							0		0		0		0		0		10		90		90		Pre-Adjuvant Therapy	WITH TUMOR	YES			Stable Disease	No	YES					3D conformal	3240	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	LIVING	76	2012				c9b500aa-3196-4dc2-8580-8696b6c52c4d	TCGA-VS-A9UC-01A-11D-A42N-01	c9b500aa-3196-4dc2-8580-8696b6c52c4d	TCGA-VS-A9UC-01A-11D-A42P-05	TCGA-VS-A9UC-01A-11R-A42V-13			c9b500aa-3196-4dc2-8580-8696b6c52c4d	7b859eb2-0c1a-41f4-80af-d84d6e50099a	c9b500aa-3196-4dc2-8580-8696b6c52c4d	7b859eb2-0c1a-41f4-80af-d84d6e50099a				TCGA-VS-A9UC-01A-11D-A42N-01	
TCGA-VS-A9UD-01	0	TCGA-VS-A9UD-01	599	0	TCGA-VS-A9UD	599	0	599	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		73		6	TCGA-VS-A9UD-F67685	Never Used		2400		HDR							Cisplatin	Stage IIIA		-26815					327					0	599			-1							Once weekly	0							2014-11-9	FEMALE	161	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	160	NO	Keratinizing squamous cell carcinoma	NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							NO			9		false			MX	NX	T3a	TCGA-VS-A9UD.D0920498-DCB8-454A-A294-204A280D4129.pdf				5			30		0		0		70		0		20		80		80		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	14		cervical	A	LIVING	64	2013		BF375F3D-D2CF-49AB-BD47-43A4062F0781		c518438f-04e1-4330-b440-4046002d10b8	TCGA-VS-A9UD-01A-11D-A42N-01	c518438f-04e1-4330-b440-4046002d10b8	TCGA-VS-A9UD-01A-11D-A42P-05	TCGA-VS-A9UD-01A-11R-A42V-13			c518438f-04e1-4330-b440-4046002d10b8	747b908f-87ff-4be9-82d0-931ac1b3cea6	c518438f-04e1-4330-b440-4046002d10b8	747b908f-87ff-4be9-82d0-931ac1b3cea6				TCGA-VS-A9UD-01A-11D-A42N-01	
TCGA-VS-A9UH-01	0	TCGA-VS-A9UH-01	1427	0	TCGA-VS-A9UH	1427	0	1427	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		53		5	TCGA-VS-A9UH-F68149	Never Used											Cisplatin	Stage IVA		-19454					1098					0	1427			1216							Once weekly	1							2014-11-13	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO						GX							NO			3		false			MX	NX	T4	TCGA-VS-A9UH.0A4B7512-EA49-4210-B588-939F58D602FE.pdf							0		0		0		0		0		25		75		90	Follow up	Other	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	3		cervical	A	LIVING		2010				2410b783-e6c3-4c07-b944-8818d0b0cacb	TCGA-VS-A9UH-01A-11D-A42N-01	2410b783-e6c3-4c07-b944-8818d0b0cacb	TCGA-VS-A9UH-01A-11D-A42P-05	TCGA-VS-A9UH-01A-11R-A42V-13			2410b783-e6c3-4c07-b944-8818d0b0cacb	e3a38918-2504-4c0e-82a0-09c50a83e009	2410b783-e6c3-4c07-b944-8818d0b0cacb	e3a38918-2504-4c0e-82a0-09c50a83e009				TCGA-VS-A9UH-01A-11D-A42N-01	
TCGA-VS-A9UI-01	0	TCGA-VS-A9UI-01	1246	0	TCGA-VS-A9UI	1246	0	1246	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		76			TCGA-VS-A9UI-F67686	Never Used		2800		HDR								Stage IIB		-27838					1050					0	1246			62								1							2014-11-9	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			5		false			MX	NX	T2b	TCGA-VS-A9UI.0907F0B0-7E43-40EB-881F-2ED5E39DB600.pdf							20		5		2		5		0		38		60		60		Pre-Adjuvant Therapy	TUMOR FREE	NO			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	5		cervical	A	LIVING	70	2011				66a29b88-60e4-4fae-90b3-5c32560dd3ba	TCGA-VS-A9UI-01A-11D-A42N-01	66a29b88-60e4-4fae-90b3-5c32560dd3ba	TCGA-VS-A9UI-01A-11D-A42P-05	TCGA-VS-A9UI-01A-11R-A42V-13			66a29b88-60e4-4fae-90b3-5c32560dd3ba	3cbee34b-984f-4e9f-bbed-649fa76db9f7	66a29b88-60e4-4fae-90b3-5c32560dd3ba	3cbee34b-984f-4e9f-bbed-649fa76db9f7				TCGA-VS-A9UI-01A-11D-A42N-01	
TCGA-VS-A9UJ-01	1	TCGA-VS-A9UJ-01	52	1	TCGA-VS-A9UJ	52	0	52	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					55				Current User												Stage IIB		-20264					538	52				0				0								1							2014-9-9	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO					false			MX	NX	T2b	TCGA-VS-A9UJ.41D3937F-69E0-4C7F-B38D-A5067B2C3C0B.pdf	Cervical Cancer						5		0		2		5		5		13		80		80	No treatment performed	Other	WITH TUMOR	NO				No	NO							Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	0		cervical	A	DECEASED		2012				9817f939-fcd5-4130-986b-95228c78e17d	TCGA-VS-A9UJ-01A-11D-A42N-01	9817f939-fcd5-4130-986b-95228c78e17d	TCGA-VS-A9UJ-01A-11D-A42P-05	TCGA-VS-A9UJ-01A-11R-A42V-13			9817f939-fcd5-4130-986b-95228c78e17d	b40c0502-5e77-4398-9f74-aa866ef07850	9817f939-fcd5-4130-986b-95228c78e17d	b40c0502-5e77-4398-9f74-aa866ef07850				TCGA-VS-A9UJ-01A-11D-A42N-01	
TCGA-VS-A9UL-01	1	TCGA-VS-A9UL-01	442	1	TCGA-VS-A9UL			442	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					79				Never Used		2800		HDR								Stage IIIB		-29033					1126	442				0				-1								1							2014-9-5	FEMALE	149	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G3							YES			5		false			MX	NX	T3b	TCGA-VS-A9UL.79869158-C990-45B6-B77B-A6CEC4886E5C.pdf	Cervical Cancer						5		0		5		5		0		15		80		80		Pre-Adjuvant Therapy	WITH TUMOR	NO			Progressive Disease	No	YES					3D conformal	5400	Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	5		cervical	A	DECEASED	56	2010				4749bc16-8e1b-4e8e-b975-f07fd2ae885e	TCGA-VS-A9UL-01A-11D-A42N-01	4749bc16-8e1b-4e8e-b975-f07fd2ae885e	TCGA-VS-A9UL-01A-11D-A42P-05	TCGA-VS-A9UL-01A-11R-A42V-13			4749bc16-8e1b-4e8e-b975-f07fd2ae885e	32bb6048-a023-4822-94f9-584c492b16fb	4749bc16-8e1b-4e8e-b975-f07fd2ae885e	32bb6048-a023-4822-94f9-584c492b16fb				TCGA-VS-A9UL-01A-11D-A42N-01	
TCGA-VS-A9UM-01	1	TCGA-VS-A9UM-01	829	1	TCGA-VS-A9UM	829	0	829	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					39				Never Used		2000		HDR							Cisplatin	Stage IVB		-14255					1068	829				0				0							Once weekly	0							2014-9-9	FEMALE	160	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Peri (6-12 months since last menstrual period)	G2							NO			5		false			MX	NX	T3b	TCGA-VS-A9UM.20927111-D875-4B7E-9E8F-F8EE861600D2.pdf							5		0		0		0		5		20		75		75		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	5		cervical	A	DECEASED	75	2011				d8259ddb-5f41-43ea-889c-1e7dba9d32bc	TCGA-VS-A9UM-01A-11D-A42N-01	d8259ddb-5f41-43ea-889c-1e7dba9d32bc	TCGA-VS-A9UM-01A-11D-A42P-05	TCGA-VS-A9UM-01A-11R-A42V-13			d8259ddb-5f41-43ea-889c-1e7dba9d32bc	2310f784-17d8-41a9-8b0c-b42525d416ff	d8259ddb-5f41-43ea-889c-1e7dba9d32bc	2310f784-17d8-41a9-8b0c-b42525d416ff				TCGA-VS-A9UM-01A-11D-A42N-01	
TCGA-VS-A9UO-01	0	TCGA-VS-A9UO-01	1260	0	TCGA-VS-A9UO	1260	0	1260	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		43		3	TCGA-VS-A9UO-F67681	Never Used		2800		HDR							Cisplatin	Stage IIB		-15813					1036					0	1260			0							Once weekly	1							2014-11-9	FEMALE	159	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO		NO	45				Peri (6-12 months since last menstrual period)	G2							NO	0		1		false			MX	N0	T2b	TCGA-VS-A9UO.53DDB03D-73DC-4496-AF47-2C03D329DDF9.pdf							5		5		0		5		10		20		70		70		Preoperative	TUMOR FREE	YES		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	1		cervical	A	LIVING	40	2011				b4df19ac-b93c-4de6-b0f6-823bca30b1d7	TCGA-VS-A9UO-01A-11D-A42N-01	b4df19ac-b93c-4de6-b0f6-823bca30b1d7	TCGA-VS-A9UO-01A-11D-A42P-05	TCGA-VS-A9UO-01A-11R-A42V-13			b4df19ac-b93c-4de6-b0f6-823bca30b1d7	ee6c31c6-f617-4bf5-a310-9436b775883f	b4df19ac-b93c-4de6-b0f6-823bca30b1d7	ee6c31c6-f617-4bf5-a310-9436b775883f				TCGA-VS-A9UO-01A-11D-A42N-01	
TCGA-VS-A9UP-01	0	TCGA-VS-A9UP-01	1316	0	TCGA-VS-A9UP	1316	0	1316	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Progressive Disease		43	34	6	TCGA-VS-A9UP-F67674	Never Used		2800		HDR							Cisplatin	Stage IIA		-15849					993					0	1316			54							Once weekly	1							2014-11-13	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO		NO					Peri (6-12 months since last menstrual period)	G3							NO			4	1	false			MX	NX	T2a	TCGA-VS-A9UP.CA4BC8DE-D4C5-4B10-AB82-8A0C766C529F.pdf							50		20		5		20		0		25		70		70		Pre-Adjuvant Therapy	WITH TUMOR	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	4		cervical	A	LIVING	68	2011				b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	TCGA-VS-A9UP-01A-11D-A42N-01	b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	TCGA-VS-A9UP-01A-11D-A42P-05	TCGA-VS-A9UP-01A-11R-A42V-13			b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	e5b3c6a1-0f61-43c3-af2f-5e7fcbf051e8	b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd	e5b3c6a1-0f61-43c3-af2f-5e7fcbf051e8				TCGA-VS-A9UP-01A-11D-A42N-01	
TCGA-VS-A9UQ-01	0	TCGA-VS-A9UQ-01	1094	0	TCGA-VS-A9UQ	1094	0	1094	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		32			TCGA-VS-A9UQ-F68152	Current User		2000		HDR			No pathologic margins	Other Location, specify				Stage IB		-11853					771					0	1094			1071								1							2014-11-13	FEMALE	160	Mucinous Adenocarcinoma of Endocervical Type	No					Wertheim Meiggs	Other	C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO		NO	22				Peri (6-12 months since last menstrual period)	G2							NO	0				false			MX	N0	T1b	TCGA-VS-A9UQ.AF3A1FB4-1FC6-4CB7-93EF-0E3E2FEE3E8B.pdf				4			40		20		0		20		0		30		70		70	Follow up	Other	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	LIVING	72	2011		D909165F-5AF8-4C45-8925-C8BA473B43F4		57955c20-b0c4-4d4c-aea6-cee9179a4118	TCGA-VS-A9UQ-01A-21D-A42N-01	57955c20-b0c4-4d4c-aea6-cee9179a4118	TCGA-VS-A9UQ-01A-21D-A42P-05	TCGA-VS-A9UQ-01A-21R-A42V-13			57955c20-b0c4-4d4c-aea6-cee9179a4118	37026fe2-ef8d-48c2-a513-ca5aabe8fd40	57955c20-b0c4-4d4c-aea6-cee9179a4118	37026fe2-ef8d-48c2-a513-ca5aabe8fd40				TCGA-VS-A9UQ-01A-21D-A42N-01	
TCGA-VS-A9UR-01	0	TCGA-VS-A9UR-01	611	0	TCGA-VS-A9UR	611	0	611	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		53		6	TCGA-VS-A9UR-F67684	Never Used		2800		HDR							Cisplatin	Stage IIA		-19688					323					0	611			591							Once weekly	1							2014-11-9	FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO		NO						GX							NO			5		false			MX	NX	T2a	TCGA-VS-A9UR.BD8A6A1F-9210-4A69-AB09-EDCFC5F28482.pdf							40		20		0		20		0		20		80		80	Follow up	Other	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	5		cervical	A	LIVING	64	2013				c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	TCGA-VS-A9UR-01A-11D-A42N-01	c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	TCGA-VS-A9UR-01A-11D-A42P-05	TCGA-VS-A9UR-01A-11R-A42V-13			c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	84cd0e64-327b-4560-8e9f-692037af4426	c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a	84cd0e64-327b-4560-8e9f-692037af4426				TCGA-VS-A9UR-01A-11D-A42N-01	
TCGA-VS-A9UT-01		TCGA-VS-A9UT-01			TCGA-VS-A9UT				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer																												210																																									50	NO																				false						TCGA-VS-A9UT.2CBE50B6-D35F-495B-AF90-7536DBA459D0.pdf							40		20		0		20		0		20		80		80																Primary Tumor	01												A							541b5a26-2819-4cab-bbc7-e88df4999681	TCGA-VS-A9UT-01A-11D-A42N-01	541b5a26-2819-4cab-bbc7-e88df4999681	TCGA-VS-A9UT-01A-11D-A42P-05	TCGA-VS-A9UT-01A-11R-A42V-13			541b5a26-2819-4cab-bbc7-e88df4999681	4b26fba7-3ae2-4fd4-be8b-8fb9cdf5fc85	541b5a26-2819-4cab-bbc7-e88df4999681	4b26fba7-3ae2-4fd4-be8b-8fb9cdf5fc85				TCGA-VS-A9UT-01A-11D-A42N-01	
TCGA-VS-A9UU-01	0	TCGA-VS-A9UU-01	442	0	TCGA-VS-A9UU	442	0	442	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		42	23	3	TCGA-VS-A9UU-F67691	Current User		2800		HDR							Cisplatin	Stage IIB		-15534					208					0	442			26							Once weekly	0							2014-11-9	FEMALE	162	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G1							NO			7	2	false			MX	NX	T2b	TCGA-VS-A9UU.D1243906-0895-4A53-B484-7317F7D834D0.pdf		HIV					60		10		0		20		0		40		60		60		Pre-Adjuvant Therapy	TUMOR FREE	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	7		cervical	A	LIVING	67	2013				ab8b70eb-04a6-4c52-8301-fa904fa5870a	TCGA-VS-A9UU-01A-11D-A42N-01	ab8b70eb-04a6-4c52-8301-fa904fa5870a	TCGA-VS-A9UU-01A-11D-A42P-05	TCGA-VS-A9UU-01A-11R-A42V-13			ab8b70eb-04a6-4c52-8301-fa904fa5870a	e9be1e02-2368-4b08-ba51-8fc9418693bc	ab8b70eb-04a6-4c52-8301-fa904fa5870a	e9be1e02-2368-4b08-ba51-8fc9418693bc				TCGA-VS-A9UU-01A-11D-A42N-01	
TCGA-VS-A9UV-01	1	TCGA-VS-A9UV-01	104	1	TCGA-VS-A9UV	104	0	104	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					74				Never Used												Stage IVA		-27348					125	104				0				-2								1							2014-8-11	FEMALE	152	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	50	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO			5		false			MX	NX	T4	TCGA-VS-A9UV.EAF200A1-9A0C-4A51-A241-14173B4F323E.pdf	Cervical Cancer						40		20		0		20		0		30		70		70	The patient did not perform treatment	Other	WITH TUMOR	NO				No	NO							Primary Tumor	01			2009		NO	YES	VS	Lifelong Non-smoker	5		cervical	A	DECEASED	31	2013				2f48ea8f-6e03-4f00-acc5-e9bc491ad673	TCGA-VS-A9UV-01A-11D-A42N-01	2f48ea8f-6e03-4f00-acc5-e9bc491ad673	TCGA-VS-A9UV-01A-11D-A42P-05	TCGA-VS-A9UV-01A-11R-A42V-13			2f48ea8f-6e03-4f00-acc5-e9bc491ad673	9473651f-c6c8-4c7c-bfa0-92e093f15954	2f48ea8f-6e03-4f00-acc5-e9bc491ad673	9473651f-c6c8-4c7c-bfa0-92e093f15954				TCGA-VS-A9UV-01A-11D-A42N-01	
TCGA-VS-A9UY-01	1	TCGA-VS-A9UY-01	555	1	TCGA-VS-A9UY			555	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					29		5				2800		HDR							Cisplatin	Stage IVB		-10707					454	555				0				0							Once weekly	2							2014-9-5	FEMALE	163	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma							G2							YES					false			MX	NX	T1b2	TCGA-VS-A9UY.DDC2DC1F-C4E3-4F51-9F0C-3EE90A7C4819.pdf	Cervical Cancer						2		0		0		0		0		0		100		80		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker			cervical	A	DECEASED	46	2012				df428368-b3b0-4e70-b930-2e143645a779	TCGA-VS-A9UY-01A-11D-A42N-01	df428368-b3b0-4e70-b930-2e143645a779	TCGA-VS-A9UY-01A-11D-A42P-05	TCGA-VS-A9UY-01A-11R-A42V-13			df428368-b3b0-4e70-b930-2e143645a779	2957b88d-c280-441e-975d-01317f3931f7	df428368-b3b0-4e70-b930-2e143645a779	2957b88d-c280-441e-975d-01317f3931f7				TCGA-VS-A9UY-01A-11D-A42N-01	
TCGA-VS-A9UZ-01	0	TCGA-VS-A9UZ-01	2044	0	TCGA-VS-A9UZ	2044	0	2044	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		61			TCGA-VS-A9UZ-F68142	Never Used		3600		HDR								Stage IB1		-22344					1723					0	2044																		2014-11-13	FEMALE	149	Mucinous Adenocarcinoma of Endocervical Type	No					Wertheim Meiggs	Other	C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO		NO	26				Peri (6-12 months since last menstrual period)	G2							NO	0		4		false			MX	N0	T1b	TCGA-VS-A9UZ.F340AC28-F1AC-4AC3-9C7D-CAC4F3EE04E5.pdf							10		2		0		3		15		0		85		60			TUMOR FREE	NO		YES	Complete Remission/Response	No	YES							Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	LIVING	54	2009				56ec376d-abc2-4bcd-87d2-cf10141ab979	TCGA-VS-A9UZ-01A-11D-A42N-01	56ec376d-abc2-4bcd-87d2-cf10141ab979	TCGA-VS-A9UZ-01A-11D-A42P-05	TCGA-VS-A9UZ-01A-11R-A42V-13			56ec376d-abc2-4bcd-87d2-cf10141ab979	714ec633-84b9-45b9-89e9-e69e92b7accb	56ec376d-abc2-4bcd-87d2-cf10141ab979	714ec633-84b9-45b9-89e9-e69e92b7accb				TCGA-VS-A9UZ-01A-11D-A42N-01	
TCGA-VS-A9V0-01	0	TCGA-VS-A9V0-01	573	0	TCGA-VS-A9V0	573	0	573	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		58	27	4	TCGA-VS-A9V0-F67690	Never Used		2800		HDR							Cisplatin	Stage IB		-21215					264					0	573			551							Once weekly	1							2014-11-9	FEMALE	158	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO		NO					Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO			7	4.5	false			MX	NX	T1b	TCGA-VS-A9V0.98E32BD3-DB7B-4E70-B254-19A5CC29B4D3.pdf							8		1		0		2		0		0		100		65	Follow up	Other	WITH TUMOR	YES			Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01		2012	2009	YES	NO	YES	VS	Current reformed smoker for < or = 15 years	7		cervical	A	LIVING	76	2013		46F8B610-944B-4BA8-A595-83B0EB4C4614		b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	TCGA-VS-A9V0-01A-11D-A42N-01	b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	TCGA-VS-A9V0-01A-11D-A42P-05	TCGA-VS-A9V0-01A-11R-A42V-13			b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	e7ea41fa-a3f9-4592-92e1-fefa569b90a8	b6c90737-2ec8-46e6-801a-7e64ba2b5b0b	e7ea41fa-a3f9-4592-92e1-fefa569b90a8				TCGA-VS-A9V0-01A-11D-A42N-01	
TCGA-VS-A9V1-01	1	TCGA-VS-A9V1-01	157	1	TCGA-VS-A9V1			157	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					46	24	5		Never Used											Cisplatin	Stage IVB		-17001					217	157				0											Once weekly								2014-9-5	FEMALE	155	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							YES			3	2.4	false			MX	NX	T3b	TCGA-VS-A9V1.BC3B49BB-004C-4079-B1A2-97B74891BFD6.pdf	Cervical Cancer			1			10		1		0		1		0		0		100		60			WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Current smoker	4		cervical	A	DECEASED	45	2013				7d481f46-fd01-47ce-b321-39240129af48	TCGA-VS-A9V1-01A-11D-A42N-01	7d481f46-fd01-47ce-b321-39240129af48	TCGA-VS-A9V1-01A-11D-A42P-05	TCGA-VS-A9V1-01A-11R-A42V-13			7d481f46-fd01-47ce-b321-39240129af48	07c8ccd3-0d6b-42d6-b3f5-ba4a552ef744	7d481f46-fd01-47ce-b321-39240129af48	07c8ccd3-0d6b-42d6-b3f5-ba4a552ef744				TCGA-VS-A9V1-01A-11D-A42N-01	
TCGA-VS-A9V2-01	0	TCGA-VS-A9V2-01	427	0	TCGA-VS-A9V2	427	0	427	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		29			TCGA-VS-A9V2-F67677	Never Used							Negative pathologic margins	Other Location, specify				Stage IB1		-10637					119					0	427			-1								1							2014-11-9	FEMALE	156	Cervical Squamous Cell Carcinoma	No					Wertheim Meiggs	Other	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	40	NO		NO	26				Peri (6-12 months since last menstrual period)	G2							NO	0	0	2		false			MX	N0	T1b	TCGA-VS-A9V2.0D5FE178-46D8-41A5-BA54-E9746F3D2B4C.pdf							2		0		0		0		0		0		100		80		Preoperative	TUMOR FREE	NO		YES	Complete Remission/Response	No	YES					3D conformal	4500	Primary Tumor	01			2009	NO	NO	YES	VS	Lifelong Non-smoker	2		cervical	A	LIVING	49	2013				8cdfa086-9681-4b94-98c7-855d713cd877	TCGA-VS-A9V2-01A-11D-A42N-01	8cdfa086-9681-4b94-98c7-855d713cd877	TCGA-VS-A9V2-01A-11D-A42P-05	TCGA-VS-A9V2-01A-11R-A42V-13			8cdfa086-9681-4b94-98c7-855d713cd877	3b6e14c5-31d5-4828-8555-4d46c18e107a	8cdfa086-9681-4b94-98c7-855d713cd877	3b6e14c5-31d5-4828-8555-4d46c18e107a				TCGA-VS-A9V2-01A-11D-A42N-01	
TCGA-VS-A9V3-01	0	TCGA-VS-A9V3-01	453	0	TCGA-VS-A9V3	453	0	453	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					62		6	TCGA-VS-A9V3-F68121	Former User		2600		HDR							Cisplatin	Stage IVB		-22990					125					0	453			-2							Once weekly	1							2014-11-13	FEMALE	164	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO		NO						G3							NO					false			MX	NX	T4	TCGA-VS-A9V3.DCCE7881-D3D1-4DCF-875F-94E83F51D5E2.pdf							3		0		3		0		0		0		97		80		Pre-Adjuvant Therapy	WITH TUMOR	YES			Complete Remission/Response	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	0		cervical	A	LIVING	60	2013				11c5127d-0115-4149-8304-1556e175d0ba	TCGA-VS-A9V3-01A-11D-A42N-01	11c5127d-0115-4149-8304-1556e175d0ba	TCGA-VS-A9V3-01A-11D-A42P-05	TCGA-VS-A9V3-01A-11R-A42V-13			11c5127d-0115-4149-8304-1556e175d0ba	8b58c90c-7ce2-4ae5-9cc6-8d94b4621b97	11c5127d-0115-4149-8304-1556e175d0ba	8b58c90c-7ce2-4ae5-9cc6-8d94b4621b97				TCGA-VS-A9V3-01A-11D-A42N-01	
TCGA-VS-A9V4-01	1	TCGA-VS-A9V4-01	132	1	TCGA-VS-A9V4			132	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					63	15	4													Cisplatin	Stage IVA		-23334					216	132				0				-1							Once weekly	2							2014-10-1	FEMALE	161	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2							YES			3	30	false			MX	NX	T4	TCGA-VS-A9V4.6AB799DF-3327-4AFA-BE86-34C638F027CC.pdf	Cervical Cancer						6		1		20		5		40		0		40		60		Pre-Adjuvant Therapy	WITH TUMOR	YES				Yes	YES					3D conformal	4500	Primary Tumor	01		2013	2009	YES	NO	YES	VS	Current reformed smoker for < or = 15 years	3		cervical	A	DECEASED	52	2013				a4e4724d-bd99-4c46-9130-e34a89c3ef7b	TCGA-VS-A9V4-01A-12D-A42N-01	a4e4724d-bd99-4c46-9130-e34a89c3ef7b	TCGA-VS-A9V4-01A-12D-A42P-05	TCGA-VS-A9V4-01A-12R-A42V-13			a4e4724d-bd99-4c46-9130-e34a89c3ef7b	e4905edb-59ab-4a12-a9b7-a00c988db840	a4e4724d-bd99-4c46-9130-e34a89c3ef7b	e4905edb-59ab-4a12-a9b7-a00c988db840				TCGA-VS-A9V4-01A-12D-A42N-01	
TCGA-VS-A9V5-01	1	TCGA-VS-A9V5-01	494	1	TCGA-VS-A9V5	494	0	494	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					50		6		Never Used											Carboplatin	Stage IIB		-18577					1019	494				0				0							Once weekly	1							2014-10-1	FEMALE	157	Mucinous Adenocarcinoma of Endocervical Type	No							C3.9	8482/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO							Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G2							NO			1		false			MX	NX	T2b	TCGA-VS-A9V5.3EF810E0-17D2-4D40-9D81-29D896915C92.pdf							5		1		0		2		0		0		100		70		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	4500	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	1		cervical	A	DECEASED	98	2011				288f90b8-5be8-4077-b578-62b80b14f0c0	TCGA-VS-A9V5-01A-11D-A42N-01	288f90b8-5be8-4077-b578-62b80b14f0c0	TCGA-VS-A9V5-01A-11D-A42P-05	TCGA-VS-A9V5-01A-11R-A42V-13			288f90b8-5be8-4077-b578-62b80b14f0c0	81fd84e0-27b2-4740-b5b7-060f8d1af730	288f90b8-5be8-4077-b578-62b80b14f0c0	81fd84e0-27b2-4740-b5b7-060f8d1af730				TCGA-VS-A9V5-01A-11D-A42N-01	
TCGA-VS-AA62-01	1	TCGA-VS-AA62-01	469	1	TCGA-VS-AA62	469	0	469	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51		5		Current User		2800		HDR							Cisplatin	Stage IIB		-18792					1608	469				0				-1							Once weekly	0							2014-11-13	FEMALE	156	Cervical Squamous Cell Carcinoma	No							C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO							Peri (6-12 months since last menstrual period)	G2							NO			4		true			MX	NX	T2b	TCGA-VS-AA62.33FDBF1D-90D6-4D05-9AC9-9983421A4CAF.pdf	Cervical Cancer						40		20		5		20		0		20		75		75		Pre-Adjuvant Therapy	WITH TUMOR	YES			Progressive Disease	No	YES					3D conformal	5400	Primary Tumor	01			2009	YES	NO	YES	VS	Lifelong Non-smoker	4		cervical	A	DECEASED	67	2009				be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	TCGA-VS-AA62-01A-11D-A42N-01	be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	TCGA-VS-AA62-01A-11D-A42P-05	TCGA-VS-AA62-01A-11R-A42V-13			be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	4b383a33-fda3-469c-b8f2-9353b1daf93a	be0d33e0-2aa6-48bb-b8e3-69259e28f8e3	4b383a33-fda3-469c-b8f2-9353b1daf93a				TCGA-VS-AA62-01A-11D-A42N-01	
TCGA-WL-A834-01	0	TCGA-WL-A834-01	791	0	TCGA-WL-A834	791	0	791	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer			Complete Response		57	43	6	TCGA-WL-A834-F66179	Former User			vaginal cuff	Other				Microscopic parametrial involvement			Cisplatin								414		0	0		0	791			791					Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Bladder Absent|Extra-Pelvic Metastatic Disease Absent|Parametrium Absent|Paraaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent	Once weekly	1							2014-10-3	FEMALE	162	Cervical Squamous Cell Carcinoma	No				Not applicable		Radical Hysterectomy	C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	120	NO	Non-keratinizing squamous cell carcinoma	NO	28	Pelvic (external iliac, internal iliac, obturator)		PRESENT	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	G3							NO	4		2	6.5	false				N1	T1b1	TCGA-WL-A834.BADCCC27-5838-469E-97AC-FADBE3757376.pdf							5		5		0		0		0		20		80		80		Post-Adjuvant Therapy	TUMOR FREE	YES		YES	Partial Remission/Response	No	YES					External beam radiation		Primary Tumor	01		2012		YES	NO	YES	WL	Current reformed smoker for < or = 15 years	3		cervical	A	LIVING	79	2012		D8E06BD2-30E2-48A5-B1CD-4F056E6CB193	TCGA-WL-A834-01A-11D-A351-09	0d138b3f-4212-47cf-a65e-fc1cbf618e99	TCGA-WL-A834-01A-11D-A350-01	0d138b3f-4212-47cf-a65e-fc1cbf618e99	TCGA-WL-A834-01A-11D-A357-05	TCGA-WL-A834-01A-11R-A358-13	TCGA-WL-A834-01A-11D-A351-09	TCGA-WL-A834-01	0d138b3f-4212-47cf-a65e-fc1cbf618e99	f47fde12-11ef-4914-98b6-318abe7f1ebf	0d138b3f-4212-47cf-a65e-fc1cbf618e99	f47fde12-11ef-4914-98b6-318abe7f1ebf	TCGA-WL-A834-01A-11D-A351-09	TCGA-WL-A834-01A-11D-A351-09	TCGA-WL-A834-01	TCGA-WL-A834-01A-11D-A350-01	
TCGA-XS-A8TJ-01		TCGA-XS-A8TJ-01			TCGA-XS-A8TJ				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer																												642																																									20	NO																				true						TCGA-XS-A8TJ.C8BBFFAA-4A45-44D3-921B-6F2BD8DB5B19.pdf							15		0		0		0		10		20		70		70																Primary Tumor	01												A							7f3a2afd-ef8e-4035-8fec-8dab2b53672c	TCGA-XS-A8TJ-01A-11D-A36I-01	7f3a2afd-ef8e-4035-8fec-8dab2b53672c	TCGA-XS-A8TJ-01A-11D-A36K-05	TCGA-XS-A8TJ-01A-11R-A36A-13		TCGA-XS-A8TJ-01	7f3a2afd-ef8e-4035-8fec-8dab2b53672c	d17f04f0-0ac9-4d59-90ee-f307c63e154c	7f3a2afd-ef8e-4035-8fec-8dab2b53672c	d17f04f0-0ac9-4d59-90ee-f307c63e154c			TCGA-XS-A8TJ-01	TCGA-XS-A8TJ-01A-11D-A36I-01	
TCGA-ZJ-A8QO-01		TCGA-ZJ-A8QO-01			TCGA-ZJ-A8QO				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					73																		-26723					2261					0	0																		2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Non-keratinizing squamous cell carcinoma																			true						TCGA-ZJ-A8QO.F1113E49-016E-4D32-86C3-2620C9839F2E.pdf							5		0		5		0		5		10		80		80								No								Primary Tumor	01					NO	YES	ZJ				cervical	A	LIVING		2007		D29EE792-E846-4EF2-A5EB-EB3C44AACD84		acb24854-1e1a-4de8-a52f-f0c742cb82a1	TCGA-ZJ-A8QO-01A-11D-A37M-01	acb24854-1e1a-4de8-a52f-f0c742cb82a1	TCGA-ZJ-A8QO-01A-11D-A37Q-05	TCGA-ZJ-A8QO-01A-11R-A37P-13		TCGA-ZJ-A8QO-01	acb24854-1e1a-4de8-a52f-f0c742cb82a1	3d80b350-54c3-444a-9e19-3bde34550fb8	acb24854-1e1a-4de8-a52f-f0c742cb82a1	3d80b350-54c3-444a-9e19-3bde34550fb8			TCGA-ZJ-A8QO-01	TCGA-ZJ-A8QO-01A-11D-A37M-01	
TCGA-ZJ-A8QQ-01	0	TCGA-ZJ-A8QQ-01	2056	0	TCGA-ZJ-A8QQ	2056	0	2056	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					24	11	6		Never Used		3000		HDR							Cisplatin	Stage IIB	40mg/m2	-8918					2165					0	2056			845							Once weekly	0							2014-2-25	FEMALE	158	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	30	NO	Non-keratinizing squamous cell carcinoma						Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	GX							NO				20	true			M0	N0	T1b2	TCGA-ZJ-A8QQ.C27506F6-D35D-4A7A-8BDA-AC3F72432DAF.pdf							2		2		5		2		5		10		80		80		Preoperative	TUMOR FREE	YES		NO	Complete Remission/Response	No	YES							Primary Tumor	01			1995	YES	NO	YES	ZJ	Current smoker	0		cervical	A	LIVING	71	2007				aefd1510-484d-43c7-ab67-931b1e7406fa	TCGA-ZJ-A8QQ-01A-11D-A37M-01	aefd1510-484d-43c7-ab67-931b1e7406fa	TCGA-ZJ-A8QQ-01A-11D-A37Q-05	TCGA-ZJ-A8QQ-01A-11R-A37P-13		TCGA-ZJ-A8QQ-01	aefd1510-484d-43c7-ab67-931b1e7406fa	5d524b96-9845-4d3a-badd-9faa0c77b85e	aefd1510-484d-43c7-ab67-931b1e7406fa	5d524b96-9845-4d3a-badd-9faa0c77b85e			TCGA-ZJ-A8QQ-01	TCGA-ZJ-A8QQ-01A-11D-A37M-01	
TCGA-ZJ-A8QR-01	1	TCGA-ZJ-A8QR-01	582	1	TCGA-ZJ-A8QR	582	0	582	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					38	36															Stage I		-14225					2173	582				0				-2								0							2014-2-25	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	840	NO	Keratinizing squamous cell carcinoma						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)	GX							NO				0.4	true			MX	NX	TX	TCGA-ZJ-A8QR.0C8716BD-1A48-4392-9F40-6A5C04FA8004.pdf							2		0		2		5		10		8		80		80		Preoperative				NO		No								Primary Tumor	01		2009	2009		NO	YES	ZJ	Current smoker			cervical	A	DECEASED	58	2007		8C2F3F49-6B5E-481A-8DAB-346D97893907		5ad0c6f5-9be9-46f2-a705-fb9c616464ae	TCGA-ZJ-A8QR-01A-11D-A37M-01	5ad0c6f5-9be9-46f2-a705-fb9c616464ae	TCGA-ZJ-A8QR-01A-11D-A37Q-05	TCGA-ZJ-A8QR-01A-11R-A37P-13		TCGA-ZJ-A8QR-01	5ad0c6f5-9be9-46f2-a705-fb9c616464ae	5c3c9472-463e-427a-95ea-24b6a3384993	5ad0c6f5-9be9-46f2-a705-fb9c616464ae	5c3c9472-463e-427a-95ea-24b6a3384993			TCGA-ZJ-A8QR-01	TCGA-ZJ-A8QR-01A-11D-A37M-01	
TCGA-ZJ-AAX4-01	0	TCGA-ZJ-AAX4-01	21	0	TCGA-ZJ-AAX4			21	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					85	23			Never Used								Positive vaginal margin				Stage II		-31258					1997					0	21																		2014-12-19	FEMALE	170	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	60	NO	Non-keratinizing squamous cell carcinoma		26			PRESENT		G3								0	0	3	.57	true			M0	N0	T2	TCGA-ZJ-AAX4.E5FA90F3-A611-4348-BD0F-16A6B97E83FA.pdf							10		0		1		0		5		24		70		70						YES		Yes								Primary Tumor	01		1949	2009		NO	YES	ZJ	Current reformed smoker for < or = 15 years	3		cervical	A	LIVING	77	2008				cc3f9a0e-0984-42dc-82bd-965f0c2b6109	TCGA-ZJ-AAX4-01A-11D-A42N-01	cc3f9a0e-0984-42dc-82bd-965f0c2b6109	TCGA-ZJ-AAX4-01A-11D-A42P-05	TCGA-ZJ-AAX4-01A-11R-A42V-13			cc3f9a0e-0984-42dc-82bd-965f0c2b6109	02e8ac5d-55af-4a1b-8b00-1f44f14183d4	cc3f9a0e-0984-42dc-82bd-965f0c2b6109	02e8ac5d-55af-4a1b-8b00-1f44f14183d4				TCGA-ZJ-AAX4-01A-11D-A42N-01	
TCGA-ZJ-AAX8-01		TCGA-ZJ-AAX8-01			TCGA-ZJ-AAX8				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					58																Stage IIIB		-21481					1789					0	0																		2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	170	NO	Non-keratinizing squamous cell carcinoma							G2												true			M0	N1	T3b	TCGA-ZJ-AAX8.8CCFD872-3834-4769-A6C6-809E77108BE5.pdf							10		5		5		5		0		25		70		70						YES		No								Primary Tumor	01			2009		NO	YES	ZJ				cervical	A	LIVING		2009		41ECD370-91AA-4D24-BF11-EE3BD9A84619		1f431436-f6bd-4f64-81ad-820e11385e94	TCGA-ZJ-AAX8-01A-11D-A42N-01	1f431436-f6bd-4f64-81ad-820e11385e94	TCGA-ZJ-AAX8-01A-11D-A42P-05	TCGA-ZJ-AAX8-01A-11R-A42V-13			1f431436-f6bd-4f64-81ad-820e11385e94	dcee720e-5244-4291-adfa-3b6bb28414b0	1f431436-f6bd-4f64-81ad-820e11385e94	dcee720e-5244-4291-adfa-3b6bb28414b0				TCGA-ZJ-AAX8-01A-11D-A42N-01	
TCGA-ZJ-AAXA-01	0	TCGA-ZJ-AAXA-01	43	0	TCGA-ZJ-AAXA			43	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					64	18															Stage IB1		-23603					1479					0	43																		2014-12-30	FEMALE	155	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8072/3	C53.9	YES		Cone Biopsy / LEEP	140	NO	Non-keratinizing squamous cell carcinoma							G2										4	26	true			MX	N0	T1b	TCGA-ZJ-AAXA.01EB0759-6676-494E-9044-263629A7BD93.pdf							0		0		0		0		10		10		80		90								No								Primary Tumor	01		1989	2009		NO	YES	ZJ	Current reformed smoker for > 15 years	4		cervical	A	LIVING	78	2009		6EE028AB-9CE6-46AD-8B4E-488E38706EDF		38d23f3a-0380-4759-930f-bdcb89a4eafe	TCGA-ZJ-AAXA-01A-11D-A42N-01	38d23f3a-0380-4759-930f-bdcb89a4eafe	TCGA-ZJ-AAXA-01A-11D-A42P-05	TCGA-ZJ-AAXA-01A-11R-A42V-13			38d23f3a-0380-4759-930f-bdcb89a4eafe	d2e43a80-c002-4b1f-847c-305245dbe994	38d23f3a-0380-4759-930f-bdcb89a4eafe	d2e43a80-c002-4b1f-847c-305245dbe994				TCGA-ZJ-AAXA-01A-11D-A42N-01	
TCGA-ZJ-AAXB-01		TCGA-ZJ-AAXB-01			TCGA-ZJ-AAXB				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					42																Stage IB2		-15492					1591					0	0																		2014-12-31	FEMALE	163	Endocervical Adenocarcinoma of the Usual Type	No							C53.9	8384/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	140	NO								G3										3		true			M0	N0	T1b2	TCGA-ZJ-AAXB.AB550C0A-6FE6-4D92-A5E3-A7141A32CC26.pdf							0		0		0		0		0		25		75		85								No								Primary Tumor	01			2009		NO	YES	ZJ	Lifelong Non-smoker	3		cervical	A	LIVING	97	2009		BE8443E8-A912-4790-A922-DE3D5D97B398		aa304440-f222-41d7-8ced-7387a8ac4ea3	TCGA-ZJ-AAXB-01A-11D-A42N-01	aa304440-f222-41d7-8ced-7387a8ac4ea3	TCGA-ZJ-AAXB-01A-11D-A42P-05	TCGA-ZJ-AAXB-01A-11R-A42V-13			aa304440-f222-41d7-8ced-7387a8ac4ea3	9e635f83-63fd-4e94-96ae-9105cd1f6005	aa304440-f222-41d7-8ced-7387a8ac4ea3	9e635f83-63fd-4e94-96ae-9105cd1f6005				TCGA-ZJ-AAXB-01A-11D-A42N-01	
TCGA-ZJ-AAXD-01		TCGA-ZJ-AAXD-01			TCGA-ZJ-AAXD				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					35																Stage IIIB		-12968					1164					0	0																		2014-12-30	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	130	NO	Non-keratinizing squamous cell carcinoma							G2												true			M0	N0	T3b	TCGA-ZJ-AAXD.AAEBC293-E409-4B14-9310-6820BA844EE6.pdf							0		0		0		0		0		40		60		70								No								Primary Tumor	01			2009		NO	YES	ZJ				cervical	A	LIVING		2010		D459FFAC-DA2A-48F3-AE6F-FB3205338C3E		fc9e612c-8909-47de-b6f0-8691d5bc67c5	TCGA-ZJ-AAXD-01A-21D-A42N-01	fc9e612c-8909-47de-b6f0-8691d5bc67c5	TCGA-ZJ-AAXD-01A-21D-A42P-05	TCGA-ZJ-AAXD-01A-21R-A42V-13			fc9e612c-8909-47de-b6f0-8691d5bc67c5	37a80d1f-26dd-4178-934d-fd088a91e5a1	fc9e612c-8909-47de-b6f0-8691d5bc67c5	37a80d1f-26dd-4178-934d-fd088a91e5a1				TCGA-ZJ-AAXD-01A-21D-A42N-01	
TCGA-ZJ-AAXF-01		TCGA-ZJ-AAXF-01			TCGA-ZJ-AAXF				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					62																Stage IIB		-22709					1264					0	0																		2015-1-28	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	270	NO	Keratinizing squamous cell carcinoma							G3												true			M0	N0	T2b	TCGA-ZJ-AAXF.DB279590-B849-44D4-B781-BA72CE72C427.pdf							40		20		5		20		0		15		80		80								No								Primary Tumor	01			2009		NO	YES	ZJ				cervical	A	LIVING		2010		AFA27E8B-A438-4D1A-9344-6E760E7A890F		48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	TCGA-ZJ-AAXF-01A-31D-A42N-01	48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	TCGA-ZJ-AAXF-01A-31D-A42P-05	TCGA-ZJ-AAXF-01A-31R-A42V-13			48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	7893a027-469a-4185-bdf9-2e9857f555a0	48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834	7893a027-469a-4185-bdf9-2e9857f555a0				TCGA-ZJ-AAXF-01A-31D-A42N-01	
TCGA-ZJ-AAXI-01		TCGA-ZJ-AAXI-01			TCGA-ZJ-AAXI				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					67																Stage IIB		-24497					1332					0	0																		2014-12-31	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma							G2												true			M0	NX	T2b	TCGA-ZJ-AAXI.D446A3B4-E137-4A6C-9C17-FEED0163DAED.pdf							5		0		0		0		5		5		90		90								No								Primary Tumor	01			2009		NO	YES	ZJ				cervical	A	LIVING		2010					TCGA-ZJ-AAXI-01A-11D-A42N-01		TCGA-ZJ-AAXI-01A-11D-A42P-05	TCGA-ZJ-AAXI-01A-11R-A42V-13				032c43b9-5eb2-4817-a80b-f04c393ea4f5		032c43b9-5eb2-4817-a80b-f04c393ea4f5				TCGA-ZJ-AAXI-01A-11D-A42N-01	
TCGA-ZJ-AAXJ-01		TCGA-ZJ-AAXJ-01			TCGA-ZJ-AAXJ				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer																												1276																																									60	NO																				true						TCGA-ZJ-AAXJ.0C3B91DD-9AA5-4D08-8B07-2E6DFA0E51A3.pdf							10		0		10		2		15		15		60		60																Primary Tumor	01												A							ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	TCGA-ZJ-AAXJ-01A-11D-A42N-01	ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	TCGA-ZJ-AAXJ-01A-11D-A42P-05	TCGA-ZJ-AAXJ-01A-11R-A42V-13			ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	d7c8c6ec-eeb0-49f6-a016-b27c4e10810e	ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4	d7c8c6ec-eeb0-49f6-a016-b27c4e10810e				TCGA-ZJ-AAXJ-01A-11D-A42N-01	
TCGA-ZJ-AAXN-01		TCGA-ZJ-AAXN-01			TCGA-ZJ-AAXN				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					34	21															Stage IB2		-12701					1190					0	0																		2014-12-31	FEMALE	173	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	250	NO	Non-keratinizing squamous cell carcinoma																	1	2.1	true			M0	N1	T1b2	TCGA-ZJ-AAXN.33662E91-6459-47D9-858A-243D8E54EB63.pdf							0		0		0		0		0		10		90		95								No								Primary Tumor	01			2009		NO	YES	ZJ	Current smoker	1		cervical	A	LIVING	59	2010		41D2098E-6DAA-424E-9FFB-24A6C1D89A13		878b8551-fb42-48bc-9403-178c568372cd	TCGA-ZJ-AAXN-01A-11D-A42N-01	878b8551-fb42-48bc-9403-178c568372cd	TCGA-ZJ-AAXN-01A-11D-A42P-05	TCGA-ZJ-AAXN-01A-11R-A42V-13			878b8551-fb42-48bc-9403-178c568372cd	7234083d-3fc8-4781-9693-d607db2219d5	878b8551-fb42-48bc-9403-178c568372cd	7234083d-3fc8-4781-9693-d607db2219d5				TCGA-ZJ-AAXN-01A-11D-A42N-01	
TCGA-ZJ-AAXT-01		TCGA-ZJ-AAXT-01			TCGA-ZJ-AAXT				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					54	20															Stage IIIB		-19847					1571					0	0																		2014-12-31	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	90	NO	Non-keratinizing squamous cell carcinoma							G2										3	0.2	true			M0	N1	T3b	TCGA-ZJ-AAXT.963154F2-CBB5-4556-B94D-3E2977CBB3D7.pdf							0		0		0		0		0		20		80		90								No								Primary Tumor	01		1982	2009		NO	YES	ZJ	Current reformed smoker for < or = 15 years	3		cervical	A	LIVING	76	2009				2e6fd34c-eccc-42a2-a806-bf69f55c0b27	TCGA-ZJ-AAXT-01A-11D-A42N-01	2e6fd34c-eccc-42a2-a806-bf69f55c0b27	TCGA-ZJ-AAXT-01A-11D-A42P-05	TCGA-ZJ-AAXT-01A-11R-A42V-13			2e6fd34c-eccc-42a2-a806-bf69f55c0b27	1fa4d74b-5899-48ac-afc1-692a9b93e513	2e6fd34c-eccc-42a2-a806-bf69f55c0b27	1fa4d74b-5899-48ac-afc1-692a9b93e513				TCGA-ZJ-AAXT-01A-11D-A42N-01	
TCGA-ZJ-AAXU-01	0	TCGA-ZJ-AAXU-01	5	0	TCGA-ZJ-AAXU			5	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					51	15															Stage IIB		-18773					1437					0	5																		2014-12-19	FEMALE	165	Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma							G2											52.86	true			M0	N0	T2b	TCGA-ZJ-AAXU.6A8C28EF-7774-492D-99D0-C197662699AE.pdf							0		0		0		0		0		15		85		95								No								Primary Tumor	01			2009		NO	YES	ZJ	Current smoker	0		cervical	A	LIVING	70	2010				39dc6ace-24eb-499b-ad94-64cf08849087	TCGA-ZJ-AAXU-01A-11D-A42N-01	39dc6ace-24eb-499b-ad94-64cf08849087	TCGA-ZJ-AAXU-01A-11D-A42P-05	TCGA-ZJ-AAXU-01A-11R-A42V-13			39dc6ace-24eb-499b-ad94-64cf08849087	bf0a2898-3572-4726-aeb0-b20f0d81bb9e	39dc6ace-24eb-499b-ad94-64cf08849087	bf0a2898-3572-4726-aeb0-b20f0d81bb9e				TCGA-ZJ-AAXU-01A-11D-A42N-01	
TCGA-ZJ-AB0H-01		TCGA-ZJ-AB0H-01			TCGA-ZJ-AB0H				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					48																Stage IIIB		-17869					2619					0	0																		2014-12-19	FEMALE		Cervical Squamous Cell Carcinoma	No							C53.9	8072/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	80	NO	Non-keratinizing squamous cell carcinoma																			true			M0	N1	T3b	TCGA-ZJ-AB0H.4D5AE266-6C48-44FA-A613-4A8BC9160CBF.pdf							0		0		0		0		0		10		90		95						YES		No								Primary Tumor	01			2009		NO	YES	ZJ				cervical	A	LIVING		2006				ad34a739-074f-4463-b053-d1368c4d34db	TCGA-ZJ-AB0H-01A-11D-A42N-01	ad34a739-074f-4463-b053-d1368c4d34db	TCGA-ZJ-AB0H-01A-11D-A42P-05	TCGA-ZJ-AB0H-01A-11R-A42V-13			ad34a739-074f-4463-b053-d1368c4d34db	b2e025a2-e526-4bdc-86c3-fe9606f121c8	ad34a739-074f-4463-b053-d1368c4d34db	b2e025a2-e526-4bdc-86c3-fe9606f121c8				TCGA-ZJ-AB0H-01A-11D-A42N-01	
TCGA-ZJ-AB0I-01		TCGA-ZJ-AB0I-01			TCGA-ZJ-AB0I				Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					25	13			Never Used												Stage IIB		-9486					2643					0	0																		2014-12-19	FEMALE	173	Cervical Squamous Cell Carcinoma	No						Radical Hysterectomy	C53.9	8071/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	200	NO	Keratinizing squamous cell carcinoma																	4	13	true			MX	N1	T2b	TCGA-ZJ-AB0I.77538CA6-8ACB-4224-BF03-DC7A4BABCEF7.pdf							0		0		0		0		0		20		80		95						YES		No								Primary Tumor	01		2006	1995		NO	YES	ZJ	Current reformed smoker for < or = 15 years	4		cervical	A	LIVING	78	2006		C9EB2866-AF28-4560-95FB-CF546AEDDD83		f77f995c-4e18-4803-a703-8f3aee49837b	TCGA-ZJ-AB0I-01A-11D-A42N-01	f77f995c-4e18-4803-a703-8f3aee49837b	TCGA-ZJ-AB0I-01A-11D-A42P-05	TCGA-ZJ-AB0I-01A-11R-A42V-13			f77f995c-4e18-4803-a703-8f3aee49837b	2486daf3-65de-4ecb-a87a-2876f3357b73	f77f995c-4e18-4803-a703-8f3aee49837b	2486daf3-65de-4ecb-a87a-2876f3357b73				TCGA-ZJ-AB0I-01A-11D-A42N-01	
TCGA-ZX-AA5X-01	0	TCGA-ZX-AA5X-01	119	0	TCGA-ZX-AA5X			119	Cervix	TCGA Cervical Cancer	cervical & endocervical cancer					64			TCGA-ZX-AA5X-F69357							Bilateral pelvic wall involvement on imaging				Participant refusal		Stage IIIB		-23440					46		-2		52	0	119			7					Bladder Present|			1	0			|Extra-Pelvic Metastatic Disease AbsentParaaortic Nodes Absent|Pelvic Nodes Absent|Supraclavicular Absent			2015-1-7	FEMALE	157	Cervical Squamous Cell Carcinoma	No				Not applicable			C53.9	8070/3	C53.9	YES		Biopsy (cervical / CT-guided / Other)	70	NO	Non-keratinizing squamous cell carcinoma	YES				ABSENT	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	G2										2		true			MX	NX	TX	TCGA-ZX-AA5X.AFCAEB29-0F3E-48E6-8F0D-92860BCF0640.pdf		Other, specify	+ for Hepatitis A	0	0		10		0		0		0		10		30		60		60		Pre-Adjuvant Therapy	WITH TUMOR		0	NO		No		Participant refusal						Primary Tumor	01	15.8		2009	NO	YES	NO	ZX	Lifelong Non-smoker	2		cervical	A	LIVING	56	2013				212eae3c-4ad5-48e0-90af-b6fe1dfc5554	TCGA-ZX-AA5X-01A-11D-A42N-01	212eae3c-4ad5-48e0-90af-b6fe1dfc5554	TCGA-ZX-AA5X-01A-11D-A42P-05	TCGA-ZX-AA5X-01A-11R-A42V-13			212eae3c-4ad5-48e0-90af-b6fe1dfc5554	10796823-a1ca-480a-b99f-5f29e42432d6	212eae3c-4ad5-48e0-90af-b6fe1dfc5554	10796823-a1ca-480a-b99f-5f29e42432d6				TCGA-ZX-AA5X-01A-11D-A42N-01	
